ML20114C385
| ML20114C385 | |
| Person / Time | |
|---|---|
| Site: | Wolf Creek  |
| Issue date: | 04/20/1992 |
| From: | WOLF CREEK NUCLEAR OPERATING CORP. |
| To: | |
| Shared Package | |
| ML20114C367 | List: |
| References | |
| PROC-920420, NUDOCS 9209020146 | |
| Download: ML20114C385 (201) | |
Text
{{#Wiki_filter:..
. ~ ~ .
k 1 i. l l OITSITE DOSE CAlfu1ATICH FRAIAL . I for , i Wolf Cmt. Nuclear Crerating Corporation Wolf Creek Generating Station Revision 9 WCOI- 02 lN D ONLY r3 x,]
), \
r}\
-d.L e- b
~
Appgavco gy -c. DATE: 4- O' S 2-Minager 'Chanistry APPROVED BY / / It? oI o A-_ DATE: //-/7'7M PSRC, i APPROVED BY .II kl sh !N;,II/I DATE: '! !< Director I[lant Operations OCi y 2.C 94
\ 'n.)
9209020146 920820 PDR ADOCK 05000482 R PDR
_ _ . . _ _ _ - _ . _ _ - - _ _ . . = . ._ _ . . _. _ .._ _ . _ _ _ , . _ _ _ _ _ . _ - . - . . O TABLE OF 00tlTDils , l Pace 1.0 afIR000C.'rIO1 1 2.0 LIQUID EmnDfIS 1 2.1 COCDTI1MTIO1 - OCNPLINCE WI11110 CPR 20 1 2.2 DOSE - OCMPLINCE WI'III 10 CIR 50 APPDOIX I 7 i 2.3 PRa1ECTED DOSE 9 - 2.4 INSTRtMD7FATIOi 10
)
3.0 GASDOUS DTLUDilS 26 3.1 DOSE RATE - CCEPLIMCE WI71110 CPR 20 27 3.2 DOSE - OCHPLINCE WIT!! 10 CIR 50 APPD01X I 33 3.3 PRa7BCTED DOSE 42 3.( INSTRtMDITATIOi 43 4.0 TOTAL DOSE 61 4.1 RDEDIAL JCTION 61 4.2 SURVEILIRCE REQUIRDiD715 61 d 5.0 RADIOwGICAL DWIRONMD7TAL MONI30RnG IRCGRAM 62 5.1 MONI70RnG PROGRAM 62 5.2 IRO USE CENSUS 62 5.3 HTTERIABTATORY CCMPARISON PROGRAM 63 5.4 RuOcruG RD3UIRDE7PS 63 t 6.0 BASES 81 7.0 REPORTS 89 7.1 ANNUAL RADICIOGICAL DWIRONMENIAL OPERATnG REIORT 89 7.2 SDiIANNUAL RADIOACTIVE DTLUDir RELEASE REFORT 89 APPDDIX At DOSE COtWERSIOi FACIOR TABLES A-1 APPENDIX Bt METEOROWGICAL MODEL B-1 $ 8 M 3/91
IJSP 0' TNYJE Jbblo IMFJ 2-1 RADIOTCPIVE LIQUID WASTE SAMPLIIG NO NEYSIS PRCGRAM 3 2-2 RADIOTCPIVE LIQUID EFFLUD(f HCHI1mDG D61Rt24E!?rATIQ1 11 2-3 RADIO 7CfIVE LIQUID EFFWDIT MCNI'IMI!G D61RII4DifATIG1 StAtVEIIIAtCE RDQUDIEMD11S I4 3-1 RADIOACTIVE GASIGUS NASTE SAMPLI!G NO MIALYSIS PROGtN4 30 3-2 RADIOtCf1VE GASIDUS EFFIEDTP MONTImDG DISTRU4D7FATIO1 45 3-3 RADIOAC1'IVE GASDOUS EFFIUDTP MONTIORI!G INSTR 124D7FATIQ1 SUINEILLNGE RDQUIRD<DilB 48 5-1 RADIGIGICAL DNIROtMDITAL MONITORDG PROGRN4 65 5-2 SAMPLI!G IDCATIQ1 Nt24BERS, DISTNGES (MILES) NO DIRECTIOG 71 5-3 DUTDCTIO1 CAPABILITIES Em DNIRGED(fAL SAMPLE ANALYSIS 72 5-4 REKRTI!G LEVEIS FDR RADIO /CTIVITY COGD71RATIOt1S IN DWIRCN4DirAL SAMPLES 75 A.1-1 BIOACCUMUIATION F/CIDRS 'IO BE USED IN 11!E ABSEtGE OF SITE SPECIFIC DATA A-2 A.1-2 DOSE FICIMS Em lOBLE GASES NO DAtI2frERS A-3 A.2-1 DEIAIATION DOSE PACIOtS ITR ADULTS A-4 A.2-2 INIIAIATION DOSE FICIORS Im TEEN 7GERS A-7 A.2-3 DEIAIATION DOSE FICIORS FOR O!ILD A-10 A.2-4 DuiAIATION DOSE FACTORS Im INFANr A-13 A.2-5 EXTERNAL DOSE FACIOR IDR STN1DDG ON COffrAMINATED GROUND A-16 A.3-1 DGESTION DOSE FACIOR FOR ADULTS A-18 A.3-2 DGESTION DOSE FACIOR FOR TED1 AGERS A-21 A.3-3 DGESTION DOSE FACIOR FOR OIIID A-24 A 3-4 UGESTION DOSE FICIOR FOR DIFMTP A-27 A.3-5 STNILE ELEMDff 7EANSFER DATA A-30
-LL-3/91
l l l 14Uff T TNEkS 1hblo !!d9'1 6- A.4-1 SITE RELATED DEISTIO1 DOSE COMI1MEtif FOR ADULT A-31 A.4-2 SITE RELATED I!CESTIO1 DOSE COMI1MErff FACIM Im TEINGUI A-34 A.4-3 SITE RE2ATED UCESTIG1 DOSE GIM11MEfff FICIm FM Q{ILD A-37 ! A.4-4 SITE REIATED I!GESTIO1 DOSE COMIniE!1f FICIUt FUt I!ENff A-40 A.5-1 nelAIATIOil LOSE PARAVETER 10111IE CIILD A-43 A.5-2 nu1AIATIO1 PM1MAY FACIOR Em ADULT (RI FACIQt) A-44 A.5-3 DDIAIATION PA11MAY F/CIOR IG TEDitGER (RI F1CIUI) A-47 A 5-4 Ua!AIATION PA11MAY FACIM FUI GiIID (RI FACIGI) A-50 A.5-5 DalAIATION PAUMAY FACIOR FW UFAlff (RI FACIOR) A-53 A.5-6 GRASS-COW-MIIX PM1MAY FACIU1 ADULT (RI F/CIG1) p OF SITE SPECIFIC DATA A-56 A.5-7 GRASS-CW-MILK PA11MAY FACIUI TEEN (RI FICIM) A-59 A.5-8 GRASS-COW-MIIX PA11MAY FICIOR OIILD (RI Factor) A-62 A.5-9 GRASS-CW-MIIX PA11MAY FACIU1 I!FNTP (RI F/CIUl) A-65 A.5-10 GRASS-CW-MEAT PM1MAY FACIUt ADULT (RI Factor) A-68 A 5-11 GRASS-CW-MFAT PA11MAY FACIOR TEEN (RI FICIOR) A-77. A.5-12 GRASS-CW-MEAT PA11MAY FACIm UENff (RI FACIM) A-74 A.5-13 VIWfATION PA11MAY FICIUt ADULT (RI FACIOR) A-77 A.5-14 VEGETATION FA11MAY FACIOR TEEN (RI FICIOR) A-80 A.5-15 VEGt?PATION PM1MAY FACIUt GIILD (RI FACIm) A-83 A.5-16 GROUND PIANE PAHMAY FACIOR (RI FACIOR) A-86 A.5 GRASS-GOAT-MILK PATHWAY FACIOR ADULT (RI FACIDR) A A.5-18 GRASS-GOAT-MIIX PAUMAY F/CIU1 TEEN (RI FACIOR) A-90
. (~ A.5-19' GRASS-GOAT-MI1X PM1MAY FACIOR CHILD (RI FACIOR) A-93 A.5-20 GRASS-GOAT-MIIX PMIMAY FICIOR INFMff (RI F/CIQl) A-96
-lii-
r-O I.l!TP O' l'lGIllS j'iguru IWyf 2.I immtY 101 LIOLIID 1711111211S 25 3.I IOUNDARY 101 CASluE EFPIlfl211S 60 5.1 AIRIOR!1E 1%311btAY SAMILI!G 11CATIOG 76 5.2 DIRIrr IMDIATIOJ PNI1MAY SAMILITU IEATIO1S 77 5.3 NATiltlDUJE PA'11MAY SN41LI!G IfrATIGE 70 _ 5.4 I!Gif7TIO11%'11MAY SAMILI!G LLmrIOS 79 5.5 DISTNfr SAMELIIG IKATIQG 80 B-1 VERTICAL STNIDARD DlWIATIQ1 OF PAT 1 RIAL IN A PIAME B-4 Ik2 FIR 4E 'limVEL DISTNCE VERSlE ITUCTION RIFAINI!G IN B-5 PIAME B-3 P11ME 'IlmVEL DISTNGE VFESUS RPJATIVE DEIOSITIO1 RATE B-6 O O -iv-3/91
1 1.0 INIMTU?I'IC1J d,, me offsite Dose Calculation !wnual describes the Imdicactive Effluent Contm1s Program. We hip 1 mentation of this program ensures empliance with the requinstents of 10 CIH 50.36,10 CFR 20.106, 10 CFR 50 Appendix I and 40 CFR 190. 1 We ODCM describes the nothodology and parannters used in the I calculation of offsite doses due to radioactive liquid and gaseoue effluents. We 0004 contents for calculation of dose aru based on "Proptration of IMdiological Effluent Technical Speci-fications for Nuclear PoWur Plants (!Uun-0133)," and Rogulatory Guide 1.109, Revision 1. he CDCM provides the limitations on the operability of radio-active liquid and gaseous nonitoring instrumentation including surveillance tests and setpoint determination. Each Surveillance Requinment shall be perfornrxi within the speciflod surveillance interval with a naximum allosable extension not to exceed 25% of the specified interval.
%e 0D04 provides the Imdiological Environriental Monitoring Pro-gram. %e program consists of nonitoring stations and sampling prograns designed to confirm the dose estinntes node under nornal or accident conditions, and confctm to NRC Iequiruinnts in 10 CFR Part 50.
23 0004 provides descriptions of the inf u c ion that should be (],j included in the Annual Rattiological Env.aumental Opexating and Satdannual Ibdiosctive Effluent Release Reports. I I 2.0 IJOm D 17FUI1NIS 2.1 Onnanntration - (broliancn With 10 CFR 20 We concentration of radioactive naterial released in liquid ef-fluents to UNRES'1RICTED ARFAS (see Figure 2.1) shall be limited ' to the concentration specified in 10 CFR Part 20, Appendix B, Table II, Column 2, for radionuclides other than dissolved or untrained noble gases. For dissolved or entrained noble gases, the concentration shall te limited to 2 x 10" miemCurie/ml total activity. 2.1.1 Ihrxxilal tction With the concentration of radioactivo nuterial releascd in licpid effluents to UNRESTRICTED AREAS excocding the above limits, im-nodiately restore the concentration to within the above limits. ODCM 1
/\
V 3/91
r- 1 2.1.2 pinnillarnt ikuluimwnts
/~* 'Ib show cczqpliance with this rupirurent, concentrations of ac-( -- tual liquid effluents will to detenninal by perfonning Isotopic Analyses. Radioacthe 11guld wastes shall tu sarqplus and analyzed acconting to the sampling and analysis prujram of 'hsle 2-1.
O CDCM 2 3/91 u f. t
-=
e "7Y T
TNU H 2-1 i RADIO /CTIVE LIQUID WASTE SAMPLUG NO NELYSIS PRO 3 RAM
, ILMD1 LIMIT w OF DI?I1rl' ION MINIMIE (1)
LIQUID RELFASE SAMPLD G MRLYSIS TYPE OF IC1'IVITY (LID) TYPE FRIEUE!CY FTUEUDCY NRLYSIS (uCi/ml)
- 1. Batch Waste P F Release Ibch Datch Idch Ibtch Principal Gunn 5x10-7 ,
(2) (3) j Tanks Dnitters I-131 1x10-6
- a. Waste I Monitor F M Dissolved and !
Tank One Ihtch/M Entraincd Gases 1x10-5 (Gannn Dnitters)
- b. Secondary -
Liquid P M (4) H-3 Waste Mon- Each Batch Camposite 1x10-5 j itor Tank Gross Alpha 1x10~ P Q (4) Sr-89, Sr-90 Each Batch Cmposito 5x10~8 Fe-55 1x10'" ,
- 2. Continuous (6) W (4) Principal Gannu (5) Daily Canposite (3) 5x10_7 Releases Grab Sample Dnittars I-131 1x10-6 Steam Generator M M Dissolved and Blowdown Grab Sanple Entrained Gases 1x10-5 (Ganma Dnitters) ;
M (4) H-3 (6) Ccanposite 1x10-5 Daily Grab Sample Gross Alpha ,7 (6) Q -(4) Sr-89, Sr-90 ! Daily Cauposite 5x10-8 ; Grab Sample Fe-55 1x10
-6 .\ /
COCM 3 3/91
- . . _ . ._- . - - - . _ , _ _ _ - . = _ . . - .- . . - -- - --
TMYE 2-1 (Onntlntwrl) O Cl TMILE torATICtB (1) The LID is defincd, as the annllest concentratior. of radio-active mterial in a sanple that will yield a not count, above systs backgrourri, that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal. For a particular nmsumnent systm, which my include radio-chmical separations 4.66 sb g ,, E
- V
- 2.22 x 106
- Y
- Decay l Whetwa i L1D = the "a priori" lower limit of detection (micttCuries per unit nass or volume),
s b
= the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate, (counts per minute), s hheres B = background sum (counts)b " W / bT LT = live tiro (minutes),
E = the counting efficiency (counts per disintegration), V = the sample size (units of mss or volume), 2.22 x 106= the number of disintegrations per minute per microcurie, Y a the fractional radiochmical yield, when applicable, Decay a decay factor (s), There are three decay factors that my
.be appropriate for use depending on the natum of the sample and the half life of the nuclide. Any cmbination of the three my be used. The factors are as fcilows:
A) This decay factor corrects for decay frm the tim of sanpling to the start of the analysis.
~ U e s, where:
Ats = decay tim = acquisition start tine - sarple tim 1 = In2/ half-life B) This decay factor corrects for decay during the analysis. RT 1-e , where: 2 RT , (' 1= In2/ half-life
'. RT = real tino of counting ODCM 4 4/92
'rNUE 2-1 (Cmt hnrvi}
( TABLE !UfATIONS (Continucx1) , O C) This decay factor cormets for decay during sampling. l 1-n
- Atd , where:
1 Atd 3=In2/ half-11fe td = deposition tine = sample tine - deposition start tino IUrE All tinns used in decay calculations should be in the sam units. Typical values of E, V, Y, tg , t should be used in the calculation, i d lt should be mcognized that the LLD is defined as an a priori (be-fore the fact) listit representing the capability of a naasurment syntan aru not as an a rosteriori (after the fact) lintit for a par-
", Jar measurment.
(2) A batch release is the discharge of liquid wastes of a discrete voltme. Prior to sampling for analyses, each batch shall b3 isolated, and then thoroughly mixed by a nothod described in plant procodares to assure representative sampling. (3) 'Ihe principal ganun citttters for which the LID specification applies include the follcwing radionuclides: Mn-54, Fe-59, Co-r 58, Co-60, Zn-65, Mo-99, Cs-134, Cs-137, Co-141 and Co-144. ( 'Ihis list does not nean that only those nuclides are to be con-sidered. Other ganna peaks that are identifiable, together with those of the above nuclides, shall also be analyzed and reported in the saniannual Radioactive "ffluent Release Report in the fonmt outlined in Regulatory Guide 1.21, Appendix B, Revision 1, June 1974. (4) A composite sanple is one in which the quanti + r of liquid sam-pled is proportional W the quantity of liquid waste dischargai and in which the nothod of sampling anployed results in a speci-nen that is representative of the liquids released. Prior to analysis, all samples taken fcr the cauposite shall be thor-oughly mixed in order for the canposite samples to be represen-tative of the effluent release. (5) A m itinuous release is the discharge of liquid wastes of a non-discrete volume, e.g., fran a volume of a systan that has an input fIcw during the continuous release. (6) Sanples shall be taken at the initiation of effluent flow and at least once per 24 hours thereafter while the release is cccur-ring. Ib be representative of the liquid effluent, the sanple volume shall be proportioned to the effluent stream dischanje volume. Tne ratio of sample voltme to effluent discharge voltme shall be naintained constant for all samples taken for the can-posite sanple. V ODCM 5 4/92
1 l
,. TNVE 2-1 (OmtIntnjj :
l3 ( ,; FTllTJJDCY !UPATIC11 l l LOTATICri FillTXff2CY S At leaco anco per 12 hours. D At least once por 24 hours. W At least once per 7 days M At least onco per 31 days. O At least once por 92 days. SA At least onco per 184 days. l i R At least once per 18 nonths. S/U Prior to each reactor startup. N.A. !bt applicable. P Canploted prior to each tulease. I RJ ODCM 6 A 't) 3/91
2.2 the - Ctsupilanm with 10 CIH 50 Namilx I (3 (
'y Tho dose or dose canitment to a MDGER OF '11E PLEIC fmn radio-active natorials in liquid effluents rol uod, fmn each unit, to IRRISIRICHO AREAS (see Figum 2.1) shall be limited:
- a. During any calendar quarter to less than or equal to 1.5 mroms to the whole body and to less than or equal to 5 mruns to any organ, and
- b. During any calendar year to less than or equal to 3 mmas to the whole body and to less than or equal to 10 mmns to any organ, 2.2.1 ihmlial Action With the calculated dose frun the rulcase of radioactive nate-rials in liquid effluents excooding any of the ateve limits, pm-pam and subnit to the Comnission within 30 days, pursuant to
'th;hnical Specification 6.9.2, a Special Report that identifies the cause(s) for exceeding the limit (s) and defines the corruc-t,1ve M ons that nave been taken to reduce the releases and the proposea arrective actions to be taken to assure that subsequent relmacs win be in canpliance with the above limits. This Special Report shall also includes (1) the results of radio-logical analyses of tbr drinking water source, and (2) the radio- ,
logical impact on fini.Jied drinking watar supplies with regard to
,q . the requirments of 40 CFR Part 141, C1mn Drinking Water Act.
This requimnant of (1) and (2) am applicable only if dririing Q water supply is taken fmn the receiving body within 3 miles of the plant discharge. 2.2.2 _ Eurvul.11ance annuinments Cumulative dose contributions fmn 11guld effluents for the cur-runt calendar quarter and the current calandar ymr shall be de-teunined using the following nethodology at last once per 31 days. m Dg , = tI (Airy Z At, Cg F) g 171 hhere, D,7
= the cumulative dose comtituent to the total Lady or any organ, T, fmn the liquid effluent for the total m
tino period E att, in mrun. 171 dtg = the length of the Lth time period over which C and gF areaveragedforallliquidreleases,ibg Q _() hours. ODCM 7 3/91
2.2.2 !Airvoillmnt Ikuplinwrit_m - Orjtirnwrl (- Cg = tho average concentration of radionuclido, 'i', in undtluted liquid effluent f1w during tim period At g , in uC1/ml. F = the ner field average dilution factor for C g' b during any liquir' offluent rulease whom: F = f 3 (F)K Whem f= Liquid Radimetivo Waste F1w F= Dischargo Structuro IMit F1w, the sum of the ru-lease and dilution flw. K= Applit *ble factor; the site dependent value for the mixing offect of the discharge structuru. 'ntis value is conservatively assumed to be 1 (one) for this section. A IT
= 'Ihe site rulated ingestion dose ttmnitent factor to the total body or any organ, 'T', for eacn iden-tified principal ganna and bota cutitter, mrun/hr pr uCi/ml. Soo Tables A.4-1 through A.4-4.
A iT
=
1.14E5 (Uf9+U.BF)DFy p f Wheru, Da = Dilution fac*or frun the near field area to the potable water intake for water consumption, for Wolf Creek Generating Station this factor is 1 (ono). ; BFf= Bioaccunnlation factor for radionuclide, 'i', in fish, pC1/Kg per pCi/1, frun Tablo A.1-1 frun Rc<Ju-- latory Guide 1.109 (Rev. 1). OFg= Dose Conversion factor for radionucado, 'i', in mrun/pC1, frun Table A.3-1 through A.3-4, frun Regu-latory Guide 1.109 (Rev. 1). U, = Water consumption, in kg/yr. Up = Fish consumption, in kg/yr. 1.14E5 a units conversion factor ' J_0 6rci/uCi ;.10 ml/Ka 3 8760 hr/yr ODCM 8 O v
i 2.2.2 Ihtryd11nrrn 1trnuinyayes - gnettJmni (9 V Sho dose calculations aru tused on tho actual sotopic analysis of the radioactivo liquid offluents, the radimetivo liquid of-fluent 11w, and the dilutic i f1w. 2.3 Protrini Ibm 7ho Liquid Ibdwasto Truatumt Systm shall to Or1RABLE and appru-priat9 portions of the systm shall be untd to reduco rolmses of rodimetivity whan the projected dosen duo the liquid of fluent, frun each unit, to tRMIRICTED AFFM (suo Figure 2.1) would ex-coed 0.06 mrun to the whole tcdy or C.2 mtun to any organ in a 31 day period. I 2.3.1 !kwrlinl Icticu _ With radtoactiva 1Jguid waste tuing discharged without troatr.unt ! and in cxmss of the above limits and any portion of the Idquid Ibdwesto Treatment Syston not in operation, pretnro and sulmit to the Ccmnission within 30 days pursuant to 7bchnical Sprification 6.9.2, a Special fieport that includes the follwing infootntion: A. Explanation of why liquid radwaste was being dischargtd with-out treatment, identificatlan of any inoperabl.a aquipnent or subsystans, and the reason for tha inoperability, g B. Action (s) *aken to rustorn the inoperable equipttmt to OPERABLE status, md C. Suamiry description of action (s) taken to pnwent a nrur-rance. 2.3.2 fyrwdlinwn TMitrimmtn 2.3.2.3 Dosea duo to liquid releases frun mch unit to UmEfttRICn:D NWM shall be projected at least once por 31 days in accordance with the follwing nethodology when Idquid Imdwaste Truatmnt Systans cre no; ining f.tlly utilized. D = A . 31 31 T
*dnern, D31 = Pr j ctn131 day doso A = Cumulativo dose for currunt quarter T a Current numter of nays in (parter 0D04 9
{q} 3/91
- 2. 0. L 2 'Its lastftl1<xi Liquid ItvAesto Tnntm,nt Systun shall in con-sidemi OtfjWHE by nycting the requitutents of Sect. ions 2.1 and O 2.4
' 2-purtnmut,3Mg}
l '1he radicactive liquid of fluent nonitoring instnarmtation chan-nels shwn ist Tablo 2-2 shall in OPDW1LE with their Alann/ Trip l Ntroints act to meatu that the limits of Sc< tion 2.1 uru not l wtcuxiod. W.e Alautt/ trip Sotpoints of Oiene channels shall te ! determjtal arri adjusted 11. acconiance with the notxdology and ! ptrarreters described in Soction 2.4.4. l 2.4.1 fysgjk1LAgtJcm l 7.4.1.1 with a Indi.:sctivo 11guld ef fluent nonitaring 17tstnmentation channoi AlautvTrip Setpoint loss conservative than mIuixed by
~
the above, inmxilately subpurri the roloGno of rndimetivo liquid effluents nonitonr3 by the affected channel; or dociaru the clvui-nel Jnoperable. 2.4.1.2 With less thui the ntiatinun number of radioactive liquid of fluent munitoring instnmentation channels OMRAILE, take the ICflui shcrm in Table 2-2. Restore the inoporable instnmentation to i OPERMLE status wit 1 tin the tino spocificxi in the 1CTIG1, or ex-clain in the next l'emiannual Radicactive Effluent Release Re[ ort, y this ligerCallity was not corrected within the tinn speci-I'i od . 2.4.2 Dinvoillancxt ItrspjLnymta Each radicactivo llquid of fluont nonitoring instaurentation chan-nel shall be d<recastrated OPERNALE by perfornanc.o of the OINN1 QRG, SOURCh Of.DCK, CIN4NEL CALIIYWI'IQ1 and AhAI.OG OINJNil OPERATIONAL TESP at the iny. uancies shcwn in Table 2-3. ODCM 10 3/91
O O O TABLE 2-2
- RADI0 ACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTE110N MINIMUM CHANNELS INSTRUMENT OPERABLE ACTION
- I. Radioactivity Monitors Providing Alana and Automatic Termination of Release
- a. Liquid Radwaste Discharge Monitor (HB-RE-18)' 1 31
- b. Steam Generator Blowdown Discharge Monitor (BM-FE-52) 1 32
.c. Turbine Building Drain Monitor (LE-RE-59). I 32 d.- Secondary Liquid Waste System Monitor (HF-RE-45) 1 33
- e. Wastewater Treatment System. Influent Monitor (HF-RE-95) 1 32
'2. Flow Rate Measurement Devices
- a. Liquid Radwaste Discharge'Line
- 1) Waste Monitor Tank A Discharge Line 1 34
- 2) Waste Monitor Tank B Discharge Line 1 34
- b. Steam Generator Blowdown Discharge Line 1 34
- c. Secondary Liquid Waste System Discharge Line 1 34 ODCM. 11 3/91
g,qr. 2-2 (Ontf rurd
) /CflON STA'lLMDf1S Action 31 - With the nurriuer of channels OPERACLE less than ruquirtd by the Mininun Channels OPDWlLE requirment, effluent zuloases via this pthway my continue for up to 14 days providad that prior to initiating a releases
- a. At 1 cast two independent sanples are analyzcd in accordance with Section 2.1.2, and
- b. At least two technically qualificd nmters of the facility staff inde;endently verify the release rate calediations and dischargo lino valving.
Otherwise, suspand release of radimetive offluonta via this pthway. Action 32 - With the number of channels OPEPAHLE less than requirtd by the Mininun Channels OPERABLE ruquimrent, effluent ruleases via this pathway nay continue for up to 30 days provided grab sanples are analyzed for principle gantra unitters ard I-131 at a lower 112 nit of detection as spe-cificd in Table 2-1.
- a. At least once per 12 hours when the specific acti- I vity of the secondary coolant is greater than 0.01
-() microcurle/ gram DOSE LTJUIVALDir I-131, or v
- b. At least once per 24 hours when the specific acti-vity of the becondary coolant is less than or equal l to 0.01 microcurie / gram DOSE EUIvr afr I-131. l Action 33 - With the number of channels OPERABLE 1.,sc tk requitui by the Mininun Channels OPERABLE requirement, effluent releases via this ptjnny may continue for up to 30 days provided that prior to initiating a releases
- a. At least two independent samples are analyzed in i accordance with Section 2.1.2, and l i
- b. At least two technically qualified nubers of the i facility staff indepandently verify the release rate calculations and discharge line valving.
L 3erwise, suspend release of radioactive etfluents via this pathway. ODCM 12 -(v 3/91
TAIVR 2-2 (anntintervi) JCTICN FrATIM2HS Action 34 - With the number of channels OPERABLE less than requimi 1:y the Mininum Channels OPDWHE requimmnt, offluent releases via this pithany nny continue for up to 30 days provided the flow rate is estinntai at lcott once per 4 hours during t.ctual releases. Pump perfonmnce curves generated in plam nny be used to estinate flaw. OCCM 13 ( 3/91
O O O TABLE 2-3 RADI0 ACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION SURVEILLANCE REQUIREMENTS ANALOG CHANNEL CliANNEL 50URCE CHANNEL OPERATIONAL INSTRUMENT CHECK CHECK CALIBRATION TEST
- 1. Radioactivity Monitors Providing
-Alarm and Automatic Termination-of Release
- a. Liquid Raderaste Discharge Monitor !
(HB-RE-18) D P R(2) Q(1) i
- b. Steam Generator Blowdown Discharga '
i Monitor (BM-RE-52)' D M R(2)- Q(1)
- c. Turbine Building Drain Monitor l- (LE-RE-59) D M R(2) Q(1) I
- d. Secondary Liquid Waste System -
Monitor (HF-RE-45) D P R(2) Q(1)
- e. Wastewater Treatment System Influent Monitor (HF-RE-95) D M R(2) Q(1)
- 2. Flou Rate Measurement Devices !
- a. Liquid Radwaste Discharge Line D(3) N.A. R N.A.
- b. Steam Generator Blowdown Discharge Line D(3) N.A. R N.A.
! c. Secondary Liquid Waste System
- Discharge Line D(3) N.A. R N.A.
- i 4
ODCM 14 3/91 4
, ~. . . . . ._ ___ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ - . _ _ _ _ _ _ _ _ _ _ . . _
s VE 2-3 (Continini) f ey TARIE IUPATIOJS U (1) The NWIG OWetEL OPEPATIONAL TEST shall also dmonstrate that autcnotic isolation of this pathway and control Iran alam an-nunciation occur as appropriate if any of the following condi-tions exists:
- a. Instnment iniicates umsured levels above the Alam/'Itip Setpoint (isolation and alam), or
- b. Circuit failure (alam only), or ,
- c. Instrunent indicates a dcunscale failure (alam only), or
- d. Instrunent controls not set in operatta node (alarm only).
(2) %e initial QWREL CALIBRATIQ1 shall be performod using one or nore of the reference (gas or liquid and solid) standards cer-tified by the Ibtional Institute of Standards and Technology ! (NIST) or using standanis that have been obtained frun suppliers j that participate in nmsuruTent assurance activities with 14IST. ~
%ese standards shall pemit calibrating the systczn over its :
intanckd range or energy, nnasuratent range, and establish non- ! itor response to a solid calibration source. I:br subsequent ' OWREL CALIBRATION, NIST traceable standard (gas, liquid, or solid) nny be used; or a gas, liquid, or solid r>oures that has ' (V~] been calibratcd by rulating it to equiprent that was previously (within 30 days) calibrated by the sann gomntry and type of i source standard traceable to NIST. i (3) QWREL OECK shall consist of verifying indication of flow dur-ing pericds of release. 0WaEL OECK shall be unde at least once per 24 hours on days an which continuous, pericdic, or tatch releases are nade. ODCM 15 ha 3/91 ,
pas sm i 2.4.3 Llimid !*1:ltor Ca]Jbrntion MrrtJrubimy to five nonitors associated with liquid mleases aru listui tu-Ot laws tbnitgI_IQ Inscript ton 0-lE-RE-52 Steam Generator Blculosn . Dischamo Monitor 0-LE-RE-59 Turbine Building Drain Manitor 0-11F-RE-4 5 Secondary Liquid Wasto Systan Fonitor
~
/ 0-l!B-11E-18 hiquid Radwaste Dischartje Manitor 0-IIF-RE-95 Wasteaater Troatnant Systan influent Monitor Liquid effluent strmns am nonitorut by an th1(Tl) Detector. Se detector operates in a gross counting nodo and is gonna sen-sitivo. Calibration of the liquid nonitors shall be perfornrxi using thrte standard solutions of Cs-137. no solutions shall . .2 the ap-propriatorangeoftpedetectorandlpveconcentrationsogap-proxinntely 5 x 10" uCi/cc, 1 x 10~ uC1/ce, and 1 x 10~ uC1/cc. Wo solutions shall in presented to the detector and the noter reading in counts per minute shall be record (xi. A graph of counts per minute versus concuntration shall be pruiuced frun the data. 2.4.4
~
Linuld Efflinit wrtitnr Sottnints
%e Alann/ Trip Setpoints for the Liquid Effluent Radiation Moni-tors are based on the instantaneous cuncontration limits of 10 CFR 20, Appendix B, Tablo II, Column 2 applied at the bounritry of the restrictal area. Specifically, the liigh Alann Setpoint will correspond to the 10 CFR Part 20 limits at the Ebundary of the i rustricted a ma; the Alert Alann Sotpoint is set one order of negnitude below the High Alarm / Trip Setpoint. Since the liigh Alann/ Trip initiates isolation of the particular System and toun-inntion of the mlease, this setpoint mpresents assurance tJmt.
the instantaneous liquid release limit of 10 CFR Part 20 is not excoeded. Auditable records shall be naintained indicating the actual setpoints used at all tines. 00CM 16 (% ul
to calculated Alarn and Trip Action Sottoint.s for the Liquid Ef fluent Line Manitors nust satisfy the follwing equation: _Ef 5 C F+1 Whem: C = Re liquid effluent concentration limit (MIC) inphrenting Section 2.1 in uCihnl. c = te Setroint, in uCihnl, of the Radioactivit,f Monitor nmsuring the radioactivity concentration in the offluont line prior to dilution and subsequent mioare; the Set-point, which is imersely protortional to the Volunetric Flw of the effluent line and dimetly pIDportional to the Volturetric F1w of the dilution stream plus the offluent stmam, repmsents a Value, which, if exceeded, wauld m-sult in concentrations exceeding the limits of 10 CFR 20 in the unmstricted area, f = %e Pump F1w Rate as neasutui at ti.a Radiation Monitor location, in Voltmo per Unit Tire, but in the sane units as F, bel w. F = %e Dilutxan Water Flw Rate as nmsured prior to the re-lease Icint, in Volunn per Unit Tinn.
%us, the expression for determining the Setpoint on the Liquid Radwaste Ef fluent Line Monitor hxxmest c $ CfF+fi (uC1/ml) f ODCM 17
1 l 2.4.4.1 Qulk{ntuna L1ggirLEff]truit Rydtnrn ! p) t %e thrw nonitors associated with continuous liquid releases are listed Lulow: Mnnitor ID Ibscription 0-1& RE-52 Steam Generator Blouicwl Discharge Monitor 0-LE-RE-59 Turbine Building Drain Mon.itor 0-IIP-RE-95 Wasco Water Truatnant Systan influent Monitor h e Stm m Generator Blowdown Discha:ge Effluent Monitor contin-uously nanitors the Blowdcwn Disc 4.arge Pump Outlet to detect ex-cess radioactivity due to Syston Danineralizer bruakthmugh or abnoural Prinary to Secondary leakage. The Blowdown Discharge Monitor's itigh Alann Sotpoint initiates CIDSURE of the Blowdown Isolation valves and the Blowdown Discharge Valve. Similarly, the High Radiation Alann on the Turbine Building Drain Monitor and Waste Water Trnatnent Monitor initiates CIDSURE of the Drain Line Isolation Valves to pmvent the release of radioactive ef-fluents. Monitor setpoints will be conservetively based on I-131, the nost restrictive isotopo expected to be present. 21s is particularly appmpriate for the Turbine Building Drain Line Monitor since the (G/ nost protable source is the Secondary Steam Systan which is ex-pocted to have negligible activity unless there is a significant Prinnry to Secondary leak. Due to changing activities, it will not be possible to select a radionuclide distribution on which to base the nonitor setpoint. Idditionally, nnxinum offluent flows and mininun dilution flows will nonto).ly be asstmxi. We High Alann/ Trip Setpoint will be set to correspond to the 1-131 MPC limit at the boundary of the restricted area frun 10 CIH Part 20, Appendix B, Table II, Column 2. The alert alcun is set one order of nagnitude below the liigh Alann/ Trip Setpoint. %1s High Idann/ Trip Setpoint assures the limits of Section 2.1 are not exceeded at the boundary of the restricted area. In the event that an alann is 'IRIPPED, an evaluation of the sys-tan will be mde by taking an actual isotopic and ficw anal.ysis of the discharge. The above continuous liquid effluents are not radioactive ef-fluents until Letivity has been detected by the Liquid Ef fluent Monitor, a Tritium analysis of the Secoxiary systan, or a gross Deta analysis of the Secondary system. At that time an analysis of the eifluent will be unde to verify activity in the systan effluent. During periods of tinn when the above liquid effluents are not radioactive the High Alarm / Trip Setpoint nay be set to 1.5 times the tuckground count rate. (V9 ODCM 18
2.4.4.1.1 Qtfum Grsvarator Blowtbwn Dirdame Mmitnr F +F SETPOINP (uCi/ml) = MPC I-131 X m B F B where, MPCI-131 ' Maximum Pennissible I-131, 3.0 E-7 uCi/ml.Concentration of F = Dilution fled rate. m F B
= BMwn flw mte.
i The setpoint calculatlon is Msed on the mininum dilution flow rate, the maxUtun possible blowdown flow rate, and, due to - changing corx11tions, I-131 which is the nest restricMve isotope expected to be present. On the event that an alarm is reached, tia setpoint will be re- { ovaluated using the actual dilution flus rate, the actual blow-down flow rate, and the actual isotopic analysis as outlined in Section 2.4.4.2. mis evaluation wi.11 be used to ensure the lintit of Section 2.1 was not exceeded. 'Ihe setpoint < ill still be based on the MPC of :.-131 due to the changing cormtions of activity and I-131 being the most restrictive isotope.
'nrrhino naildirvi Drain Mcnitor And mate mter Treatsmt 9 2.4.4.1.2 Syntan Influent Mcnitor F+F Setpoint (uC1/ml) = MPC I-131 X m_ T F
T where, '. MPC I-131 = 3.0 E-7 u W ml. F,9 = Dilution flow rate. F,p = Effluent flow rate. The setpoint is based on the mminum dilution flow rate, the max - inun possible effluent flow rate, and the most restrictive iso-tope expected to be present, I-131. On the event that an alarm is reached, the release will be eval-uated to see if the limit of Section 2.1 was exceeded by using the actual Dilution Flow Rate, the actual Effluent Flow Pate, and the actual isotopic analysis as outlined in Section 2.4.4.2. The setpoint will still be based on the MPC of I-131 due to the chang!ag conditions of activity and -I-131 being the nest restri-ctive isotope. ODCM 19 1 4
2.4.4.3 thtch Rtriimetivo Liquid Rff1tmt Mmitnr f me two nonitors associated with liquid batch releases are listed below Monitor ID Description 0-HF-RE-45 Seccadary Liquid Waste Systan Nonitor 0-HB-RE-18 Liquid Radwuste Discharge Monitor The setpoint is a function of dilution flow rate, tank flow rate, and isotopic cmposition. A laboratory isotopic analysis is made of each batch prior w discharge. Based on the isotopic analysis -- and existing flow condition, the setpoint will be calculated and set on the appropriate nonitor to ensure the concentration li. nits of 10 CFR 20, Apperxiix B, Table II, Column 2 are not exceeded. We setp31nts are determine 1 using the following nethodology:
- 1) Detennine concentrations of radioactivity of the batch ining consJdered for release.
The isotopic concentretion of the batch is the sum of the concentrations for the isotopes present as detennined frw the analysis required in Table 2-1.
=
C
$ hCg+ C, + C, + Cg+C7 Who at C
1
= %e concentration of nuclide i as c'.etennined by the analysis of the waste sample. _
C = We sum of the concentrations C of each nuasured 9 ganna enitting nuclide observed 9by gamra-ray spectroscopy of the waste sample.
*C^
= me neasured concentration C of alpha emitting nuclides observed by gross aipha analysis of the nonthly cmposite sample.
*C 8
= te neasured concentrations of Sr-89 and Sr-90 in liquid waste as detennined by analysis of the quarterly cmposite sample.
ODCM 20 0
._. . - - = . - - - _.
A *C = he masured concentration of H-3 in liquid waste t
-]-
(' as determined by analysis of the nonthly cmpo-site.
*C f
= We measured concentration of Fe-55 in liquid waste as determined by analysis of the quarterly cmposite. ,
- Values for these concentrations will be based on pmvious cmposite sample analysis as required by Table 2-1.
- 2) S e neasured radionuclide concentrations are used to calcu-late a dilution factor, F , which is the ratio of total di-lution flow rate to tank 'dlow rate required to assure that the limiting concentrations-of Section 2.1 are nut at the point of discharge. his is referred to as the required di-lution factor and is determined according to:
F d )xFs (1idC1 ) Whem:
-C1= Measured concentrations of C , C , C , C and C as defined in Step 1. 'Ibuns9C ,aC sC t nd C ,f, will be includexd in the calcul$tio8,as appropblate.
'= MFC = MPC , MPC , MPC , MPC and MPC f
, are limiting con-cen9 ratio 8s of Ehe a h iate radionuclide from 10 CFR 20, Appendix B, Table II, Column 2. For dis-solved or entrained noble gases, the concentration shall be limited to 2.0E-04, uCi/ml total activity.
Fg = The safety factor; a conservative factor used to compensate for statistical fluctuations and errers ; of measurment default value is 1.0. !
- 3) For the case Fa < 1, the waste tank effluent concentration meets the limits of 10 CFR 20 without dilution and the ef-fluent may be released at any desired flow a te. For the case F 1, a nodified dilution _ factor, F must be deter-mined No>that available dilution flow my b, apportioned anong simultaneous discharge pathways.
O ODCM 21
- - _ _ . . _ _ . ~ . _ . .
Pg =F d a ' Where F is the allocation factor which will nodify the re-quired dilution factor so that sinultaneous liquld releases my be mde without exceeding 10 CER 20 limits. The most straight-fonard determination of allocation factor ist Fa = 1/n Whem n = t e number of liquid discharge pthways for which Fd' and which are planned for sinultaneous release. Howver, this value for F my be annocessarily restrictive in that all release pthw$ys are apportioned the same frac-tion of the available dilution stream, m gardless of the re-lative concentrations of each of the sources. Sinco the radionuclide concentration of the tw continuous sources is expected to be less than that of the batch release source, it is acceptable to allocate smaller portions of the dilution stream to the continuous releases and a larger par-tion to the batch releasers.
; herefore, F is defined as a flexible quantity with a de-faultvalue8f1/n. Prior. to initiating sinultaneous re-lease, a check will be made-to assure that the sum of the allocation factors assigned to pathways for the simultaneous release'is < l.
- 4) We calculated e ximum permissible waste tank effluent flow rate F- ,:is based on the modified dilution factor, F ,
and the"$ffective dilution flow rate, F eff* Re cooling lake into which the effluent is discharged is also the source of the dilution stream. .It is therefore necessary to take into account the recirculation of pre-viously emitted radionuclides should they be detected by sam-ple analysis of the cooling lake water. This is accouplished
-by defining an effective dilution flow rate as:
Yeff " Im
~
ODCM 22 6)
Where: D F, = We expected mininum dilution water flw rate. LC = Measured concentration of nuclide i in the cooling 1 lake water sample. MPC y = LimitiwJ concentration of radionuclide i frm 10 CFR 20, Appendix B, Table II, Column 2. For the purpose of setpoint calculations the expected mininum dilution flw rate is assigned a value based upon the type and number of pumps RUNNDG into the circulating water pip-ing. Having established the values of F and F mxinn permissible waste tank flobrate 19 hiven byf , the calculated f mx 5Feff + fp F eff f#f p " Feff F dn dn Where f if the expected effluent flw rate; normlly the ratedc8pacityoftheeffluentpump. Bus the pump f1w -ute is set at or bel m f . Even though the value of . .y be larger than the aMdal effluent pump capacity, f "ft aces represent the upper limit to the effluent flw rate E whereby () U the requirment of 10 CFR 20 my-still be met. If Fg 5 1, the effluent pump f1w rate may be assigned any valuG since the waste tank effluent concentration meets the limits of 10 CFR 20 without dilution and the release my be made without regard to the setpoints for other release. pathways. For those discharge pathways selected to be secured during the release under consideration, the pump flw rate should be set at as low a value as practicable to detect any inadvertent release. A setpoint for the dilution stream f1 w rate is not app 11-cable since the minian flow rate is administratively set.
- 5) %e liquid radiation monitor setpoint my now be detemuned based on the values of 4, Ci , and f . We nndtor re-sponse is prinarily .to g$mma radiatiM* therefore, the actual setpoint is based on d , C h e calculated monitor setpoint concentrationisdeter81ne8,asfollows:
c=A I9C9 (uCi/ml) ODCM 23 U-
-Wheres.
~x-A=
- (] :
1 Idjustment factor which will allow the setpoint to be established in a practical mnner for convenience and to prevent spurious alarms. A= f P If A > 1, calculate c and determine the nnxbrum value for the
-actual monitor setpoint (uCL/ml).
If A < 1, no release nay be mde. If Fd < 1, n further dilution is required and the release nny . be nede without regard to available dilution or to other releases mde sinultaneously. Ikwaver, it is necessary to establish a nonitor setpaint which will provide alarm should the release concentration inadvertently exceed 10 CFR 20 limits. 'Ihis can be accomplished by establishing the adjustmnt factor as follows: A = 1/Fd V
/G ODCM 24 O
S n - n p -
- n - - m - .-p a -.g>> a no..a 9
FIGURE 2.1 BOUfIDARY FOR LIQUID EPPLutt!"rd I 1- ! O 5
} 5
- S 2 1 - .-
g em I(m \\rL A
} m .< /%
p-WP of c,4
- b as- t
~ ' ~
8 % s )) m mee '\
%' y k N , 1- . . . . ,
. - . , \L,c-.y o .
i 3 m.- 2. ME ' m,.- I ob t'
; woi./ CREEK Cl.NERADNG ST'.DQN UMtT No,1
\
sim 2.1
%,r .- t..... trreu
=se catte tot =<. seat s
b \ *** *
~ v im .
\ w c -o ,
)
h'[ y 2.M. ~. g
== --{ c- -t -- 9g - )). ~~
- c.t.-
n s .
....~
25 ~ e O 3/91 1
3.0 CASMIS IWIUJPNIS l ( .
\ Gaseous effluent mleases from the Unit Vent and Radwaste Building vent ern monitored continuously. 'Ihe Unit Vent is the release point for the Fuel / Auxiliary Building, access control area,-containnent purge, and condenser air discharge. The Rad-waste Building Vent is the mlease point for Waste Gas Decay !
Tanks and the Radwaste Building Ventilation Systm. j l Waste Gas Decay Tank releases and Containnent Building releases are treated as batch releases. Waste Gas Decay Tank teleases are monitored by the Radwaste Building Exhaust Monitor. Contalment ' Building releases (purges) are nonitored by the Containnent Purge Systcan nonitors and the Plant Unit Vent Monitor. Monitor identifications are as follows: Monitor ID Release Point Descriptior. O-GT-RE-21 A and B Unit Vent (Fuel / Auxiliary Building, access control aIna, containnent purge, condenser air discharge) 0-GI-REJ O A and B Radwaste Building vent (Rad-waste Building, waste gas de-cay tank discharge. Acts to isolate Waste Gas Decay Tank
-( discharge)
O-GI'-RE-22 & 23 Containment Purge System Moni-tor (acts to isolate the purge; is not an effluent non-itor) 0-GI'-RE-31 & 32 ContainmPat Atnesphere Monitor (acts to isolate purge; not an effluent nonitor) The setpoint for nunitors nay be determined either based on total body dose or skin dose rate. The dose rate limits are for dose rates at the unrestricted area boundary. The nonitor setpoint is
- the lesser of the total body dose rate or skin dose rate.
l i O l
-- -=. - -=
3.1 Drxie Rato - Complianm With 10 CFR 20 The dose rate due to radioactive materials released in gaseous effluents fim the site to arms at and beyond the SITE DOUNDARY (see Figum 3.1) shall be limited to the folluwing:
- a. For noble gases: Iass than or equal to 500 runns/yr to the wt. ole body and less than or equal to 3000 mrans/yr to the skin, and
- b. For Iodine-131 and 133, for tritium, and for all radionu-clides in particulate form with half-lives gmater than 8 days: Inss than or equal to 1500 mmns/yr to any organ.
3.1.1 Ikwodial Ictitxt With the dose rato(s) exceeding the above limits, innodiately restore the release to within the above limit (s). 3.1.2 Survellinnae amuiremmts
'Ihe dose rate to radionuclides in gaseous effluents shall be de-termined to be within the above limits in accordance with the l methodology described below by obtaining representative samples and performing analyses in accordance with the sampling and anal-ysis program specified in Table 3-1.
Based on the nethodology of NUREG-0133;
- a. Release rate limit for nobles gases fK1 (X/Q) Of <500 mmn/yr for the total body, end f(L1 + 1.1 M1) (X/Q) Q1 <3000 W yr for d e M .
hhere: Ky = Total body dose factor due to gamm emissions for eachidenpfiednoolegasradionuclide,inmrtm/yr per uCi/m , frun Table A.1-2. l (X/Q) = 2. ' E-06 sec/m3 , the highest calculated annual average relative concentration at the restricted area boundary in the north sector. i ODCM 27 b 3/91 l
3.1.2 Surveillarxxs Ihrtuimamts (Omtinini) [
- y/ -- Qi = Release rate of radionuclide i from vent, in uCi/sec.
.L 1
= Skin dose factor due to beta entissions for each identgfied noble gas radionuclide, in mtun/yr per uC1/m , frm Table A.1-2.
My = Air dose factor due to gaIma missions for each identjfiednoblegasradionuclide,inmrad/yrper uCi/m frm Table A.1-2. 1.1 = Conversion constant of air dose to skin dose,
- b. Release rate lintit for all radionuclides and radioactive -
naterials in particulate fom and radionuclides other than noble gases: 4y (P IN ' (X/Q)
- Q 1) <l500 mrm/yr to any organ.
Where Of = n e release rate of radionuclides, i, in gaseous effluent frm all vent mlmses, in uC1/sec. P(1)IN-= 'Ihe dose parameter for radionuclides other than nobles gages for the inhalation pathway, in arm /yr b,) v per uC1/m . See Table A.5-1. (X/Q) = 2.2 E-06 sec/m~, (the highest annual average). Tha highest calculated relative concentration for es-tinating the dose to an individual at the tuim-stricted area bourriary in the N sector. All radionuclides are assumed to be mleased in elernental form. The limit is applicable to the location (unmstricted area boun-dary or beyond), ch1racterized by the value of X/Q wttich results in the nuximum total body or skin dose ccrmtitment. The factors K L and M -relate the radionuclide airborne concentrations to vkr,iobs, dose bates assunting a smi-infinite cloud. These factors are taken fpi Table B-1 of_{he Regu4 l tory Guide 1.109 and raulti-plied by 10 to convert pCi to uCi and listed in Table'A.1-2. ODCM 28
o 3.1.2 Surveillarna Ihtuimmnta (Contintni) O We following equation for P 1)IN wts taken fmn 1,V4EI3 0133: lah); (i)IN P = K' (IR) DFAy (m@ p ud/m ) Wheret K' = a constant of unit conversion, 106 IC1/uCi PR = tge bmathing rate of the child age group in m /yr
~
DFAg = the maxitann organ inhalation dose factor for the child age group for the i th radionuclide, in mtun/pCi. '1he total body is considered as an organ in the selection of DFA .y ld group. The child's We age group breathing rate isconsidered is themcy/yr fmn Table E-3 1E taken as 3700 Regulatory Guide 1.109, We inhalation dose factors Ior the child, DFA are presented in Table E-9 of Regulatory Guide 1.109, id units of mrun/pC1. Resolutions of the units yields: 9 Pg (Inhalati^n) = 3.7 X 10 DFAy The Pg value for tritium ist 9 Py (Inhalation) = 3.7 x 10 DFA y ODCM 29 G.
Of ' O O TABLE 3-1
. RADIOACTIVE GASEOUS VASTE SAMPLING AND ANALYSIS FROGRAM MINIMUM .
' LOWER' LIMIT OF -;
SAMPLING ANALYSIS TYPE OF DETECTION (LLD)(1) GASEOUS, RELEASE TYPE FREQUENCY FREQUENCY ACTIVI*f ANALYSIS ' {uCi/ml) - P. P 1x10 '
~
Each Tank
- 1. Waste Gas Decay Each Tank-. Principal Gamma Emitt- J (2)
! ~ Tank 1 Grab Sample ,
' p- p-
- 2. Containment Purge' .Each Purge (3) Each Purge (3) Principal Gamma Emitters (2) 1x10-4 or Vent Grab 1 H-3 (oxide) 1x10-6
- 3. Unit Vent M(3), (4) '
M(3) Jrab Principal Gamma Emitters (2) 1x10~4 Sample H-3 (oxide) 1x10-6
- 5. Radwaste Building M M '
Vent Grab Sample Principal Gamma Emitters (2) 1x10"4 M H-3 (oxide) 1x10-6 ( i
- 6. Release' Types Continuous !
as listed in 3. (6) W(7) I-131' 1x10~12 and 5. above Charcoal Sample I-133 1x10-10 Continuous W(7) Particulate (6) c ample Priacipal Garza Emitters (2) 1x10-1*, Continuous (6) M Particu-Composite late Sample Gross Alpha 1x10~Il 4 Continuous Q ~yy (6) Composite Parti- Sr-89, Sr-90 1x10 ; culate Sample t ODCM 30 12/91- , y (
,y
TNu 3-1 (Contirmi) A TABLE IUPATIONS (1) The LLD in defined, as the smllest concentration of radioactive mterial in a sample that will yield a net count, above system tackground, that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal. l
- For a particular measurerent systen, which my include radio-chenical separation:
4.66 ab E
- V
- 2.',.2 x 106 7 . Decay Where LLD = the "a priori" lower limit of detection (microcuries per unit mass or volune),
a b
= the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate, (counts per minute),. = F / LT W.ere B = ba sum (counts)
LT = live time (minutes), (O w) E = the counting efficiency (counts per disintegration), V = the sample size (units of mss or volumo), 2.22 x 106 = the number of disintegrations per minute per microcurie, Y = the fractional radiochemical yield, when applicable, Decay = decay factor (s), 'Ihere are three decay factors that my be appropriate for use depending on the nature of the sample and the half life of the nuclide. Any canbination of the three my be used. 'Ihe factors are as follows: A) 'Ihis decay factor corrects for decay fran the time of sampling to the start of the analysis. e -3 at g , Ats = decay thu = acquisition start tine - sample tire A = In2/ half-life B) This decay factor corrects for decay during the analysis. 1-e
~
# , where:
'A . RT f A= In2/ half-life
( RT = real tim of counting ODCM 31 4/92
TMYR 3-1 (Cbatintxyf) O TABLE IMATIONS (Continued) O , C) %is decay factor corrects for decay during samphng. i
~
1-e , where l Atd J = 2n2/ half-11fe td = deposition time = sample tire - deposition start tim j i lore All tims used in decay calculations should be in the ! sam units. Typical values of E, V, Y, t , t should be used in the calculation. s d It should be recognized that the LLD is defined as an a priori (be-fom the fact) limit representing the capability of a masurment systm ard not as an a posteriori (af ter the fact) limit for a par-ticular measurenent. (2) '1he principal gama mitters for which the LLD specification ap-plies include the following radionuclides: Kr-87, Kr-88, Xe-133, 133, Xe-133m, Xe-135, and Xe-138 in noble gas releases and Mn-54, Fe-59, Co-38, Co-60, Zn-65, Mo-99, I-131, Cs-134, Cs-137, Ce-141 and Ce-144 in iodine and particulate releases. 'Ihis list does not man that only these nuclides are to be considered. Other gamm peaks that are identifiable, together with those of the above nuclides, shall also be analyzed and reported in the semi-annual Radioactive Effluent Release Report in the fonst outlined d in Regulatory Guide 1.21, Appendix B, Recision 1, June 1974. (3) Sampling and analysis shall also be perfomed following shutdown, startup, or a 'mEIWAL PGER change exceeding 15% of RATED THERMAL POWER within 1 hour period. (4) Tritium grab samples shall be taken and analyzed at least once per 24 hours when the refueling canal is flooded. (6) 'Ihe ratio of the sample flow rate to the sampled stream flow rate shall be known for the tim period covered by each dose or dose n te calculation made in accordance with Sections 3.1, 3.2 and 3.3. (7) Samples shall be changed at least once per 7 days and analyses shall be completed within 48 hours after changing, or after re-mval from sampler. For unit vent, sampling shall also be per-fomed at least once per 24 hours for a least-7 days following each shutdown, startup or 'IHERMAL POWER change exceeding 15% of RATED 'IEERMAL POWER within a 1-hour period, and analyses shall be empleted within 48 hours of changing. When samples collected for 24 hours are analyzed, the corresponding LLD's may be in-creased by a factor of 10. This requirment does not apply if: (1) analysis shows that the EOSE EQUIVALENT I-131 concentration q in the reactor coolant has not increased nore than a factor of 3, Q and (2) -the noble gas monitor shows that effluent activity has not increased mre than a factor of 3. ODCM 32 4/92
3.2 Dose - comtiance with 10 CPR 50 Amrsr11x I j r 3.2.1 !*tles Gases
~ 's
'Ihe air dose due to nobles gases released in gaseous effluents, frtm each unit, to areas at and beyond the SITE BOUNDARY (see ,
Figure 3.1) shall be limited to the following: !
- a. Dtu.ing any calendar quarter: less than or equal to 5 mrads ,
for ganma radiation and less than or equal to 10 mrads for beta radiation, and i
- b. During any calendar year: less than or equal to 10 mrads for ganma radiation and less than or equal to 20 mrads for beta radiation.
3.2.1.1 Itsrxiial Acticn With the calculated air dose from radioactive noble gases in gaseous effluents exceeding any of the above limits, pmpam and subnit to the Ccmnission within 30 days, pursuant to Techni::tl Specification 6.9.2, a smcial report that identifies the cause(s) for exceeding the limit (s) and defines the corrective actions that have been taken to reduce the releases and the_ pro-posed corrective actions to be taken to assure that subsetpent releases will be in coupliance with the atove limits. 3.2.1.2 Surveillanco Roauimrrnts . (d Cumulative dose contributions for the current calendar quarter and calendar year for noble gases shall be determined in accor~ dance with the following nethodology at least once per 31 days.
'Ihe dose calculations for the actual releases of radioactive noble gases in gaseous effluent will be consistent with the methodology provided in Reg. Guide 1.109, Rev. 1. The following dose calculations will be_ perforrred:
- a. During any calendar quarter; For gamna radiation; D = 3.17 E-8 hy My [( /Q) ' Q 1] 5 5 mrad.
For beta radiation; D = 3.17-E-8 y Ny [( /Q) ' O f] 5 10 mrad. ODCM 33 3/91 l
3.2.1.2 Surveillancn lurruimmwits (Contirurx1) A
- b. During any calendar year:
V) i For ganm3 radiation: 4 D -= 3.17 E-8 7,1 M1 ((X/Q)
- Of ] 5 10 mrad.
For beta radiation: 4 3.17 E-8 31 Ng ((X/0)
- Q 1] 5 20 mrad.
D = Where: 3.17 E-8 = %e inverse of the number of seconds in a year. My = We air dose factor due to gante anissions for each identffled noble gas radionuclide, in mrad, yr per uC1/m fmn Table A.1-2 (Reg. Guide 1.109, Table B-1, Col. 4). N 1
= We air dose factor due to beta anissions for each identgfied noble gas radionuclide, in mrad / year per uCi/m frun Table A.1-2 (Reg. Guide 1.109, Table B-1, Column 2).
3 (X/Q) = 2.2 E-6 sec/m The highest calculated annual ave-
,q rage mlative concentration for any ama at the un-t t restricted area boundary.
v Q1 = The mlease of noble gas radionuclides, 'i', in gas-eous effluents, in uC1. Releases shall be cumulative over the calendar quarter or year as appropriate. An average nonthly air dose schedule should be setup to ensum section 3.2.3 is not exceeded. The average nonthly air dose should be as follows:
- a. For ganma- radiation 5 1.6 mrad /no.
For beta radiation 5 3.3 mrad /no. If the nonthly average air dose for: (a) is exceeded, it should be noted that if the release is continued at the sane (or higher) frequencies or activities the quarterly limit of Section 3.2.1.A will be exceeded.
- b. For ganna radiation 5 0.8 mrad /no.
For beta radiation 51.6 mrad /no. If the nonthly average air dose for: (b) is exceeded, it should be noted that if the release is continued at the sane (or higher) frequencies or activities the annual . limit of' Section 3.2.1.B will be exceeded. ( ODCM 34
l 3.2.1.2- SurvnL11 anon Ivxiuirtamts fCantirnxxi) l ,m i
- If aby of the ahwe monthly average air doses are exceeded, eval-CJ uation of the causes of the high air dose should be performed and l
steps should be taken to reduce the activity or frequency (e.g. delay the release of a Waste cas Decay Tank) of the release. 3.2.2 Rxlinicriines, Ihrticulates mr1 Other Rvilcutuclidm
'Ihe dose to a MPABER OF THE PUBLIC frm Iodine-131 and 133, tri-Lium, and all radionuclides in particulate fom with half-lives greater than 8 days in gaseous effluents released, frm mch unit, to areas at and beyond the SITE B00tOARY (see Figure 3.1) shall be limited to the following
- a. During any calerr'.ar quarter: less than or equal to 7.5 mrare to any organ; and
- b. During any calendar year: less than or equal to 15 mrms to any organ.
3.2.2.1 11'snedial Action With the calculated dose frm the release of Iodine-131 and 133, tritium, and radionuclides in particulate fom with half-lives greater than 8 days, in gaseous effluents e cceeding any of the above limits, prepare and sutmit to the Ccrmission within 30
,m days, pursuant to Technical Specification 6.9.2, a special report t] \
that identifies the cause(s) for exceeding the limits and defines ! the corrective actions that have been taken to reduce the re- ! leases arxi the proposed corrective actions to be taken to assure ! that subsequent releases will be in cmpliance with the above i limits. l
?
3.2.2.2 Surveillance Ikrauimnmts i Cumulative dose contributions for the current calendar quarter and current calendar year for Icdine-131 and 133, tritium, ani radionr.clides in particulate fom with half-lives greater than 8 i days shall be detemined in accordance with the following metho- l dology at least once per 31 days. To show emp1 unce, the dose ' calculations for the actual releases of the subject materials are consistent with the methodology provided in Regulation Guine 1.109, Revision 1. '1he following dose calculations will be per-fomed:
- a. D (mtm) = 3.17E-8 R 1 [(hQ1 )] < 7.5 mrm
- b. D (mrm) = 3.17E-8 R1 [(NQ )} < 15 mrm (oj OCC4 35 J,/91
7 3.2.2.2 Eurveulance finatrucnta (chqtintn!) 4 kJ gnere: 3.17 E-8 = %e inverse of the number of seconds in a year.
= m e release of radiolodines, radio 6ctive raterials Q.
In particulate fann and radionuclides other than noble gases in gaseous effluents, 'i', in uC1. Releases shall be cumulative over the calendar quarter or year as appropriate. We Q4 value shall be detennined as the product of the fIcw rate through the release point and grab samples of the , effluent analyzed in accordance with Table 3-1. W = W e annual average dispersion parameter for esti-nuting the dose to an individual at the controlling location. 3 W = (X/Q), 2.2 x 10~0 sec/m for the inhalation pathe y. W = (D/Q), 1.8 E-8 m" , for the food and ground plane patheys. R. = Thedosefactorforeachgdentifiedradionuclide, 1 _n 'i', in nran/yr per uC1/m . See Table A.5-2 through Table A.5-20. Where: Inhalation Pathway Factor, R g [X/Q) R [X/Q) = K' (BR)a (DFAf ) (mrum/yr per uCi/m ) Where: 6 K' = a constant of unit conversion, 10 pCi/uCi.
=
(BR)a e breathing rgte of the receptor of age group (a), in m /yr. for the various age groups Thetabulated are breathing ratesas balow, (BR),iven g in Regulatory Guide 1.109, Table E-5.
'N3E GROUP (a) BREA1190 RATE (m /yr)
Infant 1400 Child 3700 Teen 8000 klult 8000 c ODCM 36
3.2.2.2 Sutwillance Ivrntirurrnta (Ctntintrx1) (DFA1 )a
= e maximum organ inhalation dose factor for the receptor of age group (a) for the i th radionuclide, in mmn/pC1. The total bxty is considered as an organ in the selection
. See Tebles A.2-1, A.2-2, A.2-3, of (DFA1 )"Frun Regulatory Guide 1- 109,
& A.2-4.
Tables E-7, E-0, E-9 crd E-10. Grtud Plane Pathway Factor. R ([D/O] R G [D/Q]=K'K" (SF) DFGt [Il-e b~i)/hi}(m mmn/yr per uCi/sec) hhem: K' = A constant of wtit convernion, 10 6pCi/EC1. , K" = A constant of unit conversion, 8760 hr/ year. g = The_gecayconstantfortheithradionuclide,
.see t = The expst'm tinu, 4.73 E8 sec (15 years).
DIC = 1he ground plane dose conversion fgetor for the i 1 th rnitonuclide (mrun/hr per pCi/m ). See Table
']
A.2-5. (Regulatory Guide 1.109, Table E-6) . (V SF = The shielding factor (dimensionless), 0.7 g. leg. Guide 1.109) Grass-Cow-Milk Pathway Factor, R g[D/Q) t R f(D/Q) = K' ( F ,(r) (DFL g )a I /Y p ) Ig g f) (m 'mren/yr per uC1/sec) hhere: 6 K' = A constant of unit conversion, 10 pCi/uCi. OF = e c w's consumption rate, in Kg/ day (wet weight), 50 kg/ day. (Reg. Guide 1.109, Table E-3). , U = The receptor's milk consumption rate for aca (a), aE in liters /yr. (Reg. Guide 1.109, Table E-5) OCCM 37 ( v
,3 3.2.2.2 3:rvel.11ance itecminwnts (OantinundJ
.( )
\ Infant = 330 1/yr Child = 330 1/yr km = 400 1/yr
/dult = 310 1./yr Y
E
=
%e agricultural productfvity by un{t area of pas-ttum feed grass, in kg/m , 0.7 kg/m . (Peg. Guide 1.109, Ttble E-15)
= he stable elanent transfer coefficients, in F* days / liter, see Table A.3-5. (Reg. Guide 1.109, Table E-1) r = Fraction of deposited activity mtained on cvs I feed grass, rel for radiciodine and r=0.2 for par-ticulates. (Reg. Guide 1.109, Table E-lS)
(DFLf )g = We muimum organ ingestion dose factor for the i th radionuclide for the mceptor in age group 'a', , in mtun/pC1. See Tables A.3-1, A.3-2, A.3-3, and A.3-4. (Reg. Guide 1.109, Table E-11, E-12, E-13, and E-14) 21
=
The_gecay constant for the i th radionuclido, in sec
\p /
4 = W e dec?y constant for re rval of activity on l p f , and plant mirfaces by weathering, 5.73 E-7 sec (corresponding to a 14 day half-life). t = We transport tine ftun pasture to cow, to milk, to f receptor, in sec, 1.73 E5 secs (2 days). (Reg. Guide 1,109, Table E-15). FUIE: 'Ito fracticn of the year that tie cow is cm pastum ard the fracticn of thn cow feed that is pasturu grass is assimxi to be 1.0, which is the noct restrictive case. Graba-Goat-Rilk Fathway Factor, R 1[D/Q] t i[D/Q) = K' ( )Fm (r) (DFL1)a I / Yp) (* i f) (m2 'mtun/yr per uC1/sec) OIX24 39 v s
3.2.2.2- EktrvnLTlarm it<nulmnrmts f(bntirttxxil 1 1 V items i Q.g
= 7he goat's cavsumption rate, in Eg/ day (wet i weight), 6 Kg/ day. (Reg. Guide 1.109. Table E-3). l tg = The trarupart tim fran pasture to epat, to milk, j to receptor, in sec, 1.73 ES sec (2 days). (Reg.
Guide 1.109, Table E-15). I all o*her terms are definext under the Grass-Cow-Milk-Pathway Fac-ter. M71'2: The fractim of tM year that the gxit is on pasturn arri the frnc.tJrri of the gaat feed that is past:ste grass is asmmed to be 1.0, whidt .in the most restrictive caso. She concentration of tritium in milk is tused on the airborge concenuation rather than the depition. Therefore, the R y is based on (X/g), R 1 (X/0) = K'K"' F ,Op Uap (DFLg )a (0.75 (0.5/H] (mrun/yr per uCi/m3 ) hheres
/ms 3
K"' = a constant of unit conversion, 10 mfg g, H = Absolute humidity of the atnesphere, 8 gm/m3 , (Reg. Guide 1.109). 0.75 = The fraction of total feed that is mter (ElREG 0133) 0.5 = The ratio of the specific activity of the fer- 1 grass water to the atnespheric water. (m]Rb 0133) Grass-Cow-Meat Pathway Factor, R"g[D/Q]
!Yp ) I* 'I f) 1[D/Q) = K' )Ff (r) _ f)a (m'"mran/yr per uCi/sec) hhere:
F = Uhe stable elanent transfer coefficiants, Ln f days /kg, 7bble A.3-5. (Reg. Guide 1.109, Table E -
'1).
ODCM 39 (" (
3.2.2.2 Surveillance Itriuironmta (0:mtintxd) _G_,
-b U aP
= e receptor's meat consumption rate for age (a),
in kg/yr. (Reg. Guide 1.109, Table E-5) . Infant = 0 Child = 41 Teen = 65 Mult = 110 tg = ne transport time frm pasture to receptor, in sec. ,1.73 E6 (20 days) (Reg. Guide 1.109, Table E-15). S e concentration of tritium in mut is based on its airba e
. concentration rather than the deposition. %erefore, the is f
based on (X/Q): U 1(X/Q] = K'K" Ff 07Uap (DEf )a (0.75 (0.5/H)) (mrem /yr per aci/m )
< tre:
All terms defined above. Vegetat. ion Path'*ey Factor, R 1[D/Q) C Man is considered to consum two types of vegetation (fresh and storod) that differs only in the tima period between harvest and consumption, therefore: T R [D/Q]=K'[ r
)(DEf )a I(U )(fL)(* )+( a)If g)(g A1 h))
Yy (ki + k) (m2 . mrm /yr per uC1/sec)
-Where:.
K' = A constant of unit conversion, 106 pCi/uCi. U'I a = The consumption rate of fresh leafy vegetation by the receptor in age group (a), in kg/yr. (Reg. Guide 1.109, Table E-5). Infant = 0 kg/yr Child = 26 kg/yr Teen = 42 kg/yr Mult = 64 kg/yr ^ [a = m e consumption ra m of sto M vege w on W de receptor in age erroup (a), Kg/yr. (Reg. Guide 1.109, Table E-5). + G 0D01 40
(y 3.2.2.2 Surveillance Heauimmmts (Cbntintxrl) U Infant = 0 kg/yr Child = 520 kg/yr Teen = 630 kg/yr l Adult = 520 kg/yr j f g
= %e frac *'.on of the annual intake of fresh leafy vegetation grown locally. (default = 1.0) (Reg.
Guide 1.109). f = h e fraction of the annual intake of stored vege-9 tation grown locally. (default = 0.76) (Reg. Guide 1.109). tg = We average tine between harvest of leafy vegeta-tion and its consumption, in seccads, 8.6 E4 secs (1 day). (Reg. Guide 1.109). t h
=
t e average time between harvest of stored vege-tation and its consumption, in seconds, 5.18 E6 secs (60 days) (Reg. Gui_de 1.109, Table E-15) . Yy = te vegetation area density, 2.0 kg/m 2. (Reg. Guide 1.109, Table E-15). _ All other factors previously defined. I '\ (/ The concentration of tritium in vegetation is based en the air-bpe concentration rather than the deposition. Therefore, the R y is based on (X/Q): b R 1[X/Q) = K' K"' [ fg+U a fl( g l [0.75 (0.5/H)] ia 3 (nmn/yr per uC1/m ) hhere: All terms defined previously. All values indicated are default values fIcm Reg. Guide 1.109, Rev. 1.
- An average nonthly dose schedule should be setup to ensure Sec-tion 3.2.2 is not exceeded. The average nonthly dose due to radiciodines, particulates, and other radionuclides which are included in this section should te as follows:
- a. < 2.5 mran/no.
ODCM 41 i o i I-
3.2.2.2 Surveillance Ihtuimmits fContinixxji ,e\ . (
/ If the Inonthly average dose for (a) is exceecied, it should be notal that if the release is continued at the sane (or higher) frequencies or activities the quarterly limit of Section 3.2.2.a will be exceeded.
- b. < 1.2:, mtun/no.
If the nonthly average dose for (b) is exceeded, it should be noted that if the release is continued at the sann (or ,agher) frequencies or activities the yearly limit of Section 3.2.2.b will be exceeded. If any of the above nonthly doses are exceeded, evaluation of the causes should be perfonned and steps taken to reduce the activity or frequency of the release. 3.3 Iwriectn1 thm The VDfrILATICN EKHAUST 'IREA'IMENT SYSTEM and the WASTE GAS HOLDUP SYSTEM shall be OPERABLE and appropriate portions of these sys-tans shall be used to reduce releases of radioactivity when the projected doses in 31 days due to gaseous effluent releases, fran each unit, to areas at and beyond the SITE BOUNDARY (see Figure 3-1) would exceed: p a. C.2 mrad to air from ganna radiation, cr V b. 0.4 mrad to air frun beta radiation, or
- c. 0.3 mren to any organ of a MamER OF 'lHE PUBLIC.
3.3.1 Ivmriial Actim With radioactive gaseous waste being discharged without treataent ; and in excess of the above limits, prepare and subnit to the Ccra- l mission within 30 days, pursuant to Technical Specification ' 6.9.2, a special report that includes the following infornation: i
- a. Identification of any inoperable equipnent or subsystens, and the reason for the inoperability,
- b. Action (s) taken to restore the inoperable equiprent to OPERABLE status, and
- c. Sunmary description of action (s) taken to prevent a recur-rence.
OCm 42 q Q 3/91
3.3.2 Surveillance Ikx1uirmrmts j (e) v' 3.3.2.1 Doses due to gaseous releases frm each unit to areas at and te-yond the SI~'E DOUNDARY shall be projected at least once per 31 l days in accordance with the following mthodology when Gaseous Radwaste Tmatmnt Systens are not being fully utilized. D = A . 31 31 T Where: D 31
= Projected 31 day dose A = Cumulative dose for current quarter T = Current numter of days into quarter 3.3.2.2 The installed VDRIIATION EXHAIJST TREATMEtE SYSTD4 and WASTE GAS HOLDUP SYSTEM shall be considered OPERABLE by meeting Section 3.1 ard 3.2 limits.
- 3.4 Instnamtatian The radicactive gaseous effluent nonitoring instrumentation chan- l nels shown in Table 3-2 shall be OPERABLE with their Alarm / Trip l
,3
, Setpoints set to ensure that the limits of Section 3.1 are not i
("j exceeded. The Alarm / Trip Setpoints of these channels meeting Section 3.1 shall be detennined and adjusted in accordance with the nnthodology and paramters of Section 3.4.4 below. , 3.4.1 Ikwriini Actics i i
- a. With a radioactive gaseous effluent nonitoring instrunenta- l tion channel Alarm / Trip Setpoint less conservative than re- l quired by the above specification, imnediately suspend the release of radioactive gaseous effluents nonitored by the ;
affe :ted channel, or declare the channel inoperable.
- b. With less than the minimum number of radioactive gaseous ef-fluent nonitoring instrumentation channels OPERABLE take the ACTION shown in Table 3-2. Restore the inoperable instru- j mentation to OPERABLE status within the time specified in the ACTION, or explain in the next Saniannual Radioactive Ef-fluent Release Report, why this inoperability was not cor-rected within the tine specified.
ODCM- 43
/~N
- C) 3/91
3.4.2 Survetilanm thininmmts [ Each radioactive gase us effluent nonitoring instrumentation
\~ - channel shall be dmanstrated UPERABLE by perfonunce or the CHANNEL OIECK, SOURCE 01ECK, QIANNEL CALIBRATION and ANAILG 01ANNEL OPERATIONAL TCST at the frequencies sham in Table 3-3.
m
's 44 t ) 3/91
's
r f p N). LJ _ L] TABLE 3-2 RADI0 ACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION MINIMUM CHANNELS INSTRUMENT OPERABLE APPLICABILITY ACTION
- 1. Unit Vent System
- a. Noble Gas Activity Monitor - Providing Alarm (GT-RE-21) 1 40
- b. Iodine. Sampler. 1 43
- c. Particulate Sampler 1 43
- d. Flow Rate N.A.
- 45
- e. Sampler Flow. Rate Monitor 1 39
- 2. Containment Purge. System
- a. Noble Gas Activity Monitor - Providing Alarm and Automatic Termination of Release (GT-RE-22 GT-RE-33) 1 41
- b. Iodine Sampler 1 43
- c. Particulate Sampler 1 3
- d. Flow Rate 4.A.
- 45
- e. Sampler Flow Rate Monitor 1 39-ODCM 45 3/91
., f3 -y.
L.}
' %.) -
TABLE 3-2 (Continued) RADI0 ACTIVE GASE0US EFFLUENT MONITORING INSTRUMENTATION MINIMUM CHANNELS INSTRUMENT OPERABLE APPLICABILITY ACTION
- 3. 'Radwaste Building Vent System
- a. Noble Gas' Activity Monitor - Providing Alarm and Automatic Termination of
- 38,40 Release-(GH-RE-10) -1 Iodine. Sampler *
- b. 1 43
- c. Particulate Sampler 1 43
- d. Flow Rate' N.A. 45
- e. Sampler Flow Rate Monitor 1 39 i
{ l ODCM 46 3/91
I i TA_!VE 3-2 farm ninvil 1AJ}LE !UTATIOJS
- At all tires.
R
/CTIO1 STATIM 2 TIS
/CTIQ1 38 - With the number of channels OPDmBLE less than rrquirtd by the minimum channels OPERABLE rtquixtuent, tue con-tents of the tank (s) nay be releaso:: to the environnent ,
for up to 14 days pn7vidad that prior to initiating the j rOloasOf 1 i
- n. At least two independent semples of the tank's con-tents are analyzed, and !
- b. At least two technically qualified mmters of the facility staff independently verify the release rato calculations and discharge valvo lineup.
Otherwise, suspend release of radioactivo ef fluents via this pthway. IcrIOJ 39 - With the number of channels OPERABLE less tNin nquiIud i by the minimum channels OPERABLE requiluent, effluent releases via this pathway msy continue for up to 30 days pwvided the flc e rate is estinated at least once por 4
/O hours.
V 1CTION 40 - With the number of channels OPERABLF less than roquLrtd by the minimum channels OPERABLE req.irruent, effluent rolosses via this pathway nay continue ser *v to 30 days provided grab samples are taken at 15.ct A par 12 hours and these samples are analyzo. for oxiii. activity within 24 hocrs. ACTIOl 41 - With the number of channels OPERABLE leca than nquirtd by the mininun channels OPERABLE requirt= tent, inte-diately suspend PURGDG of radioactive effluents via this pathway. 1CTION 43 - With the numbar of channels OPERABLE less tj ' ' quired l by the minimum channels OPERABLE requixtuent (.a'luent , releases via the affected pthway nny continue for up to 'i 30 days pmvided samples are continuously collected with auxiliary sanple equipent as required in Table 3-1. AcrIQ4 45 - Flow ut.o for this systan shall be based on fan status and opermdng curves or actual neasutuents. 0D04 47 A l V 3/91
L O. O . O . I' TABLE 3-3 RADIOT.CTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION J RVE!LLANCE REQUIREMENTS , ANALOG l
- CHANNEL MODES FOR WHICH !
! CHANNEL OPERATIONAL. SOURCE- CHANNEL SURVEILLANCE INSTRUMENT CHECK CHECK CALIBRATION TEST 15 REQUIRED l I
- 1. Unit Vent System 1-
! ;a. Noble Gas' Activity Monitor- ]- Providing Alarm (GT-RE-21) D M R(3) -Q(2)
- i
- b. ' Iodine Sampler. W .N.A. N.A. N.A.
- i
, c. Particulate Sampler W N.A. N.A.- N.A.
- i'
- j d. Flow Rate N.A. N.A. R(4) N.A.
l o
- e. Sampler Flow Rate Monitor D N.A. R Q i
} l l
- 2. Containment Purge System !
- a. _ Noble Gas Activity Monitor- t Providing Alarm and Automatic ,
Termination of Release I (GT-RE-22,GT-RE-33) D P R(3) Q(1)
- b. Iodine Sampler W N.A. N.A. N.A.
- i !
], c. Particulate Sampler W N.A. N.A. N.A.
- i
- d. Flow Rate N.A. N.A.
- j R(4) N.A. [
i
}
! e. Sampler Flow Rate Monitor D N.A. R N.A.
- t t I I
i ! ODCM 48 L t 3/91 ! l- ! i t
O O O_
'/
TABLE 3-3 (Coatinued) RADI0 ACTIVE GASEOUS EFFLUENT MONITORING c.1STRUMENTATION SURJEILLANCE REQUIREMENTS ANALOG CHANNEL MODES FOR hHICH CHANNEL SOURCE CHANNEL OPERATIONAL SURVEILLANCE INSTRUMENT CHECK CHECK- CALIBRATION TEST IS REOUIRED
. 3. Radwaste Building Vent System
- a. Noble Gas Activity Monitor-
) Providing Alarm and Auto-matic Termination of Release D,P M,P * (GH-RE-10) R(3) Q(1) . ,
- b. Iodine Sampler W N.A. N.A. N.A. *
- c. Particulate Sampler- W N.A. N.A. N.A. *
- d. Flow Rate N.A. N.A. R(4) N.A. *-
- e. . Sampler Flow Rate Monitor
- D N.A. R N.A.
4 i e ODCM 49 3/91 e - - >m,. , , a v - -,,-e- m ---.--,-,n
TNUR 3-3 IOnLitunh C\ g TNHE !UPATIONS
- At all tinos.
(1) %e NE03 QWHE OPDMTIOE TEST shall also dmonstrate that autantic isolation of this Inthway and contml wcrn alam an-nunciation as appmpriate occur if any of the follcwing condi- l tions exists
- a. Instrunent indicates naasumd levels above the Alam/ Trip Setpoint (isolation and alam), or
- b. Circuit failuru (alam onlyl, or
- c. Instrunent indicates a dcunscale failuru (alam only) or
- d. Instnment controls not set in operate node (alam only).
(2) We N&IDG OIAlalEL OPDIATION TEST shall also dcnonstrate that control recun alam annunciation occurs if any one or ccanbination of the follcwing conditions exists:
- a. Instnment indicates noasured levels above the alarm set-point
- b. Circuit failurn
- c. Instrutent indicates a dcunscale failure
- d. Instnrant contmls not set in operate node.
(3) We initial QWINEL CALIBRATIO1 shall be perfornrxl using one or nore of the referunce (gas or liquid and solid) standards cer-tified by the tutional Institute of Standards and 'Ibchnology (NIST) or using standards that have been obtained frun suppliers that participate in measurunant assurance activities with NIST.
%ese standartis shall pemit calibrating the systen over its intended range of energy, neasurunent range, and establish non-itor response to a solid calibration source. For substguent DIANtE CALIBRATIOi, NIST traceable standard (gas, liquid or solid) any be used; or a gas, liquid, or solid source that has '
been calibrated by relating it to equiptunt tJat was previcusly ' (within 30 days) calibrated by the sano gcaretry and type of ;
-source traceable to NIST.
ODCM 50 3/91
l l TNVE 3-3 (Oritirnwx1)
,T_ARIE IUTATICTE (4) If flow rate is detennifvxi by exhaust fan status and fan per-fontance curves, the folicwing surveillar :o operations shall b3 perfonted at least once per 18 nanths:
- a. The specific vent f1cus by direct naasuturent, or
- b. 1he differuntial pressure across the exhaust fan and vent ficw established by the fan's " flow- P" curve, or
- c. 1he fan notor horse mer neasured and vent flow establishod by the fan's "flos-hcrnepower" turve.
O ODCM 51 3/91
_ _ _ _ - ._ _ - - _ - _ _ _ _ _ _ _ _ ~ _ _ _ _ _ . _ _ _ 3.4.3 Aidorrn Ikulintion wpitnr Calibmtion Madnb1my 7he following manitors am associatcd with gaseous releases. Monitor ID Monitor Ibscription Monitor 'Ivro 0-Ur-RE-21A Plant Unit Vant Particulate, Icdine 0-Gi-RE-10A iMdvaste Duilding Ef fluent Particulate, Icx11ne 0-GT-RE-21B Plant Unit Vent Wide ihnge Gas 0-Gi-RE-10B Ibdwaste Building Effluent Wide Ibnge Gas O-CT-RE-22 & 33 Containnent Purge Exhaust Particulate, Iodine, Gas 0-Gr-RE-31 & 32 Containnent Atnosphere Particulate,Icdine, Gas 3.4.3.1 Particulain Detrctor Deta pnrticulate is nanitored by a 50 me dianuter by 0.25 un thick plastic scintillator optically coupled to a 50 nn dianetar photcnultiplier tube. This detector shall be calibrated over its range of energy and rate capabilities. For energy range calibration four sourcec shall be used. Each source consists of a filter paper inpregnatrd with a beta mdt-ps ting radionuclide. 1he radionuclides used should be 7W 99, Cs-Q 137, Cl-36, ard Rh-106. Each source shall be positioned in the filter paper retaining ring and counted separately. 1he count rates for each rtdionuclide source shall be recordo:t and the data plotted on a graph of cpn/uCi versus average beta energy. 1his curve represents the detectors response characteristics over the range of beca energies observod. 1he efficiency for setpoint calculations shall be insod on the efficiency of the detector for Cs-137. The detector shall be calibrated for its rate capabilities using a filter paper inprognated with standam activities of Cs-137. Increasing anounts of a standard Cs-137 solution shall be inprty-nated on a filter paper. 1he counts per minute for each Cs-137 stardard shall be recorded and the data plotted on a graph of counts p,r minute versus activity. At least thite sources covering appmxinutely 1/4,1/2, and 3/4 of full scale shall tn checked. l ODCM 52 O v 1
. - - -- ~ _ -- - _~ - .- - - .- - - -- - . - - - . - - . - - ~ -
l 3.4.3.2 I(xilno Detectnr Iodine gas is nonitorr.d by absorbing the gas on a charcoal filter elment. We chan:oal filter is viewd by an tuI(T1) integral line ganim scintillator assmbly. ; Bocause of itn short half-life and the dif ficulty in hanciling gaseous lodina, inrium souwes shall be used ior calibration.
%e photo poaks of interust are as follows:
A. Ba-131: 356 FaV ganim is 0.69 efficient / disintegration B. 1-131: 364 kev ganma in 0.82 efficient /diointegration
%erefore, each iodine disintogration will produce 0.82/0.69 x barium disintegrations. Assuming that the detector efficiency ,
for 356 kev is the r.ano as for the 364 kev, the sensitivity for I-131 equals 1.19 x Ba-133 (counts / min)/uci. We standard > sources shall bo constructed by imprognating a standani Lu-133 ; solution into the charcoal filter elment. %e gowntry shall simulate the icxiine rutention on the first surface of the char-coal. Sourcea shall be pn4cred to cover approxistely 1/4,1/2 and 3/4 of fall scale. We barium counts per minute for each standard chall be adjustod to icdine counts per minute as des-cribed atove. W e adjusted counts per minute shall be plottod a graph of counts per minute versus activity. 3.4.3.3 Gan Detector
%e gas detectors associated with nonitors O GT-RE-22 & 33, 0-GT-RE-31 & 32 and the low-range detectors of nonitors O-GT-RE-21B and 0-Gi-RE-10B are a plastic scintillator identical to the par-ticulate detector. We mid-range and high-range detectors of nonitors O-GT-RE-21B and 0-Gi-RE-10B aru cadmium tellurido, solid state sensors.
Sources for all gas detectors shall be produced by evacuating the sample chamber with a vacuum pump. %e sample chanber then shall tu backfilled to the desitud pressum with a source of standard Xe-133. W e source is then counted and the counts per minute recorded. A graph of counts per minute versus concentration shall be produced frun the data. Soumes ahall be prepared to cover approxistely 1/4,1/2 and 3/4 of full scale for the de-tectors associated with nonitors O-GT-RE-2; and 33, 0-GT-RE-31 and 32 and the low-range detectors of nonitors O-GT-RE-21B and O-GI-RE-10B. Sources shall be prepared for the mid/high range detector to cover two points on the mid-range scale. For AIMA purposes, response for the high-range scale shall in extrapolated using the data frun the mid-range calibration. , ODCM 53 l O l l u , - . - --- ,
3.4.4 Aldntm Mrnitor MTninta V- 3.4.4.1 Tbtal..Luty run Rate ontTnipt calculations the lindt of the total body dose rate is 500 nuudyr at the un- ; restricted area boundary. She amitor alandtrip setpoint tused ' on total body dose will be calculated as follows: Sg 5 (SF x AF) x Dg xR (1) M1ere Sg = The nmitor alandtrip setpoint tused on the total bcdy dose rate. Dg= Lindt of 500 mrudyr total body, conservatively interpruted as a continuous release over a one year period. SF = lbrnally will be set to 0.85. This number is chosen since the gaseous nonitors are set using Xe-133 energy level. Xo-133 cmprises 85% of total noble gaseous activity expcd. (Soo USAR Table 11.1-1). If necessary the 0.85 can be fur-ther un11fied to ccmpansete for statistical flue-tuat. ions and errors of nmsurtment. h d AF = Allocation factor for mch release so that sinu 1-taneous releases can be nude without executing the limit. !brnally AF is calculated as follows: AF = JLF TF hherus RF = Roloase flow rate of the release point under unsideration. TF = 7btal flow rate of all release points in-cluding release under consideration. R t
= nonitor Insponse per mtudyr to the total bcdy, detennined acconiing to:
C Rt * < ( (X/Q) p Kg Og) p occi 54 O
3.4.4.1 'Ibtal_.trxiv iwqJete SotTnint Calculat.hnn (Crmttuuri) (_ ( Wiem: 1 c= The nonitor msponse to the gaseous offluent noble gas (uC1/cc) cormsponding to grab sample radio- ) nuclide concentrations. 1 (X/Q)= 1ho highest calcu l dispre.rsion (sec/m}ated ) at the annual restrictedaverage atnospheric area boundary. Kg= The total body dose factor due to ganna anissions frun isotope 1 (mrun/yr per uC1/m3 ) frun Table A.1-2. Og= Rate of release of noble gas radionuclide 1 (uC1/sec)(concentration of radionuclido 1 x release ficw rate) 3.4.4.2 Gdn Dono Pato Calculation 1he limit of the skin dose rate is 3000 mrun/yr at the matricted area boundary. 7ho nonitor alann/ trip sotpoint is calculated as follcus Sg ,5 (SF x AF) x D, x Rg (2) . hherus S g
= The nonitor alann/ trip setpoint based on the skin doso rate.
D, a Limit of 3000 mrun/yr to the skin of the body, con-servatively interpretcri as a continuous release over a one year period. Rg = Monitor response per mrun/yr to the skin of the body, c R ( (M) i(Li + l lM )i 0.1 ) hheres by= Skin dose factor due 3to beta cmissions frun isotope 1 (mrun/yr per uC1/m ) frun Table A.1-2. 1.1 = Conversion factor to mrun skin dose per mrad air dose. My= Air dose factor due to3 ganna anissions frun isotope 1 (mrad /yr per uC1/m ) frun Table A.1-2. O g ocos 55
3.4.4.2 Skin thx, [bte Calculatim (Omtirnrril
~
%e factors EF, AP, c, (X/Q) and Qg aru as defined in Section 3.4.4.1.
We results of equations frun Sections 3.4.4.1 and 3.4.4.2 aru canpwad to detennine the maller sotpoint. %e actual nonitor sotpoint is the lower of the two values. A pre-ruloase isotopic analysis is perfonrad for batch releases frun Waste Gas Decay Tanks and contalicant Building purges to detentine the identity and quantity of the principal radio-nuchdes. We appropriate alann/ trip setpoint(s) are adjusted accordingly to ensure that the limits of 3.1 aru not execeded. 3.4.4.3 Alert Alann Setroint CalatlatJons he !bble Gas Alert Alann for the Plant Unit Vent (0-GT-RE-21) and Radwaste Bullding Exhaust Monitor (O-Gi-RE-10), is set to alert operators to that average concentration which if maintained for a full year would result in the 10 CFR 50, Appendix I Annual Dose Guidelines being reachod. Section 3.2.1 limits the annual dose due to noble gases to I 10 mrada for ganna radiation and 5 20 mrads for beta radiation. Section 3.2.2 limits the annual dot.o to a MEMBER OF 'IIIE PUBLIC frun Iodine-131, Iodine-133, tri-tium and all radianuclides in particulate form with half-lives O greater than 8 days in gascons effluents to 3 15 mrun to any or-gan. W ese two sections contain the annual dose limits due to C/ gaseous releases found in 10 CFR 50, Appendix I. 3.4.4.3.1 feble Gw Alert Alana Setroint Calculatim me alert alann setpoint is the lesser of Sy 5 (SF x A"' x Dix R y S p5 (SF x AF) x Dp x Rp ODCM 56
3.4.4.3.1 Noblo Gin Alert Alarm [ctroint (hleulatlan (Onntintnt) Wheru Sg= Monitor setpoint tased an gamin radiation. Dr = Limit f 10 mrad /yr conservatively interpruted as a continuous release over a one par period. Rg a Manitor response per mrad /yr determined accortling to: C R ]( = ( (X/Q) My xQ1) Wheros My = Gmma 3 air dose factor (mrad /yr per uCi/m ). See Table A.1-2. Sp = Monitcr setpoint based on beta radiation. Dr = Limit of 20 mrad /yr conservatively interpreted as a continuous release over a an year period. Rp = Monitor response per mrad /yr determined acconting to: O c Rp = ( (X/Q) Ny xQ1) Where: Ng = Detagirdosefactor(mrad /yrper uC1/m ). See Table A.1-2. A sani-fixed alert alarm setpoint for the Plant thtit Vent Monitor (0-GT-RE-21) and Radwaste Dullding Vent Monitor (0-Gi-RE-10) is calculated using the following: (10 mrad /vri (.85)(AF) Setpoint (uCi/cc) = ( (X/Q) Pf xM yx Q) (5) 6 O ODCM 57
3.4.4.3.1 4tle Qtn Alert Alarm fictinint Oilculation inntirnavi) hherus Py = rrartional value of isotope expected, C /C 1 'T hhere Cg = hemWon b uCUcc of iso @. g = 'Ibtal Gaseous Activity flun USAR Table 11.1-1 AF = Either unit vent flow or Radeste Building vent fIcw divido1 by the canbined f1cu of the unit vent ard Radmoto iktilding vent. Q = Vent flow rate in ec/sec. Isotop3s uso1 and yP values are as folloast ISUIOPE fg Kr-85M .018 Kr-87 .010 Kr-88 .033 Xo-133M .017 Xe-133 .851 O Xe-135 .051 V Should this sani-fixed alert alam cause a continuous alarm con-dition, then actual setpoints will be calculated. 3.4.4.4 Particulate Anri Tortim Alarm SetTointa9 Setpoints for the gaseous of fluent partis -.w and iodine chan-nels are set using Cs-137 MPC for pirticulates and I-131 MPC for ( iodines. '1he following is the calculation used:
.LMfCy ) (AP) (SF)
Setpoint (uC1/cc) = (Q) (X/Q)
3.4.4.4 lurticulate Arvi Icxtim Alarn !btn ir}ts KX11tirurri) hhatm MPC 1
= 5 x 10-10 uCi/cc for Cs-137
= 1 x 10 -10 uC1/cc for I-131 AF = as defined pnniously l SF = .0625 for I-131 *
= .9375 for Cs-137 *
- derived fruu ratio of isotope activity (either I-
)
131 cr Cs-137) to sum of activity of Cs-137 and - I-131 found in USAR Table 11.1-1 for reactor coolant. 0 = vent flow in M 3 fggc This_will provide a hi alann setpaint. The alert alann set-point is 10% of th. . alann setpoint.
,O -
V ODCM 59 [ v l.
a A a. . - - k F I CUitt 3.1 DOUtJDAR Y FOR GASEOUS ErruJc;tTO (
; /
i _. R , 3 _.. _ _ _ _ ._. u_.,
~ ,. ..- , _ .,
s g ( fl -.
*.x ,
a .rvs
% s, g .
- .e %. sa
~
,._ v ,,N y L Yd k a r N
*",,.s 4 '"""\-
C \ s.au w a t > =-~ . s y) g l m . -. 6 3 ; -, .,
-ge t7 _.
\ ., L aygy u ~~
C rs,- 3.1 teur=84rr for Cagewt (f florett w / OstTe tom.ed (**(
- . (\a )pT \
x x
=. . .. ,
g p .- SM . e ** l ,-e . - 60 . l 1 l 3/91 1 1
l 4.0 1UPAL DOSP, b d
'Ihe annual (Calendar year) dose or dose ccmnitnent tc any MDGD1 OF ME PUFLIC due to releases of radioactivity and to radiation fmn uranium fuel cycle sources shall be limited to less than or equal to 25 nttuns to the whole body or any organ, except the thy-roid, which shall be lintited to less than or equal to 75 mmns.
4.1 Tuncrital Acticm With the calculatal doses fmn the rulease of radioactive m-terials in liquid or gaseous effluents exceeding twice the lintits : of Section 2.2a, 2.2b, 3.2.la, 3.2.lb, 3.2.2.a and 3.2.2b calcu- I latian should be mde including direct radiation contributions fmn the units and fmn outside storage tanks to detennine whe-ther the above limits of Section 4.0 above have been exceeded. If such is the case, prepam and subnit to the Ccmnission within 30 days, pursuant to Technical Specification 6.9.2, a special report that defines the corrective action to be taken to reduce subsequent releases to prevent recurrence of exceeding the above Ihnits. 'Ihis special report, as defined in 10 CFT120.405c, shall , include an analysis that estimtes the radiation exposure (dose) ! to a MDER OF ME PUBLIC fmn uranium fuel cycle sources, in-cluding all effluent pathways and direct radiation, for the ca-lendar year that includes the release (s) covered by this report. It shall also describe levels of radiation and concentrations of radioactive material involved, and the cause of the exposure le-vels or concentrations. If the estimted dose (s) exceeds the above lintits, and if the release condition resulting in violation ( of 40 CFR Part 190 has not already been corrected, the special report shall include a request for a variance in accordance with the provisions of 40 CFR Part 190. Subnittal of the repart is considered a timely request, and a variance is granted until staff action on the request is cmplete. 4.2 Surveillance Tkrtuimnanta 4.2.1 Cumulative dose contributions fmn liquid and gaseous effluents shall be determined in accordance with the methodology of Sec-tions 2.2 and 3.2 at least once par 31 days when the release of 1 radioactive materials in liquid or gaseous affluents exceed twice the limits of Section 2.2a, 2.2b, 3.2.la, 3.2.lb, 3.2.2a and 3.2.2b. Otherwise, no further evaluation is required. 4.2.2 Cumulative dose contribution fmn di. rect radiation fmn the reac-tor unit and fmn Radwaste storage tanks shall be detennined utilizing the results of routine plane perimeter surveys, TLD data or a cmbination of both, when necessary. This requimient is applicab]e only under conditions set forth in the remedial action abcrm. ODCM 61 O t 3/91
5.0 TW)1(Ymit's. IwmDMNI'AT. )(NI'IUWG IMUW1 () his section descritos the Radio 1cgical Env1.ronmntal Monitoring
' Program specified in Section 6.8.4 F of the Wolf Creek Technical >
Specifications. 5.1 Mmitnrim Prutragi Table 5-1 provides a schadule which describes the pthaeys, sp& cific locations, sample collection frequencies, and analyses to be performxt to imp 1 ment the Radiological Envirtmental Muni-toring Progrum. Figures 5.1 through 5.5 contain mps depicting sampling locations in relation to the WCGS site. Table 5-2 lista distances and di-rections to these locations frm the WoGS site. Table 5-3 lists requirrd detection capabilities for the analyses performrxi. 5.2 Iard uno Ormun A land Use Census shall be conducted anr.cally during tne gttwing season to identify the nearest (1) milk animal, (2) residence, and (3) garden of greater than 500 square feet producing brtad-leaf vegetation
- in each of the 16 noteorological sections within five miles of the NOGS site. Methods shall be used in conducting g3 the census that provide the best rusults, such as door-to-dcor V surveys, telephone surveys, consulting the U.S.D.A office in Burlington, inspection of aerial photographs of the area, or re-viwing leasing recortis for area farms and residences.
If a location (s) is identified which yields a calculated dose or dose cmmitment (via the sam exposum pthway) 20% greater Gun at a location frm which samples azu catrently being obtained, the new location (s) shall be added to the Radiological Environ-mntal Monitoring Program within 30 days as described in Table 5-1, tbte (1) . We indicator sampling location (s) having the icw-est cc.lculated dose or dose cmmitnent my then be deleted from the monitoring prTyram. The revision to Table 5-1 and the cor-responding Figure (s) as a result of such substitutions shall be documnted in accordance with Section 6.14 of the Wolf Creek
'Ibchnica1 Specifications.
The results of the Iand Uco Census shall be included in the An-nual Radiological Environmntal Operating Report describ:d in Sectlon 7.1.
- Broad leaf vegetation sampling of available vegetation my be ,
perfonned at the site boundary in each of two different direction ' sectors with the highest prulicted D/Os in lieu of the gattien census. Specifications for broad leaf vegetation sampling in
/ Table 5-1, Part 4.c. shall to followed, including analysis of Q] 0004 control samples.
62 3/91 1
l 5.3 Interlaborat_ory Crxigtrintr_Pruiram
'lhe antalysis hharatory contracted to analyze samples frcm the
('U} Padiological Envuumuntal Monitating Pagram participates in the PPA laboratory Intercomparison Pr: gram. Results of intertxxn-pnisons are provideri to VCt0C ncwinnnually in revisions to the l analysis laboratory's Quality Contrtl :nanual, a crntroLM copy ; of which is naintainad by the WC?OC Nuclear Services Divbion. A suntxiry of interccraparison retu)ts shall be included in the Annual Radiological Environmental Operating Report descriinJ in S(ction 7.1. 5.4 14Tnctim Ibxminvxs3tJ 5.4.1 _Artmnl Radin1mical_Parinnnmtal Operatim wxurt
'Ib meet the requirurents of Wolf Creek 'Ibchnical Sp3cification I 6.9.1.3, the Annual Radiological Erwironmental Operating Report ;
covering the prvvious year of operation shall be sulaittal to the NRC by May 1 of each year. 'Iha conta.t of this report is des-cribed in Section 7.1. 5.4.2 Srrnial it.vnrts A special report sh&ll be pmpamd and subnitted to the IRC { within 30 days if levels of radioactivity as a msult of plant : effluents detected in an environnental milum at a specified Joc- ! O ation exceed the reporting levels of Table 5-4 when averaged aver (d my cajendar quarter. The special ruport shall identify the causa(s) for exceeding the limit (s) and define the corrective ' ntions to be taken to ntuce ractioactive erfluents so that the i potential annual dose
- to a mmter of the publin is less than the I calendar year limits of Wolf Creek Technical Specification 6.8.4.e. When one or nore of the radionuclides in Table 5-4 are detected in the sampling natium, thin mport shall be subnittad '
if: Concentration i1) + Concentra11on f2) +,..>1.0 . Reporting level (1) Reporting Imm1 (2) ; When radionuclides other than those in Table 5-4 are detected and are the result of plant effluents, this report shall be subnittni , if the patential annual dose
- to a nenber of the public frcm all radionuclides is egaal to or gmater than the calendar year li-mits of Techidcal Specification 6.8.4.e. ,
i
*'Ihe nothodology and paraneters used to estinate the potential j annual riose to a netter of the public shall to indicatM in this report.
n ODCM 63 ( 3/91 s _ _ .,,m _ J
[u) O v (v) TABLE 5-1 RADIOLOGICAL ENVIROKTNTAL MONITMING PROGPlM Number of Samples Exposure Pathway / and Sareple Type and Frequency Sac!ple Type Sample Locations (1) Collection Frecuency of Anale:is i 1 AIRBORNE FIGURES 5.1 & 5.5 Rao , iodine and Samples from five locations Continuous sampler Analyze radiciodine Particulates operation with sample canister weekly for Samples from locations near collection weekly, or 1-131. the site boundary in three sec- more frequently if tors having the highest calcu- required by dust lated annual average D/0 (Loca- loading. tions 2,3 and.37 on Figure 5.1); Analyze particulate fil-Sarapie from che vicinity of ter weekly for gross beta a community having the activity (2); perform highest calculated annual quarterly gamma isotopic average D/Q (Location 32 analysis (3) composite (by on Figurt. 5.1, New Strawn); location). Sample from a control loca-tion 10-20 miles distant in a icw D/Q Sector (Location 40 on Figure 5.5). (11) CDCM 64 3/91
('n, p (/ V V TABLE S-1 (Con't.) RADIOLOGICAL ENVIR0l# ENTAL MONITORING PR0i; RAM g Number of Samples Exposure Pathway / and Sample Type and frequency Sample Type Sample Locations (1) Collection Frequency of Analysis
- 2. DIRECT RADIATION FIGURES 5.2 and 5.5 l (4) j 40 routine monitoring sta- Quarterly Gamoa dose quarterly j tions with two or more dosi- l meters measuring dose contin-uously, placed as follows:
An inner ring of stations, one ! in each meteorological sector , 0 - 3 mile range from the site ! (Locations 1 - 14, 18, 26 -31, ! 37, and 38 on Figure 5.2).
- An outer ring of stations, one ,
in each meteorological sector + in the 3 to 5 mile range from. l the site (Locations 15, 16, 17, ! 19 -22, 24, 25 and 32 - 36 on : Figure 5.2). l The balance of the stations to be placed in special interest ; areas such as population ren- i ters (Locations 23 and 32), i nearby residences (Many loca- 'l tions are near a residence), schools (Location 23), and in one or two areas to serve as control stations 10 - 20 miles distant from the site (Loca-l tions 39 and 40 ;n Figure 5.5). (11) ODCM 65 3/91
TABLE 5-1 (Con't.) , RADI0 LOGICAL ENVIRONMi MTAL MON!TORING PROGR/M i Number of Samples and Sample Type and Frequency l Exposure Pathway / c' Analysis j Sample Type Sample Locations (1) Collection Frecuency
- 3. WATERBORNE FIGURE 5.3 One sample upstream (5)(Loca- Monthly grab sample Monthly gama isotor c i Surface analysis (3) and com tion MUSH on Figure 5.3) and one sample downstream (Loca- posite for tr tium tion DC on Figure 5.3). analysis quarterly. i Samples from one or No sources Quarterly Quarterly ganma isotopic Ground analysis (3) and tritium only if likely to be affected analysis. ,
Indicator samples at ;ocations hydrologically downgradient of the site (Locations C-10, C-49 and D-65 on Figure 5.3); con-trol sample at a location hydro-logically upgradient of the site (Location B-12 on Figure 5.3). (6) I Sample of municipal water sup Monthly composite (7) Monthly gama isotopic Drinking analysis (3) and gross ply at an indicator location beta analysis of composite downstreara of the site (Loca- sample. Quarterly tritium ' tion LW-40 on Figure 5.5); con-trol sample from location up- analysis o' composites (8). stream of the site (Location BW-15 on Fiaure 5.3). i Semiannually Semiannual gamma iso-Shoreline One sample ' rom the vicinity topic analysis (3) Sediment of Wolf Creek Cooling Lake i discharge cove (Location DC on Figure 5.3). j 65 ODCM 3/91
- , .(
O O O
'd V 5,j TABLE 5-1 (Con't.)
RADIOLOGICAL ENVIR0fMENTAL NONITORING PROGRM I
~
5 Number of Samples Exposure Pathway / and Sample Type and Frequency { Sample Type Sample locations (1) Collection Frequency of Analysis l
- 4. INGESTION FIIGURES 5.4 AND 5.5 i
Milk Samples from milking animals at Semimonthly while Gama isotopic analysis three indicator locations with- animals are on pasture (3) and I-131 analysis in 5 miles of the site having (Apri to November); of each sample. the highest dose potential (cur- monthly at other times rently there are no locations (Decerber-March)(9) producing milk for human con- ! sumption within 5 miles of the , site); one sample from a control location greater than 10 miles from the site (Location 5-3 on Figure 5.5). (11). ; Fish Indicator samples of 1 to 3 re- Semiannually Gamma isotopic analysis i creationally important species (3) on edible portions. l from Wolf Creek Cooling Lake ; (several sampling areas indica-ted in Figure 5.4); control sam-ples of similar species from , John Redmond Reservoir Spillway , (indicated on Figure 5.4). Food Products Samples of available broadleaf Monthly sten avail- Gacna isotos;c analysis vegetation from two indicator able (9) (3) on edible portions. locations with highest calcu-lated annual average U/0 (Loca-tions A-1 and G-1 and alternata location R-1 on Figure 5.4); sen-
- ple of similar broadleaf vegeta- ;
tion from a control location 2 greater than 10 miles from the site in a low D/Q sector (Loca-
- tion S-4 on Figure 5.5).(11)
ODCM 67 3/91
(- y m , O O TABLE 5-1 (Con't.) RADIOLOGICAL ENVIR0le4 ENTAL MONITORING PROGRAM T,vSer of Samples Exposure Pathway /. and Sample Type and Frequency cs25ple Type sample Locations (1) Collection Frequency of Analysis
' 95 TION (cont'd) FIPJRES 5.4 and 5.5 Food Products 5xmple of crops irrigated with At time of harvest (10) Gamma isotopic analysis water f rom the Neosho River (3) on edible portions.
downstream of the Neosho River-Wolf Creek confluence (Loca-tions will vary from year to year, e.g., location NR-01 and and NR-D2 on Figure 5.5). ODCM 68 3/91
i TMUE 5-1 (gN'T. ) TABLE !DIATICUS (1) Dentiaticcs are pennitted f run the Itquilud sanpling schedule if , spvinens aro unobtainable due to hazardous conditions, scosonal unu 21 ability, nn1 function of autcuatic sanpling equipurt, and other legitivate reasons. If specimns are unobtainable due to j sanpling equipent un1 function, overy effort shall be unde to i ccuplete oormctive action prior to the end of the next sanpling period. All deviations frun the sanpling schedule shall be do- , cununted in the Annual Radiological Environnontal Operating Re- 1 I port describcd in Section 7.1. It is recognized that, at tines, it nay not be possible or ! practicable to continue to obtain sanples of the nodia of choico I at the nest desirtd location or tine. In these instances, enitable specific alternative nrxiin and locations nny be chosen for the p rticular patJuy in question and appropriate substi- ' tutions nade within 30 days. Revisions to this Table ard to the l corresponding Figurn(s) as a result of such substitutions shall be documented in accordance with Section 6.14 of Walf Creek Gbchnical Specifications. 1his docunentation shall provide in-form tion identifying the cause of the unavailability of sanples for that patJuay and justifying the selection of the new loca-tion (s) for obtaining samples. ! A (2) Airtorne particulate sanple filters shall be analyzed for gross ' () beta radioactivity 24 hours or noto af ter sanpling to alkw for Rn-220 and Rn-222 daughter decay. If gross beta activity in air i particulate sanples is greater than 10 tines the yearly nmn of , control sanples, ganna isotopic analysis shall be perforntx1 on ' the individual sanples. ! (3) Ganna isotopic analysis nnans the identification and quan- , tification of gannn-unitting radionuclides that uny be at- ' tributable to the effluents frun the facility. (4) One or nore instrunents, such as a pressurized ion chantor, for l nmsuring and reconiing dose rate continuously nay be used in l place of, or in addition to, integrating dosineters. For the ! purposes of this table, a thenichzninescent dosinnter (TLD) is ! considertd to be one phosphor; two or note phosphors in a packet I are considered as two or note dosinnters. F11Jn badges shall not { be used as dosineters for nuasuring direct radiation. The 40 i stations is not an absolute number. 'Ihe number of dixtw rad-iation_ nonitoring stations nay be reduced according to geogra-phical 112nitations, e.g. , scue sectors are over water so that the number of dosineters nny be reduccd accordingly. The fre-quency of analysis or readout for the TU systan depends upon the characteristics of the specific systan used and is selected to obtain optimtrn dose infornation with mininal fading. ODCM 69 3/91
TNyE 5-1 (UN'T. i b U TAllLE IUTATIG4S (5) 'Ihe " upstream" sanple is taken at a distanco tcyond significant influence of the dischargo. (6) Gmund water samples shall te taken when this sourco is tagxd for drinking or irrigation purposes in areas whero tho hydraulic gradient or rocharge pwporties am suitable for contandnation. (7) A ccritosito sanple is ano in which the quantity (aliquot) of 11guld sanpled is consistemt over the sanpling period and in which the nothod of sanpling (nployed results in a specimm that is representativo of the 11guld concentrato. In tJds program, composito sanple aliquots shall be collected at tino intervals that are very short (e.g., overy tw hours) rulative to the cam- , positing period (o.g., nontJ0y) in order to assuru obtaining a ; reprusentativo sanple. (8) If the doso calculated for consunption of water (using OD04 nothodology and parannters) execuls one millirun per year, can-posite sanpling at the indicator location shall be perfonnsi overy two weeks and I-131 analysis shall be perfonmd on the canposito sanples. (9) Milk and tuxudleaf vegetation sanples am often tanporarily, but , not pentanently, unavailable at the scheduled sanplo collection l ( tines. Alternato sanpling locations nny therefore be listcd in : the Table and usod at these tines to provido continued noni- > toring of these pathways. If sanples are considered parnunently l unavailable at a location, another location will be selectcd (if available) as describod in tbte (1). (10) If harvest occurs nore than once a year, sanpling shall be per- i fonrad during each discrete harvest. If harvest occurs contin-uously, sanpling shall tu nonthly. Attention shall be m id to including sanples of tuberous and mot food products. (11) 'Ihe purpose of this sanple is to obtain background infornation. j If it is not practical to establish control locations in accor-dance with the distanco and wind direction critoria, other sites that provide valid background data nuy te substituted. l l j_ 0D04 70 l-I. l 1 Q 3/91 i
O O O TABLE 5-2 SAMLING LOCATION NUPEERS, DISTANCES (miles) AND DIRECTIONS TLD and Air Particulate Location Distance / Location Distance / Location Distance / Location Distance / Number Direction Number Direction Number Direction Number Direction 1 1.4/N fl 1.6/E 21 3.8/S 31 3.0/WNW 2 2.7/N 12 1.8/ESE 22 4.1/SSW 32 3.2/WNW 3 3.0/NNE 13 1.5/SE ?3 4.5/SW 33 3.7/WNW 4 4.0/NNE .14 2.6/SE 24 4.1/WSW 34 4.0/NW 5 4.0/NE 15 4.5/ESE 25 3.6/W 35 4.6/NNW 6 4.4/ENE 16 4.2/E 26 2.6/WSW 36 4.2/N 7 1.9/NE 17 3.6/SE 27 2.1/SW 37 2.1/NNW 8 1.6/NNE 18 3.2/SSE 28 2.8/SW 38 1.2/NW 9 2.0/ENE 19 4.0/SSE 29 2.6/SSW 39 13.0/N 10 2.4/ENE 20 3.3/5 30 2.2/W 40 >15.0/WMW Groundwater Drinkina Water Surface Water , B-12 2.2/NNE BW-15 3.9/SW MUSH 3.6/W C-10 2.8/W LW-40 10/SSE DC 0.6/WNW C-49 2.9/SW D-65 3.9/S Milk and Food Products A-1 1.4/N R-1 2.1/NNW G-1 1.6/SE S-3 >15.0/WNW S-4 >15.0/WNW Fish Shoreline Sediments Irricated Crops WCLL DC 0.6/WFN NR-D1 9.El: l JRR 4/W NR-02 >10/S i i 00CM 71
O O O TABLE.5-3 DETECTION CAPABILITIES FOR ENVIRONMENTAL SAMPLE ANALYSIS III LOWER LIMIT OF DETECTION'(LLD) (2,3) i. ANALY.<IS ' WATER . FISH MILK FOOD PRODUCTS SEDIMENT l (pCill) AIRBORNEPARTIg) OR GAS (pCi/m LATE
.(pCi/kg, wet) (pCi/1) .(pCi/kg, wet) (pCi/kg. dry) l l Gross Beta 0.01 4 ! -
f H-3 2000(4) j i Mn-54 15 130 i Fe-59 30 260 l Co-58, 60 15 130 Zn-65 30 260 ! l
- 4 Zr-Nb-95 15 ;
{ I-131 1(5). 0.07 1 60 f Cs-134 :15 0.05 130 15 60. 150 - 0.06 i Cs-137 18 150 18 80 180 Ba-La-140 15 15 , r I
. i i
i ! [ I I 1 1 j t . ODCM 72 3/91 i i :
~ _ - . - -.
,TNEE 5-3 ICahl'T. )
/G TMILE IMATIONS (1) 'Ihis list does not nmn that ordy these nuclides aru to be con-sidemd. 7ther peaks that a m identifiable, together with those of the above nuclides, shall also be analyzed and riported in the Annual Radiological Envircrmantal Operating Report describcd 3 in Scct. ion .1. l (2) Required detection cambilities for thereluntinescent dosinnters ! used for envirmnental noasurments shall be in accordanco with ! the recumurdations of Regulatory Guide 4.13, Revision 1,1977. ; (3) The LID is defined, as the anallest concentration of radioactive noterial in a sample that will yield a net count, above systm tackground, that will be detected with 95% pro M bility with only 5% protability of falsely concluding that a blank observation represents a "ruala signal. For a particuler neasurmont systm, which nny include radio-chmical separation: 4.66 Sb E V 2.22 Y exp (- 2 o t) Wheret / \ U LLD = the "a priori" lower limit of detection (picoChriet per unit nass or volume), S b
= the standard deviation of the tackground counting rate or of the counting rate of a blank sample as appropriate (counts per minuto),
E = the counting effIcie .:y (counts per disintegration), V = the sample size (units of ass or volune), 2.22 = the nunter of disintegrations per minute per picocurie, Y = the fractional radiochmdcal yield, when applicable, J = the radioagive decay constant for the particular radto-nuclide (s ), and : i At = the elapsed tine between sample collection, or end of ! the sample collection period, and tino of counting (s). i Typical values of E, V, Y, and A t should be used in the cal-culation. COCM 73 3/91 ( x
i i 1 l TAIVE 5-3 IGN'T.1 0 -- It should te wcognized that the LID is defined as an a priori (tefore the fact) 11ntit mpmsenting the capability of a nm-surutant syntan and nor as an a costeriori (af ter the fact.) limit for a particular uns lurent. Analyses shall Le perform.d in such a Itanner that the stated LIDS will be acideved under routino canditions. Occasionally inckgmund fluctuations, un-avoidable snall sample sizes, the pmsence of interfering nuc-lides, or other uncont rollable circumstances my mader these LLDs unachievable. In such cases, the contrituting factors shall to identified and described in the Annual Radiological , Environnental Operating Report descriled in Section 7.1. { (4) LLD for drinking water samples. If no drinking water pathway exf sts, a value of 3000 pC1/ liter my te used. (5) LID for drinking water sampics. If no drink.ing water pathway > exists, the LID of ganna isotopic analysis nay be used. l O ODCM 74 i'91
~
TABLE 5-4 , REPORT 3NG LEVELS FOR RADI0 ACTIVITY CONCENTRATIONS IN ENVIRONMENTAL SAMPLES , REPORTING LEVELS-ANAliSIS FATER AIRBORNEPARTIgULATE FISH- MILK FOOD PRODUCTS (pCi/ ' OR. GAS (pCi/m )' (pCi/kg, wet) (pCii') (pCi/kg, wet) H-3 20,000* , Mn 53 1,000 30,000 Fe-59 400 10,000 i Co-58 1,000 30,000 Co-60 300 10,000 _a-65 300 20,000 Zr-Nb-95 400 I-131 2- 0.9 3 100 Cs-134 30 10 1,000 60 1,000 Cs-137 50 20 2,000 70 2,000 Ba-la-140 200 300
*For drinking water samples. This is 40 CFR Part 141 value. If no drinking water. pathway exists,. a value of 30,000 pCi/l may be used. ,
ODCM 75 3/91
FIGURE 5.1
~
I l \ )A---- - h ~~~~
;R
\
j , x B f [Y
/
~'
e / . l
,1 JEJ , ),
3,,.n: i,U 1
.f 4
T '
, O _ _ /_ ..
l I
'::s::*( 'l .
/ \
~
Y ,l/ ~~~ N / A ' a ~T~ E Ic h _,
~1- / b
'-- [h
~_
e j ._ P I _ ' '
)
[_
- 3 ,
' a, .
l N f: k s
') "7/M'4@ /
]
1 91 _)y l l 'ty/ i
-jy/ N~
ef ( f
-2
~ ~ \ \
f ~ u_ ,1 s&. -%,$'k.f, h,---\~~ ' -
>V t<
.L N e
~.
~. . ' n\
' G1\j W
[_ . ) i _ 8
/ \ / >\
s ~'~i7 /
/-
i ri J,_f ( Ti " , \f'd___i\ hn ,f k o. E !V l- f AIRBORNE PATHWAY SAMPLING- LOCATIONS
*- AIRBORNE PARTICULATE AND RADIOlODINE O o>:x >e
FIGJRC 5,2 I l l l s [A i I A ,/ ! l AR \j , .., ,,
/ By f' ~ ~ ~ ~
- x. 3., .e/
... w-
~
~
. e
~
- Y$ f$ i [lC '
~~
J~./J , \ s l, =:'Q@x{ .7%,.~4 .- . .,,'N - ,4,~~
$ vi ..11 \-- pal-"1.a u' /.,
+ . ... n . .
,/, i,' - f1\6~ ,
.c.. .. : , 'N6:.5%', ,, - 1's/ 7 /__/...
,/ /r et, ' *
#, ~,.~
i v.,~ -
, . j t ,;. w p mf : - ,
' A *" b ' '
y' 2 5 -
-u --- .
l i iE N @f- '
^
x( 1 i n- ___ --
. . t,4, C I
' y; -
f
-f'/ A yi /1 _ '
s l ' n: '\ 2: . t 7 e an, \\
) #{' ) rb N .s g- si i
e i,/ . ., . ,/ .
/ 2> \ ;s h' .
l*l l
^
-\ Al l ly. x~E.$$ g Jb)Wst
';. / i Q g ,
f,
'l"R --T~ \,0 -
l L Q'( Nr ~.;;,..j fi,> \*~~ > } , Gl^~~ ' lY
/ 3 \ V , \, -
., / h . K 1; > \ , ;
p/
~
'\ ) ,y
~..: K's8 <
j '4l ,
\
-y,H l.
("~~^'tn ~
\
s \.s. rj_i - _-_ , ,~ J 1V( ,- i - N\ m f ,l. t < DIRECT- RADIATION PATHWAY SAMPLING LOCATIONS
=- TLD LOCATIONS ODCM 77 0
FIGURE 5.3 i )A~ ~~ h Y
~~~~
O x '" Q/ f_ "4 i
! M 4 , Xc ~~
fd[/! ~1f ~y./s/ f h~~ \ s
~
i,..n: b-T,
~
' la; W* ,y L w
\ /A /
m/ ' ~2- ~~~ N / . k \ is 'l' E D',[ ~" i' ,_ j\ x - _ j /[ N -- -- s, pri a 'Q / ,
=~ \ s !
l
<?Q /} '
ps I, %')'
\
Yh O e'Ensig
^
'-n J \ T V {"
M f ' -)1., }=f i j\ ia o y~ f a
/ i J
~K.i ~f ,J \ ff ,.h.
kn J !V" l } WATERBORNE PATHWAY SAMPLING LOCATIONS
*- DRINKING WATER A-SURFACE WATER m-GROUND WATER v-SHORELINE SEDIMENT ODCM 78
. . .. - - . ... . _ _ . - . . . . . . . - - - . . - . _ - = _ . -
i FICURE 5.4
\ )A h Y Q -R
) ,- ,-- - Bj ' ----
N / ____ x w
/ !
l[ ___ _ __
..T h
[' J'"[ p' ) 4.1 f
%~
W/A *
./.
... f
/\ \\
o
\
' ~EA'b7 (N l. ,j \,
( r> _.f
,-) ~= 4
=c - . - - _ _ .. ____
f ; /W g ~. ' y j
-l : t!p ' __ s
//' J -
e t (_ ] /
\! A .
J y g , fN Ff O _ MMsgh N Hgp '-'
\
1// &? i'L l 1......, l /
.G, ;---
j y f _ ,. t~ i s
/ \ ~
_ .' s C,
- l) l I j 4K ,j
\ f g ; r --
INGESTION PATHWAY . SAMPLING LOCATIONS m-FOOD PRCDUCTS i G-FISH (WCCL) A-FISH (JRR) g i O_ ,,
.- . . _ . . . -- .-.-_.-.->,.-~~u-s,-n a.. . . .
l FIGURE 5.5_ _- 7 m y - -
- .g ,
3 (a) s OLO u,8. 50 , e t 10 IdlL g WAVERLYh i
,\
F A_2 .?i g '1 M40 SUMMIT E s-.. b) s u,Le y
*o*Y I ras iss
.. i i s
Ti 7, l {" - m 1 o 5is
\ **. io y 2 '( T<
_.\ 4 o sunu <ag, ,j LsIn 1 I I 83 $
& ~,.., /!
e w. *
.wom otev
~
v {j l g _ h no-os f f " DISTANT SAMPLING LOCATIONS
*-TLD -a-DRINKING WATER 4- MILK *-BROADLEAF VEGETATION /
IRRIGATED CROPS ODCN 80 l~ 1
6.e ivas (j- he bases contained on the succetxiing pages surmarizes the gen-eral requirements of Section 2.0, 3.0, 4.0 and 5.0 of the ODCM. l t Sectim 2.0 Linuiti Efflumts l Section 2.10nonntantion i mis section is provided to ensure that the concentration of rad-ioactive materials released in liquid waste effluents to UN-luSTRICTED AREAS will be less than the concentration levels spe-cified in 10 CFR Part 20, Appendix B, Table II, Column 2. This limitation provides additional assurance that the levels of rad-ioac't.ivo naterials in bodies of water in UNRFSTRICTED AREAS will ! result in exposures within: (1) the Section II.A design objec- i tives of Aroendix I,10 CFR Part 50, to a MEMBER OF mE PUBLIC, ' and (2) the limits of 10 CPR Part 20.106(e) to the population. We concentration limit for dissolved or entrained nobles gases is based upon the assunption that Xe-135 is the controlling rad- ! loisotope and its MPC in air (subersion) was converted to an ! equivalent concentration in water using the nethods described in ; International Comission on Radiological Protection (ICRP) Put>- lication 2. l
}
me required detection capabilities for radioactive naterials in j liquid waste samples are tabulated in terms of the lower limits i of detection (LLDs). Detailed discussion of the LLD, and other (G ) detection limits can be found in HASL Procedures Manual, HASL-300 (revised annually), Currie, L.A., " Limits for Qualitative Detec-tion and Quantitative Determination - Applicati0n to Radio-chemistry," Anal. Chm. 40, 586-93 (1968), and Hartwell, J.K.,
" Detection Limits for Radioanalytical Counting Techniques, "At-lantic Richfield Hanford Cmpany Report ARH-SA-215 (June 1975).
ODCM 81 m) 3/91
l Strtion 2.2 Rxm (3 -i
' )
Thin section is provided to implemnt the requitumnts of Section II.A, III.A and IV.A of Appendix I, 10 CFR Part 50. We rmedial action inplements the guides set forth in Section II.A of Appen-dix I and provides the requiral operating flexibility and at the sam tinn inplment the guides set forth in Section IV.A of Ap-pendix I to assure that the releases of radioaccive naterial in liquid effluents to UNRESTRICI'ED AREAS will be kept *as low as is reasonably achievable." Also, for fresh water sites with drink-ing water supplies that can be potentially affccted by plant ope-rations ,there is reasonable assurance that the operation of the facility will not result in radionuclide concentrations in the ; finished drinking water that are in excess of the requirments of i 40 CFR Part 141. 'Ihe dose calculation nethodology and paraneters i in the ODCM implment the requixunents in Section III.A of Ap-pendix I which specify that confontence with the guides of Ap-pendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MDIBER OF '1ES PUBLIC through appropriate pathe ys is unlikely to be substantially un- i detestimted. '1he equations specified in the ODCM for calcu-lating the doses due to the actual release rates of radioactive , mterials in liquid effluents are consistent with the nethodology provided in Regulatory Guide 1.169, " Calculation of Annual Doses to Man frm Routine Releases of Reactor Effluents for the Purpose of Evaluating Cmpliance with 10 CFR Part 50, Appendix I, "Revi- ; sion 1, October 1977 and Regulatory Guide 1.113, "Estim ting rs- Aquatic Dispersion of Effluents frun Accidental and Routine Rmetor Releases for the Purpose of Implmenting Aprendix I," April 1977. ; Section 2.3 Linuid Radwnste Tmatzmt Systm The OPERABILITY of the Liquid Radwaste Treatment Systms ensures i that this system will be available for use whenever liquid ef- ; fluents require treatnent prior to release to the environnent. ' The rapirement that the appropriate portions of this systen be used when specified provides assurance that the releases of ra-dioactive m terials in liquid effluents will be kept "as low as is reasonably achievable." 'Ihis section inplemnts the require-nents of 10 CFR Part 50.36a, General Design Criterion 60 of Ap-penriix A to 10 CFR Part 50 and design objective given in Section II.D of Appendix I to 10 CPR Part 50. The specified limits go- i verning the use of appropriate partions of the Liquid Radwaste Treatment System were specified as a suitable fraction of the dose design objective set forth in Section II.A of Appendix I, 10 CFR Part 50, for liquid effluents. ODCM 82 m b 3/91
Section 2.4 lbdianctivo Liquid Eff1tsmt Manitnelm pg Instnamtation ~( The radioactive liquid effluent instrunnntation is pInvided to nrxtitor and control, as applicable, the releases of radioactive mterials in liquid effluents during actual or potential mleases of liquid effluents. We Alarm / Trip Setpoints for these instru-nonts shall be calculated and adjusted in accordance with the methodology and paranntats in the ODCM to ensure that the alarm / trip will occur prior to excooding the limits of 10 CPR Part 20. We OPERABILITY and use of this instnmentation is con-sistent with the requixurents of General Design Criteria 60, 63, and 64 of Appondi.x A to 10 CPR Part 50. l Section 3.0 Guxnm Effltunta l Section 3.1 Done Rate mis section is provided to ensuru that the dose at any tinn at and beyond the SITE DOUNDARY frun gaseous effluents frun a11 units on the site will be within the annual dose limits of 10 CFR < Part 20 to UNRES'IRICTED AREAS. We annual dose limits are the ! doses associated with the concentrations of 10 CFR Part 20, Ap-pendix B, Table II, Column 1. %ese limits provide reasonable assurance that radioactive material discharged in gaseous ef-fluents will not msult in the exposure of a MEMBER OF ME PUBLIC in an UNRES'IRICTED AREA, either within or outside the SITE , A BOUNDARY, to annual average concentrations exceeding the limits ! Q specified in Appendix B, Table II of 10 CFR Part 20 (10 CFR 20.106(b)). For MEMBERS OF ME PUBLIC who nay at times be within ! the SITE BOUNDARY, the occupancy of that MENBER OF ME PUBLIC w2.11 usually be suificiently low to campensate for any increase in the atnespheric diffusion factor above that for the SITE DOUNDARY. Se speciff exi mlease rate limits restrict, at all , tires, the corresponding gamna and beta dose rates above back- i ground to a MERBER OF ME PUBLIC at or beyond the SITE DOUNDARY to less than or equal to 500 mruns/ year to the whole body or to less than or equal to 3000 mruns/ year to the skin. % ese release rate limits also restrict, at all tines the corresponding thyroid dose rate above background to a child via the inhalation pathway , to less than or equal to 1500 mrems/ year, i i The required detection capsbilities for radioact.tve materials in ' gasecus waste samnles are tabulated in terms of the lower limits of detection (LLDs). Detailed discussion of the LLD, and other detection limits can be found in HASL Procedures Manual, HAS1-300 (reviscxi annually), Currie, L.A. , " Limits for Qualitative Detec-tion and Quantitative Determination - Application to Radio-chemistry," Anal. Chem 40, 586-93 (1968), and Hartwell, J.K.,
" Detection Limits for Radioanalytical Counting Techniques," At-lantic Richfield Hanford Ccmpany Report ARH-SA-215 (June 1975) .
ODCM 83 A V 3/91
fkrt_lan 3.2.1 Doon - Mtle Game This section is provided to inp1 ment the requirments of Section b II.8, III.A and IV.A of Apperriix I, 10 CFR Part 50. We mwxilal action implments the guides set forth in Section II.B of Ap-perxiix I and provides the required operating flexibility and at the sano tine inp1 ment the guides cet forth in Section IV.A of AIpendix I to assure that the releases of radioactive naterial in gaaecus effluents to UNRES'IRICTED ARFIS will be kept "as low as is reasonably achievable." %e surveillance requirments inple-nent the IU1uirments in Section III.A of Apperviix I that con-fornance with the guides of Appervilx I be shown by calculational procedures based on nadels and data suen that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is un- , likely to be substantially underestinated. %e dose calculation nothodology and paraneters established in the ODCM for calcu- i lating the doses due to the actual release rates of radioactive noterials in gaseous effluents are consistent with the notho-dology provided in Regulatory Guide 1.109, " Calculation of Annual Doscs to Man frun Routine Releases of Reactor Effluents for the Purpose of Fvaluating Cmpliance with 10 CFR Part 50, Appuviix , I," Revision 1, October 1977 and Regulatory Guide 1.111, "Mechods for Estinating Atnespheric Transport and Dispersion of Gaseous Effluents in Routine Releases fmn Light -Water Cooled Reactors," Revision 1.-July 1977. She ODCM equations provided for deter- ! mining the air doses at and beyond the SITE BOUNDARY are based i upon either the historical average or real tine atmospheric con- ; ditions, j f-k I ODCM 84 .p d 3/91
Section 3.2.2 Ihm - Todire-131 ard 133, Tritium ard niylicactive Material in Particulate Fbnu This section is provided to imp 1 ment the requirments of Scc-tions II.C, III.A and IV.A of Appendix I, 10 CFR Part 50. The rwedial actions are the guides set forth in Section II.C of Ap-pendix I, ard provide the required operating flexibility and at the sane time implment the guides set forth in Scction IV. A of Apperxiix I to assure that the mleases of radioactive mterials in gaseous effluents to UNRESTRICTED AREAS will be kept "as Icw as is reasonably achievable." The 00CM calculational nethods specifie:1 in the curveillance requirments implment the require- j i ments in Section III.A of Appendix I that conformnce with the guides of Appendix I be shr.xn by calculational procedures insed on nodels and data, such that the actual exposum of a MEM3ER OF THE PUBLIC through appropriate pathways is unlikely to be sub-stantially underestimted. The ODCM calculational nothodology and paraneters for calculating the doses due to the actual re-lease rates of the subject m terials are consistent with the nethodology provided in Regulatory Guide 1.109, " Calculational of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Cmpliance with 10 CFR Part 50, Appendix I," Revision 1, October 1977 and Regulatory Guide 1.111,
" Methods for Estimating Atnospheric Transport and Dispersion of ,
Gaseous Effluents in Routine Releases fmn Light-Water-Cooled Reactors," Revision 1, July 1977. These equations also provide for determining the actual doses based upon either the historical average or mal time conditions. The release rate limits for t lodine-L51 and 133, tritium, and radionuclides in particulate form with half lives greater that 8 days are dependent upon the existing radionuclide pathways to nun, in the areas at and beyond the SITE BOUNDARY. The pathways that were examined in the de-velopnent of these calculations were: (1) individual inhalation , of airborne radionuclides, (2) deposition of radionuclides onto green leafy vegetation with subsequent consuuption by mn, (3) deposition onto grassy areas where milk anim]s and meat pro-ducing animla graze with consumption of the milk and meat by nan, and (4) deposition on the grrund with subsequent exposure of mn . Section 3.3 Garanis IWhnste Tmt_mnt System The OPERABILITY of the WASTE GAS HGLDUP SYSTEM ard the VErffIIA-TION EXHAUST TREA3MEtf1' SYSTEM ensures that the systems will be available for use whenever gaseous effluents require trestnent prior to release to the environment. The requirenent that the appropriate portions of this systen be used when specified pro-vides reasonable assurance that the releases of radioactive ma-terials in gaseous effluents will be kept "as low as is reason-ably achievable." This section impleents the requitwents of 10 CFR 50.36a, General Design Criterion 60 of Appendix A to 10 CFR Part 50 and the design objectives given in Section II,D of Ap-pendix I to 10 CFR Part 50. 'Ihe specified limits governing the s- use of appropriate portions of the systms wre sp ;ified as a s suitable fraction of the dose design objectives set forth in Sec-tion II.B and II.C of Appendix I, 10 CFR Part 50, for gaseous effluents. ODCM 85 3/91
Sec tian 3.4 Rrlicactive Gancrus Eff1trmt Mmitoring Instnamtatim The radioactive gaseous ef fluent instnmentation is provided to , nonitor and control, as applicable, the mleases of radioactive naterials in gaseous effluents during actual or potential re- , leases of gaseous effluents. The Alann/ Trip Setpoints for these j instrunents shall be adjusted to values calculated in accordance with the nethodology and parannters in the 000i to ensum that the alann/ trip will occur prior to excecxiing the limits of 10 CFR i Part 20. The OPERABILITY and use of this instnmentation is con- ! sistent with the requirments of Canacal Design Criteria 60, 63 and 64 of Appendix A to 10 CFR Part 50. The sensitivity of any noble gas activity nonitor used to show cmpliance with the gaseous effluent release requimrento of Soction 3.2 shall be such that concentrations as low as 1 x 10- uCi/cc are neasur- - able. Sectim 4.0 4btal Ibse this section is provided to noet the dose limitations of 40 CFR Part 190 that have been incorporated into 10 CFR Part 20 by 46 FR 19525. The section requires the pmparation and subnittal of a special report whenever the calculated doses due to releases of radioactivity and the radiation frm uranium fuel cycle sources exceed 25 mrems to the whole body or any organ, except the thy-roid, which shall be limited to less than or equal to 75 mrms. O For sites containing up tc four reactors, it is highly unlikely that the resultant dose to a MEMBER OF TUE PUBLIC will exceed the dase limits of 40 CFR Part 190 if the individual reactors mnain within twice the dose design objectives of Appendix I, and if direct radiation doses frm the reactor units and fmn outside storage tanks are kept small. The Special Report will describe a course of action that should result in the limitation of the an- . nual dose to a MEMBER OF THE PUBLIC to within tha 40 CFR Part 190 limits. For the purposes of the Special Report, it nay be as-sumed that the dose cmnitment to the MEMBER OF THE PUBLIC from other uranium fuel cycle sources is negligible, with the excep-tion that dose contributions frm other nuclear fuel cycle facil-ities at the same site or within a radius of 8 )cn must be con-sidered. If the dose to any MEMBER OF THE PUBLIC is estinated to exceed the requirments of 40 CFR Part 190, the Special Report. with a request for a variance (provided the release conditions resulting in violation of 40 CFR Part 190 have not alrmdy been corrected), in accordance with the provisions of 40 CFR 190.11 and 10 CFR 20.405c, is considered to be a tinely request and ful-fills the requimrents of 40 CFR Part 190 until NRC staff action is empleted. The variance only relates to the limits of 40 CFR Part 190, and does not apply in any way to the other mquirments for dose limitation of 10 CFR Part 20. An individual is not con-sidered a MEMBER OF THE PUBLIC during any period in which he/she is engaged in carrying out any operation that is part of the l nuclear fuel cycle. l O ODCM 86 3/91
Sectim 5.0 Ikritological Envimmontal Rnitorim Prtnrum 'q Section 5.1 Mnitorim Prmram The Radiological Environmental Monitoring Program provides m-presentative noasumtents of radiation and of radioactive i materials in those exposure pathways and for those radionuclides i that load to the highest potential radiation exposures of MEMBERS i OF THE PUBLIC resulting fmn the station operation. This moni-toring program implenents Section IV.E.2 of Appendix I to 10 CFR l Part 50 and thereby supplenents the Radiological Effluent Moni- ! toring Program by verifying that the umsurable concentrations of radioactive naterials and levels of radiation are not higher than expected on the basis of the effluent neasumrents and the nodeling of the environnental exposura pathways. Guidance for this nonitoring program is provided by the Radiological Asscss-nent Branch 7bchnical Position on Environnental Monitoring, Re-vision 1, Novutter 1979. The required detection capabilities for environm mtal sample ana-lyses are tabulated in tenns of the lower limits of detection (IlDs ) . The LIDS are considered optimum for routine environ-nental neasureinnts in industrial laboratories. It should be recognized that the LLD is defined as an a, priori (before the fact) limit representing the capability of a neasumtent systan and not as an an a r;osteriori (after the fact) limit for a par-ticular measummnt. Detailed discussion of the LLD, and other detection limits, can be found in HASL Procedures Manual, HASL-300 (revised annually), Currie, L.A., " Limits for Qualitative Detection and Quantitative Detennination-Application to Radiochenistry," Anal. Chm. 40, 586-93 (1968), and Hartwell, J.K., " Detection Limits for Radio-analytical Counting Techniques," Atlantic Richfield Hanford Com-pany Report A_RH-SA-215 (June 1975). prtian 5.2 Iarrt um Ommm 7his section is providal to ensure that changes in the use of areas at and beyond the SITE BOUNDARY are identifiErl and that modifications to the Radiological Environnental Monitoring Pro-gram given in the CCCM are nade if required by the results of this census. Information that will provide the best results, such as door-to-door survey, aerial survey, or consulting with local agricultural authorities, shall be used. This census sa-tisfies the requiments of Section IV.B.3 of Apperriix I to 10 CFRgart50. Restricting the census to gardens of greater than 50 m provides assurance that significant exposure pathways via leafy vegetables will be identified and nonitored since a garden of this size is the minimum required to produce the quantity (26 i kg/ year) of leafy vegetables assune in Regulatory Guide 1.109 Cor consumption by a child. l ODCM 87 l l 3/91
Section 5.2 Tarri the crumun (Continued)
,rg .'( ,) To detennine this mininun getden size, the following assunptions were unde: (1) 20% of the garden was used for growing broad leaf vegetation (i.e., simil y to lettuce and cabbage), and (2) a veg-etation yield of 2 kg/m .
section 5.3 Intrr. laboratory ctwnrinan F11xumu The requirment for participation in an approved Interlaboratory Comparison Prcxpcun is provided to ensure that independent checks on the precielon and accuracy of the neasurments of radioactive naterial in environmental sample natrices are perforned as part of the quality assurance program for environmental nonitoring in order to dmonstrate that the results are valid for the purposes i of Section IV.B.2 of Append.tx I to 10 CFh Part 50. m 0004 88 fh-3/91
7.0 REIUUS n 7.1 Nintal Ikrifolacilml Envimrarrital Operatim Hooort lb' -
%e Annual Radiological Environmental Operating Report shall in-clude simunries, interpretations, and an analysis of trets of the results of the radiological environnental surveillance ac-tivities for the report period, including a comparison with pre-operational stuiles, with operational controls and with previous i environnental surveillance reports, and an assessmnt of the ob- :
served impacts of the plant operation on the envirtinnent. We reports shall also include the results of the land Use Census described in Section 5.2. We Anntul Radiological. divironmental Operating Report shall in-clude the results of N elysis of all radiological environmental samples and of all ovironnental radiation masurur. ants taken during the period pursuant to the locations specified in Teble 5-1 as well as sunnarized and tabulated results of these analyses and measurements in the fornat of the table in the Radiological Assessment Branch Technical Position, Revision 1, ikwember 1979. In the event that scue individual results are not available for inclusion with the report, the report shall be suhnitted noting and explaining the reasons for the missing results. We missing data shall be subattted as soon as possible in a supplenuntary report. q % e reports shall also include the following a sunnury de-(y scription of the Radiological Environwntal Monitoring Program;
. legible maps covering all sampling locations keyed to a table giving distances and directions from the centerline of the reac-tor;_the results of licensee participation in the Interlaboratory Cmparison Program and the corrective acti.ons being taken if the specified program is not being performed as required by Section 5.3; reasons for not conducting the Radiological Environaental Program as required by Section 5.1 with plans for preventing a recurrence and discussion of all deviations fram the sampling.
schedule of Table 5-1; discussion of environmental sample mea-surements that exceed the reporting levels of Table 5-4 bat are not the result of plant effluents, and discussions of all analyses in which the ILD required by Table 5-3 was not achiev-able. 7.2 Smianntal Railoactive Efflixmt Release Report The Semiannual Radioactive Effluent Release Reports shall include a simunry of the quantities of radioactive liquid and gaseous effluents and solid waste released frm the Unit as outlined in Regulat.ory Guide 1.21, " Measuring, Evaluating, and Reporting i Radioactivity in Solid Wastes and Releases of Radioactive Materials in Liquid and Gaseous Effluents frm Light-Water-Cooled Nuclear Pow r Plants," Revision 1, June 1974, with data A ODCM 89
) 3/91
7.2 Seminnnual IWilmetive Rffhrmt iblmso IWnrt (Continixd) i surmarized on a quarterly basis following the fontat of Appendix
\
B thereof. For solid wastes, the fourat for Table 3 in Appendix B shall be supplemnted with three additional categories: class of solid waste (as defined by 10 CFR Part 60), type of container (e.g. , LSA, Type A, Type B, large Quantity), and SOLIDIFICATION ! agent or absorbent (e.g. , cenent, uma fontaldehyde) . ! l
%e Saniannual Radioactive Effluent Relece Report to be subnit- I ted 60 days after January 1 of each year shall also include an l' annual summry of hourly noteorological data collected over the previous year. 21s annual sar.muy may M either in tne fann of an hour-by-hour listhg oa magnetic tape of wind speetl, wind dir-ection, and atnespheric stability, and precipitation (if
. measumd), or in the fonn of joint frequency distributions of _ wird speed, wind direction, and etmspheric stability.* Wis sane report shall include an assessnent of the radiation doses due to the radioactive liquid and gaseous ef fluents released frun the Unit or Station during the previous calendar year. 'Ihis sane report shall also include an assessment of the radiation doses fran radioactive liquid and gaseous effluents to MEMBERS OF 'lHE PUBLIC due to their activities inside the SITE BOUNDARY during the report period using historical average atmosphere conditions. All ass'imptions used in naking these assessnents, i.e. , specific activity, exposure tine and location, shall M included in these reports. We neteorological conditions con-n current with the tine of release of radioactive naterials in Q gaseous effluents, as detennined by sampling frequency and nea-surement, shall be used for detennining the gaseous pathway doses. We assessnent of radiation doses shall be performd in accordance with the nethcdology and parameters in the OTM. We Semiannua) Radioactive Effluent Release Report to be sub-mitted within 60 days after January 1 of each year shall also [ include an assessnent of radiation doses to the likely mst ex-posed MEMBER OF THE PUBLIC frun reactor releases and other nearby uranium fuel cycle sources, including doses fran prinary effluent pathways and direct radiat. ion, for the previous calendar year to show confornunce with 40 CFR Part 190, " environmental Radiation Protection Standards for Nuclear Po er Operation." Acceptable methods for calculating the dose contribution fran liquid and gaseous effluents are given in Regulatory Guide 1.109, Rev. 1, October 1977. The Saniannual Radioactive Effluent Release Report shall include:
- a. A list and description of unplanned releases frun the site to UNRESTRICI'ED AREAS of radioactive materials in gaseous and liquid effluents made during the reporting period.
ODCM 90 C h 3/91
7 . '! Smianntn1 Rixiloactive Effhwrit M1mno Rxnrt (Prxxtiraxx1)
- b. Any changes nude during the mporting period to the 00CM, pursuant to 'Ibchnical Specification 6.14.
- c. Major changes to the Radwaste Tmatznnt Systems for the period in which the evaluation was nuiewul and accepted by the P3RC. 'Iha discussion of each change shall contain:
*ln lieu of suhnission with the Satiannual RadioactJve Effluent Release Report, the licensee has the option of Artaining this stumary of requinr1 metcorological data on site in a file that shall be provided to the !@C upon Iuluest.
l) A sunnary of the evaluation that led to the detennination that the change could be made in accordance with 10 C..t ' 50.59;
- 2) Sufficient detailed infonmtion co totally support the reason for tha change without benefit of additicnal and suppleental infonmtion;
- 3) A detailed description of the equirnent, cmponents, and processes involved ano the interfaces with other plant ,
systms.
- 4) An evaluation of the change wttich shows the praticted mleases of radioactive nuterials in liquid and gaseous O. effluents and/or quantity of solid mste that dif fer fram those provicusly pradicted in the license application and anendments thereto;
- 5) An evaluation of the change, t,ttich shows the expectN maxinun exposures to a MTBIR OF THE PUBLIC in the UN-RES'IRICI'ED ^REA and to the general population that differ _
frun those previously estfrated in the license appli-cation and amendments thereto;
- 6) A comparison of the predicted mleases of radioactive naterials, in liquid and gaseous effluents and in solid waste, to the actual releases for the period prior to when the changes are to be made;
- 7) An estinate of the exposure to plant operating personnel as a result of the change; and
- 8) Documentation of the fact that the change was reviewed ,
and found acceptable by the PSRC. !
- d. A listing of new locations for dose calculations identified by the land Use Census, OCG 91 3/91
7.2 Smiarvunl Rvlimetiwtiffitrmt Ih11mso Ikxnrt (Ctutintrdj
- e. A description cf the events loading to liquid holdup tanks or (V) gas storage tanks excesiing the limits of Technical Speci-fication 3.11.1.4 or J.11.2.6 respcctively,
- f. An explanation as to why the inoperability of a liquid or gaseous effluent nonitoring instrumentation was not corrected within the tire specified,
- g. A description of the events lead'ng to a missed sample re-quired by Table 2-1 c;r 3-1.
(
\
l l' I l i ODCM 92 l)
'( y 3/91
O APIYMMX A Dose Conversion Factor Tables O
" ~'
O
TNVE A.1-l* i% BIGACClMULATION F1CKRS 'IO BP, USED IN
.- ()
THE ABSENCE OF SITE-SPECIFIC DATA (pCi/kg per pCi/ liter) FRESHMG'ER ELEPJ27P FISH H 9.0E-01 C 4.6E 03 Na 1.0E 02 P 1.0E 05 Cr 2.0E 02 Mn 4.0E 02 Fe 1.0E 02 Co 5.0E 01 - NL 1.0E 02 Cu 5.0E 01 Zn 2.0E 03 Br 4.2E 02 Rb 2.0E 03 Sr 3.0E 01 Y 2.5E 01 Zr 3.3E 00 Nb 3.0E 04 Mo 1.0E 01 7t 1.5E 01 e Ru 1.0E 01
.( Rh 1.0E 01 7b 4.0E 02 I. 1.5E 01 Cs 2.0B 03
.Da 4.0E 00 La 2.5E 01 Ce 1.0E 00 _
Pr 2.5E 01 Nd 2.5E 01 W 1.2E 03
'Np 1.0E 01
**Ag 2.3E 00
**Sb 1.0E 00
*Taken fran Regulatory Guide 1.109 (Rev.1)
**Taken fran Regulatory Guide 1.109 (Rev. 0)
ODCM A-2 l
f~% /
.V D) M[\
TABLE A.1-2 DOSE FACTORS FOR NOBLE GASES AND DAUGHTERS
- Total Body .
Gamma Air Beta Air. Dose Factor Skin Dose Factor. Dose Factor Dose Factor Kg .L; My N4 i.adionuclide (mrem /vr per uCi/m3) (mrem /vr Der uCifu3) (mrad /vr per uCi/m3) (mrad /vr ter uCi/m3)
.;;r-83M 7.56E-02** ---
1.93E+01 .2.88E+02
'Er-85M 1.17E+03 1.46E+03 ,1.23E+03 1.97E+03 Kr-85 1.61E+01 1.34E+03 1.72E+01 -1.95E+03 Kr-87 5.92E+03 9.73E+03 6.17E+03 1.03E+04 Kr-88 1.47E+04 2.37E+03 1.52E+04 2.93E+03 Kr-89 1.66E+04 1.01E+04 1.73E+04 1.06E+04 Kr-90 1.56E+04 7.29E+03 1.63E+04 7.83E+03 Xe-131H 9.15E+0] 4.76E+02 1.56E+02 1.11E+03 Xe-133 2.94E+02 3.06E+02 3.53E+02 1.05E+03 Xe-133M 2.51E+02 9.94E+02 3.27E+02 1.48E+03
.Xe-135M 3.12E+03 7.11E+02 3.36E+03 7.39E+02 Xe-135 1.81E+03 1.86E+03 1.92E+03 2.46E+03 Xe-137 1.42E+03 1.22E+04 1.51E+03 1.27E+04 Xe-138 8.83E+03 4.13E+03 9.21E+03 4.75E+03 Ar-41 8.84Ef03 2.69E+03 9.30E+03 3.2SE+03
- Based on Regulatory. Guide 1.109 (Rev. 1).
**7.56E-02 = 7.56 x 10 -2 ODCM A-3
- - - - - - - ~ - - - --
l TMME A.2-1* IMIAIATION DOSE FACITS FOR ADULTS (MREM PER PCI IMIALED) NUCLIDE EONE LIVER T DODY ' THYROID KTDNEY LUtO GI-LLI H 3 to DATA 1.58E-07 1.58E-07 1.58S-07 1.58E-07 1.58E-07 1.58E-07 C 14 2.27E-06 4.26E-07 4.26E-07 4.26E-07 4.26E-07 4.26E-07 4.26E-07 NA- 24 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06 P 32 1.65E-04 9.64E-06 6.26E-06 to DATA 10 DATA 10 DATA 1.08E-05 CR 51 to DATA 10 DATA 1.25E-08 7.44E-09 2.85E-09 1.80E-06 4.15E-07 _MN 54 to DATA 4.95E-06 7.87E-07 to DATA 1.23E-06 1.75E-04 9.67E-06 MN 56 to DATA 1.55E-10 2.29E-11 10 DATA 1.63E-10 1.18E-06 2.53E-06 FE 55 3.07E-06 2.12E-06 4.93E-07 10 DATA 10 DATA 9.01E-06 7.54E-07 FE 59- 1.47E-06 3.47E-06 1.32E-06 to DATA 10 DATA 1.27E-04 2.35E-05 f CO 58 to DATA 1.98E-07 2.59E-07 10 DATA 10 DATA 1.16E 94 1.33E-05 CO 60 10 DATA 1.44E-06 1.85E-06 to DATA 10 DATA 7.46E-04 3.56E-05 NI 63 5,40E-05 3.93E-06 1.81E-06 to DATA to DATA 2.23E-05 1.67E-06 NI 65 1.92E 2.62E-11 1.14E-11 to DATA 10 DATA 7.00E-07 1.54E-06 CU 64 10 DATA 1.83E-10 7.69E-ll 10 DATA 5.78E-10 8.48E-07 6.12E-06 g ZN 65 4.05E-06 1.29E-05 5.82E-06 TO DATA 8.62E-06 1.08E-04 6.68E-06 ZN 69 4.23E-12 8.14E-12 5.65E-13 NO DATA 5.27E-12 1.15E-07 2.04E-09 BR 83 to DATA NO DATA 3.01E-08 10 DATA 10 DATA 10 DATA 2.90E-08 BR 84 10 DATA to DATA 3.91E-08 10 DATA to DATA 10 DATA 2.05E-13 BR 85 to DATA NO DM'A 1.60E-09 to DATA 10 DATA 10 DATA LT E-24 RB 86 10 DATA 1.69E-05 7.37E-06 10 DATA FO DATA 10 DATA 2.08E-06 RB -88 10 DATA 4.84E-08 2.41E-08 NO DATA NO DATA to DATA 4.18E-19 RB 89 to DATA 3.20E-08 2.12E-08 to DATA NO DATA NO DATA 1.16E-21 SR 89- 3.80E-05 to DATA 1.09E-06 NO DATA NO DATA 1.75E-04 4.37E-05 _SR 90- 1.24E-02 10 DATA 7.62E-04 to DATA to DATA- 1.20E-03 9.02E-05 SR 91 7.74E-09 to DATA 3.13E-10 to DATA to DATA 4.56E-06 2.39E-05 SR 92 c $3E-10 NO DATA 3.64E-ll 10 DATA 10 DATA 2.06E-06 5.38E-06 Y 90 2.61E-07 NO DATA 7.01E-09 to DATA FO DATA 2.12E-05 6.32E-05 Y 91M 3.26E-11 to DATA 1.27E-12 NO DATA NO DATA 2.40E-07 1.66E-10 Y 91 5.78E-05 10 DATA 1.55E-06 to DATA 10 DATA 2.13E-04 4.81E-05
.Y l'. 29 E-09 to DATA 3.77E-11 10 DATA to DATA 1.96E 9.19E-06
~92
- *Taken frun Regulatory Guide 1.109 (Rev.1)
A-4
G - TMNE A.2-1 (cont'd) ItEIATATION DOSE FACIORS IT]R ADULTS (MREM PER PCI IMiALED) tRCLIDE TONE LIVER T BODY THYtOID KIDNEY LUtG GI-ILI Y 93 1.18E-08 to DATA 3.26E-10 10 DATA 10 DATA 6.06E-06 5.27E-05 ZR 95 1.34E-05 4.30E-06 2.91E-06 10 DATA 6.77E-06 2.21E-04 1.88E-05 ZR 97 1.21E-08 2.45E-09 1.13E-09 to DATA 3.71E-09 9.84E-06 6.54E-05 NB 95 1.76E-06 9.77E-07 5.26E-07 10 LATA 9.67E-07 6.31E-05 1.30E-05 MO 99 to DATA 1.51E-08 2.87E-09 to DATA 3.64E-08 1.14E-05 3.10E-05 7C 99M 1.29E-13 3.64E-13 4.63E-12 to DATA 5.52E-12 9.55E-08 5.20E-07 TC 101 5.22E-15 7.52E-15 7.38E-14 10 DATA 1.35E-13 4.99E-08 1.36E-21 RU 103 1.91E-07 to DATA 8.23E-08 to DATA 7.29E-07 6.31E-05 1.38E-05 Ep 105 9.80E-11 to DATA 3.89E-11 to DATA 1.27E-10 1.37E-06 6.02E-06 RU 106 8.642-06 to DATA 1.09E-06 10 DATA 1.67E-05 1.17E-03 1.14E-04 1G 110M 1.35E-06 1.25E-06 7.43E-07 10 DATA 2.4GE-06 5.79E-04 3.78E-05 TE 125M 4.27E-07 1.98E-07 5.84E-08 1.31E-07 1.55E-06 3.92E-05 8.83E-06 TE 127M 1.58E-06 7.21E-07 1.96E-07 4.11E-07 5.72E-06 1.20E-04 1.87E-05 TE 127 1.75E-10 8.03E-11 3.87E-11 1.32E-10 6.37E-10 8.14E-07 7.17E-06 TE 129M 1.22E-06 5.84E-07 1.98E-07 4.30E-07 4.57E-06 1.45E-04 4.79E-05 (. -
' TE 129 6.22E-12 2.99E-12 1.55E-12 4.87E-12 2.34E-11 2.42E-07 1.96E-08 TE 131M 8.74E-09 5.45E-09 3.63E-09 6.88E-09 3.86E- 9 1.82E-05 6.95E-05 TE 131 1,39E-12 7.44E-13 4.49E-13 1.17E-12 5.46E-12 1.74E-07 2.30E-09 TE 132- 3.25E-08 2.69E 2.02E-08 2.37E-08 1.82E-07 3.60E-05 6.37E-05 I -130 5.72E-07 1.68E-06 6.60E-07 1.42E-04 2.61E-06 10 DATA 9.61E-07 I 131 3.15E-06 4.47E-06 2.56E-06 1.49E-03 7.66E-06 to DATA 7.85E-07
-I 132 1.45E-07 4.07E-07 1.45E-07 '.43E-05 6.48E-07 to DATA 5.08E-08 I 133 1.08E-06 1.85E-06 5.65E-07 e.69E-04 3.23E-06 to DATA 1.11E-06 I 134 8.05E-08 2.16E-07 7.69E-08 3.73E-06 3.44E-07 to DATA 1.26E-10 I 135 3.35E-07 8.73E-07 3.21E-07 5.60E-05 1.39E-06 to DATA 6.56E-07 CS 134 4.66E-05 1.06E-04 9.10E-05 to DATA 3.59E-05 1.22E-05 1.30E-06 CS 136 4.88E-06 1.83E-05 1.38E-05 to DATA 1.07E-05 1.50E-06 1.46E-06 CS 137 5.98E-05 7.76E-05 5.35E-05 10 DATA 2.78E-05 9.40E-06 1.05E-06 CS 138 4.14E-08 7.76E-08 4.05E-08 to DATA 6.00E-08 6.07E-09 2.33E-13 BA- 139 1.17E-10' 8.32E-14 3.42E-12 10 DATA 7.78E-14 4.70E-07 1.12E-07 A-5
-O
f's ( TAIRE A.2-1 (ccrit'd) IlefAIATICN DOSE F/CIWS KR ADUL'IS (MRD4 PER PCI 11aiALED)
?RCLIDE PONE LIVER T EODY 'IHYROID KIDNEY LUtG GI-ILI BA 140 4.88E-06 6.13E-09 3.21E-07 10 DATA 2.09E-09 1.59E-04 2.73E-05 1R 141 1.25E-11 9.41E-15 4.20E-13 10 DATA 8.75E-15 2.42E-07 1.45E-17 fw 142 3,29E-12 3.38E-15 2.07E-13 to DATA 2.86E-15 1.49E-07 1.96E-26 IA 140 4.30E-08 2.17E-08 5.73E-09 10 DATA 10 DATA 1.70E-05 5.73E-05 IA 142 8.54E-11 3.88E-11 9.65E.12 10 DATA 10 DATA 7 . 91E--07 2.64E-07
_C_E,__141 2.49E-06 1.69E-06 1.91E-07 to DATA 7.83E-07 4.52E-05 1.50E,95 CE 143 2.33E-08 1. */ 2E-08 1.91E-09 NO DATA 7.60E-09 9.97E-06 2.83E-05 CE 144 4.29E-04 1.79E-04 2.30E-05 to DATA 1.06E-04 9.72I:-04 1.02E-04 PR 143 1.17E-06 4.69E-07 5.80E-08 10 DATA 2.70E-07 3. 51 E- 05 2.50E-05 PR 144 3.76E-12 1.56E-12 1.91E-13 to DATA 8.81E-13 1.27E-07 2.69E-18 ND 147 6.59E-07 7.62E-07 4.56E-08 to DATA 4.45E-07 2.76E-05 2.16E-05 W 187 1.06E-09 8.85E-10 3.10E-10 to DATA 10 DATA 3.63E-06 1.94E-05 NP 239 2.87E-08 2.82E-09 1.55E-09 10 DATA 8.75E-09 4.70E-06 1.49E-05 O V A-6 0
._ _ _ _ --. _ _ _ .-- . _ _ _ - - . . _ . . - _m q TALLE A.2-2*
-b ItalAIATICH DOSE FACIORS FOR TEEtFCER (MREM PER PCI DelALED) NUCLIDE BOffE - LIVFR T IODY '111YROID KIDNEY LUtG GI-ILI H 3 10 DATA 1.59E-07 1.59E-07 1.59E-07 1.59E-07 1.59E-07 1.59E-07 C- 14 3.25E-06 6.09E-07 6.09E-07 6.09E-07 6.09E-07 6.09E-07 6.09E-07 NA' 24 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 P 32 2.36E-04 1.37E-05 8.95E-06 10 DATA 10 DATA 10 DATA 1.16E-05 CR 51 10 DATA 10 DATA 1.69E-08 9.37E-09 3.84E-09 2.62E-06 3.75E-07 MN 54 to DATA 6.39(-06 1.05E-06 10 DATA 1.59E-06 2.48E-04 8.35E-06 MN 56 10 DATA 2.12E-10 3.15E-11 to DATA 2.24E-10 1.90E-06 ~7.18E-06 FE 55 4.18E-06 2.98E-06 6.93E-07 10 DATA to DATA 1.55E-05 7.99E-07 FE 59 1.99E-06 4.62E-06 1.79E-06 to DATA -to DATA 1.91E-04 2.23E-05 CO 58 to DATA 2.59E-07 3.47E-07 to DATA to DATA 1.68E-04 1.19E-05 CO 60 to DATA 1.89E-06 2.48E to DATA 10 DATA 1,09E-03 3.24E-05 NI 63 7.25E-05 5.43E-06 2.47E-06 to DATA 10 DATA 3.84E-05 1.77E-06 NI 65 2.73E-10 3.66E-11 1.59E-31 10 DATA 10 DATA 1.17E-06 4.59E-06 CU 64 10 DATA 2.54E-10 1.06E-10 to DATA 8.01E-10 1.39E-06 7.68E-06 ZN 65 4.82E-06 1.67E-05 7.80E-06 to DATA 1.08E-05 1.55E-04 5.83E-06 ZN- 69 6.04E-12 1.15E-11 8.07E-13 to DATA 7.53E-12 1.98E-07 3.56E-08 BR 83 10 DATA 10 DATA 4.30E-09 10 DATA 10 DATA NO DATA LT E-24 BR 94 10 DATA ?O DATA 5.41E-08 10 DATA 10 DATA NO DATA LT E-24 BR 85 to DATA 10 DATA 2.29E-09 10 DATA NO DATA 10 DATA LT E-24 RB 86 to DATA 2.38E-05 1.05E-05 10 DATA 10 DATA NO DATA 2.21E-06 RB -88 NO DATA 6.82E,Q8 3.40E-08 to DATA to DATA- to TATA 3.65E-15 RB 89 10 DATA 4.40E-08 2.91E-08 10 DATA 10 DATA 10 DATA 4.22E-17 SR 89 5.43E-05 10 DATA 1.56E-06 NO DATA to DATA 3.02E-04 4,64E '05 SR 90 1.35E-02 NO DATA 8.35E-04 10 DATA 10 DATA 2.06E-03 9.56E-05
.SR 91 1.10E-08 NO DATA 4.39E-10 10 DATA 10 DATA 7.59E-06 3.24E-05 SR 92 1.19E-09 NO DATA 5.08E-11 NO DATA 10 DATA 3.43E-06 1.49E-05 Y 90 3.73E-07 10 DATA 1.00E-08 10 DATA 10 DATA 3.66E-05 6. 99E -05 Y 91M 4.63E-11 to DATA 1.77E-12 to DATA 10 DATA 4.00E-07 3.77E-09 Y 91 8.26E-05 NO DATA 2.21E-06 to DATA 10 DATA 3.67E-04 5 11E-05 Y 92 1.84E-09 NO DATA 5.36E ' NO DATA 10 DATA - 3.35E-06 2.06E-05 *Taken frun Regulatory Guide 1.109 (Rev.1)
A-7
TMER A.2-2 (cont'd) ItEAIATION DOSE FACIORS 10R TEEt#GER (MRD4 PER FCI IIEALED) FOCLIDE BONE LIVER T DODY TinTOID KTDNEY IU?U GI-ILI Y 93 1.69E-08 to DATA 4.65E-10 10 DATA 10 DATA 1.04E-05 7.24E-05 ZR 95 1.82E-05 5.73E-06 3.94E-06 10 DATA 8.42E-06 3.3bE-04 1.86E-05 _ZR 97 1.72E-08 3.40E-09 1.57E-09 10 DATA 5.15E-09 1.62E-05 7.88E-05 NB 95 2.32E-06 1.29E-06 7.08E-07 10 DATA 1.25E-06 9.39E-05 3.21E-05 FO 99 10 DATA 2.11E-08 4.03E-09 10 DATA 5.14E-08 1.92E-05 3.36E-05
'IC 99M 1.73E-13 4.83E-13 6.24E-12 10 DATA 7.20E-12 1.44E-07 7.66E-07
'IC 101' 7.40E-15 1.05E-14 1.03E-13 10 DATA 1.90E-13 8.34E-01 1.09E-16 RU 103 2.63E-07 to DATA 1.12E-07 to DATA 9.29E-07 9.79E-05 1.36E-05 RU 105 1.40E-10 10 DA'l?, 5.42E-11 10 DATA ' 76E-10
. 2.27E-06 1.13E-05 RU 106 1.23E-05 ID DATA 1.55E-06 to DATA 2.38E-05 2.01E-03 1.20E-04 AG -110M. 1.73E-06 1.64E-06 9.99E-07 10 DATA 3.13E-06 8.44E-04 3.41E-05 TE 125M 6.10E-07 2.80E-07 8.34E-08 1.75E-07 10 DATA 6.70E-05 9.38E-06 TE 127M 2.25E-06 1.02E-06 2.73E-07 5.48E-07 8.17E- 06 2.07E-04 1.99E-05 TE 127 2.51E-10 1.14E-10 5.52E-11 1.77E-10 9.10E-10 1.40E-06 1.01E-05
' p TE 129M 1.74E-06 8.23E-07 2.8]E-07 5.72E-07 6.49E-06 2.47E-04 5.06E-05 O TE 129 0.87E-12 4.22E-12 2.20E-12 6.48E-12 3.32E-11 4.12E-07 2.02E-07 TE 131M 1.23E-08 7.51E-09 5.03E-09 9.069-09 5.49E-08 2.97E-05 7.76E-65 _TE 131 1.97E-12 1.04E-12 6.30E-13 1.55E 42 7.72E-12 2.92E-07 1.89E-09 TE 132 4.50E-08 3.63E-08 2.74E-08 3.07E-08 2.44E-07 5.61E-05 5.79E-05 I 130 7.80E-07 -2.24E-06 8.9eE-07 1. 86E -04 3.44E-06 10 DATA 1.14E-06 I 131 4.43E-06 6.14E-06 3.30E-06 1.83E-03 1.05b-05 to DATA 8.11E-07
-I. 132 1.99E 5.47E-07 1.97E-07 1. 89B-05 8.65E-07 10 DATA 1.59E-07 I 133 -1.52E-06 2.56E-06 7.78E-07 3.65E-04 4.49E-06 10 DATA 1.29E-06
.I 134 1.11E-07 2.90E-07 1.05E-07 4.94E-06 4.58E-07 to DATA 2.55E-09 I 135 4.62E 1.18E-06 4.36E-07 7.76E-05 1.86E-06 10 DATA 8.69E-07 CS 134 .6.28E-05 1.41E-04 6.86E-05 to DATA 4.69E-05 1.83E-05 1.22E-06 CS' 136 6.44E-06 2.42E-05 1.71E-05 FO DATA 1.38E-05 2.22E-06 l'.36E-06 CS 137 8.38E-05 1.06E-04 3.89E-05 10 DATA 3.80E-05 1.51E-05 1.06E-06 CS '13e 5.82E-08 1.07e-07 5.58E-08 ic DATA 8.28E-0C 9.84E-09 3.38E-11
- BA 139 1.67E-10 1.18E-13 4.87E-12 to DATA 1.11E-13 8.08E-07 8.06E-07 A-8 O
TMEE A.2-2 (cont'd) l DalAIATION DOSE F/CIORS FOR TEDEER (MRD4 PER PCI DEALED)
-tRCLIDE BONE LIVER T EODY 'IHYROID KIDNEY UEO GI-ILI BA 140 6.84E-06 8.38E-09 4.40E-07 10 DATA 2.85E-09 2.54E-04 2.86E-05 BA 141 1.78E-11 1.32E-14 5.93E-13 10 DATA 1.23E-14 4.11E-07 9.33E-14 PA 142 4.62,E-12 4. 63E-15 2.84E-13 10 DATA 3.92E-15 2.39E-07 5.99E-20 IA 140 5.99E-08 2.95E-08 7.82E-09 to DATA 10 DATA 2.68E-05 6.09E-05 IA 142 1.20E-10 5.31E-11 1.32E-11 10 DATA 10 DATA 1.27E-06 1.50E-06 CE 141 3.55E-06 2.37E-06 2.71E-07 10 DATA 1.11E-06 7.67E-05 1.58E-05 CE 143 3.32E-08 2.42E-08 2.70E-09 10 DATA 1.08E-08 1.63E-05 3.19E-05 CE 144 6.11E-04 2.53E-04 3.28E-05 to DATA 1.51E-04 1.67E-03 1.08E-04 PR 143 1.67E-06 6.64E-07 8.28E-08 to DATA 3.86E-07 6.04E-05 2.67E-05 PR 144 5.37E-12 2.20E-12 2.72E-13 10 DATA 1.26E-12 2.19E-07 2.94E-14 to 147 9.83E 1.07E-0C 6.41E-08 10 DATA 6.28E-07 4.65E-05 2.28E-05 W 187 1.50E-09 1.22E-09 4. 29E-10 PO DATA 10 DATA 5.92E-06 2.21E-05 NP 239 4.23E-08 3.99E-09 2.21E-09 10 DATA 1.25E-08 8.11E-06 1.65E-05 O
A-9 O
TAIRE A.2-3* INHAIATION DOSE FACIORS 10R CHILD (MREM PER PCI INHALED) NUCLIDE BONE LIVER T DODY THYROID KIDNEY LUTO GI-LLI H 3 to DATA 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07 C 14 9.70E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 NA 24 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 P 32 7.04E-04 3.09E-05 2.67E-05 10 DATA 10 DATA NO DATA 1.14E-05 CR 51 to DATA to DATA 4.17E-08 2.31E-08 6.57E-09 4.59E-06 2.93E-07 MN 54 10 DATA 1.16E-05 2.57E-06 to DATA 2.71E-06 4.26E-04 6.19E-06 MN 56 NO DATA 4.48E-10 8.43E-11 10 DATA 4.52E-10 3.55E-06 3.33E-05 FE 55 1.28E-05 6.80E-06 2.10E-06 10 DATA 10 DATA 3.00E-05 7.75E-07 FE 59 5.59E-06 9.04E-06 4 . 51.E-06 to DATA 10 DATA 3.43E-04 1.9]E-05 CO 58 NO DATA 4.79E-07 8.55E-07 10 DATA to DATA 2.99E-04 9.29E-06
'CO 60 to DATA 3.55E-06 6.12E-06 to DATA 10 DATA 1.91E-03 2.60E-05 NI 63 2.22E-04 1.25E-05 7.56E-06 10 DATA 10 DATA 7.43E-05 1.71E-06 NI 65 8.08E-10 7.99E-11 4.44E-11 10 DATA 10 DATA 2.21E-06 2.27E-05 CU 64 10 DATA 5.39E-10 2.90E-10 10 DATA 1.63E-09 2.59E-06 9.92E-06 ZN 65 1.15E-05 3.06E-05 1.909-05 ?O DATA 1.93E-05 2.69E-04 4.41E-06 ZN 69- 1.81E-11 -2.61E-11 2.41E-12 to DATA 1.58E-11 3.84E-07 2.75E-06 BR 83 10 DATA NO DATA 1.28E-07 10 DATA 10 DATA NO DATA LT E-24
_BR 84 10 DATA to DATA 1.4BE-07 NO DATA NO DATA 10 DATA LT E-24 BR 85 to DATA to DATA 6.84E-09 10 DATA 10 DATA 10 DATA LT E-24 RB 86' FO DATA 5.36E 3.09E-05 10 DATA to DATA NO DATA 2.16E-06 BB P8 to DATA 1.52E-07 9.90E-08 to DATA 10 DATA to DATA 4.66E-09 RB 89 10 DATA 9.33E-08 7.83E-08 to DATA 10 DATA to DATA 5.11E-10
'SR 89 1 62E-04 10 DATA 4.66E-06 NO DATA FO DATA 5.83E-04 4.52E-05 SR 90 2.73E-02 to DATA 1.74E-03 to DATA 10 DATA 3.99E-03 9.28E-05 SR 91- 3.28E-08 10 DATA 1.24E-09 NO DATA 10 DATA 1.445'.05 4.70E-05 SR 92 3.54E-09 NO DATA 1.42E-10 10 DATA 10 DATA 6.49E-;6 6.55E-05 Y 90 1.11E-06 to DATA 2.99E-08 to DATA PO DATA 7.07E 7.24E-05 Y 91M .1.37E-10 NO DATA 4.98E-12 NO DATA 10 DATA 7.60E-07 4.64E-07
-Y 91 2.47E-04 10 DATA 6.59E-06 NO DATA 10 DATA 7.10E-04 4.97E-05 Y 92 5-50E-09
. NO DATA 1.57E-10 NO DATA 10 DATA 6.46E-06 6.46E-05
*Taken frtm Regulatory Guide 1.109 (Rev. 1)
l f.= . TAlVP. A.2-3 (aunt.'d) 110' '.ATION DOSE FICIUG FUt Cl!IID (MRD4 PI71 ICI ItailsLED) MCA DE INE 1,IVD1 T KOY '111YROID KIDNE"/ IM GI-IL1 Y 93 5.04E-08 10 DATA 1.38E-09 10 DATA 10 DATA 2.01E-05 1.05E-04 ZR 95 5.13E-05 1.13E-05 1.00E-05 10 DATA 1.61E-05 6.03E-04 1.65E-05 ZR 97 5.07E-08 " 34E-09
. 4.32E-09 10 twTA 1.05E-08 3.06r-05 9.49E-05 lin 95 6.35E-06 2.48E d5 1.77E-00 10 IATA 2.33E-06 1.66E-04 1.00E-05 10 99 10 DATA 4.66E-08 1.15E-08 10 IATA 1.06E-07 3.66E-05 3.42E-05
'IC 99M 4.81E-13 9.41E-13 1.56E-11 r0 DATA ' 37E-11
., 2.57E-07 1.30E-06
'IC 101 2.19E-14 1.30E-14 2.91E-13 10 UATA 3.92E-13 1.58E-07 4.41E-09 RU 103 7.55E-07 10 DATA 2.90E-07 10 DATA 1.90E-06 1.79E-04 1.21E-05 RU 105 4.13E-10 !? DATA 1.50E-10 10 IATA 3.63E-10 4.30E-06 2.69E-05 RU 106 3.680-05 lo DATA 4.57E-06 10 DATA 4.97E-05 3.87E-03 1.16E-04 IC 110M 4.56E-06 3.08E-06 2.47E-06 10 DATA 5.74E-06 1.48E-03 2.71E-05 TE 125M 1.8?E-06 6.29E-07 2.47E-07 5 2_QE-07 to 1%TA 1.29E-04 9.13E-q6 TE 127M 6.72E-06 2.31E-06 8.16E-07 1.64E-06 1.72E-05 4.00E-04 1.93E-05
- 1E 127 7.49E-10 2.57E-10 1.65E-10 5.30E-10 1.91E-09 2.71E-06 1.52E-05 TE 129M 5.19E-06 1.85E-06 8 22E-07 1.71E-06 1.36E-05 4.76E-04 4.91E-05 7E 129 2.64E-11 9.45E-12 6. 44 D-12 1.93E-11 6.49E-11 7.93E-07 6.89E-06 TE 131M 3.63E-08 1.60E-08 1.37E-08 2.64E-08 1.08E-07 5.56E-05 8.32E-05 TE 1 11 5.87E-12 2.20E-12 1.78E-12 4.59E-12 1.59E-11 5.55E-07 3.60E-07 TE 132 1.30E-07 7.36E-08 7.12E-08 8.58E-08 4.79E-07 1.02E-04 3.72E-05 I 130 2.21E-06 4.43E-06 2.28E-06 4.99E-04 6.61E-06 10 DATA 1.38E-06 I 131 1.30E-05 1.30E-05 7.37E-06 4.39E-03 2.13E-05 10 DATA 7.68E-07 I 132 5.72E-07 1.10E-06 5.07E-07 5.23E-05 1.69E-06 10 DATA 8.65E-07 I 133 4.48E-06 5.49E-06 2.08E-Oti 1.04E-03 9.13E-06 10 DATA 1.48E-06 1 134 3.17E-07 5.84E-07 2.69E 07 1.37E-05 8.92E-07 to DATA 2.58E-07 I 135 1.33E-06 2.36E-06 1.12E- 06 2.14E-04 3.62E-06 to DATA 1.20E-06 CS 134 1.76E-04 2.74E-04 6.07E-05 10 DATA 8.93E-05 3.27E-05 1.04E-06 CS 136 1.76E-05 4.62E-05 L14E-05 to DATA 2.58E-05 3.93E-06 1.1]E-06 CS 137 2.45E-04 2.23E-04 3.47E-05 10 DATA 7.63E-05 2.81E-05 9.78E-07 CS 138 1.71E-07 2.27E-07 1.50E-07 10 DATA 1.68E-07 1.84E-08 7.29E-08 Jm 139 4.9BE-10 2.66E-13 1.45E-11 to DATA 2.33E-13 1.56E-06 1.56E-05
^~"
O
j r i l l TAluk: A.2-3 ((xxit,'d) IteMLATICN DOSE F/CIORS 1011 OIIID (MRIM Pli. ICI 11amilD) 11tELLDE TCHE LIVD1 T IGN 'I1NTOID KIIM N IUtG GI-ILI Im 140 2.00E-05 1.75E-08 1.17E-06 to IMTA 5.71E-09 4.71E-04 2.75E-05 En 141 5.29E-11 2.95E-14 1.72E-12 to t%TA 2.56E-14 7.89E-07 7.44E-08 1 IM 142 1.35E-11 9.73E-15 7 14E-13 to twTA 7.87E-15 4.44E-07 7.41E-10 i IA-140 1.74E 6.08E-08 2.04E-08 to [WTA 10 DATA 4.94E-05 6.10E-05 IA 142 3.50E-10 1.11E-10 3.49E-11 10 IMTA 10 DATA 2.35E-06 2.05E-05 g: 141 1.06E-05 5.2h 06 3 7.83E-07 to twTA 2.31E-06 1.47E-04 1. 53E-M t CE 143 9.89E-08 5.37E-08 7.77E-09 to DATA 2.26E-08 3.12E-05 3.44E-05 CE 144 1.83E-03 5.72E-04 9.77E-05 10 IATA 3.17E-04 3.23E-03. 1.05E-04 PT, 14] 4.99E-06 1.50E-06 2.47E-07 to DATA 8.11E-07 1.17E-04 2.63E-05 15 144 1.617 11 - 4 '. 99 E-12 8.10E-13 10 IATA 2.64E-12 4.23E-07 5.32E-08 10 147 2. 9. . 06 2.36E-06 1.84E-07 10 DATA 1.30E-06 8.87E-05 2.22E-05 W 187 4.41E-09 2.61E-09 1.17E-09 to IRTA 10 DAT6 1.11E-05 2,46E-05 f@ 239 1.26E-07 9.04E-09 6.35E-09 10 DATA 2.63E-08 1.57E-05 1.73E-05 O I 5
^"'
O
- -_.~._ ..._ _ ,,._. _ ...-,.,._ _ _ .. _ _ _... _ .- _ _- _ _ . -
"I'AlVE A.2-4*
ItE{A1ATICH LISE F/CIGS 101 It1FAffr (MRIM PIR ICI ItalALED) iJtK1TDE TO1E LTVIP T IGr/ 'MlYROID KIDIJEY IMtG GI-TM 11 3 10 DATA 4.62E-07 4.62E-07 4.62E-07 4.62E-07 4.62E-07 4.62E-07 C 14 1.89E-05 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 th_ 24 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 P 32 1.45E-03 8.03E-05 5.53E-05 10 DATA to DATA to DATA 1.15E-05 CR 51 10 IATA 10 DATA 6.39E-00 4.11E-08 9.45E-09 9.17E-06 2.55E-07 MN 54 10 DATA 1.81E-05 3.56E-06 10 DATA 3.56E-06 7.14E-04 5.04E-06 - 104 56 10 DATA 1.10E-09 1.58E-10 10 DATA 7.86E-10 8.95E-06 5.12E-05 PE 55 1.41E-05. 8.39E-06 2.30E-06 10 DATA 10 DATA 6.21E-05 7.82E-07 TE 59 9.69E-06 1.68E-05 6.77E-06 10 DATA to DATA 7.25E-04 1.77E-05 CO 58 10 DATA 8.71E-07 1.30E-06 10 DNrA 10 DATA 5.55E-04 7.95E-06 CO 60 10 DATA 5.73" 06 8.41E-06 10 DATA 10 DATA 3.22E-03 2.28E-05 NI 63 2.42E-04 1.46L.05 8.29E-06 10 DATA 10 DATA 1.49E-04 1.73E-06 NI 65 1.71E-09 2.03E-10 8.75E-11 10 DNTA 10 DATA 5.80E-06 3.58E-05 CU 64 10 DATA 1.34E-09 5.53E-10 10 DATA 2.84E-09 6.64E-06 1.07E-05 7.N 65 1.38E-05 4.47E-05 2.22E-05 to DATA 2.32E-05 4.62E-04 3.67E-05 24 69 3.85E-11 6.91E-11 5.13E-12 10 DATA 2.87E-11 1.05E-06 9.44E-06 IR 83 10 DATA 10 DATA 2.72C-07 10 DNrA 10 DATA 10 DATA LT E-24 HR 84 10 DATA 10 DATA 2.86E-07 to DATA 10 DATA to DATA LT E-24 BR 85 to DATA 10 DATA 1.46E-08 10 DATA 10 DATA 10 DATA LT E-24 _ RB 86 10 DATA 1.36E-04 6.30E-05 10 CATA 10 DATA 10 DATA 2.17E-06 - RB 88 to DATA 3.9fE-07 2.05E-07 10 DATA 10 DATA 10 DATA 2.42E-07 RB 89 10 DATA 2.29E-07 1.47E-07 10 DATA 10 DATA 10 DATA 4.87E-08 SR 89 2.84E-04 to DATA 0.15E-06 10 DATA 10 DATA 1.45E-03 4.57E-05 SR 90 2.92E-02 to DATA 1.Q5E-03 to DATA to DATA 8.03E-03 9.36E-05 SR 91 6.83E-08 10 DATA 2.47E-09 10 DATA to DATA 3.76E-05 5.24E-05 FJs 92 7.50E-09 10 DATA 2.79E-10 10 DATA 10 DATA 1.70E-05 1.00E-04 Y 9r 2.35E-06 PO DATA 6.30E-08 to DATA 10 DATA 1,92E-04 7.43E-05 Y 91M 2.91E-10 to DATA 9.90E-12 10 DNEA 10 DATA 1.99E-06 1.68E-06 Y 91 4.20E-04 to DATA 1.12E-05 to DATA 10 DATA 1.75E-03 5.022-05 Y 92 1.17E-08 to DATA 3.29E-10 10 DATA 10 DATA 1.75E-05 9.04E-05
*Taken f run Regulatory Guide 1.109 (Rev.1)
A-13 0
t TAIU1: A.2-4 (tint'd) 11MAIATICN DOSE 17CIUlS FUt INFNE (MRt24 PER ICI 11 DIALED) 13UClaIDE TOE LIVD1 T TODY 'IUYROID KIDtEY IUto GI-ILI Y 93 1.07E-07 to DATA 2.91E-09 to DATA 10 DATA 5.46E-05 . WE-04 ZR 95 8.24E-05 1.99E-05 1.45E-05 10 DATA 2.22E-05 1.25E-03 . 55E-05 ER 97 1.07E-07 1.83E-08 8.36E-09 to DATA 1.85E-08 7.88E-05 1.00E-04 im 95 1.12E-05 4.59E-06 2.70E-06 to DATA 3.37E-06 3.42E-04 9.05E-06 10 99 to DATA 1.18E-07 2.31E-08 to DATA 1.89E-07 9.63E-05 3.48E-05
'IC 99M 9.98E-13 2.06E-12 2.6SE-11 to DATA 2.22E-11 5.79E-07 1.45E-06
'IC 101 4.65E-14 5.88E-14 5.80E-13 10 DATA 6.99E-13 4.17E-07 6.03E-07 RU 103 1.44E-06 10 DATA 4.85E-07 10 DATA 3.03E-06 3.94E-04 1.15E-05 RU 105 0.74E-10 to DATA 2.93E-10 to DATA 6.42E-10 1.12E-05 3.46E-05 RU 106 6.20E-05 10 DATA 7.77E-06 10 DATA 7.61E-05 8.26E-03 1.17E-04
/G 110M 7.13E-06 5.16E-06 3.57E-06 10 DATA 7.80E-06 2.62E-03 2.36E-05 TB 125M 3.40E-06 1.42E-06 4.70E-07 1.16P-06 to DATA 3.19E-04 9.22E-9.Q TE 127M 1.19E-05 4.93E-06 1.48E-06 3.48E-06 2.68E-05 9.37E-04 1.95E-05 TE 127 1.59E-09 6 '1E-10 3.49E-10 1.32E-09 3.47E-09 7.39E-06 1. 4E-05 TE 129M 1.01E-05 4.,tE-06 1.59E-06 3.91E-06 2.27E-05 1.20E-03 4.93E-05 TE 129 5.63E-11 2.48E-11 1.34E-11 4.82E-11 1.25E-10 2.14E-06 1.88E-05 TE 131M 7.62E-08 3.93E-08 2.59E-08 6.38E-08 1.89E-07 1.42E-04 8.51E-05 TB 131 1.24E-11 5.87E-12 3.57E-12 1.13E-11 2.85E-1] 1.47E-06 5.87E-06 TE 132 2.66E-07 1.69E-07 1.26E-07 1.99E-07 7.39E-07 2 43E-04 3.15E-05 I -130 4.54E-06 9.91E-06 3.98E-06 1.14E-03 1.09E-05 Na DATA 1.42E-06 I 131 2.71E-05 3.17E-05 1.40E-05 1.06E-02 3.70E-05 n ETA 7.56E-07 I 132 1.21E-06 2.53E 8.99E-07 1.21E-04 2.82E-06 to DATA 1.36E-06 I 133 9.46E-06 1.37E-05 4.00E-06 2.54E-03 1.60E-05 10 DATA 1.54E-06 I 134 6.58E-07 1.34E-06 4.75E-07 3.18E-05 1.49E-06 to DATA 9.21E-07 1 135 2.76E-06 5.43E-06 1.98E-06 4.97E-04 6.05E-06 to DATA 1.31E-06 CS 134 2.83E-04 5.02E-04 5.32E-05 10 DATA 1.36E-04 5.69E-05 9.53E-07 CS 136 3.45E-05 9.61E-05 3.78E-05 to DATA 4.03E-05 8.40E-06 1.02E-06 CS 137 3.92E-04 4.37E-04 3.25E-05 to DATA 1.23E-04 5.09E-05 9.53E-07 CS 138 '3.61E-07 5.58E-07 3.84E-07 to DATA 2.93E-07 4.67E 6.26E-07 1% 139 1.06E-09 7.03E-13 3.07E-11 to DATA 4.23E-13 4.25E-06 3.64E-05 A-14
_ _ - _ _ . _ . . - _____.__m_____ TNVE A.2-4 (mit'd) ItalA1ATICH DOSE FACITS IG 11FNII' l (MRIM PER TC1 lla1ALED) i MCLIDE IONE LIV!71 T DODY 'IUYROID KIDNEY 11]tT3 GI-ILI M 140 4.00E-05 4.00E-08 2.07E-06 10 DATA 9.59E-09 1.14E-03 2.74E-05 M 141 1.12E-10 7.70E-14 3.55E-12 10 DATA 4.64E-14 2.12E-06 3.39E-06 BA 142 2.84E-11 2.36E-14 1.40E-12 10 DATA 1.36E-14 1.11E-06 4.95E-07
.IA 140 3.61E-07 1.43E-07 3.C8E-08 to DATA 10 DATA 1.20E-04 6.06E-05 LA 142 7.36E-10 2.69E-10 6.46E-11 10 DATA 10 DATA 5.87E-06 4.25E-05 CE 141 1.9BE-05 1.198-05 1.42E-06 10 DATA 3.75E-06 3.69E-04 1.54E-05 CE 143 2.09E-07 1.38E-07 1.58E-08 to DATA 4.03E-08 8.30E-05 3.55E-05 CE 144 2.28E-03 8.65E-04 1.26E-04 10 DATA 3.84E-04 7.03E-03 1.06E-04 PR 143 1.00E-05 3.74E-06 4.99E-07 10 DATA 1.41E-06 3.09E-04 2,66E-05 PR 144 3.42E-11 1.32E-11 1.72E-12 10 DATA 4.80E-12 1.15E-06 3.06E-06 10 147 5.67E-06 5.81E-06 3.57E-07 10 DATA 2.25E-06 2.30E-04 2.23E-05 W 187 9.26E-09 6.44E-09 2.23E-09 70 DATA to DATA 2.83E-05 2.54E-05 NP 239 2.65E-07 2,37E-08 1.34E-08 10 DATA 4.73E-08 4.25E-05 1.78E-05 O
A-15 O
T/dRJ A.2-5* LTI'URNAL DOGE(mrtm/hr F1CIWSperImpCi/m STNOI!G g)CotfrAMI!Wl'II) GROU!O Eltwnt 'Jbtal IKdy f}(11} 11- 3 0.0 0.0 C-14 0.0 0.0 Na-24 2.50E-00 2.90E-08 P-32 0.0 0.0 Cr-51 2.20E-10 2.60E-10 Mn-54 5.80E-09 6.80E-09 Mn-56 1.10E-08 1.30E-08 Fe-55 0.0 0.0 Fo-59 0.00E-09 9.40E-09 _ Co-58 7.00E-09 8.20E-09 Co-60 1.70E-08 7.00E-08 Ni-63 0.0 0 Ni-65 3.70E-09 i .J-09 Cu-64 1.50E-09 1 /0F-09 an-65 4.00E-09 4.60E-09 Zn-69 0.0 0.0 Br-83 6.40E-11 9.30E-11 Br-84 1.20E-08 1.40E-08 Br-85 0.0 0.0 Rb-86 6.30E-10 7.20E-10 Rb-80 3.50E-09 4.00E-09 1.50E-08 1.80E-00 0Rb-89 Sr-89 5.60E-13 6.50E-13 Sr-91 7.10E-09 8.30E-09 Sr-92 9.00E-09 1.00E-08 Y-90 2.20E-12 2.60E-12 Y-9tM 3.80E-09 4.40E-09 Y-91 2.40E-11 2.70E-11 _ Y-92 1.60E-09 1.90E-09 Y-93 5.70E-10 7.80E-10 Zr-95 5.00E-09 5.80E-09 Zr-97 5.50E-09 6.40E-09 Nb-95 5.10E-09 6.00E-09 Mo-99 1.90E-09 2.20E-09 Tc-99M 9.60E-10 1.10E-09 Tt-101 2.70E-09 3.00E-09 Ru-103 3.60E-09 4.20E-09 Ru-105 4.50E-09 5.10E-09 Ru-106 1.50E-09 1.80E-09 Ag-110M 1.80E-08 2.10E-08
-Tu-125M 3.50E-11 4.80E-11 Tu-127M 1.10E-12 1.30E-12 Tu-127 1.00E-11 1.10E-11 Tu-129M 7.70E-10 9.00E-10 Te-129 7.10E-10 8.40E-10 0 *Taken frun Regulatory Guide 1.109 (Rrn.1)
A-16
TAIRE A.2-5 (cxnt'd) EWrER!aL DOSE F/CIORS IG STANDIIC (mru dhr per rCi/m g)C07rRmUdTD GGIO Eh w nt Total Ibly Skin Tu-131M 8.40E-09 9.90E-09 Tu-131 2.20E-09 2.60E-06 7b-132 1.70E-09 2.00E-09 I-130 1.40E-08 1.70E-08 I-131 2.80E-09 3.40E-09 I-132 1.70E-08 2.00E-08 I-133 3.70E-09 4.50E-09 I-134 1.60E-08 1.90E-08 I-135 1.20E-08 1.40E-08 Cs-134 1.20E-08 1.40E-08 Cs-136 1.50E-08 1.70E-08 Cs-137 4.20E-09 4.90E-09 Cs-138 2.10E-08 2.40E-08 Ba-139 2.40E-09 2.70E-09 Da-140 2.10E-09 2.40E-09 Ba-141 4,30E-09 4.90E-09 Ba-142 7.90E-09 9.00E-09 La-140 1.50E-08 1.70E-08 La-142 1.50E-08 1.80E-08 5.50E-10 6.20E-10 O Co-141 Co-143 Co-144 2.20E-09 3.20E-10 2.50E-09 3.70E-10 Pr-143 0.0 0.0 Pr-144 2.00E-10 2.30E-10 Nd-147 1.00E-09 1.20E-09 W-187 3.10E-09 3.60E-09 Np-239 9.50E-10 1.10E-09 A-17 O
l TAIEF. A.3-1* l I!CESTIOff DOSE FACIO"S IG ADULTS l (MREM PER l'CI IlGESTED) gr1TDE TONE LIVER T TODY 'IllYBOID KIINEY 11110 GI-ILI H 3 10 DATA 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 C 14 2.84E-06 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 NA 24 1.70E-06 1.70E-06 1.70E-06 1.7CE-06 1.70E-06 1.70E-06 1.700-06 P 32 1.93E-04 1.20E-05 7.46E-06 10 IATA 10 DATA 10 DATA 2.17E-05 CR 51 10 DATA 10 DATA 2.66E-09 1.59E-09 5.86E-10 3.53E-09 6.69E-07 Mt1 54 to DATA 4.57E-06 8.72E-07 10 DATA 1.36E-06 10 DATA 1.40E-05 Mr1 56 10 DATA 1.15E-07 2.04E-08 10 DATA 1.46E-07 10 DATA 3.67E-06 FE 55 2.75E-06 1.90E-06 4.43E-07 10 IATA 10 DATA 1.06E-06 1.09E-06 FE 5 9,_. 4.34E-06 1.02E-05 3.91E-Of 10 DATA 10 DATA 2.85E-06 3.40E-05 CD 58 10 DATA 7.45E-07 1.67E-06 10 DATA 10 DATA 10 DATA 1.51E-05 CO 60 10 DATA 2.14E-06 4.72E-06 to DATA 10 DATA 10 DATA 4.02E-05 NT 63 1.30E-04 9.01E-06 4.36E-06 to DATA to DATA 10 DATA 1.88E-06 NI 65 5.28E-07 6.86E-08 3.13E-08 10 DATA 10 DATA 10 DATA 1.74E-06 , CU 64 10 DATA 8.33E-08 3.91E-08 10 DATA 2.10E-07 10 DATA 7.10E-06 p1 65 4.84E-06 1.54E-05. 6. 96E- 06 to DATA 1.03E-05 10 DATA 9.70E-06 ZN 69 1.03E-08 1.97E-08 1.37E-09 10 DATA 1.28E-08 to DATA 2.96E-09 DR 83 10 DATA 10 DATA 4.02E-08 10 DATA 10 DATA 10 DATA 5.79E-08 jl1 84 10 DATA 10 DATA 5.21E-08 to DATA to DATA !O DATA 4.09E-13 P BR 85 10 DATA 10 DATA 2.14E-09 10 DATA 10 DATA 10 IATA I!f E-24 RB Bd - 10 DATA 2.11E-05 9.83E-06 to DATA to DATA 10 DATA 4.16E-06 RB 88- 10 DATA 6.05E-08 3.21E-08 10 DATA 10 DATA to DATA 8.36E-19 RB 89 10 DATA 4.01E-08~ 2.82E-08 10 DATA 10 DATA to DATA 2.33E-21 SR 89 3.08E-04 to DATA 8.84E-06 10 DATA 10 DATA 10 DATA 4.94E-05 SR 90 7.58E-03 to DATA 1.86E-03 to DATA to DATA 10 DATA 2 19E-04 SR 91 5.67E-06 10 DATA 2.29E-07 to DATA !O DATA 10 DATA 2.70E-05 SR 92 2.15E-06 10 DATA 9.30E-08 to ).ATA 10 DATA to DATA 4.26E-05 Y 90 9.62E-09 to DATA 2.58E-10 to IMTA to DATA to DATA 1.02E-04 Y 91M -9.09E-11 10 DATA 3.52E-12 10 DATA 10 DATA 10 DATA 2.67E-10
.Y 91 1.41E-07 to DATA 3.77E-09 10 DATA 10 DATA 10 DATA 7.76E-05 Y 92 8.45E-10 to DATA 2.47E-11 to DATA to DATA to DATA 1.48E-05
*Taken frun Regulatory Guide 1.109 (Rev.1)
A-18 ' l t I e .. - -. . .- . - - -. _ _ - . -.._-_- - . - . _ - - . . . - - - -
TAIEE A.3-1 (unt'd) IlGESTION DOSE FAC10lS 101 ADUL'IS (MRIM PER l'CI 11GESTED) 1RCDTDE IQE LIVER T IDDY 'IliYROID KIDfEY Iy!G GI-iM Y 93 2.68E-09 10 IATA 7.40E-11 10 DATA 10 DATA 10 DATA 8.50E-05 KR 95 3.04E-08 9.75E-09 6.60E-09 10 DATA 1.53E-08 10 DATA 3.09E-05 ZR 97 1.68E-09 J . 39E-10 1.55E-10 !T2 DATA 5.12E-10 !O DATA 1.05E-04 tiB 95 6.22E-09 3.46E-09 1.86E-09 10 DNrA 3.42E-09 10 DATA 2.10E-05 10 99 to DATA 4.31E-06 8.20E-07 to DATA 9.76E-06 10 DATA 9.99E-06
'IC 99M 2.47E-10 6.98E-10 8. 89E--Q9 10 twTA 1.06E-08 3.42E-10. 4.13E-07 'IC 101 2.54E-10 3.66E-10 3.59E-09 10 DATA 6.59E-09 1.87E-10 1.10E-21 RU 103 1.85E-07 10 DATA 7.97E-08 10 DATA 7.06E-07 10 DATA 2.16E-05 RU 105 1.54E-08 10 DATA 6.08E-09 10 DATA 1.99E-07 to DATA 9.42E-06 RU 106 2.75E-06 10 DATA 3.48E-07 10 DATA 5,31E-06 10 DATA 1.78E-04 ,
IG 110M 1.60E-07 1.40E-07 8.79E-08 10 DATA 2.91E-07 10 DATA 6.04E-05 TE 125M 2.68E-06 9.71E-07 3.59E-07 8.06E-07 1.09E-05 10 DATA 1.07E-05 TE 127M 6.77E-06 2.42E-06 8.25E-07 1.73E-06 2.75E-05 10 DATA 2.27E-05 TE 127 1.10E-07 3.95E-08 2.38E-08 8.15E-08 4.48E-07 10 DATA 8.68E-06 TE 129M 1.15E-05 4.29E-06 1.02E-06 3.95E-06 4.80E-05 10 DNTA 5.79E-05 TE 129 3.14E-08 1.18E-08 7.65E-09 2.41E-08 1.32E-07 10 DATA 2.37E-08 TE 131M 1.73E-06 8.46E-07 7.05E-07 1.34E-06 8.57E-06 10 DNrA 8.40E-05 TE 131 1.97E-08 8.23E-09 6.22E-09 1.SE-08 8.63E-08 to D,*TA 2.79E-09 TE 132 2.52E-06 1.63E-06 1.53E-06 1.80E-06 1.57E-05 10 DATA 7.71E-05 I 130 7.56E-07 2.23E-06 8.80E-07 1.09E-04 3.48E-06 10 DATA 1.92E-06 I 131 4 .16E- 06 5.95E-06 3.4]E-06 1.95E-03 1.02E-05 to DATA 1.57E-06 I 132 2.03E-07 5.43E-07 1.90E-07 1.90E-05 8.65E-07 10 DATA 1.02E-07 I 133 1.42E-06 2.47E-06 7.53E-07 3.63E-04 4.31E-06 to DATA 2.22E-06 I 134 1.06E-07 2.88E-07 1.03E-07 4.99E-06 4.58E-07 to DATA 2.51E-lQ I 135 4.43E-07 1.16E-06 4.28E-07 7 65E-05 1.86E-06 !O DATA 1.31E-06 CS 134 6.22E-05 1.40E-04 1.21E-04 10 DATA 4.79E-05 1.59E-05 2.59E-06 CS 136 6.51E-06 2.57E-05 1.85E-05 to DATA 1.43E-05 12 9f3-06 2.9?E-06 CS 137 7.97E-05 1.09E-04 7.14E 05 to DATA 3.70E-05 1.23E-05 2.11E-06 CS 138 5.52E-08 1.09E-07 5.40E-08 to DATA 8.01E-08 7.91c-09 4.65E-13 Im 139 9.7 k -08 5.91E-11 2.84E-09 10 DATA 6.46E-11 3.92E-11 1.72E-07 A-19 O
TAIVJ! A.3-1 ((Int'd) 11GESTION DOGE F/CIORS ITR ADULTS i (MREM PER ICI I!GESI'ED) JLCt.j]DU EO{E LIVER T IODY TIIYRGID KIDNEY IUto GI-IM In 140 2.03E-05 2.55E-08 1.33E-06 10 DATA 0.67E-09 1.46E-08 4.18E-05 In 141 4.71E-08 3.56E-11 1.59E-09 10 DATA 3.31E-11 2.02E-11 2.22E-17 fA 142 2.13E-08 2.19E-11 1.34E-09 10 DATA 1.85E-11 1.24E-11 3.00E-25 IA 140 2.50E-09 1.26E-09 3.33E-10 10 DATA 10 DATA 10 DATA 9.25E-05 I.A 142 1.28E-10 5.82E 11 1.45E-11 10 DATA 10 DATA 10 DATA 4.25E-07 CE 141_ 9.36E-09 6.33E-09 7.18E-10 10 DATA 2.94E-09 to DATA ._2.42E-05 CE 143- 1.65E-09 1.22E-06 1.35E-10 10 DATA 5.37E-10 10 DATA 4.56E-05 CE 144 4.88E-07 2.04E-07 2.62E-08 to DATA 1.21E-07 to DA..'. 1.65E-04 PR 143 9.20E-09 3.69E-09 4.56E-10 10 DATA 2.13E-09 to DATA 4.03E-05 PR 144 3.01E-11 1.25E-11 1.53E-12 10 DATA 7.05E-12 10 DATA 4,33E-18 10 147 6.29E-09 7.27E-09 4.35E-10 10 DATA 4.25E-09 10 DATA 3.49E-05 W 187 1.03E-07 8.61E-08 3.01E-08 10 DATA 10 DATA to DATA 2.82E-05 IIP 239 1.19E-09 1.17E-10 6.45E-11 10 DATA 3.65E-10 !ODATA 2.40E-05 Sb 124** 2.80E-06 5.29E-08 1.11E-06 6.79E-09 10 DNIA 2.18E-06 7.95E-05 125** 1.79E-06 2.00E-08 4.26E-07 1.82E-09 to DATA 1.38E-06 1.97E-05 O' .SbEb 126** 1.15E-06 2.34E-08 4.15E-07 7.04E-09 10 DATA 7.05E-07 9.40E-05 Co 57** 10 DATA 1.75E-07 2.91E-07 10 DATA 10 DATA 10 DATA 4.44E-06
* *Taken frun Rogulatory Guide 1.109 (Rev. 0)
A-20 0
12-A 0
)1.veR( 901 1 ediuG yrotalugeR nurf nekaT*
50-E23 3 ATAD ot ATAD 01 ATAD 01 11-E05 3 ATAD ot 90-E12 1 29 Y 50-E42 8 ATAD 01 ATAD 01 ATAD 01 90-E93 5 ATAD 01 70-E10 2 19 Y 90-E90 6 ATAD 01 ATAD 01 ATAD 01 21-E39 4 ATAD 01 01-E92 1 M19 Y 40-E31 1 ATAD 01 ATAD 01 ATAD 01 01-E96 3 ATAD ot 80-E73 1 09 Y 50-E77 7 ATAD 01 ATAD 01 ATAD ot 70-E03 1 ATAD 01 60-E50 3 29 RS 50-E66 3 ATAD 01 ATAD 01 ATAD ot 70-E12 3 ATND ot 60-E70 8 19 RS 40-E33 2 ATAD 01 ATAD 01 APWI ot 30-C50 2 ATAD ot 30-E03 8 09 RF 50-E42 5 ATAD ot ATAD 01 ATAD 01 50-E62 1 ATAD 01 40-E04 4 98 RS 71-E34 8 ATAD 01 ATAD 01 ATAD ot 80-E98 3 80-E05 5 ATAD 01 98 BR 51-E03 7 ATAD 01 ATAD 01 ATAD 01 80-E45 4 80-E25 8 ATAD 01 88 BR 60-E14 4 ATAD 01 ATAD ot ATAD 01 50-E04 1 50-E89 2 ATAD 01 68 BR 42-E TL ATAD 01 ATAD 01 ATAD 01 90-E50 3 AIND 01 ATAD 01 58 RB 42-E TL ATAD 01 AT6D OT ATAD 01 80-E22 7 ATAD ot ATAD 01 48 tR 42-E TL ATAD 01 ATAD 01 ATAD 01 80-E47 5 ATAD 01 ATAD 01 38 RB 80-E61 5 ATAD 01 80-E38 1 ATAD 01 90-E69 1 80-E08 2 80-E74 1 96 NZ 60-E74 8 ATAD 01 50-E82 1 ATAI ot 60-E33 9 50-E00 2 60-E67 5 36 NZ 60-E29 8 ATAD 01 70-E19 2 ATAD 01 80-E14 5 70-E51 1 ATAD 01 46 UC 60-E91 5 ATAD 01 ATAD 01 ATAD 01 80-E63 4 80-E75 9 70-E94 7 56 IN 60-E99 1 ATAD ot ATAD ot ATAD ot 60-E00 6 50-E52 1 40-E77 1 36 IN 50-E66 3 ATAD 01 ATAD 01 ATAD 01 60-E33 6 60-E18 2 ATAD 01 06 OC 50-E43 1 ATAD 01 ATAD 01 ATAD 01 60-E42 2 70-E27 9 ATAD 01 85 OC 50-E42 3 60-E23 4 ATAD OL ATAD 01 60-E92 5 50-E73 1 60-E78 5 95 EF 60-E61 1 60-E07 1 ATAD 01 ATAD 01 70-E52 6 60-E86 2 60-E87 3 55 EE 50-E40 1 ATAD ot 70-E00 2 ATAD 01 80-E18 2 70-E85 1 ATAD 01 65 NM 50-E12 1 ATAD 01 50-E67 1 ATAD 01 60-E71 1 60-E09 5 ATAD ot 45 NM 70-E50 6 90-E41 5 01-E98 7 90-E00 2 90-E06 3 ATAD 01 ATAD ot 15 RC 50-E23 2 ATAD 01 ATAD 01 APND 01 50-E70 1 50-E17 1 40-E67 2 23 P 10-E03 2 60-E03 2 60-E03 2 60-E03 2 60-E03 2 60-E03 2 60-E03 2 42 m1 70-E21 8 70-E21 8 70-E21 8 70-E21 8 70-E21 8 70-E21 8 60-E60 4 41 C 70-E60 1 70-E60 1 70-E60 1 70-E60 1 70-E60 1 70-E60 1 A3AD ot 3 11 dlI-IG GfUI YEUTIK DIOPYHI' YDOI T REVIL ENOT EDILOL!I
)EELAlatI ICI IRP mRM(
SREGUDET tUI 3UIC7F ESOC miTAIA!011 82-3.A ERIAT l
_ _ , _ - - . ,_ ._ _ m. _ _. _ _ . . . _ . - . _ - - _ _ _ . . _ _ _ _ _ _ _ I I l TAIRE A.3 (Omt'd. ) O I!OESTIQ1 DOSE F/CIGS IG TEEtFGERS (MREM PER PCI IIGESTED) i NlCl>IDE TOTE LIVER T IODY 'IHYROID KIDNEY IMG GI-IL1 Y 93 3.83E-09 10 DATA 1.05E-10 10 DATA 10 tRTA 10 DATA 1.17E-04 ZR 95 4.12E-08 1.30E-08 8.94E-09 10 DATA 1.91E-08 to DATA 3.00E-05 ZR 97- 2.37E-09 4.69E-10 2.16E-10 10 DATA 7.11E-10 to DATA 1.27E-04 NB 95 8.22E-09 4.56E-09 2.51E-09 to DATA 4.42E-09 10 DATA 1.95E-05
}O 99 10 DATA 6.03E-06 1.15E-06 10 DATA 1.38E-05 10 DATA 1.08E-05
'IC 99M 3.32E-10 9.26E-10 1.20E-08 to DATA 1.38E-08 5.14E-10 6.08E-07
'It 101 3.60E-10 5.12E-10 5.03E-09 10 DATA 9.26E-09 3.12E-10 8.75E-17 RU ' 103 2.55E-07 - 10 DATA 1.09E-07 10 DATA 8.99E-07 10 DATA 2.13E-05 Rtl 105 2.18E-08 10 DATA 8.46E-09 to DATA 2.75E-07 10 DATA 1.76E-05 RU- 106 3.92E-06 10 DATA 4.94E-07 10 DATA 7.56E-06 10 DATA 1.88E-04 1G 110M 2.05E-07 1.94E-07 1.18E-07 10 DATA 3.70E-07 to DATA 5.45E-05 TE 125M 3.83E-06 1.38E-06 5.12E-07 1.07E-06 to DATA to DATA 1.13E-05 TE 127M 9.67E-06 3.43E-06 1.15E-06 2.30E-06 3.92E-05 to DATA 2.41E-05
- TE 127 1.58E-07 5.60E-08 3.40E-08 1.09E-07 6.40E-07 10 DATA 1.22E-05 ,
TE 129M 1.63E-05 6.05E-06 2.58E-06 5. 26 E-06 6.82F-05 to DATA 6.12E-05 TE 129 4.48E-08 1.67E-08 1.09E-08 3.20E-08 1.88E-07 10 DATA 2.45E-07 TE 131M 2.44E-06 1.17E-06 9.76E-07 1.76E-06 1.22E-05 10 DATA 9.39E-05 TB 131 2.79E-08 1.15E-08 8.72E-09 2.15E-08 1.22E-07 to DATA 2.29E-09 , TE 132 3.49E-06 2.21E-06 2.08E-06 2.33E-06 2.12E-05 10 DATA 7.00E-05 1 130 1.03E-06 2.98E-06 1.19E-06 2.43E-04 4.59E-06 10 DATA 2.29E-06
,1 131 5.85E-06 8.19E-06 4.40E-06 2.39E-03 1.41E-05 10 DATA 1.62E-06 I 132 2.79E-07 7.30E-07 2.62E-07 2.46E-05 1.15E-06 10 DATA 3.18E-07 I 133 2.01E-06 3.41E-06 1.04E-06 4.76E 5.98E-06 10 DATA 2.58E-06 1 134 1.46E-07 3.87E-07 1.39E-07 6.45E-06 6.10E-07 10 t%TA 5.10E-09 I 135 6.10E-07 1.57E-06 5.82E-07 1.01E-04 -2.48E-06 10 DATA 1.74E-06 CS -134 8.37E-05 1.97E-04 9.14E-05 10 DATA - 6.26E-05 2.39E-05 2.45E-06 CS 136 8.59E-06 3.38E-05 2.27E-05 to twTA 1 B4E-05 2.90E-06 2.72E-06
- CS 137 1.12E-04 1.49E-04 5.19E-05 10 DATA 5.07E-05 1.97E-05 2.12E-06
- CS 138 7.76E-08 1.49E-07 7.45E-08= 10 DATA 1.10E-07 1.28E-08 6.76E-11
.pA 139 1,39E-07 9.78E-11 4.05E-09 to DATA 9.22E-11 6.74E-11 1.24E-06 A-22 O
TNUE A.3-2 (Oczit'd. ) ItGESTICII DOSE 17CIORS KR TEE!UGERS (MRD4 PER PCI 1!GISI'ED) EqCLIDE !ONE LIVER T IODY 'IliYROID KID?E"/ IJJIG GI-ILI In 140 2.84E-05 3.48E-08 1.83E-06 10 IATA 1.18E-00 2.34E-08 4.38E-05 im 141 6.71E-08 5.01E-11 2.24E-09 10 IRTA 4.65E-11 3.43E-11 1.43E-13 M 142 2.99E-08 2.99E-11 1.84E-09 to IATA 2.538-11 1.99E-11 9.18E-20 1A 140 3.48E-09 1.71E-09 4.55E-10 to DATA to thTA 10 DATA 9.82E-05 1A 142 1.79E-10 7.95E-11 1.98E-11 10 DATA 10 DATA 10 DATA 2.42E-06 CE 141 1.33E-08 8.88E-09 1.02E-09 10 IMTA 4.18E-09 to DATA 2.54E-05 _ CE 143 2.35E-09 1.71E-06 1.91E-10 10 twTA 7.67E-10 10 DATA 5.14E-05 CE 144 6.96E-07 2.88E-07 3.74E-08 to DATA 1.72E-07 10 DATA 1.75E-04 PR 143 1.31E-08 5.23E-09 0.52E-10 to DATA 3.04E-02 to imTA 4.31E-05 PR 144 4.30E-11 1.76E-11 2.18E-12 10 DATA 1.01E-11 10 DATA 4.74E-14 10 147 9.30E-09 1.02E-08 6.11E-10 10 DATA 5.99E-09 10 DATA 3.68E-05 W 187 1.46E-07 1.19E-07 4.17E-08 10 DATA 10 DATA 10 DATA 3.22E-05 NP 239 1.76E-09 1.66E-10 9.22E-11 to DATA %21E-10 10 DATA 2.67E-05
-Sb 124** 3.87E-06 7.13E-08 1.51E-06 8.78E-09 10 DATA 3.38E-06 7.80E-05 Sb 125** 2.40E-06 2.71E-08 5.80E-07 2.37E-09 to 1%TA 2.18E-06 1.93E-05 Sb 126** 1.59E-06 3.25E-00 5.71E-07 8.99E-09 10 DATA 1.14E-06 9.41E-05 Co 57** 10 DATA 2.38E-07 3.99E-07 10 DATA 10 DATA to DATA 4.44E-06
**Taken frm Regulatory Guide 1.109 (Rev. 0)
M A-23
"J.lHE A.3-3*
I!GESTION DOSE 17C1mS IOR CHIID (MREM PER PCI I!GESTED) IU2JDE D0ffE LIVER T IODY 'HWROID KIDNEY IUtB GT-I .LI H 3 to DATA 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07 C 14 1.21E-05 2.42E-06 2.42E-06 2.42E-06 2.42E-06 2.42E-06 2.42E-06 NA 24 5.80E-06 5.80E-06 5.80E-06 5.00E-06 5.00E-06 5.80E-06 5.80E-06 P 32 8.25E-04 3.86E-05 3.18E-05 10 DATA 10 DATA 10 DATA 2.20E-05 CR 51 10 DATA 10 DATA 8.90E-09 4.94E-09 1.35E-09 9.02E-09 4.72E-07 MN 54 10 DATA 1.07E-05 2.85E-06 10 DATA 3.00E-06 to DATA 8.98E-06 101 56 10 DATA 3.34E-07 7.54E-08 10 DATA 4.04E-07 10 DATA 4.84E-05 FE 55- 1.15E-05 6.10E-06 1.89E-06 10 DATA 10 DATA 3.45E-06 1.13E-06 FE 59 1.65E-05 2.67E-05 1.33E-05 to DATA 10 DATA 7.74E-06 2.78E-05 CO 58 to DATA 1.80E-06 5.51E-06 10 DATA 10 DATA 10 DATA 1.05E-05 CO 60 10 DATA 5.29E-06 1.56E-05 to DATA 10 DATA 10 DATA 2.93E-05 NI 63 5.38E-04 2.88E-05 1.83E-05 to DATA 10 DATA- to DATA 1.94E-06 NI 65 2.22E-06 2.09E-07 1.22E-07 to DATA 10 DATA 10 DATA 2.56E-05 CU 64 10 DATA 2.45E-07 1.48E-07 to DATA 5.92E-07 10 DATA 1.15E-05 ZN 65 1.37E-05 3.65E-05 2.27E-05 10 DATA 2.30E,95 to DATA 6.41E-06 ZN 69 4.38E-08 6.33E-08 5.85E-09 10 DATA 3.84E-08 to DATA 3.99E-06 BR 83 10 DATA 10 DATA 1.71E-07 10 DATA 10 DATA 10 DATA LT E-24 RR 84 10 DATA 10 DATA 1.98E-07 10 DAT)) to DATA 10 DATA LT E-24 DR '35 to DATA 10 DATA 9.12E-09 10 DATA 10 DATA 10 DATA LT E-24 RB 86 to DATA 6.70E-05 4.12E-05 to DATA to DATA 10 DATA 4.31E-06 RB 88 NO DA1A 1.90E-07 1.32E-07 10 DATA 10 DATA 10 DATA 9.32E-09 RB 89 10 DATA 1.17E-07 1.04E-07 10 DATA 10 DATA 10 DATA 1.02E-09 SR 89 1.32E-03 to DATA 3.77E-05 to DATA 10 DATA 10 DATA 5.11E-05 SR 90 1.70E-02 10 DATA 4.31E-03 10 DATA 10 DATA 70 DATA 2.22E-04 SR 91 2.40E-05 10 DATA 9.06E-07 10 DATA 10 DATA 10 DATA 5.30E-05 SR 92 9.03E-06 to DATA 3.62E-07 10 DATA 10 DATA 10 DATA 1.71E-04 Y 90 4.11E-08 to DATA 1.10E-09 10 DATA 10 DATA to DATA 1.17E-04 Y 91M 3.82E-10 10 DATA 1.39E-ll 10 DATA 10 DATA to DATA 7.48E-07 Y 91 6.02E-07 to DATA 1.61E-08 10 DATA 10 DATA 10 DATA 8.02E-05 Y 92 3.60E-09 to DATA 1.03E-10 to DATA to DATA 10 DATA 1.04E-04
*Taken frun Regulatory Guide 1.109 (Rev.1)
A-24 O
TAIRE A.3-3 (Omt'd)
' 110ESTION DOSE FICIORS 10R CIIIID (MREM PER ICI I!GESTED)
IJtOLIDE LONE LTVER T IODY 'Il{YROID KItWEY IUtG GT-!{d Y 93 1.14E-08 10 DATA 3.13E-10 10 DATA 10 DATA 10 DATA 1.70E-04 ZR 95 1.16E-07 2.55E-08 2.27E-08 10 DATA 3.65E-08 10 DATA 2.66E-05 , ZR 97 6.99E-09 1.01E-09 5.96E-10 10 DATA 1.45E-09 10 DATA 1.53E-04
!JB 95 2.25E-08 8.76E-09 6.26E-09 10 DATA 8.23E-09 10 DATA 1.62E-05
, MO 99 10 DATA 1.33E-05 3.29E-06 10 DATA 2.84E-05 10 DATA 1.10E-05 i K 99M 9.23E-10 1.81E-09 3.00E-08 10 DATA 2.63E-08 9.19E-10 1.03E-06 _ E 101 1.07E-09 1.12E-09 1.42E-08 10 CATA 1.91E-08 5.92E-10 3.56E-09 RU 103 7.31E-07 10 DATA 2.81E-07 10 DATA 1.84E-06 to DATA 1.89E-05 RU 105 6.45E-08 10 DATA 2.34E-08 10 DATA 5.67E-07 to DATA 4.21E-05 RU 106 1.17E-05 to DATA 1.46E-06 10 DATA 1.58E-05 10 DATA 1.82E-04 IG 110M 5.39E-07 3.64E-07 2.91E-07 10 DATA 6.78E-07 10 DATA 4.33E-05 TE 125M 1.14E-05_ 3.09E-06 1.52E-06 3.20E-06 10 DATA 10 DATA 1.10E-05 TE 127M 2.89E-05 7.78E-06 3.43E-06 6.91E-06 8.24E-05 to DATA 2.34E-05 TE 127 4.71E-07 1.27E-07 1.01E-07 3.26E-07 1.34E-06 10 DATA 1.84E-05 TE. 129M 4.87E-05 1.36E-05 7.56E-06 1.57E-05 1.43E-04 10 DATA 5.94E-05 TE 129 1.34E-07 3.74E-08 3.18E-08 9.56E-08 3.92E-07 10 DATA 8.34E-06 TE 131M 7.20E-06 2.49E-06 2.65E-06 5.12E-06 2.41E-05 10 DATA 1.01E-04 TE 131 0.30E-08 2.53E-08 2.47E-08 6.35E-08 2.51E-07 10 DATA 4.36E-07 i TE 132 1.01E-05 4.47E-06 5.40E-06 6.51E-06 4.15E-05 10 DATA 4.50E-05 I 130 2.92E-06 5.90E-06 3.04E-06 6.50E-04 8.82E-06 10 DATA 2.76E-06 I 131 1.723-05 1.73E-05 9.83E-06 5.72E-03 2.84E-05 to DATA 1.54E-06 I 132 8.00E-07 1.47E-06 6.76E-07 6.82E-05 2.25E-06 to DATA 1.73E-06 I 133 5.92E-06 7.32E-06 2.77E-06 1.36E-03 1.22E-05 to DATA 2.95E-06 I 134 4.19E-07 7.78E-07 3.58E-07 1.79E-05 1.19E-06 to DATA 5.16E-07 I 135 1.75E-06 3.15E-06 1.49E-06 2.79E-04 4.83E-06 10 DATA 2.40E-06 CS 134 2.34E-04 3.84E-04 8.10E-05 10 DATA 1.19E-04 4.27E-05 2.07E-06 CS 136 2.35E-05 6.46E-05 4.18E-05 10 DATA 3.44E-05 5.13E-06 2.27E-06 CS 137 3.27E-04 3.13E-04 4.62E-05 10 DATA 1.02E-04 3.67E-05 1.96E-06 CS 138 2.28E-07 3.17E-07 2.01E-07 10 DATA 2.23E-07 2.40E-08 1.46E-07 BA 139 4.14E-07 2.21E-10 1.20E-08 10 DATA 1.93E-10 1.30E-10 2.39E-05 A-25 A U
TMRJ! A.3-3 (Cont.'d) I!GESI' ION DOSE FICKES ICR OfIlD (!G124 PER PCI IIGESITD)
!RCLIDE DCNE LTVER T IODY 'IHYROID KIDNEY IUTC GI-ILI M 140 8.31E-05 7.28E-08 4.85E-06 10 DATA 2.37E-08 4.34E-08 4.21E-05 EA 141 2.00E-07 1.12E-10 6.51E-09 to DATA 9.69E-11 6.58E-10 1.14E-07 M 142 8.74E-08 6.29E-11 4.88E-09 to DATA 5.09E-11 3.70E-11 1.14E-09 l
l IA 140 1.01E-08 3.53E-09 1.19E-09 10 DATA 10 DATA 10 DATA 9.84E-05 LA 142 5.24E-10 1.67E-10 5.23E-11 10 DATA 10 DATA NO DATA 3.31E-05 CE 141 3.97E-08 1.9BE-08 2.94E-09 10 DATA 8.68E-09 10 DATA 2.47E-05 CE 143 6.99E-09 3.79E-06 5.49E-10 10 QATA 1.59E-09 10 DATA 5.55E-05 CE 144 2.08E-06 6.52E-07 1.11E-07 10 DATA 3.61E-07 10 DATA 1.70E-04 PR 143 3.93E-08 1,18E-08 1.95E-09 to DATA 6.39E-09 to DATA 4.24E-05 PR 144 1.29E-10 3.99E-11 6.49E-12 10 DATA 2.11E-11 10 DATA 8.59E-08 10 147 2.79E-08 2.26E-08 1.75E-09 to DATA 1.24E-08 10 DATA 3.58E-05 W 187 4.29E-07 2.54E-07 1.14E-07 .to DATA 10 DATA 10 DATA 3.57E-05 NP 239 5.25E-09 3.77E-10 2.65E-10 10 DATA 1.09E-09 10 DATA 2.79E-05 Sb 124** 1.11E-05 1.44E-07 3.89E-06 2.45E-08 10 DATA 6.16E-06 6.94E-05 Sb 125** 7.16E-06 5.52E-08 1.50E-06 6.63E-09 to DATA 3.99E-06 1.71E-05 V Sb 126** 4.40E-06 6.73E-08 1.58E-06 2.58E-08 10 DATA 2.10E-06 8.87E-05 Co 57** to DATA 4.93E-07 9.98E-07 to DATA 10 DATA to DATA 4.04E-06
**Taken fmn Recy.11atory Guide 1.109 (Rev. 0)
A-26 0
TNUC A.3-4
- I!GESTION DOSE FICIORS FOR INFAlff (MIUM PIR ICI I!OISPED)
NIX 3.1DE IONE LIWR T FODY '11m OID KIDNEY 1,Uto GI-LLI 11 3 10 DATA 3.08E-07 3.08E-07 3.08E-07 3.08E-07 3.08E-07 3.08E-07 C 14 2.37E-05 5.06E-06 5.06E-06 5.06E-06 5.06E-06 5.06E-06 5.06E-06 NA 24 1.01E-05 1.01E-05 1.012-05 1.01E-05 1.01E-05 1.01E-05 1.018-M_ P 32 1.70E-03 1.00E-04 6.59E-05 10 DATA to DrcA 10 DATA 2.30E-05 CR 51 10 DATA 10 DATA 1.41E-08 9.20E-09 2.01E-09 1.79E-08 4.11E-07 MN 54 10 DATA 1.99E-05 4.51E-06 to DWA 4.41E-06 10 DATA 7. 31 E-06 - MN 56 10 DATA 8.18E-07 1.41E-07 10 DATA 7.03E-07 10 DATA 7.43E-05 FE 55 1.39E-05 8.98E-06 2.40E-06 10 DATA 10 DATA 4.39E-06 1.14E-06 FE 59 3.08E-05 5.38E-05 2.12E-05 to DATA 10 DATA 1.59E-05 2.57E-05 CO 58 10 DATA 3.60E-06 8.98E-06 10 DATA 10 DATA 10 DATA 8.97E-06 CO 60 10 DATA 1.08E-05 2.55E-05 10 DATA 10 DATA 10 DATA 2.57E-05 NI 63 6.34E-04 3.92E-05 2.20E-05 to DATA to DATA to DATA 1.95E-06 III 65 4.70E-06 5.32E-07 2.42E-07 10 DATA 10 DATA 10 DATA 4.05E-05 CU 64 10 DATA 6.09E-07 2.82E-07 to DATA 1.03E-06 10 DATA 1.25E-05 ( IN 65 1.84E-05 6.31E-05 2.91E-05 to DATA 3.00E-05 to DATA 5.33E-05 ZN 69 9.33E-08 1.68E-07 1.25E-08 10 DATA ' 6.98E-08 10 DATA 1.37E-05 BR 83 10 DATA 10 DATA 3.63E-07 10 DATA 10 DATA !O DATA LT E-24 BR 84 to DATA 10 DATA 3.82E-07 to DATA 10 DATA 10 DATA LT E-24 IR 85 10 DATA 10 DATA 1.94E-08 10 DATA 10 DATA 10 DATA Ilr E-24 RB 60 to DATA 1.70E-04 8.40E-05 10 DATA 10 DATA 10 DATA 4.35E-06 - RB 80 to DATA 4.98E-07 2.73E-07 to DATA 10 DATA to DATA 4.85E-07 RB 89 to DATA 2.86E-07 1.97E-07 10 DATA 10 DATA 10 DATA 9.74E-08 SR 89 2.51E-03 to DATA 7.20E-05 10 DATA 10 DATA 10 DATA S.16E-05 ER 90 1.85E-02 to DATA 4.71E-03 to DATA to DATA 10 DATA 2.31E-04 SR 91 5.00E-05 to DATA 1.01E-06 10 DATA 10 DATA 10 DATA 5.92E-05 SR 92 1.92E-05 to DNTA 7.13E-07 10 DATA 10 DATA to DATA 2.07E-04 Y 90 0.69E-09 to DATA 2.33E-09 to DATA to DATA rn DATA 1.20E-04 Y 91M 8.10E-10 10 DATA 2.76E-11 10 DATA to DNTA 10 DATA 2.70E-06 Y 91 1.13E-06 to DATA 3.01E-08 10 DATA 10 DNTA 10 DATA 8.10E-05 Y 92 7.65E-09 to DATA 2.llE-10 to DATA to DATA to DATA 1.46E-04
*Taken fmn Regulatory Gttide 1.109 (Rev.10 A-27 )
v
TNVE A.3-4 (Omt.'d) I!GESTICt1 DOSE FACIORS FOR INFNTP (hREM PER TCI ltCESTED) tROJDE IGE LIVER T DODY SifYROID KIDNPY 1010 GT-ILI Y 93 2.43E-08 10 DATA 6.62E-10 10 DATA 10 DATA 10 DATA 1.92E-04 ZR 95 2.06E-07 5.02E-08 3.56E-08 10 DATA 5.41E-08 10 DATA 2.50E-05 ZR 97 1.48E-08 2.54E-09 1.16E-09 10 I%TA 2.56E-09 to DATA 1.62E-04 NB 95 4.20E-08 1.73E-03 1.00E.08 10 DATA 1.24E-08 to DATA 1.46E-05 10 99 10 DATA 3.40E-05 6.63E-06 10 DATA 5.08E-05 10 DATA 1.12E-05 SC 49M 1.92E-09 3.96E-09 5.10E-08 10 DATA 4.26E-08 2.07E-09 1.15E-06 1C 101 2.27E-09 2.86E-09 2.83E-08 10 DATA 3.40E-08 1.56E-09 4.86E-07 RU 103 1.48E-06 10 DATA 4.95E-07 10 DATA 3.08E-06 10 DATA 1.80E-05 RU 105 1.36E-07 10 DATA 4.58E-08 ?O DATA 1.00E-06 10 DATA 5.41E-05 RU 106 2.41E-05 10 DATA 3.01E-06 E %TA 2.85E-05 10 DATA 1.83E-04 AG 110M 9 96E-07 7.27E-07 4.81E-07 to DATA 1.04E.06 10 DATA 3.77E-05 TE 125M 2.33E-05 7.79E-06 3.15E-06 7.84E-06 to DATA 10 DATA 1.11E-05 TE 127M 5.85E-05 1.94E-05 7.08E-06 1.69E-05 1.44E-04 10 DATA 2.36E-05 TE 127 1.00E-06 3.35E-07 2.15E-07 8.14E-07 2.44E-06 10 DATA 2.10E-05 TE 129M 1.00E-04 3.43E-05 1.54E-05 3.84E-05 2.50E-04 to DATA 5.97E-05 TE 129 2.84E-07 9.79E-08 6.63E-08 2. 38E-0', 7.07E-07 10 DATA 2.27E-05 TE 131M 1.52E-05 6.12E-06 5.05E-06 1.24E-05 4.21E-05 10 DATA 1.03E-04 TE 131 1.76E-07 6.50E-08 4.94E-08 1.57E-07 4.50E-07 10 DATA 7.11E-06 TE 132 2.08E-05 1.03E-05 9.61E-06 1.52E-05 6.44E-05 10 DATA 3.81E-05 1 130 6.00E-06 1.32E-05 5.30E-06 1.488-03 1.45E-05 10 DATA 2.83E-Of I 131 3.59E 4.23E-05 1.86E-05 1.39E-02 4.94E.05 to IRTA 1.51E-06 I 132 1.66E-06 3.37E-06 1.20E-06 1.58E-04 3.76E-06 to DATA 2.73E I 133' 1.25E-05 1.82E-05 5.33E-06 3.31E-03 2.14E-05 10 DATA 3.68E-06 I 134 8.69E-07 1.78E-06 6.33E-07 4 15E-05 1.99E-06 10 DATA 1.84E-06 I 135 3.64E-06 7.24E-06 2.64E-06 6.49E-04 8.07E-06 10 DATA 2.62E-06 CS 134- 3.77E-04 7.03E-04 7.10E-05 to DATA 1.81E-04 7.42E-05 1.91E-06 CS 136 4.59E-05 1.35E-Q4 5.04E-05 to DAI'A 5.38E-05 1.10E-05 2.05E-06 i CS 137 5.22E-04 6.11E-04 4.33E-05 to DATA 1.64E-04 6.64E-05 1.91E-06 CS 138- 4.81E-07 7.82E-07 3.79E-07 to DATA 3.90E-07 6.09E-08 1.25E-06 1% 139 8.81E-07 5.84Pc10 2.55E-08 tO DATA 3,51E-10 3.54E-10 5.5BE-05 A-28 O l i L
TAIRE A.3-4 (Ont'd) IIGESTIO1 DOSE FAC1m S E m INFNTP (MIU24 PER PCI I!UESTED) ECLIDE ITNE I.IVIE T IODY 'IIIYROID KIDNEY 11110 GI-ILI M 140 1.71E-04 1.71E-07 8.81E-06 10 IATA 4.06E-08 1.05E-07 4.20E-05 m 141 4.25E-07 2.91E-10 1.34E-08 10 DATA 1.75E-10 1.77E-10 5.19E-06 PA 142 1.84E-07 1J)J-10 9.053-09 10 DATA BJ13-11 9.26E-11 7.59E-07 1A 140 2. 2.1E-08 8.32E-09 2.14E-09 10 DATA 10 DATA 10 DATA 9.77E-05 LA 142 1.10E-09 4.04E-10 9.67E-11 10 DATA 10 DA"A 10 !%TA 6.86E-05 CE 141 7.87E-08 4.80E-08 5.65E-09 10 !%TA 1.48F-08 10 DATA 2.48E-05 _ CE 143 1.48E-08 9.82E-06 1.12E-09 10 DATA 2.86E-09 10 DATA 5.73E-05 CE 144 2.98E-06 1.22E-06 1.67E-07 10 DATA 4.93E-07 10 DATA 1.71E-04 PR 143 8.13E-08 3.04E-08 4.03E-09 10 t%TA 1.13E 10 DATA 4.29E-05 PR 144 2.74E-10 1.06E-10 1.38E-11 10 DtdA 3.84E-11 10 DATA 4.93E-06 ND 147 5.53E-08 5.68E-08 3.48E-09 10 DATA 2.19E-08 10 DATA 3.60E-05 W 107 9.03E-07 6.291-07 2.17E 10 DATA 10 MTA 10 DATA 3.69E-QL e NP 239 1.11E-08 9.93E-1C 5.61E-10 10 DNrA 1.98E-09 10 ImTA 2.87E-05 Sb 124** 2.14E-05 3.1SE-07 6.63E-06 5.68E-0E 10 DATA 1.34E-05 6.60E-05 Sb 125** 1.23E-05 1,19E-07 2.53E-06 1.54E-08 10 DATA 7.72E-05 1.64E-03 Sb 126** 8.06E-06 1.58E-07 2.91E-06 6.19E-08 10 DATA 5.07E-06 8.35E-06 Co 57** 10 DATA 1.15E-06 1.87E-06 10 DATA 10 DATA 10 DATA 3.92E-06
**Taken frta Rcqulatory Guide 1.109 (Rev 0)
A-29 O
l
'IMANE A.3-56
( STAHIE EIWJWP 'HW1SPFJL[BTo l j Dgy F, @v) F f Elenmt Voa/Soll }ttik Id/1) Jivtt fd/kai j 11 4.8E 00 1.00-02 + 1.2E-02 ! C 5.5B 00 1.2E-02 + 3.1E-02 l Na 5.2E-02 4.0E-02 3.0E-02 P 1.1E 00 2.5E-02 + 4.6E-02 Cr 2.5E-04 3.2E-03 2.4E-03 Mn 2.9E-02 2.5E-04 8.0E-04 Fo 6.6E-04 1.2E-03 + 4.0E-02 Co 9.4E-03 1.0E-03 1.3E-02
.N1 1.9E-02 6.7E-03 5.3E-02 Cu 1.2E-01 1.4E-02 + 8.0E-03 Zn 4.0E-01 3.9E-02 1.0E-02 ,
Rb 1.3E-01 3.0E-02 3.1E-02 t
-Sr 1.7E-02 8.0E-04 + 6.0E-04 Y 2.6E-03 1.0E-05 4.6E-03 Er 1.7E-04 5.0E-06 3.4E-02 '
Nb- 9.4E-03 2.5E-03 2.8E-01 Mo 1.2E-01 7.5E-03 8.0E-03 Tc 2.5E-01 2.5E-02 4.0E-01 Ru 5.0E-02 1.0E-06 4.0E-01 Rh 1.3E 01 1.0E-02 1.5E-03 Ag 1.5E-01 5.0E-02 1.7E-02 Tb 1.3E 00 1.0E-03 7.7E-02 I 2.0E-02 6.0E-03-+ 2.9E-03 Cs 1.0E-02 1.2E-02 + 4.0E-03 Ba 5.0E-03 4.0E-04 3.2E-03 La 2.5E-03 5.0E-06 2.0E-04 Co 2.5E-03 l'.0E-04 1.2E-03 Pr 2.5E-03= 5.0E-06 4.7E-03 Nd 2.4E-03 '5.0E-06 3.3E-03 W 1.8E-02 5.0E-04 1.3E-03 Np- 2.5E-03 5.0E-06 2.0E-04
*F,,'(Goat) values for milk (d/1)
Elannnt -Milk (d/1) II 1.7E-01 C 1.0E-01 P' ;2.5E .Fe 1.3E-04 CM 1.3E 02 Sr 1.4E-02 I 6.0E-02 Cs 3.0E-01 N *Taken f tun Rogulatory Guide 1.109 (Rev. 3 ) ; ()- A-30
. . - - - - - . - - - - . = - - _ - . - . - .
T/dVE A.4-1 SITE RELttTIP DOSE COMI'IMUff FICIm AIT
- l. M/lIR PD! :C1/ML ALULT IM2dDE !YNE LIVl3 T IUW 'IUYROID E1DNEY IARG G1-ILI 11 3 0.00E-01 8.96E 00 B.96E 00 8.96E 00 8.96E 00 8.96E 00 8.96E 00 C 14 3.15E 04 6.30E 03 6.30E 03 6.30E 03 6.30E 03 6.30E 03 6.30E 03 US 24 5.48E 0? 5.48E 02 5.48E 02 5.48E 02 5.48E 02 5.48E 02 5.48E_02 P 32 4.62E 07 2.87E 06 1.79E 06 0.00E-01 0.00E-01 0.00E-01 5.20E 06 CR 51 0.00E-01 0.00E-01 1.49E 00 8.94E-01 3.29E-01 1.9BE 00 3.76E 02 MN 54 0.00E-01 4.76E 03 9.08E 02 0.00E-01 1.42E 03 0.00E-01 1.46E 04 MN 56 0.00E-01 1.20E 02 2.12E 01 0.00E-01 1.52E 02 0.00E-01 3.82E 03 FE 55 8.87E 02 6.13E 02 1.43E 02 0.00E-01 0.00E-01 3.42E 02 3.52E 02 FE 59 1.40E 03 3.29E 03 1.26E 03 0.00E-01 0.00E-01 9.19E 02 1.10E 04 J
Co 58 0.00E-01 1.51E 02 3.39E 02 0.00E-01 0.00E-01 0.00E-01 3.06E 03 00 60 0.00E-01 4.34E 02 9.5BE 02 0.00E-01 0.00E-01 0.00E-01 8.16E 03 UI 63 4.19E 04 2.94E 03 1.41E 03 0.00E-01 0.00E-01 0,00E-01 6.07E 02 NI 65 1.70E 02 2.21E 01 1.01E 01 0.00E-01 0.00E-01 0.00E-01 5.61E 02 CU 64 0.00E-01 1.69E 01 7.93E 00 0.00E-01 4.26E-01 0.00E-01 1.44E 03 ZN 65 2.36E 04 7.50E 04 3.39E 04 0.09E-01 5.02E 04 0.00E-01 4.73E 04 ZN 69 5.02E 01 9.60E 01 6.67E 00 0.00E-01 6.24E-01 0.00E-01 1.44E 01 BR 83 0.00E-01 0.00E-01 4.38E 01 0.00E-01 0.00E-01 0.00E-01 6.30E 01 BR 84 0.00E-01 0.00E-01 5.67E 01 0.00E-01 0.00E-01 0.00E-01 4.45E-01 BR 85 0.00E-01 0.00E-01 2.33E 00 0.00E-01 0.00E-01 0.00E-01 1.09E-19 RB 86 0.00E-01 1.03E 05 4.79E 04 0.00E-01 0.00E-01 0.00E-01 2.03E 04 RB 88 0.00E-01 2.95E 02 1.56E 02 0.00E-01 0.00E-01 0.00E-01 4.07E-09 RB 89 0.00E-01 1.95E 02 1.37E 02 0.00E-01 0.00E-01 0.00E-01 1.13E-11 SR 89 4.78E 04 0.00E-01 1.37E 03 0.00E-01 0.00E-01 0.00E-01 7.66E 03 SR 90 1.1RE 06 0.00E-01 2.88E 05 0.00E-01 0.00E-01 0.00E-01 3.40E 04 SR 91 8.79E 02 0.00E-01 3.55E 01 0.00E-01 0.00E-01 0.00E-01 4.19E 03 SR 92 3.33E 02 0.00E-01 1.44E 01 0.00E-01 0.00E-01 0.00E-01 6.60E 03 Y ,90 1.38E 00 0.00E-01 3.69E-02 0.00E-01 0.00E-01 0.00E-01 1.4El_Q4 l Y 91M 1.30E-02 0.00E-01 5.04E-04 0.00E-01 0.00F-01 0.00E-01 3.82E-02 Y 91 2.02E 01 0.00E-01 5.39E-01 0.00E-01 0.00E-01 0.00E-01 1.11E 04 Y 92 1.21E-01 0.00E-01 3.53E-03 0.00E-01 0.00E-01 0.00E-01 2.12E 03 A-31 O
TMEJs A.4-1 (otnt'd) O SITE RE1ATED DDSE COMI'IMENT FICIOR AIT MRIM/HR PER UCI/ML ADULT NtEIMP TONE LIVER T DODY '11IYROID KIDNEY IDG GI-I.LI Y 93 3.83E-01 0.00E-01 1.06E-02 0.00E-01 0.00E-01 0.00E-01 1.22E 04 ZR 95 2.77E 00 8.88E-01 6.01E-01 0.00E-01 1.39E 00 0.00E-01 2.82E 03 KR 97 1,53E-01 3.09E-02 1.41E-02 0.00E-01 4.67E-02 0.00E-01 9.57E 03 NB 95 4.47E 02 2.49E 02 1.34E 02 0.00E-01 2.46E 02 0.00E-01 1.51E 06 MD 99 0.00E-01 4.62E 02 8.79E 01 0.00E-01 1.05E 03 0.00E-01 1.07E 03 _ TC 99M 2.94E-02 8.32E-02 1.06E 00 0.00E-01 1.26E 00 4.07E-02 4.92E 01 TC 101 3.03E-02 4.36E-02 4.28E-01 0.00E-01 7.85E-01 2.23E-02 1.31E-13 RU 103 1.98E 01 0.00E-01 0.54E 00 0.00E-01 7.57E 01 0.00E-01 2.31E 03 RU 105 1.65E 00 0.00E-01 6.52E-01 0.00E-01 2.13E 01 0.00E-01 1.01E 03 RU 106 2.95E 02 0.00E-01 3.73E 01 0.00E-01 5.69E 02 0.00E-01 1.91E 04 AG 110M 1.42E 01 1.31E 01 7.80E 00 0.00E-01 2.58E 01 0.00E-01 5.36E 03 TE 125M 2.79E 03 1.01E 03 3.74E 02 8.39E 02 1213E 04 0.00E-01 1.11E Of TE 127M 7.05E 03 2.52E 03 8.59E 02 1.80E 03 2.86E 04 0.00E-01 2.36E 04 TE 127 1.14E 02 4.11E 01 2.48E 01 8.48E 01 4.66E 02 0.00E-01 9.03E 03 1.20E 04 4.47E 03 4.11E 03 5.00E 04 6.03E 04 OTE 129M 1,89E 03 0.00E-01 3- TE 129 3.27E 01 1.23E 01 7.96E 00 2.51E 01 1.37E 02 0.00E-01 2.47E 01 TE 131M 1.80E 03 8.81E 02 7.34E 02 1.39E 03 8.92E 03 0.00E-01 8.74E 04 TE 131 2.05E 01 8.57E 00 6.47E 00 1.69E 01 8.98E 01 0.00E-01 2.90E 00 TT 132 2.62E 03 1.70E 03 1.59E 03 1.87E 03 1.63E 04 0.00E-01 8.02E 04 I 130 9.01E 01 2.66E 02 1.05E 02 2.25E 04 4.15E 02 0.00F-01 2.29E 02 I 131 4.96E 02 7.09E 02 4.06E 02 2.32E 05 1.22E 03 0.0r6-01 2 1.87E 02 I 132 2.42E 01 6.47E 01 2.26E 01 2.26E 03 1.03E 02 0.00E-01 1.22E 01 I 133 1.69E 02 2.94E 02 8.97E 01 4.32E 04 5.13E 02 0.00E-01 2.64E 02 I 134 1.26E 01 3.43E 01 1.23E 01 5.94E 02 5.46E 01 0.00E-01 2.99E-02 I 135 5.28E 01 1.38E 02 5.10E 01 9.11E 03 2.22E 02 0.00E-01 1.56E 02 CS 134 3.03E 05 7.21E 05 5.09E 05 0.00E-01 2.33E OS 7.75E 04 1.26E 04 CS 136 3.17E 04 1.25E 05 9.01E 04 0.00E-01 6.97E 04 9.55E 03 1.42E 04
- C3 137 3.88E b5 5.31E 05 3.48E 05 0.00E-01 1.80E 05 5.99E 04 1.03E 04 CS 138 2.69E 02 5.31E 02 2.63E 02 0.00E-01 3.90E 02 3.85E 01 2.27E-03 BA 139 9.00E 00 6,41E-03 2,64E-01 0.00E-01 5.99E-03 3.64E-03 1 6.0p 01 3
A-32 O
TNEE A.4-1 (nnt'd) SITE RELATED DOSE CQtil'11G2il' FICIUt AIT MREM /IDI PIE (CI/ML ADULT 14tCLIDE IUJE LIVER T IODY 'I1NROID KIDtJEY IUfG GI-ILI BA 140 1.88E 03 2.37E 00 1.23E 02 0.00E-01 8.05E-01 1.35E 00 3.88E 03 BA 141 4.37E 00 3.30E-03 1.48E-01 0.00E-01 3.07E-03 1.87E-03 2.06E-09 PA 142 1.988 00 2.03E-03 1.24E-01 0.00E-01 1.72E-03 1.15E-03 2.78E-18 LA 140 3.58E-01 1.80E-01 4.76E-02 0.00E-01 0.00E-01 0.00E-01 1.32E 04 LA 142 1.83E-02 8.33E-03 2.07E-03 0.00E-01 0.00E-01 0.00E-01 6.08E 01 CE 141 0.01E-01 5.42E-01 6.15E-02 0.00E-01 2.52E-01 0.00E-01 2.07E 03 CE 143 1.41E-01 1.04E 02 1.16E-02 0.00E-01 4.60E-02 0.00E-01 3.90E 03 CE 144 4.18E 01 1.75E 01 2.24E 00 0.00E-01 1.04E 01 0.00E-01 1.41E 04 PR 143 1.32E 00 5,28E-01 6.52E-02 0.00E-01 3.05E-01 0.00E-01 5.77E 03 PR 144 4.31E-03 1.79E-03 2.19E-04 0.00E-01 1.01E-03 0.00E-01 6.19E-10 14D 147 9.00E-01 1.04E 00 6.22E-02 0.00E-01 6.08E-01 0.00E-01 4.99E 03 W 187 3.04E 02 2.55E 02 8.90E 01 0.00E-01 0.00E-01 0.00E-01 8.34E 04 NP 239 1.28E-01 1.25E-02 6.91E-03 0.00E-01 3.91E-02 0.00E-01 2.57E 03 Sb 124 2.40E 02 4.53E 00 9.50E 01 5.819-01 0.00E-01 1.87E 02 6.81E 03 Sb 125 1.53E 02 1.71E 00 3.65E 01 1.56E-01 0.00E-01 1.18E 02 1.69E 03 Sb 126 9.85E 01 2.00E 00 3.55E 01 6.03E-01 0.00E-01 6.04E 01 8.05E 03 Co 57 0.00E-01 3.55E 01 5.90E 01 0.00E-01 0.00E-01 0.00E-01 9.01E 02 A-33
TluMJs A.4-2 SITE RELATED DOSE CG911'1MDif EtCIOR AIT MRH4/HR PER 1EI/ML TEEN t NUCLIDE DONE LIVER T lYXJY 'HIYROID KIDNEY UJfC GI-ILI H 3 0.00E-01 6,34E 00 6.34E 00 6.34E 00 6.34E 00 6.34E 00 6.34E 00 , C 14 3.43E 04 6.86E 03 6.86E 03 6.86E 03 6.86E 03 6.86E 03 6.86E 03 BA 24 5.53E 02 5.53E 02 5.53E 02 5.53E 02 5.53E 02 5.53E 02 5.53E 02 > P 32 5.04E 07 3.12E 06 1.95E 06 0.00E-01 0.00E-01 0.00E-01 4.23E 06 CR 51 0.00E-01 0.00E-01 1.52E 00 8.46E-01 3.34E-01 2.17E 00 2.56E 02 FW 54 0.00E-01 4.65E 03 9.22E 02 0.00E-01 1.39E 03 0.00E-01 9.53E 03 MN 56 0.00E-01 1.24E 02 2.21E 01 0.00E-01 1.58E 02 0.00E-01 8.19E 03 FE 55 9.09E 02 6.45E 02 1.50E 02 0.00E-01 0.00E-01 4.09E 02 2.79E 02 FE 59 1.41E 03 3.30E 03 1.27E 03 0.00E-01 0.00E-01 1.04E 03 7.79E 03 00 58 0.00E-01 1.45E 02 3.35E 02 0.00E-01 0.00E-01 0.00E-01 2.00E 03 00 60 0.00E-01 4.20E 02 9.45E 02 0.00E-01 0.00E-01 0.00E-01 5.47E 03 NI 63 4.26E 04 3.01E 03 1.44E 03 0.00E-01 0.00E-01 0.00E-01 4.79E 02
-NI 65 1.80E 02 2.30E 01 1.05E 01 0.00E-01 0.00E-01 0.00E-01 1.25E 03 i 64 0.00E-01 1.72E 01 8.08E 00 0.00E-01 4.35E 01 0.00E-01 1.33E 03 2.13E 04 7.41E 04 3.46E 04 0.00E-01 4.74E 04 0.00E-01 3.14E 04
()CUEN 65 ZN 69 5.45E 01 1.04E 02 7.26E 00 0.00E-01 6.78E 01 0.00E-01 1.91E 02 BR 83 0.00E-01 0.00E-01 4.73E 01 0.00E-01 0.00E-01 0.00E-01 8.24E-16 ER 84 0.00E-01 0.00E-01 5.95E 01 0.00E-01 0.00E-01 0.00E-01 8.24E-16 BR : 85 0.00E-01 0.00E-01 2.51E 00 0.00E-01 0.00E-01 0.00E-01 8.24E-16 RB 86 0.00E-01 1.10E 05 5.10h' 04 0.00E-01 0.00E-01 0.00E-01 1.63E V4 RB 88 0.00E-01 3.16E 02 1.scA 02 0.00E-01 0.00E-01 0.00E-01 2.71E-05 RB -89 0.00E-01 2.04E 02 1.44E 02 0.00E-01 0.00E-01 0.00E-01 3.12E-07 SR 89 4.97E 04 0.00E-01 1.42E 03 0.00E-01 0.00E-01 0.00E-01 5.91E 03 SR 90 9.37E 05 0.0QE-01 2.31E_05 0.00E-01 0.00E-01 0.00E-0) 2.63E Q4 SR' 91 9.11E v4 0.00E-01 3.G2E 01 0.00E-01 0.00E-01 0.00E-01 4.13E 03 SR 92 3.44E 02 -0.00E-01 1.47E 01 0.00E-01 0.00E-01 0.00E-01 8.77E 03 Y 90 1.42E 00 0.00E-01 3.83E-02 0.00E-01 0.00E-01 0.00E-01 1.17E 04 Y 91M 1.34E-02 0.00E-01 5.11E-04 0.00E-01 0.00E-01 0.00E-01 6.32E-01 Y' 91. 2.09E 01 0.00E 5.59E-01 0.00E-01 0.00E-01 0.00E-01 8.55E 03 Y 92 1.26E-01 0.00E-01 3.63E-03 0,00E-01 0.00E-01 0.00E-01 3.44E 03 A-34 O
TAILH A.4-2 (cant'd) O SITE REIATED r'EE COMIFI!fI' FICIOR AIT MR m/HR PER IEI/ML TEEN NUC*LTDE !YNE LIVER T TODY 71n7tOID KIDNEY LU!G GI-ILI Y 93 3.97E-01 0.00E-01 1.09E-02 0.00E-01 0.00E-01 0.00E-01 1.21E 04 ZR 95 2.64E 00 8.34E-01 5.74E-01 0.00E-01 1.23E 00 0.00E-01 1.92E 03 ER 97 1.52E-01 3.01E-02 1.39E-02 0.00E-01 4.56E-02 0.00E-01 8.15E 03 ND 95 4.50E 02 L's0E 02 1.37E 02 0.00E-01 2.42E 02 0.00E-01 1.07E 06 FO 99 0.00E-01 4.61E 02 8.78E 01 0.00E-01 1.05E 03 0.00E-01 0.25E 02 TC 99M 2.84E-02 7.92E-02 1.03E 00 0.00E-01 1.18E_00 4.39E-02 5.20E 01 7C 101 3.08E-02 4.38E-02 4.30E-01 0.00E-01 7.92E-01 2.67E-02 7.48E-09 RU 103 1.95E 01 0.00E-01 8.33E 00 0.00E-01 6.87E 01 0.00E-01 1.63E 03 RU 105 1.67E 00 0.00E-01 6.46E-01 0.00E-01 2.10E 01 0.00E-01 1.34E 03 RU 106 2.99E 02 0.00E-01 3.77E 01 0.0CE-01 5.77E 02 0.00E-01 1.44E 04 AG 110M 1.20E 01 1.21E 01 7.36E 00 0.00E-01 2.31E 01 0.00E-01 3.40E 03 7T 125M 3.02E 03 1.09E 03 4.03E 02 8.438 02 0.00E-01 0. 03,E-01 8.908 03 ' TE 127;M 7.62E 03 2.70E 03 9.06E 02 1.81E 03 3.09E 04 0.00E-01 1.90E 04 n TE 127 1.24E 02 1.20E 04 4.41E 01 2.68E 01 8.59E 01 5.04E 02 0.00E-01 9.61E 03 ( ,) TE 129M 4.77E 03 2.03E 03 4.14E 03 5.37E 04 0.00E-01 4.82E 04 TE 129 3.53E 01 1.32E 01 8.59E 00 2.52E 01 1.48E 02 0.00E-01 1.93E 02 TE 131M 1.92E 03 9.22E 02 7.69E 02 1.39E 03 9.61E 03 0.00E-01 7.40E 04
'IE 131 2.20E 01 9;06E 00 __6.87E 00 1.69E 01 9.61E 01 0.00E-01 1.80E 00 TE 132 2.75E 03 J.74E 03 1.64E 03 1.84E 03 1.67E 04 0.00E-01 5.51E 04 I 130 8.81E 01 2.55E 02 1.02E 02 2.05E 04 3.92E 02 0.00E-01 1.96E 02 l
I 131 5.00E 02 7.00E 02 3.76E 02 2.04E 05 1.2iE 03 0.00E-01 1.39E_02 I 132 2.39E 01 6.24E 01 2.24E 01 2.10E 03 9.83E 01 0.00E-01 2.72E 01 1 I 133 1.72E 02 2.92E 02 8.89E 01 4.07E 04 5.11E 02 0.00E-01 2.21E 02 1 134 1.25E 01 3.31E 01 1.19E 01 5.51E 02 5.22E 01 0.00E-01 4.36E-01 I 135 5.22E 01 1.34E 02 4.98E 01 8.64E 03 2.12E 02 0.00E-01 1.49E 02 CS 134 3.10E 05 7.30E 05 3.39E 05 0.00E-01 2.32E 05 8.86E 04 9.08E 03 CS 136 3.18E 04 1.25E 05 8.41E 04 0.00E-01 6 82E 04 1.07E 04 1.01E 04 l- CS 137 4.15E 05 5.52E 05 1.92E 05 0.00E-01 1.88E 05 7.30E 04 7.86E 03 i CS 138 2.88E 02 5.52E 02 2.76E 02 0.00E-01 4208E 02 4.74E 01 :.51E-01 RA 139 9.10E 00 6.40E-03 2.65E-01 0.100E;01 6.0}F-03 ,,J.41E-03 8.11E 01 A-35 O
TNHE A.4-2 (cont'd) SITE RIIATED DOSE COMI1MDTI' F/CIOR AIT MREM /HR PER lCI/ML 1 Tnt NtCLIDE TOJE LIVER T TODY 'IUYROID .;I_Dti!N I)JfD GI-ILI , PA .140 1.86E 03 2.28E 00 1.20E 02 0.00E-01 7.72E-01 1.53E 00 2.87E 03 BA 141 4.39E 00 3.28E-03 1.47E-01 0.00E-01 3.04E-03 2.24E-03 9.36E-06 im 142 1.96E 00 1.96E-03 1.200-01 0.00E-01 1.66E-03 1.30E-03 -3. 01 E .1_2 IA 140 3.61E-01 1.77E-01 4.72E-02 0.00E-01 0.00E-01 0.00E-01 1.02E 04 1A 142 1.86E-02 8.25E-03 2.05E-03 0.00E-01 0.00E-01 0.00E-01 2.51E 02 i CE 141 7.9BE-01 5.32E-01 6.12E-02 0.00E-01 2.51E-01 0.00E-01 1.52E 03 l l CE 143 1.41E-01 1.03E 02 1.15E-02 0.00E-01 4.60E-02 0.00E-01 3.08E 03 ) CE 144 4.17E 01 1.73E 01 2.24E 00 0.00E-01 1.03E 01 0.00E-01 1.05E 04 i PR 143 1.36E 00 5.43E-01 6.76E-02 0.00E-01 3.15E-01 0.00E-01 4.47E 03 ' PR 144 4.46E-03 1.83E-03 2.26E-04 0.00E-01 1.05E-03 0.00E-01 4.92E-06 IH) 147 9.73E-01 1.06E 00 6.34E-02 0.00E-01 6.21E-01 0.00E-01 3.82E 03 W 187 3.28E 02 2.67E 02 9237E 01 0.00E-01 0.00E-01 0 10E-01 7.24E 04 NP 239 1.34E-01 1.27E-02 7.04E-03 0.00E-01 3.98E-02 0.00E-01 2.04E 03 Sb 124 2.32E 02 4.28E 00 9.05E 01 5.26E-01 0.00E-01 2.03E 02 4.68E 03 Sb 125 1.49E 02 1.63E 00 3.48E 01 1.42E-01 0.00E-01 1.31E 02 1.16E 03 Sb 126 9.53E 01 1.95E 00 3.42E 01 5.39E-01 0.00E-01 6.84E 01 F.64E 03 Co 57 0.00E-01 3.55E 01 5.96E 01 0.00E-01 0.00E-01 0.00E-01 6.63E 02 A-36 0
l TNVP. A.4-3 SITE REMTED COSE CCINI'IMDif FICIOl AIT MlIM/HR PER (CI/ML 0 1111) tRCLTDE BONE LIVER T DODY "3NHOID
; KIDNFY IMG QI-ILI H 3 0.00E-01 . 49E 01 1.19E 01 1.19E 01 1.19E 01 1.19E 01 1.19E 01 C 14 4.45E 04 8.90E 03 8.90E 03 8.90E 03 8.90E 03 8.90E 03 8.90E 03 UA 24 7.93E 02 7.93E 02 7.93E 02 7.93E 02 7.93E 02 7.93E 02 7.93E 02 P 32 6.49E 07 3.04E 06 2.50E 06 0.00E-01 0.00E-01 0.00E-01 1.79E 06 CR 51 0.00E-01 0.00E-01 1.92E 00 1.06E 00 2.91E-01 1.94E 00 1.02E 02 -
F94 54 0.00E-01 3.99E 03 1.06E 03 0.00E-01 1.12E 03 0.00E-01 3.35E 03 F91 56 0.00E-01 1.25E 02 2.81E 01 0.00E-01 1.51E 02 0.00E-01 1.80E 04 FE 55 1.57E 03 8.34E 02 2.59E 02 0.00E-01 0.00E-01 4.72E 02 1.55E 02 PE 59 2.26E 03 3.65E 03 1,82E 03 0.00E-01 0.00E-01 1.06E 03 3,80E 03 00 58 0.00E-01 1.75E 02 5.37E 02 0.00E-01 0.00E-01 0.00E-01 1.02E 03 CO 60 0.00E-01 5.16E 02 1.52E 03 0.00E-01 0.00E-01 0.00E-01 2.86E 03 NT '3 7.36E 04 3.94E 03 2.50E 03 0.00E-Q1 0.00E-01 0.00E-01 2.65E 02 NI 65 3.04E 02 2.86E 01 1.67E 01 0.00E-01 0.00E-01 0.00E-01 3.50E 03 64 0.00E-01 2.39E 01 1.440 01 0.00E-01 5.77E 01 0.00E-01 1.12E 03 , OCU ZN 65 2.23E 04 5.95E 04 3.70E 04 0.00E-01 3.75E 04 0.00E-01 1.05E 04 DN 69 7.15E 01 1.03E 02 9.54E 00 0.00E-01 6.26E 01 0.00E-01 6.51E 03 BR 83 0.00E-01 0.00E-01 6.64E 01 0.00E-01 0.00E-01 0.00E-01 3.89E-16 BR 84 0.00E-01 0.00E-01 7.69E 01 0.00E-01 0.00E-01 0.00E-01 3. 89E-16 BR 85 0.00E-01 0.00E-01 3.54E 00 0.00E-01 0.00E-01 0.00E-01 3.89E-16 - RB 86 0.00E-01 1.09E 05 6.72E 04 0.00E-01 0.00E-01 0.00E-01 7.03E 03 RB 88_ 0.00E-01 3.10E 02 2.15E 02 0.00E-01 0.00E-01 0.00E-01 1.52E 01 RB 89 0.00E-01 1.91E 02 1.70E 02 0.0CE-01 0.00E-01 0.00E-01 1.66E 00 SR 89 1.08E 05 0.00E-01 3.08E 03 0.00E-01 0.00E-01 0.00E-01 4.18E 03 SR 90 1.39E 06 0.00E-01 3.52E 05 0.00E-01 0.00E-01 0.00E-01 1.87E 04 SR 91 1.96E 03 0.00E-01 7.41E 01 0.00E-01 0.00E-01 0.00E-01 4.33E 03 SR 92 7.38E 02 0.00E-01 2.96E 01 0.00E-01 0.00E-01 0.00E-01 1.40E 04 Y 90 3.20E 03 0.00E-01 8.56E-02 0.00E-01 0.00E-01 0.00E-01 9.10E 02 Y 91M 2.97E-02 0.00E-01 1.08E-03 0.00E-01 0.00E-01 0.00E-01 5.82E 01 Y 91 4.68E 01 0.00E-01 1.25E-02 0.00E-Ot 0.00E-01 0.00E-01 6.24E 03 Y 92 2.80E-01 0.00E-01 0.01E-03 0.00E-01 0.00E-01 0.00E-01 8.09E 03 A-37 e
TNER A.4-3 (cxnt'd) SITE REIATED DOSE CCI41I'IM2f1' F/CIOR AIT
!GU24/HR PER 1C'/ML CHIID 1RCLTDE KWE LIVPR TTYDY 'I1NROID KIDifCY 1101 GI-LT.I Y 93 8.87E-01 0.00E-01 2.44E-02 0.00E-01 0.00E-01 0.00E-01 1.32E 04 ZR 95 7.05E 00 1.55E 00 1.38E 00 0.00E-01 't.22E 00 0.00E-01 1.62E 03 KR 97 4.25E-01 6.138-02 3.62E-02 0.00E-01 8.81E-02 0.005-01 9.29E 03 IH1 95 5.32E 02 2.07E 02 1.48E 02 0.00E-01 1.95E 02 0.00E-01 3.83E 05 MO 99 0.00E-01 8.78E C2 2.17E 02 0.00E-01 1.87E 03 0.00E-01 7.26E 02
'IC 99M 6.46E-02 1.27E-01 2.10E 00 0.00E-01 1.84E 00 6.43E-02 7,200 01 _
TC 101 7.48E-02 7.83E-02 9.93E-01 0.00E-01 1.34E 00 4.14E-02 2.49E-01 RU 103 4.83E 01 0.00E-01 1.85E 01 0.00E-01 1.21E 02 0.00E-01 1.25E 03 RU 105 4.26E 00 0.00E-01 1.54E 00 0.00E-01 3.74E 01 0.00E-01 2.78E 0}
-RU- 106- 7.72E 02 0.00E-01 9.64E 01 0.00E-01 1.04E 03 0.00E-01 1.20E 04 N3 110M 3.23E 01 2.18E 01 1.74E 01 0.00E-01 4.06E 01 0.00E-01 2.60E 03 TE 125M 4.25E 03 1.15E 03 5.67E 02 1.19E 03 0.00E-01 0.00E-01 4.10E 03 TE 127M 1.08E 04 2.90E 03 1.28E 03 2.58E 03 3.07E 04 0.00E-01 8.72E 03 TE 127 1.76E 02 4.73E 01 3.775 01 1.22E 02 5.00E 02 0.00E-01 6.86E 03 TE 129M 1.82E 04 5.07E 03 1.70E 03 5.85E 03 5.33E 04 0.00E-01 2.21E 04 TE 129 5.00E 01 1.39E 01 1.19E 01 3.56E 01 1.46E 02 0.00E-01 3.11E 03 TE 131M 2.68E 03 9.28E 02 9.88E 02 1.91E 03 8.98E 03 0.00E-01 3.77E 04 TE 131 3.09E 01 9.43E 00 9.21E 00 2.37E 01 9.36E 01 0.00E-01 1.63E 02 TE 132 3.77E 03 1.67E 03 2.01E 03 2.43E 03 1.55E 04 0.00E-01 1.68E 04 ~
I- 130 2.04E 02 4.13E 02 2.13E 02 4.55E 04 6.17E 02 0.00E-31 1.93E 02 ~ I 1}1 1.20E 03 1.21E 03 6.88E 02 4.00E 05 1.99E 03 0.00E-01 1.08E 02 I 132 5.60E 01 1.03E 02 4.73E 01 4.77E 03 1.57E 02 0.00E-01 1.21E 02 I 133 4.14E 02- 5.12E 02 1.94E 02 9.51E 04 8.53E 02 0.00E-01 2.06E 02
- 1. 134 2.93E 01 5.44E 01 2.50E 01 1.25E 03 P 32E 01 0.00E-01 3.61E 01 I 135 1.22E 02 2.20E 02 1.'1E 02 1.95E 04 3.38E 02 0.00E-01 1.68E 02 CS 134 3.82E 05 6.26E 05 1.J2E 05 0.00E-01 1.94E 05 6.97E 04 3.38E 03 e CS 136 3.83E 04 1.05E 05 1 32f 04 0.00E-01 5.61E 04 8.37E 03 3.70E 03 CS 137 5.33E 05 5.11E 05 - s,e 04 0.00E-01 1.66E 05 5.99E 04 3.20E 03
', CS '38 3.72E 02 5.17E 02 :.28E 02 0.00E-01 3.64E 02 3.92E 01 2.38E 02 Im 139 2.54E 01 1.35E-02 7J5E-01 0.00E-01 1.18E-02 7.97E-03 1.47E 03 A-38 O
17duJ: A.4-3 (cont'd) SITE RELATED DOSE COEI'IMENT F/Clut AIT MRFFfm PER UCI/ML CHIID NUCLTDE IME LIVER T DCDY TinTIO1D KIDNEY LU!G GI-II] BA 14U 5.09E 03 4.46E 00 2.97E 02 1.00E-01 1.45E 00 2.66E 00 2.58E 03 BA 141 1.23E 01- 6.86E-03 3.99E-01 0.00E-01 5,94E-03 4.03E-02 6.99E 00 BA 142 5.36E 00 3.85E-03 2.998-01 0.00E-01 2 12E-03 2.27E-03 6.99E-02 LA 140 7.86E-01 2.75E-01 9.26E-02 0.00E-01 0.00E-01 0.00E-01 7.66E 03 LA 142 4.0BE-02 1.30E-02 4.07E-03 0.00E-01 0.00E-01 0.00E-01 2.58E 03 CE 141 2.34E 00 1.17E 00 1.73E-01 0.00E-01 5.11 E-01 0.00E-01 1.46E 03 _ CE 143 4.12E-01 2.23E 02 3.24E-02 0.00E-01 9.37E-02 0.00E-01 3.27E 03 CE 144 1.23E 02 3.84E 01 6.54E 00 0.00E-01 2.13E 01 0.00E-01 1.00E 04 G g PR 143 3.06E 00 9.18E-01 1.52E-01 0.00E-01 4.97E-01 0.00E-01 3.30E 03 FR 144 1.00E-02 3.10E-03 5.05E-04 0.00E-01 1.64E-03 0.00E-01 G.68E 00 ND 14r 2.17E 00 1.76E 00 1.36E-01 0.00E-01 9.65E-01 0.00E-01 2.79E 03 W 187 4.30E 02 2.55E 02 1.14E 02 0.00E-01 0.00E-01 0.00E-01 3.58E 04 NP 239 3.47E-01 2.49E-02 1.75E-02 0.00E-01 7.19E-02 0.00E-01 1.84E 03 Sb 124 6.54 02 8.49E 00 2.29E 02 1.44E 00 0.00E-01 3.63E 02 4.09E 03 Sb 125 4.22E 02 3.25E 00 8.84E 01 3.91E-01 0.00E-01 2.35E 02 1.01E 03 Sb 126 2.59E 02 3.97E 00 9.31E 01 1.52E 00 0.00E-01 1.241 - 5.23E 03 Co 57 0.00E-01 4.81E 01 9.73E 01 0.00E-01 0.00E-01 0.r eo 3,94E 02 A-39 O r - -
TNEE A.4-4 J SITE RELATED DOSE COMPIMENT FAC'IOR AIT MREM /HR PER UCI/ML IN N P NIELIDE BONE LIVER T BODY THYROID .4IDNEY GI-LLI H -3 0.00E-01 1.16E 01 1.16E 01 1.16E 01 1.16E 01 1.16d s1 1.16E 01 C - 14 8.92E 02 1.90E 02 1.90E 02 1.90E 02 1.90E 02 1.90E 02 1.90E 02 NA 24 3.80E 02 3.80E 02 3.80E 02 3.80E 02 3.80E 02 3.00E 02 3.80E 02 P 32 6.40E 04 3.76E 03 2.40E 03 0.00E-01 0.00E-01 0.00E-01 8.65E 02 CR 51 0.00E-01 C.00E-01 5.30E-01 3.46E-01 7.56E-02 6.73E 01 1.55E 01
- N 54 0.00E-01 7.49E 02 1.70E 02 0.00E-01 1.66E 02 0.00E-01 2.75E 02 MN 56 0.00E-01 3.08E 01 5.30E 00 0.00E-01 2.64E 01 0.00E-01 2.80E 03 FE 55 5.23E 02 3.38E 02 9.03E 01 0.00E-01 0.00E-01 1.65E 02 4.29E 01 FE 59 . 16E 03 2.02E 03 7.98E 02 . 0.00E-01 0.00E-01 5.98E 02 9.67E 02 00 58 0.00E-01 1.35E 02 3.38E 02 0.00E-01 0.00E-01 0.00E-01 3.37E 02 00 60 0.00E-01 4.06E 02 9.59E 02 0.00E-01 0.00E,01 0.00E-01 9.67E 02 NI ' 63 2.39E 04 1.47E 03 8.28E 02 0.00E-01 0.00E-01 0.00E-01 7.34E 01 NI 61 1.77E 02 2.00E 01 9.10E 00 0.00E-01 0.00E-01 0.00E-01 1.52E 03 64 0.00E-01 2.29E 01 1.06E 01 0.00E-01 3.87E 01 0.00E-01 4.70E 02 6.92E 02 2.37E 0, 1.09E 03 0.00E-01 1.15E 03 0.00E-01 2.01E 03
()CUZN 65 ZN . 69 3.51E 00 6.32E 00 4.70E-01 0.00E-01 2.63E 00 0.00E-01 5.15E 02 BR 83 0.00E-01 0.00E-01 1.37E 01 0.00E-01 0.00E-01 0.00E-01 3.76E-17 BR- 84 0.00E-01 0.00E-01 1.44E 01 0.00E-01 0.00E-01 0.00E-01 3.76E-17 BR 85 0.00E-01 0.00E-01 7.30E-01 0.00E-01 0.00E-01 0.00E-01 3.76E-17 RB 86 0.00E-01 '6.40E 03 3.16E 03 0.00E-01 0.00E-01 0.00E-01 1.~64E 02 RB 98 0.00E-01 1.87E 01 1.03E 01 0.00E-01 0.00E-01 0.00E-01 1.82E 01 RB 1 89 0.00E-01 1.08E 01 7.41E 00 0.00E-01 0.00E-01 0.00E-01 3,66E 00 SR 89 9.44E 04 0.00E-01 2.71E 03 0.00E-01 0.00E-01 0.00E-01 1.94E 03 SR 90 6.96E 05 0.00E-01 1.77E 05 0.00E-01 0.00E-01 0.00E-01 8.69E 03 _ SR ' 91 1.88E 03 0. 00E- 01 6.81E 00 0.00E-01 0.00E-01 0.00E-01 2.23E 03 SR 92 7.22E 02 0.00E-01 2.68E 01 0.00E-01 0.00E-01 0.00E-01 7.79E 03 Y 90 3.278 00 0.00E-01 8.77E-02 0.00E-01 0.00E-01 0.00E-01 4.51E 03 Y 91M 3.05E 0.00E-01 1.04E-03 0.00E-01 0.00E-01 0.00E-01 1.02E 02 Y. 91 4.25E 01 0.00E-01 1.13E 00 0.00E-01 0.00E-01 0.00E-01 3.05E 03 Y 92 2.88E-01 0.00E-01 8.09E-03 0.00E-01 0.00E-01 0.00E-01 5.49E 03 f% A-40 G
t n TMLE A.4-4 (cont'd) SITE RF2ATED DOSE CO@il1MErff F/CIOR AIT MREM /HR PER UCI/ML INPNIP NUCLIDE BONE LIVER T DODY THYROID KIDNEY TRG GI-ILI Y 93- 9.14E-01 0.00E-01 2.49E-02 0.00E-01 0.00E-01 0.00E-01 7.22E 03 ZR 95 7.75E 00 1.89E 00 1.34E 00 0.00E-01 2.04E 00 0.00E-01 9.41E 02 ZR_ 97 5.57E-01 9.56E-02 4.36E-02 0.00E-01 9.63E-02 0.00E-01 6.09E 03 1.58E 00 6.51E-01 ' 6E-01 0.00E-01 NB 95 4.66P-01 0.00E-01 5.49E 02 MO 99 0.00E-01 1.28E 03 2.49E 02 0.00E-01 1.91E 03 0.00E-01 4.21E 02 SC 99M' 7.22E-02 1.49E-01 1.92E 00 0.00E-01 1.60E 00 7.79E-02 4.33E 01 3C 101 8.54E-02 1.08E-01 1.06E 00 0.00E-01 1.28E 00 5.87E-02 1.83E 01 RU 103 5.57E 01 0.00E-01 1.86E 01 0.00E-01 1.16E 02 0.00E-01 6.77E 02 RU 105 5.12E 00 0. 00 E-01 1.72E 00 0.00E-01 3.76E 01 0.00E-01 2.04E 03 RU 106 9.07E 02 0.00E-01 1.13E 02 0.00E-01 1.07E 03 0.00E-01 6.88E 03 AG 110M 3.75E 01 2.73E 01 1.81E 01 0.00E-01 3.91E 01 0.00E-01 1.42E 03 TE 12L.4 8.77E 02 2.93E 02 1.19E 02 2.95E 02 0.00E-01 0.00E 4.18E 02 TE 127M 2.20E 03 7.30E 02 2.66E 02 6.36E 02 5.42E 03 0.00E-01 8.88E 0? TE 127 3.76E 01 1.26E 01 8.09E 00 3.06E 01 9.18E 01 0.00E-01 7.90E 02 TE 129M 3.76E 03 1.29E 03 5.79E 02 1.44E 03 9.41E 03 0.00E-01 2.25E 03 TE 129 1.07E 01 3.68E 00 2.49E 00 8.95E 00 2.66E 01 C.00E-01 8.54E 02 TE 131M 5.72E 02 2.30E 02 1.90E 02 4.66E 02 1.58E 03 0.00E-01 3.87E 03 TE 131 6.62E 00 2.45E 00 1.8EE 00 5.91E 00 1.69E 01 0.00E-01 2.67E 02
-TE- 132 7.82E 02 3.87E 02 3.62E 02 5.72E 02 2.42E 03 0.00E-01 1.43E 03 I 130 2.26E 02 4.97E 02 1.99E 02 5.57E 04 5.45E 02 0.00E-01 1.06E 02 I 131 1.35E 03 1.59E 03 7.00E 02 5.23E 05 1.86E 03 0.00E-01 5.6BE 01 .I 132 6.24E 01 1.27E 02 4.51E 01 5.94E 03 1.41E 02 0.00E-01 1.03E 02 I' -13I 4.70E 02 6.85E 02 2.01E 02 1.25E 05 8.05E 02 0.00E-01 1.16E 02 I 134 3.27E 01 6.70E 01 2.38E 01 1.56E 03 7.49E 01 0.00E-01 6.92E 01 I 135 1.37E 02 2.72E 02 9.93E 01 2.44E 04 3.04E 02 0.00E-01 9.86E 01 CS L134 1.42E 04 2.64E 04 2.67E 03 0 '00E-01 6.81E 03 2.42E 03 7.19E 01 - CS 136 1.73E 03 5.08E 03 1.90E 03 0.00E-01 2.02E 03 4.14E 02 7.71E 01 CS ~ 137 1.96E 04 2.30E 04 1.63E 03 0.00E-01 6.17E 03 2.50E 03 7.19E 01 CS 138 1.81E 01 2.94E 01 1.43E 01 0.00E-01 1.47E 01 2.29E 00 4.70E 01 BA 139 3.31E 01 2.20E-02 9.59E-01 0.00E-01 1.32E-02 1.33E-02 2.10E 03 A-41 O
=
TNER A.4-4 (cont'd) SITE N DOSE COMI'IME2R FACIOR AIT MRdVHR PER UCI/ML INFRE tRX1TDE DONE LIVER T DODY 'mYROID KIDNEY IRC GI-ILI BA 140 6.43E 03 6.43E 00 3.31E 02 0.00E-01 1.53E 00 3.95E 00 1.5BE 03 BA 141 1.60E 01 1.09E-02 5.04E-01 0.00E-01 6.58E-03 6.66E-03 1.95E 02 BA 142 6.92E 00 5.76E-03 3.41E-01 0.00E-01 3.31E-03 3.48E-03 2,86E 01 LA 140 7.94E-01 3.13E-01 8. 05E- 02 0.00E-01 0.00E-01 0.00E-01 3.68E 03 LA 142 4.14E-02 1.52E-02 3.64E-03 0.00E-01 0.00E-01 0.00E-01 2.58E 03 CE 141 2.96E 00 1.81E 00 2.13E-01 0.00E-01 5.57E-01 0.00E-01 9.33E 02 CE 143 5.57E-01 3.69E 02 4.21E-02 0.00E-01 1.08E-01 0.00E-01 2.16E 03 CE 144 1.12E 02 4.59E 01 6.28E 00 0.00E-01 1.85E 01 0.00E-01 6.43E 03 PR 143 3.06E 00 1.14E 00 1.52E-01 0.00E-01 4.25E-01 0.00E-01 1.61E 03 PR 144 1.03E-02 3.99E-03 5.19E-04 0.00E-01 1.44E-03 0.00E-01 1.85E 02 ND 147 2.08E 00 2.14E 00 1.31E-01 0.00E-01 8.24E-01 0.00E-01 1.35E 03 W 187 3.40E 01 2.36E 01 8.16E 00 0.00E-01 0.00E-01 -0.00E-01 1.39E 03 NP 239 4.18E-01 3.74E-02 2.11E-02 0.00E-01 7.45E-02 0.00E-01 1.08E 03 Sb 124 8.05E 02 1.19E 01 2.49E 02 2.14E 00 0.00E-01 5.04E 02 2.48E 03 Sb 125 4.63E 02 4.48E 00 9.52E 01 5.79E-01 0.00E-01 2.90E 02 6.17E 02 Sb 326 3.03E 02 5.94E 00 1.09E 02 2.33E 00 0.00E-01 1.91E 02 3.14E 03 Co 57 0.00E-01 4.33E 01 7.03E 01 0.00E-01 0.00E-01 0.00E-01 1.47E 02 A-42 o
[ TAHLE A.5-1 INHALATION DOSE PARAMETER FOR 7HE CHI 1D, PI 3 MREM /YR per uCi/M H-3 1.12E 03 RU-103 6.62E 05 C-14 3.59E 04 RU-105 9.95E 04 NA-24 1.61E 04 RU-106 1.43E 07 P-32 2.60E 06 AG-110M 5.48E 06 CR-51. 1.70E 04 TE-125M 4.77E 05 MN-54 1.58E 06 TE-127M 1.48E 06
-MN-56 1.23E 05 TE-127 5.62E 04 FE-55 1.11E 05 TE-129M 1.76E 06 FE-59 1.27E 06 TE-129 2.55E 04 C0"58 1.11E 06 TE-13tM 3.08E C3 00-60 7.07E 06 TE-131 2.05E 03 NI-63 8.21E 05 TE-132 3.77E 05 NI-65 8.40E 04 I-130 1.85E 06 CU-64 3.67E 04- I-131 1.62E 07 ZN-65 9.95E 05 I-132 1.94E 05 KN-69 1.02E 04 I-133 3.85E 06 BR-83 4.74E 02 I-134 5.07E 04 BR-84 5.48E 02 I-135 7.92E 05
'BR-85 2.53E 01 CS-134 1.01E 06 RB-86 1.98E 05 CS-136 1.71E 05 RB-88 5.62E 02 CS-137 9.07E 05
\~- RB-89 3.45E 02 CS-138 8.40E 02 SR-89 2.16E 06 BA-139 5.77E 04 SR-90. 1.01E 08 BA-140 1.74E 06 SR 1.74E 05 BA-141 2.92E 03 SR-92 2.42E 05 BA-142 1.64E 03 Y-90 2.68E 05 LA-140 2.26E 05 Y-91M. 2.81E 03 LA-142 7.59E 04
-Y-91 2.63E 06 CE-141 5.44E 05
.Y-92 2.39E 05 CE-143 1.27E 05 Y 3.89E 05 CE-144 1.20E 07
-ZR-95 2.23E 06 -PR-143 4.33E 05 ZR-97 3.51E 05 PR-144 1.57E 03 NB 6.14E 05 ND-147 3.28E 05 MD-99 1.35E 05 W-187 9.10E 04 TC-99M- 4.81E 03 NP-239 6.40E 04
'7C-101 5.85E 02 f A-43
( I I
\
s' TABLE A.5-2 _MIAIATION PAM Fp MRD4/YR PER UC1/M" ADULT (RI FICIORS) NUCLIDE BONE I.IVER T BODY 'IHYROID KIDNEY LUG GI-ILI 11 3 0.00E 01 1.26E 03 1.26E 03 1.26E 03 1.26E 03 1.26E 03 1.26E 03 C 14 1.82E 04 3.41E 03 3.41E 03 3.41E 03 3.41E 03 3.41E 03 3.41E 03 NA 24 1.02E 04 1.02E 04 1.02E 04 1.02E 04 1.02E 04 1.02E 04 1.02E 04 P 32 1.32E 06 7.71E 04 5.01E 04 0.00E-01 0.00E-01 0.00E-01 8.64E 04 CR 51 0.00E 01 0.00E 01 1.00E 02 5.95E 01 2.28E 01 1.44E 04 3.32E 03 MN 54 0.00E 01 3.96E 04 6.30E 03 0.00E-01 9.84E 03 1.40E 06 7.74E 04 _ MN 56 0.00E 01 1.24E 00 1.83E-01 0.00E-01 1.30E 00 9.44E 03 2.02E 04 FE 55 2.46E 04 1.70E 04 3.94E 03 0.00E-01 0.00E-01 7.21E 04 6.03E 03 FE 59 1.18E 04 2.78E 04 1.06E 04 0.00E-01 0.00E-01 1.02E a6 1.88E 05 00 58 0.00E 01 1.58E 03 2.07E 03 0.00E-01 0.00E-01 9.28E 05 1.06E 05 00 60 0.00E 01 1.15E 04 1.48E 04 0.00E-01 0.00E-01 5.97E 06 2.85E 05 NI -63 4.32E 05 3.14E 04 1.45E 04 0.00E-01 0.00E-01 1.78E 05 1.34E 04 NI- 65 1.54E 00 2.10E-01 9.12E-02 0.00E-01 0.00E-01 5.60E 03 1.23E 04 CU- 64 0.00E 01 1.46E 00 6.15E-01 0.00E-01 4.62E 00 6.78E 03 4.90E 04 ZN 65 3.24E 04 1.03E 05 4.66E 04 0.00E-01 6.90E 04 8.64E OF 5.34E 04 ( - ZN 69 3.38E-02 6.51E-02 4.52E-03 0.00E-01 4.22E-02 9.20E 02 1.63E 01 BR 83 0.00E-01 0.00E-01 2.41E 02 0.00E-01 0.00E-01 0.00E-01 2.32E 02 BR 84 0.00E-01 0.00E-01 3.13E 02 0.00E-01 0.00E-01 0.00E-01 1.64E-03 BR 85 0.00E-01 0.00E-01 1.28E 01 0.00E-01 0.00E-01 0.00E-01 8.00E-15 RB 86 0.00E-01 1.35E 05 5.90E 04 0.00E-01 0.00E-01 0.00E-01 1.66E 04 _ RB 88 0.00E-01 3.87E 02 1.93E 02 0.00E-01 0.00E-01 0.00E-01 3.34E-09 RB 89 0.00E-01 2.56E 02 1.70E 02 0.00E-01 0.00E-01 0.00E-01 9.28E-12 SR 89 3.04E 05 0.00E-01 8.72E 03 0.00E-01 0.00E-01 1.40E 05 3.50E 05-SR 90 9.922 07 0.00E-01 6.10E 06 0.00E-01 0.00E-01 9.60E 06 7.22E 05 SR- 91 6.19E 01 0.00E-01 2.50E 00 0.00E-01 0.00E-01 3.65E 04 1.91E 05 SR 92 6.74E 00 0.00E-01 2.91E-01 0.00E-01 0.00E-01 1.65E 04 4.30E 04
-Y -90 2.09E 03 0.00E-01 5.61E 01 0.00E-01 0.00E-01 1.70E 05 5.06E 05 Y 91M 2.61E 0.00E-01 1.02E-02 0.00E-01 0.00E-01 1.92E 03 1.33E 00 Y 91 4.62E 05 0.00E-01 1.24E 04 0.00E-01 0.00E-Oi 1.70E 06 3.85E 05 Y 92 1.03E 01- 0.00E-01 3.02E-01 0.00E-01 0.00E-01 1.57E 04 7.35E 04 A-44 0
hu nn u s - .
TMEF. A.5-2 (carit'd) INHAIATION PATIMAY FlpIOR MREM /YR PER UCI/M-ADULT (RI FAC'IDRS)
!KCLIDE BONE LIVFR T BODY 'I1NROTD KIDNF'Y IUtG GI-ILI Y 93 9.44E 01 0.00E-01 2.61E 00 0.00E-01 0.00E-01 4.85E 04 4.22E 05 ZR 95 1.07E 05 3.44E 04 2.33E 04 0.00E-01 5.42E 04 1.77E 06 1.50E 05 ZR 97 9.68E 01 1.96E 01 9.04E 00 0.00E-01 2.97E 01 7.87E 04 5.23E 05 NB 95 1.41E 04 7.82E 03 4.21E 03 0.00E-01 7.74E 03 5.05E 05 1.04E 05 MO 99 0.00E-01 1.21E 02 2.30E 01 0.00E-01 2.91E 02 9.12E 04 2.48E 05 TC 99M 1.03E-03 2.91E-03 3.70E-02 0.00E-01 4.42E-02 7.64E 02 4.16E 03 TC 101 4.18E-05 6.02E-05 5.90E-04 0.00E-01 1.08E-03 3.99E 02 1.09E-11 RU 103 1.53E 03 0.00E-01 6.58E 02 0.00E-01 5.83E 03 5.05E 05 1.10E 05 .RU 105 7.90E-01 0.00E-01 3.11E-01 0.00E-01 1.02E 00 1.10E 04 4.82E 04 RU 106 6.91E 04 0.00E-01 8.72E 03 0.00E-01 1.34E 05 9.36E 06 9.12E 05 AG 11GM 1.08E 04 1.00E 04 5.94E 03 0.00E-01 1.97E 04 4.63E 06 3.02E 05 TE 125M 3.42E 03 1.58E 03 4.67E 02 1.05E 03 1.24E 04 3.14E 05 7.06E 04 TE 127M 1.26E 04 5.77E 03 1.57E 03 3.29E 03 4.58E 04 9.60E 05 1.50E 05 TE 127 1.40E 00 6.42E-01 3.10E-01 1.06E 00 5.10E 00 6.51E 03 5.74E 04 TE 129M 9.76E 03 4.67E 03 1.58E 03 3.44E 03 3.66E 04 1.16E 06 3.83E 05 TE 129 4.98E-02 2.39E-02 1.24E-02 3.90E-02 1.87E-01 1.94E 03 1.57E 02 TE 13U3 6.99E 01 4.36E 01 2.90E 01 5.50E 01 3.09E 02 1.46E 05 5.56E 05 TE 131 1.11E-02 5.95E-03 3.59E-03 9.36E-02 4.37E-02 1.39E-03 . 84E 01 TE 132 2.60E 02 2.15E 02 1.62E 02 1.90E 02 1,46E 03 2.88E 05 5.10E 05 I 130 4.58E 03 1.34E 04 5.28E 03 1.14E 06 2.09E 04 0.00E-01 7.69E 05 ~
I 131 2.52E 04 3.58E 04 2.05E 04 1.19E 07 6.13E 04 0.00E-01 6.28E 03 I 132 1.16E 03 3.26E 03 1.16E 03 1.14E 05 5.18E 03 0.00E-01 4.06E 02 I 133 8.64E 03 1.48E 04 4.52E 03 2.15E 06 2.58E 04 0.00E-01 8.88E 03 I 134 6.44E 02 1.73E 03 6.15E 02 2.98E 04 2.75E 03 0.00E-01 1.01E 00 I 135 2.68E 03 6.98E 03 2.57E 03 4.48E 05 1.11E 04 0.00E-01 5.25E 03 CS 134 3.73E 05 8.48E 05 7.28E 05 0.00E-01 2.87E 05 9.76E 04 1.04E 04 CS 136 3.90E 04 1.46E 05 1.10E 05 0.00E-01 8.56E 04 1.20E 04 1.17E 04 CS 137 4.78E 05 6.21E 05 4.28E 05 0.00E-01 2.22E 05 7.52E 04 8.40E 03 CS 138 3.31E 02 6.21E 02 3.24E 02 0.00E-01 4.80E 02 4.86E 01 1.86E-03 BA 139 9.36E-01 6.66E-04 2.74E-02 0.00E-01 6.22E-04 3.76E 03 8.96E 02 A-45 O
,q TN3LE A.5-2 (cnnt'd) 1 s
INHALATICN PR11MAY Fpt MREM /YR PER UCI/M ' ADULT (RI FA M) NUCLIDE DONE LIVER T BODY THYROID KIDNEY IRC GI-LLI BA 140 3.90E 04 4.90E 01 2.57E 03 0.00E-01 1.67E 01 1.27E 06 2.18E 05 BA 141 1.00E-01 7.53E-05 3.36E-03 0.00E-01 7.00E-05 1.94E 03 1.16E-07 BA 142 2.63E-02 2.70E-05 1.66E-03 0.00E-01 2.29E-05 1.19E 03 1.57E-16 LA 140 3.44E 02 1.74E 02 4.58E 01 0.00E-01 0.00E-01 1.36E 05 4.58E 05 LA 142 6.83E-01 3.10E-01 7.72E-02 0.00E-01 0.00E-01 6.33E 03 2.11E 03 CE 141 1.99E 04 1.35E 04 1.53E 03 0.00E-01 6.26E 03 3.62E 05 1.20E 05 CE 143 1.86E 02 1.38E 02 1.53E 01 0.00E-01 6.08E 01 7.98E 04 2.26E 05 CE 144 3.43E 06 1.43E 06 1.84E 05 0.00E-01 8.48E 05 7.78E 06 8.16E 05 PR 143 9.36E 03 3.75E 03 4.64E 02 0.00E-01 2.16E 03 2.81E 05 2.00E 05 PR 144 3.10E-02 1.25E-02 1.53E-03 0.00E-01 7.05E-03 1.02E 03 2.15E-08 ND 147 5.27E 03 6.10E 03 3.65E 02 0.00E-01 3.56E 03 2.21E 05 1.73E 05 W 187 8.48E 00 7.08E 00 2.48E 00 0.00E-01 0.00E-01 2.90E 04 1.55E 05 NP 239 2.30E 02 2.26E 01 1.24E 01 0.00E-01 7.00E 01 3.76E G1 1.19E 05 O V A-46
T1uYE A.5-3 INHAIATION PA'I1MAY FpIOR MRm/YR PER UCI/M TEEN (RI FICIUG) NUCLIDE EONE I,IVER T IODY 'IHYROID KIDNEY IJJfG GI-LLI H 3 0.00E-01 1.27E 03 1.27E 03 1.27E 03 1.27E 03 1.27E 03 1.27E 03 C 14 2.60E 04 4.87E 03 4.87E 03 4.87E 03 4.87E 03 4.87E 03 4.87E 03 NA 24 1.38E 04 1.38E 04 1.38E 04 1.38E 04 1.38E 04 1.38E 04 1,38E 04 P 32 1.89E 06 1.10E 05 7.16E 04 0.00E-01 0.00E-01 0.00E-01 9.28E 04 CR 51 0.00E-01 0.00E-01 1.35E 02 7.50E 01 3.07E 01 2.10E 04 3.00E 03 MN 54 0,00E-01 5.11E 04 8.40E 03 0.00E-01 1.27E 04 1.98E 06 6.68E 04 MN 56 0.00E-01 1.70E 00 2.52E-01 0.00E-01 1.79E 00 1.53E 04 5.74E 04 FE 55 3.34E 04 2.38E 04 5.54E 03 0.00E-01 0.00E-01 1.24E 05 6.39E 03 FE 59 1.59E 04 3.70E 04 1.43E 04 0.00E-01 0.00E-01 1.53E 06 1.78E 05 00 58 0.00E-01 2.07E 03 2.78E 03 0.00E-01 0.00E-01 1.34E 06 9.52E 04 00 60 0.00E-01 1.51E 04 1.98E 04 0.00E-01 0.00E-01 8.72E 06 2.59E 05 NI 63 5.80E 05 4.34E 04 1.98E 04 0.00E-01 0.00E-01_ 3.07E 05 1.42E 04 NI 65 2.18E 00 2.93E-01 1.27E-01 0.00E-01 0.00E-01 9.36E 03 3.67E 04 CU 64 0.00E-01 2.03E 00 8.48E-01 0.00E-01 6.41E 00 1.11E 04 6.14E 04 65 3.86E 04 1.34E 05 6,24E 04 0.00E-01 8.64E 04 1.24E 06 4.66E 04 (}ZN ZN 69 4.83E-02 9.20E-02 6.46E-03 0.00E-01 6.02E-02 1.58E 03 2.85E 02 BR 83 0.00E-01 0.00E-01 3.44E 02 0.00E-01 0.00E-01 0.00E-01 8.00E-15 BR 84 0.00E-01 0.00E-01 4.33E 02 0.00E-01 0.00E-01 0.00E-01 8.00E-15 BR 85 0.00E-01 0.00E-01 1.83E 01 0.00E-01 0.00E-01 0.00E-01 8.00E-15 RD 86 0.00E-01 1.90E 05 8.40E 04 0.00E-01 0.00E-01 0.00E-01 1.77E 04 RB 88 0.00E-01 5.46E 02 2.72E 02 0.00E-01 0.00E-01 0.00E-01 2.92E-05 RB 89 0.00E-01 3.52E 02 2.33E 02 0.00E-01 0.00E-01 0.00E-01 3.38E-07 SR 89 4.34E 05 0.00E-01 1.25E 04 0.00E-01 0.00E-01 2.42E 06 3.71E 05 SR 90 1.08E 08 0.00E-01 6.68E 06 0.00E-01 0.00E-01 1.65E 07 7.65E 05 SR 91 8.80E 01 0.00E-01 3.51E 00 0.00E-01 0.00E-01 6.07E 04 2.59E 05 SR 92 9.52E 00 0.00E-01 4.06E-01 0.00E-01 0.00E-01 2.74E 04 1.19E 05 Y 90 2.98E 03 0.00E-01 8.00E 01 0.00E-01 0.00E-01 2.93E 05 5.59E 05 Y 9tM 3.70E-01 0.00E-01 1.42E-02 0.00E-01 0.00E-01 3.20E 03 3.02E 01 Y 91 6.61E 05 0.00E-01 1.77E 04 0.00E-01 0.00E-01 2.94E 06 4.09E 05 Y 92 1.47E 01 0.00E-01 4.29E-01 0.00E-01 0.00E-01 2.68E 04 1,65E 05 A-47 _ . __ _ _ _ _ - . _ _ _ - - _ _ _ - _ _ m_
TMIE A.5-3 (cant'd)
'Ov IMIALATION PATHWAY JF1 IOR MREM /YR PER LEI /M' TEEN (RI FAC10RS) f,@CLIDE BONE LIVER T DOnY THYROID KIDNEY 13G GI-LLI Y 93 1.35E 02 0.00E-01 3.72E 00 0.00E-01 0.00E-01 8.32E 04 5.79E 05 ZR 95 1.46E 05 4.58E 04 3.15E 04 0.00E-01 6.74E 04 2.69E 06 1.49E 05 Zn 97 1.38E 02 2.72E 01 1.26E 01 0.00E-01 4.12E 01 1.30E 05 6.30E Q}
NB 95 1.86E 04 1.03E 04 5.66E 03 0.00E-01 1.00E 04 7.51E 05 9.68E 04 MD 99 0.00E-01 1.69E 02 3.22E 01 0.00E-01 4.11E 02 1.54E 05 2.69E 05 TC 99M 1.38E-03 3.86E-03 4.99B-02 0.00E-01 5.76E-02 1.15E 03 6.13E 03 7C 101 5.92E-05 8.40E-05 8.24E-04 0.00E-01 1.52E-03 6.67E 02 8.72E-07 RU 103 2.10E 03 0.00E-01 8.96E 02 0.00E-01 7.43E 03 7.83E 05 1.09E 05 RU 105 1.12E 00 0.00E-01 4.34E-01 0.00E-01 1.41E 00 1.828 04 9.04E 04 RU 106 9.84E 04 0.00E-01 1.24E 04 0.00E-01 1.90E 05 1.61E 07 9.60E 05 AG 110M 1.38E 04 1.31E 04 7.99E 03 0.00E-01 2.50E 04 6.75E 06 2.73E 05 TE '125M 4.88E 03 2.24E 03 6.74E 02 1.40E 03 0.00E-01 5.36E 05 7.50E 04 TE 127M 1.80E 04 8.16E 03 2.18E 03 4.38E 03 6.54E 04 1.66E 06 1.59E 05
.ZE 127 2.01E 00 9.12E-01 4.42E-01 1.42E 00 7.28E 00 1.12E 04 8.08E 01 TE 129M 1.39E 04 6.58E 03 2.25E 03 4.58E 03 5.19E 04 1.98E 06 4.05E 05 TE 129 7.10E-02 3.38E-02 1.76E-02 5.18E-02 2.66E-01 3.30E 03 1.62E 03 i -TE 131M 9.84E 01 6.01E 01 4.20E 01 7.25E 01 4.39E 02 2.38E 05 6.21E 05 TE' 131 1.58E-02 8.32E-03 5.04E-03 1.24E-02 6.18E-02 2.34E 03 1.51E 01 TE 132 3.60E 02 2.90E 02 2.19E 02 2.46E 02 1.95E 03 4.49E 05 4.63E 05 I 130 6.24E 03 1.79E 04 7.17E 03 1.49E 06 2.75E 04 0.00E-01 9.12E 03 I__ 131 3.54E 04 4.91E 04 2.64E 04 1.46E 07 8.40E 04 0.00E-01 6.49E 03 I 132 1.59E 03 -4.38E 03 1.58E 03 1.51E 05 6.92E 03 0.00E-01 1.27E 03 I 133 1.22E 04 2.05E 04 6.22E 03 2.92E 06 3.59E 04 0.00E-01 1.03E 04 1 134 8.88E 02 2.32E 03 8.40E 02 3.95E 04 3.66E 03 0.00E-01 2.04E 01 I 135 3.70E 03 9.44E 03 3.49E 03 6.21E 05 1.49E 04 0.00E-01 6.95E 03 CS 134 5.02E 05- 1.13E 06 5.49E 05 0.00E-01 5.75E 05 1.46E 05 9.76E 03 CS 136 5.15E 04 1.94E 05 1.37E 05 0.00E-01 1.10E 05 1.78E 04 1.09E 04 CS 137 6.70E 05 8.48E 05 3.11E 05 0.00E-01 3.04E 05 1.21E 05 8.48E 03 CS 138 4.66E 02 8.56E 02 4.46E 02 0.00E-01 6.62E 02 7.87E 01 2.70E-01 BA 139 1.34E 00 9.44E-04 3.90E-02 0.00E-01 8.88E-04 6.46E 03 6.45E 03 A-48 O
i l l l TM1LE A.5-3 (omt'd) INHAIATION PRITMAY ,pF - NREM/YR PER LEI /r TEEN (RI F1CIGLS) EJCLTDE DONE LIVER T DODY 7HYROID KIDNEY LUtG GI-ILI BA 140 5.47E 04 6.70E 01 3.52E 03 0.00E-01 2.28E 01 2.03E 06 2.29E 05 BA 141 1.42E-01 1.06E-04 4.74E-03 0.00E-01 9.84E-05 3.29E 03 7.46E-04 RA 142 3.70E-02 3.70E-05 2.27E-03 0.00E-01 3.14E-05 1.91E 03 4.79E-10 1A 140 4.79E 02 2.36E 02 6.26E 01 0.00E-01 0.00E-01 2.14E 05 4.87E 05 LA 142 9.60E-01 4.25E-01 1.06E-01 0.00E-01 0.00E-01 1.02E 04 1.20E 04 CE 141 2.84E 04 1.90E 04 2.37E 03 0.00E-01 8.88E 03 6.14E 05 1.26E 05 CE 143 2,66E 02 1.94E 02 2.16E 01 0.00E-01 8.64E 01 1.30E 05 2.55E 05 CE 144 4.89E 06 2.02E 06 2.62E 05 0.00E-01 1.21E 06 1.34E 07 8.64E 05 PR 143 1.34E 04 5.31E 03 6.62E 02 0.00E-01 3.09E 03 4.83E 05 2.14E 05 PR 144 4.30E-02 1.76E-02 2.18E-03 0.00E-01 1.01E-02 1.75E 03 2.35E-04 ND 147 7.86E 03 8.56E 03 5.13E 02 0.00E-01 5.02E 03 3.72E 05 1.82E 05 W -187 1.20E 01 9.76E 00 3.43E 00 0.00E-01 0.00E-01 4.74E 04 1.77E 05 NP 239 3.38E 02 3.19E 01 1.77E 01 0.00E-01 1.00E 02 6.49E i 1.32E 05 l A-49 0
TNRE. A.5-4 INHALATION PATIMAY ,Fp_ MREM /YR PER UCI/r CHIID (RI FACIORS) NLCLTDE BONE LIVER T BODY 'IHYROID KIDNEY LIRE GI-LLI H 3 0.00E-01 1.12E 03 1.12E 03 1.12E 03 1.12E 03 1.12E 03 1.12E 03 C 14 3.59E 04 6.73E 03 6.73E 03 6.73E 03 6.73E 03 6.73E 03 6.73E 03 1R 24 1.61E 04 1.61E 04 1.61E 04 1.61E 04 1.61E 04 1.61E 04 1.61E 04 P 32 2.60E 06 1.14E 05 9.88E 04 0.00E-01 0.00E-01 0.00E-01 4.22E 04 CR 51 0.00E 0.00E-01 1.54E 02 0.00E-01 2.43E 01 1.70E 04 1.08E 03 MN 54 0.00E-01 4.29E 04 9.51E 03 0.00E-01 1.00E 04 1.58E 06 2.29E 04 MN 56 0.00E-01 1.66E 00- 3.12E-01 0.00E-01 1.67E 00 1.31E 04 1.238 05 FE 55 4.74E 04 2.52E 04 7.77E 03 0.00E-01 0.00E-01 1.11E 05 2.87E 03 FE 59 2.07E 01 3.34E 04 1.67E 04 0.00E-01 0.^9B-01 1.27E 06 7.07E 04 00 58 0.00E-01 1.77E 03 3.16E 03 0.00E-01 0.00E-01 1.11E 06 3.44E 04 00 60 0.00E-01 1.31E 04 2.26E 04 0.00E-01 0.00E-01 7.07E 06 9.62E 04 NI 63 8.21E 05 4.63B 04 2.80E 04 0.00E-01 0.00E-01 2.75E 05 6.336_M3 NI- 65 2.99E 00 2.96E-01 1.64E-01 0.00E-01 0.00E-01 8.18E 03 8.40E 04 CU 64 0.00E 1.99E 00 1.07E 00 0.00E-01 6.03E 00 9.58E 03 3.67E 04 ZN 65 4.26E 04 1.13E 05 7.03E 04 0.00E-01 7.14E 04 9.95E 05 1.63E 04 ZN 69 6.70E-02 9.662-02 8.92E-03 0.00E-01 5.85E-02 1.42E 03 1.02E 04 BR 83 0.00E-01 0 00E-01 4.74E 02 0.00E-01 0.00E-01 0.00E-01 3.70E-15 BR 84 0.00E-01 U.00E-01 5.48E 02 0.00E-01 0.00E-01 0.00E-01 3.70E ! BR 85 0.00E-01 0.00E-01 2.53E 01 0.00E-01 0.00E-01 0.00E-01 3.70E-15 RB- 86 0.00E-01 1.98E 05 1.14E 05 0.00E-01 0.00E-01 0.00E-01 7.99E 03 RB 88- 0.00E-01 5.62E 02 3.66E 02 0.00E-01 0.00E-01 0.00E-01 1.72C 01 RB 89 _0.00E-01 3.45E 02 2.90E 02 0.00E-01 0.00E-01 0.00E-01 1.89E 00 SR 89 ~ 5.99E 05 0.00E-01 1.72E 04 0.00E-01 0.00E-01 2.16E 06 1.67E 05 SR 90 1.01E 08 0.00E-01 6.44E 06 0.00E-01 0.00E-01 1.48E 07 3.43E 05 SR 91 1.21E 02 0.00E-01 4.95E 00 0.00E-01 0.00E-01 5.33E 04 1.74E 05
'SR 92 1.31E 01- 0.00E-01 5.25E-01 0.00E-01 0.00E-01 2.40E 04 2.42E 05 Y 90 4.11E 03 0.00E-01 1.11E 02 0.00E 0.00E-01 2.62E 05 2.68E 05
-Y 91M- 5.07E-01 0.00E-01 1.84E-02 0.00E-01 0.00E-01 2.81E 03 1.72E 03 Y. 91 9.14E 05 0.00E-01 2.44E 04 0.00E-01 0.00E-01 2.63E 06 1.84E 05
.Y 92 2.04E 01 0.00E-01 5.81E-01 0.00E-01 0.00E-01 2.34E 04 2.39E 05 j A-50 O
l
CNIE A.5-4 (cxrit'd) nEAIATION PATHM MREM /YR PER UCI CHILD (RI FACIORS) LRELIDE DONE LIVER T BODY 1EYROID KIDNEY IRG GI-ILI Y 93 1.86E 02 0.00E 5.11E 00 0.00E-01 0.00E-01 7.44E 04 3.89E 05
- ZR 95 1.90E 05 4.18E 04 3.70E 04 0.00E-01 5.96E 04 2.23E 06 6.11E 04 ZR 97 1.88E 02 2.72E 01 1.60E 01 0.00E-01 3.88E 01 1.13E 05 3.51E 05 NB 95 2.35E 04 9.18E 03 6.55E 03 0.00E-01 8.62E 03 6.14E 05 3.70E 04 MO 99 0.00E-01 1.72E 02 4.25E 01 0.00E-01 3.92E 02 1.35E 05 1.27E 05 iC 99M 1.78E-03 -3.48E-03 5.77E-02 0.00E-01 5.07E-02 9.51E 02 4.81E 03 TC 101 8.10E-05 '8.51E-05 1.08E-03 0.00E-01 1.45E-03 5.85E 02 1.63E 01 RU 103 2.79E 03 0.00E-01 1.07E 03 0.00E-01 7.03E 03 6.62E 05 4.48E 04 RU 105 1.53E 00 0.00E-01 5.55E-01 0.00E-01 1.34E 00 1.59E 04 9.95E 04 RU 106 1.36E 05 0.00E-01 1.69E 04 0.00E-01 1.84E 05 1.43E 07 4.29E 05 AG. 110M 1.69E 04 1.14E 04 9.14E 03 0.00E-01 2.12E 04 5.48E 06 1.00E 05 TE 125M 6.73E 03 2.33E 03 9.14E 02 1.92E 03 0.00E-01 4.77E 05 3.38E 04 TE 127M 2.49E 04 8.55E 03 3.02E 03 6.07E 03 6.36E 04 1.48E 06 7.14E 04 TE 127 2.77E 00 9.51E 01 6.10E 01 1.96E 00 7.07E 00 1.00E 04 5.62E 04
- TE 129M 1.92E 04 6.85E 03 3.04E 03 6.33E 03 5.03E 04 1.76E 06 1.82E 05 f3 ks l TE 129' 9.77E-02 3.50E-02 2.38E-02 7.14E-02 2.57E-01 2.93E 03 2.55E 04 TE 13EM 1.34E 02 5.92E 01 5.07E 01 9.77E 01 4.09E 02 2.06E 05 3.08E 05 TE 131 2.17E-02 8.44E-03 6.59E-03 1.70E-02 5.88E-02 2.05E 03 1.33E 03 TE 132 4.81E 02 2.72E 02 2.63E 02 3.17E 02 1.77E 03 3.77E 05 1.38E 05 I' 130 8.18E 03 1.64E 04 8.44E 03 1.85E 06 2.45E 04 0.00E-01 5.11E 03 I 131 4.81E 04 4.81E 04 2.73E 04 1.62E 07 7.88E 04 0.00E-01 2.84E 03 I 132 2.12E 03 4.07E 03 1.88E 03 1.94E 05 6.25E 03 0.00E-01 3.20E 03 I- 133 1.66E 04' 2.03E 04 7.70E 03 3.85E 06 3.38E 04 0.00E-01 5.481 ~3 I 134 1.17E 03- 2.16E 03 9.95E 02 5.07E 04 3.30E 03 0.00E-01 9.55E 02 I 135 4.92E 03 8.73E 03 4.14E 03 7.92E 05 1.34E 04 0.00E-01 4.44E 03 CS 134 6.51E 05- 1.01E 06 2.25E 05 0.00E-01 3.30E 05 1.21E 05 3.85E 03 CS 136 6.51E 04 1.71E 05 1.16E 05 0.00E-01 9.55E 04 1.45E 04- 4.18E 03 l-l CS 137 9.07E 05 8.25E 05 1.28E 05 0.00E-01. 2.82E 05 1.04E 05 3.62E 03 CS 138 6.33E 02 8.40E 02 5.55E 02 0.00E-01 6.22E 02 6.81E_01 2.70E 02 BA 139 1.84E 00 9.84E-04 5.36E-02 0.00E-01 8.62E-04 5.77E 03 5.77E 04 l
A-51 O i l- l
)
TNEE A.5-4 (cont'd)
- IMIAIATION PRIllWAY MREM /YR PER UCI/
- CHILD (RI FNMORS)
- NICLIDE DONE LIVER T BODY 'IHYROID KIDNEY LIRC GT-Ib1 BA 140 7.40E 04 6.48E 01 4.33E 03 0.00E-01 2.11E 01 1.74E 06 1.02E 05 BA 141 1.96E-01 1.09E-04 6.36E-03 0.00E-01 9.47E-05 2.92E 03 2.75E 02 BA 142 4.99E-02 3.60E-05 2.79E-03 0.00E-01 2.91E-05 1.64E 03 2.74E 00 LA 140 6.44E 02 2.25E 02 7.55E 01 0.00E-01 0.00E-01 1.83E 05 2.26E 05 LA 142 1.29E 00 4.11E-01 1.29E-01 0.00E-01 0.00E-01 8.70E 03 7.59E 04 CE 141 3.92E 04 1.95E 04 2.90E 03 0.00E-01 8.55E 03 5.44E 05 5.66E 04 CE 143 3.66E 02 1.99E 02 2.87E 01 0.00E-01 8.36E 01 1.15E 05 1.27E 05 CE 144 6.77E 06 2.12E 06 3.61E 05 0.00E-01 1.17E 06 1.20E 07 3.89E 05 PR 143 1.85E 04 5.55E 03 9.14E 02 0.00E-01 3.00E 03 4.33E 05 9.73E 04 PR 144 5.96E-02 1.85E-02 3.00E-03 0.00E-01 9.77E-03 1.57E 03 1.97E 02 ND 147 1.08E 04 8.73E 03 6.81E 02 0.00E-01 4.81E 03 3.28E 05 8.21E 04 W 187 1.63E 01 9.66E 00 4.33E 00 0.00E-01 0.00E-01 4.11E 04 9.10E 04 NP 239 4.66E 02 3.34E 01 2.35E 01 0.00E-01 9.73E 01 5.81E 04 6.40E 04 Q
v A-52 i
TNU.E A 5-5 IMIAIRFION PA'I1MAY Fp MREM /YR FER UCI/M INFNfr (R1 F1CIORS) MU.IDE DONE I.IVER T BODY '1EYROID KTDNEY wtG GI-ILI H 3 0.00E-01 6.47E 02 6.47E 02 6.47E 02 6.47E 02 6.47E 02 6.47E 02 C 14 2.65E 04 5.31E 03 5.31E 03 5.31E 03 5.31E 03 5.31E 03 5.31E 03 NA 24 1.06E 04 1.06E 04 1.06E 04 1.06E 04 1.06E 04 1.06E 04 1.06E 04 P 32 2.03E 06 1.12E 05 7.74E 04 0.00E-01 0.COE-01 0.00E-01 1.61E 04 CR 51 0.00E-01 0.00E-01 8.95E 01 5.75E 01 1.32E 01 1.28E 04 3.57E 02 F21 __54 0.00E-01 2.53E 04 4.98E 03 0.00E-01 4.98E 03 1.00E 06 7.06E 01 _ bei 56 0.00E-01 1.54E 00 2.21E-01 0.00E-01 1.10E 00 1.25E 04 7.17E 04 FE 55 1.97E 04 1.17E 04 3.33E 03 0.00E-01 0.00E-01 8.69E 04 1.09E 03 FE 59 1.36E 04 2.35E 04 9.4bE 33 0.00E-01 0.00E-01 1.02E 06 2.48E 04 CO 58 0.00E-01 1.22E 03 1.82E 03 0.00E-01 0.00E-01 7.77E 05 1.11E 04 CO 60 0.00E-01 8.02E 03 1.18E 04 0.00E-01 0.00E-01 4.51E 06 3.19E 04 NI 63 3.39E 05 2.04E 04 1.16E 04 0.00E-01 0.00E-01 2.09E 05 2.42E 03 NI 65 2.39E 00 2.84E-01 1.23E-01 0.00E-01 0,00E-01 8.12E 03 5.01E 04 CU 64 0.00E-01 1.88E 00 7.74E-01 0.00E-01 3.98E 00 9.30E 03 1.50E 04 ZN 65 1.93E 04 6.26E 04 3.11E 04 0.00E-01 3.25E 04 6.47E 05 5.14E 04 ZN 69 5.39E-02 9.67E-02 7.18E-03 0.00E-01 4.02E-02 1.47E 03 1.32E 04 BR 83 0.00E-01 0.00E-01 3.81E 02 0.00E-01 0.00D-01 0.00E-01 1.40E-15 BR 84 0.00E-01 0.00E-01 4.00E 02 0.00E-01 0.00E-01 0.00E-01 1.40E-15 BR 85 0.00E-01 0.00E-01 2.04E 01 0.00E-01 0.00E-01 0.00E-01 1.40E-15 . RB 86 0.00E-01 1.90E 05 8.82E 04 0.00E-01 0.00E-01 0.00E-01 3.04E 03 - RB 88 0.00E-01 5.57E 02 2.87E 02 0.00E-01 0.00E-01 0.00E-01 3.39E 02 RB 89 0.00E-01 3.21E 02 2.06E 02 0.00E-01 0,00E-01 0.00E-01 6.82E 01 SR 89 3.98E 05 0.00E-01 1.14E 04 0.00E-01 0.00E-01 2.03E 06 6.40E 04 SR 90 4.09E 07 0.00E-01 2.59E 06 0.00E-01 0.00E-01 1.12E 07 1.31E 05 SR 91 9.56E 01 0.00E-01 3.46E 00 0.00E-01 0.00E-01 5.26E 04 7.34E 04 SR 92 1.05E 01 0.00E-01 3.91E-01 0.00E-01 0.00E-01 2.38E 04 1.40E 05 Y 90 3.29E 03 0.00E-01 8.82E 01 0.00E-01 0.00E-01 2.69E 05 1.04E 05 Y 91M 4.07E-01 0.00E-01 1.39E-02 0.00E-01 0.00E-01 2.79E 03 2.35E 03 Y 91 5.88E 05 0.00E-01 1.57E 04 0.00E-01 0.00E-01 2.45E 06 7.03E 04 Y 92 1.64E 01 0.00E-01 4.61E-01 0.00E-01 0.00E-01 2.45E 04 1.27E 05 A-53 0
TNVE A.5-5 (omt'd) O ' INHAIATION PATIMAY FiqIORS MREM /YR PER UCI/r INFNff (RI F1CIORS) NUCLIDE BONE LIVER T BODY 'IEYROID KIDNEY LUfG GI-U;I Y 93 1.50E 02 0.00E- 01 4.07E 00 0.00E-01 0.00E-01 7.64E 04 1.67E 05 ZR 95 1.15E 05 2.79E U4 2.03E 04 0.00E-01 3.llE 04 1.75E 06 2.17E 04 ZR 97 1.50E 02 2.56E 01 1.17E 01 0.00E-01 2.59E 01 1.10E 05 1.40E 05 NB 95 1.57E 04 6.43E 03 3.78E 03 0.00E-01 4.72E 03 4.79E 05 1.27E 04 i MO 99 0. 00E- 01 1.65E 02 3.23E 01 0.00E-01 2.65E 02 1.35E 05 4.87E 04 TC 99M 1.40E-04 2.88E-03 3.72E-02 0.00E-01 3.11E-02 8.11E 02 2.03E 03 _ TC 101 6.51E-05 8.23E-05 8.12E-04 0.00E-01 9.79E-04 5.84E 02 8.44E 02 RU 103 2.02E 03 0.00E-01 6.79E 02 0.00E-01 4.24E 03 5.52E 05 1.61E 04 RU 105 1.22E 00 0.00E-01 4.10E-01 0.00E-01 8.99E-01 1.57E 04 4.84E 04 i RU 106- 8.68E 04 0.00E-01 1.09E 04 0.00E-01 1.07E 05 1.16E 07 1.64E 05 AG 110M 9.98E 03 7.22E 03 5.00E 03 0.00E-01 1.09E 04 3.67E 06 3.30E 04 TE 125M 4.76E 03 1.99E 03 6.58E 02 1.62E 03 0.00E-01 4.47E 05 1.29E 04
.Y 127M 1.67E 04 6.90E 03 2.07E 03 4.87E 03 3.75E 04 1.31E 06 2.73E 04 T 127 2.23E 00 9.53E-01 4.89E-01 1.85E 00 4.86E 00 1.03E 04 2.44E 04 Ti 1.'9M 1.41E 04 6.09E 03 2.23E 03 5.47E 03 3.18E 04 1.68E 06 6.90E 04 TE 129 7.88E-02 3.47E-02 1.88E-02 6.75E-02 1.75E-01 3.00E 03 2.63E 04 TE 131M 1.07E 02 5.50E 01 3.63E 01 8.93E 01 2.65E 02 1.99E 05 1.19E 05 TE 131 1.74E-02 8.22E-03 5.00E-03 1.58E-02 3.99E-02 2.06E 03 8.22E 03 TE 132 3.72E 02 2.37E 02 1.76E 02 2.79E 02 1.03E 03 3.40E 05 4.41E 04 I 130 6.36E 03 1.39E 04 5.57E 03 1.60E 06 1.53E 04 0.00E-01 1.99E 03 _
I 131 3.79E 04 4.44E 04 1.96E 04 1.48E 07 5.18E 04 0.00E-01 1.06E 03 I 132 1.69E 03 3.54E 03 1.26E 03 1.69E 05 3.95E 03 0.00E-01 1.90E 03 I 133 1.32E 04 1.92E 04 5.60E 03 3.56E 06 2.24E 04 0.00E-01 2.16E 03 I 134 9.21E 02 1.88E 03 6.65E 02 4.45E 04 2.09E 03 0.00E-01 1.29E 03 I 135 3.86E 03 7.60E 03 2.77E 03 6.96E 05 8.47E 03 0.00E-01 1.83E 03 CS 134 3.96E 05 7.03E 05 7.45E 04 0.00E-01 1.90E 05 7.97E 04 1.33E 03 CS 136 4.83E 04 1.35E 05 5.29E 04 0.00E-01 5.64E 04 1.18E 04 1.43E 03 CS 137 5.49E 05 6.12E 05 4.55E 04 0.00E-01 1.72E 05 7.13E 04 1.33E 03 CS 138 5.05E 02 7.81E 02 3.98E 02 0.00E-01 4.10E 02 6.54E 01 8.76E 02 BA 139 1.48E 00 9.84E-04 4.30E-02 0.00E-01 5.92E-04 5.95E 03 5.10E 04 A-54 O
TNRE A.5-5 (crxit'd) INHA1ATION PAT!MAY FIqIORS MREM /YR PER LEI /M" INFN C (RI FICIORS) NUCLIDE BONE LTVER T BODY 'IHYROID KIDNIN LUfG GI-ILI BA 140 5.60E 04 5.60E 01 2.90E 03 0.00E-01 1.34E 01 1.60E C5 3.84E 04 BA 141 1.57E-01 1.08E-04 4.97E-03 0.00E-01 6.50E-05 2.97E 03 4.75E 03 RA 142 3.98E-02 3.30E-05 1.96E-03 0.00E-01 1.90E-05 1.55E 03 6.93E 02 LA 140 5.05E 02 2.00E 02 5.15E 01 0.00E-01 0.00E-01 1.68E 05 8.48E 04 1A 142 1.03E 00 3.77E-01 9.04E-02 0.00E-01 0.00E-01 8.22E 03 5.95E 04 _ CE 141 2.77E 04 1.67E 04 1.99E 03 0.00E-01 5.25E 03 5.17E 05 2.16E 04 CE 143 2.93E 02 1.93E 02 2.21E 01 0.00E-01 5.64E 01 1.16E 05 4.97E 04 CE 144 3.19E 06 1.21E 06 1.76E 05 0.00E-01 5.38E 05 9.84E 06 1.48E 05 PR 143 1.40E 04 5.24E 03 6.99E 02 0.00E-01 1.97E 03 4.33E 05 3.72E 04 PR 144 4.79E-02 1.85E-02 2.41E-03 0.00E-01 6.72E-03 1.61E 03 4.2BE 03 ND 147 7.94E 03 8.13E 03 5.00E 02 0.00E-01 3.15E 03 3.22E 05 3.12E 04 W 187 1.30E 01 9.02E 00 3.12E 00 0.00E-01 0.00E-01 3.96E 05 3.56E 04 NP 239 3.71E 02 3.32E 01 1.88E 01 0.00E-01 6.62E 01 5.95E 04 2.49E 04 - O A-55 O l
TAIEE A.5 COW-MILK PA'11MAY FAC'IOR GRASgM MRDt/YR PER UCI/SDC ADULT (RI FICIORS) NUCLIDE BONE LIVER T BODY 'IEYROID KIDNEY LlRG GI-LLI
'H 3 0.00E-01 7.63E 02 7.63E 02 7.63E 02 7.63E 02 7.63E 02 7.63E 02 C 14 2.63E 08 5.27E 07 5.27E 07 5.27E 07 5.27E 07 5 27E 07 5.27E 07 NA 24 2.44E 06 2.44E 06 2.64E 06 2.44E 06 2.44E 06 2.44E 06 2.44E 06 P 32 1.71E 10 1.06E 09 6.6tE 08 0.00E-01 0.00E-01 0.00E-01 1.92E 09 CR 51 0.00E-01 0.00E-01 2.86E 04 0.00E-01 6.30E 03 3.79E 04 7.19E 06 MN 54 0.00E-01 8.41E 06 1.61E 06 0.00E-01 0.00E-01 0.00E-01 2.58E 07 MN 56 0.00E-01 4.16E-03 7.38E-04 0.00E-01 5.28E-03 0.00E-01 1.33E-01 FE 55 2.51E 07 1.73E 07 4.04E 06 0.00E-01 0.00E-01 9.67E 06 9.95E 06 FE 59 2.97E 07 6.98E 07 2.68E 07 0.00E-01 0.00E-01 1.95E 07 2.33E 08 C0 58 0.00E-01 4.71E 06 1.06E 07 0.00E-01 0.00E-01 0.00E-01 9.56E 07 CO 60 0.00E-01 1.64E 07 3.62E 07 0.00E-01 0.00E-01 0.00E 3.08E 08 NT 63 6.73E 09 4.71E 08 2.26E 08 0.00E-01 0.00E-01 0.00E-01 9.73E 07 NI 65 4.63E-01 6.02E-02 2.75E-02 0.00E-01 0.00E-01 0.00E-01 1.53E 00 CU 64 0.00E-01 2.39E 04 1.12E 04 0.00E-01 6.02E 04 0.00E-01 2.03E 06 ZN 65 1.37E 09 4.37E 09 1.97E 09 0.00E-01 2.92E 09 0.00E-01 2.75E 09 ZN 69 5.22E-12 9.99E-12 6.95E-13 0.00E-01 6.49E-12 0.00E-01 1.50E-12 BR 83 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 85- 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB 86 0.00E-01 2.59E 09 1.21E 09 0.00E-01 0.00E-01 0.00E-01 5.12E 08 'RB- 88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB- 89 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 SR 89 1.45E 09 0.00E-01 4.16E 07 0.00E-01 0.00E-01 0.00E-01 2.33E 08 SR- 90 4.68E 10 0.00E-01 1.15E 10 0.00E-01 0.00E-01 0.00E-01 1.35E 09 SR 91 2.87E 04 0.00E-01 1.16E 03 0.00E-01 0.00E-01 0.00E-01 1.37E 05 SR- 92 4.90E-01 0.00E-01 2.12E-02 0.00E-01 0.00E-01 0.00E-01 9.70E 00 Y :90 7.07E 01 0.00E-01 1.90E 00 0.00E-01 0.00E-01 0.00E-01 7.50E 05 .Y 19UK 6.03E-20 0.00E-01 2.34E-21 0.00E-01 0.00E-01 0.00E-01 1.77E-19 Y 19 1 8.59E 03 0.00E-01 2.30E 02 0.00E-01 0.00E-01 0.00E-01 4.73E 06 Y- 92 5.59E-05 0.00E-01 1.63E-06 0.00E-01 0.00E-01 0.00E-01 9.79E-01 A-56 O
TMVR A.5-6 (cxnt.'d) COW-MILK PADIWAY FIC KR GRASg M MRDVYR PER UCI/SDC ADULT (RI FICIORS) NtCLIDE DO!E LIVER T IODY MIYROID KIDtEY LUIC GT-ILI Y 93 2.33E-01 0.00E-01 6.44E-03 0.00E-01 0.00E-01 0.00E-01 7.39E 03 KR 95 9.44E 02 3.03E 02 2.05E 02 0.00E-01 4.75E 02 0.00E-01 9.59E 05 4.33E-01 8.75E-05 4.00E-02 0.00E-01 1.32E-01 0.00E-Ol 2.71E,01 ]} ZR 97 NB 95 8.26E 04 4.59E 04 2.47E 04 0.00E-01 4.54E 04 0.00E 01 2.79E 08 MD 99 0.00E-01 2.48E 07 4.71E 06 0.00E-01 5.61E 07 0.00E 5.74E 07 _ TC 99M 3.33E 00 9.40E 00 1.20E 02 0.00E-01 1.43E 02 4.60E 00 5.56E 03 TC 101 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RU 103 1.02E 03 0.00E-01 4.38E 02 0.00E-01 3.88E 03 0.00E-01 1.19E 05 RU 105 8.58E-04 0.00E-01 3.39E-04 0.00E-01 1.11E-02 0.00E-01 5.250-01 RU 106 2.04E 04 0.00E-01 2.58E 03 0.00E-01 3.94E 04 0.00E-01 1.32E 06 AG 110M 5.82E 07 5.39E 07 3.20E 07 0.00E-01 1.06E 08 0.00E-01 2.20E 10 TE 1: "M 1.63E 07 5.90E 06 2.18E 06 4.90E 06 6.63E 07 0.00E-01 6.50E 07 TE 1*t /M 4.58E 07 1.64E 07 5.58E 06 1.17E 07 1.86E 08 0.00E-01 1.54E 08 TE 127 6.54E 02 2.35E 02 1.41E 02 4.84E 02 2.66E 03 0.00E-01 5.16E 04 129M 6.02E 07 2.25E 07 9.53M 06 2.07E 07 2.51E 08 0.00E-01 3.03E 08 l l TE TE 129 2.84E-10 1.07E-10 6.29E-11 2.18E-10 1.19E-09 0.00E-01 2.14E-10 TE 131M 3.61E 05 1.77E 05 1.47E 05 2.80E 05 1.79E 06 0.00E-01 1.73E 07 TE 131 3.67E-33 1.53E-33 1.16E-33 3.01E-33 1.61E-32 0.00E-01 0.00E-01 TE 132 2.40E 06 1.55E 06 1.46E 06 1.72E 06 1.50E 07 0.00E-01 7.35E 07 : I 130 4.20E 05 1.24E 06 4.89E 05 1.05E 08 1.94E 06 0.00E-01 1.07E 06 I 131 2.96E 08 4.24E 08 2.43E 08 1.39E 11 7.26E 08 0.00E-01 1.12E 08 I 132 1.65E-01 4.41E-01 1.54E-01 1.54E 01 7.02E-01 0.00E-01 8.28E-02 I 133 3.67E 06 6.73E 06 2.05E 06 9.90E 08 1.18E 07 0.00E-01 6.05E 06 I 134 2.03E-12 5.52E-12 1.98E-12 9.57E-11 8.78E-12 0.00E-01 4.81E-15 I 135 1.29E 04 3.37E 04 1.24E 04 2.22E 06 5.40E 04 0.00E-01 3.80E 04 CS 134 5.65E 09 1.35E 10 1.10E 10 0.00E-01 4.35E 09 1.45E 09 2.35E 08 CS 136 2.61E 08 1 03E 09 7.42E 08 0.00E-01 5.73E 08 7.86E 07 1.17E 08 CS 337 7.38E 09 1.01E 10 6.61E 09 0.00E-01 3.43E 09 1.14E 09 1.95E 08 CS 138 9.16E-24 1.81E-23 8.97E-24 0.00E-01 1.33E-23 1.31E-24 7.72E-29 BA 139 4.56E-08 3.25E-11 1.34E-09 0.00E-01 3.04E-11 1.84E-11 8.09E-08 A-57
l l l
'IMME A.5-6 (cant'd)
GRAS $-GM-MILK PA'IiMAY FICIOR M' MREM /YR PER UCI/SEC ADULT (RI FIC10RS) NUCLIDE BONE LTVER T BODY 'IRYROID KIDtEY LIRG GI-LLI BA 140 2.69E 07 .3.38E 04 1.76E 06 0.00E-01 1.15E 04 1.93E 04 5.54E 07 BA 141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BA 142 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 LA. 140 4.52E 00 2.28E 00 6.02E-01 0.00E-01 0.00E-01 0.00E-01 1.67E 05 LA- 142 9.39E-12 4.27E-12 1.06E-12 0.00E-01 0.00E-01 0.00E-01 3.12E-08 CE 141- 4.84E 03 3.28E 03 '3.72E 02 0.00E-01 1.52E 03 0.00E-01 1.25E 07 CE 143 4.16E 01 3.07E 04 3.40E 00 0.00E-01 1.35E 01 0.00E-01 1.15E 06 CE 144 3.58E 05 1.50E 05 1.92E 04 0.00E-01 8.87E 04 0.00E-01 1.21E 08 PR 143= 1.58E 02 6.33E 01 7.83E 00 0.00E-01 3.66'3 01 0.00E-01 6.92E 05 PR 144 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-d1 0.00E-01 0.00E-01 to 147 .9.46E 01 1.09E 02 6.55E 00 0.00E-01 6.40E 01 0.00E-01 5.25E 05 W 187 6.56E 03 5.49E 03 1.92E 03 0.00E-01 0.00E-01 0.00E-01 1.80E 06 NP 239 3.67E 00 3.61E-01 1.99E-01 0.00E-01 1.13E 00 0.00E-01 7.41E 04 l O
- A-58
-O-
TNIE A.5-7 GRl6g-OJW-MIIK PATIMY FIC1GR M MREM /YR PER UCI/SEC TEEN (RI F/CIORS) MU,IDE IYJNE I,IVER T BODY 'IUYROID KIDNEY URE GI-ILI H 3 0.00E-01 9.94E 02 9.94E 02 9.94E 02 9.94E 02 9.94E 02 9.94E 02 C 14 4.86E 08 9.72E 07 9.72E 07 9.72E 07 9.72E 07 9.72E 07 9.72E 07 NA 24 4.26E 06 4.26E 06 4.26E 06 4.26E 06 4.26E 06 4.26E 06 4.26E 06 P 32 3.15E 10 1.95E 09 1.22E 09 0.00E-01 0.00E-01 0.00E-01 2.65E 09 CR 51 0.00E-01 0.00E-01 4.99E 04 2.77E 04 1.09E 04 7.13E 04 8.39E 06 MN 54 0.00E-01 1.40E 07 2.78E 06 0.00E-01 4.18E 06 0.00E-01 2.87E 07 _ MN 56 0.00E-01 7.37E-03 1.31E-03 0.00E-01 9.33E-03 0.00E-01 4.85E-01 FE 55 4.45E 07 3.16E 07 7.36E 06 0.00E-01 0.00E-01 2.00E 07 1.37E 07 FE 59 5.18E 07 1.21E 08 4.67E 07 0.00E-01 0.00E-01 3.81E 07 2.86E 08 CO 58 0.00E-01 7.94E 06 1.83E 07 0.00E-01 0.00E-01 0.00E-01 1.09E 08 CO 60 0.00E-01 2.78E 07 6.26E 07 0.00E-01 0.00E-01 0.00E-01 3.62E 08 NI 63 1.18E 10 8.35E 08 4.01E 08 0.00E-01 0.00E-01 0.00E-01 1.33E 08 NI 65 8.48E-01 1.08E-01 4.94E-02 0.00E-01 0.00E-01 0.00E-01 5.88E 00 CU 64 0.00E-01 4.25E 04 2.00E 04 0.00E-01 1.08E 05 0.00E-01 3.30E 06 ZN 65 2.11E 09 7.31E 09 3.41E 09 0.00E-01 _4.68E 09 0.00E-01 3.10E 09 ZN 69 9.62E-12 1.83E-11 1.28E-12 0.00E-01 1.20E-11 0.00E-01 3.38E-11 BR 83 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 85 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 _ RB 86 0.00E-01 4.73E 09 2.22E 09 0.00E-01 0.00E-01 0.00E-01 7.00E 08 . RB 88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB 89 0.00E-01 0 00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 SR 89 2.67E 09 0.00E-01 7.66E 07 0.00E-01 0.00E-01 '0.00E-01 3.19E 08 SR 90 6.61E 10 0.00E-01 1.63E 10 0.00E-01 0.00E-01 0.00E-01 1.86E 09 SR 91 5.27E 04 0.00E-01 2.10E 03 0.00E-01 0.00E-01 0.00E-01 2.39E 05 SR 92 8.96E-01 0.00E-01 3.82E-02 0.00E-01 0.00E-01 0.00E-01 2.28E 01 Y 90 1.30E 02 0.00E-01 3.50E 00 0.00E-01 0.00E-01 0.00E-01 1.07E 06 Y 91M 1.11E-19 0.00E-01 4.22E-21 0.00E-01 0.00E-01 0.00E-01 5.22E-18 Y 91 1.58E 04 0.00E-01 4.24E 02 0.00E-01 0.00E-01 0.00E-01 6.48E 06 Y 92 1.03E-04 0.00E-01 2.99E-06. 0.00E-01 0.00E-01 0.00E-01 2.83E 00 A-59 9
TNEE A.5-7 (cont'd)
-O GRASg-C04-MILK PATIMAY FC ^
M MRm/YR PER UCI/SEC i TE m (RI FACTORS) NiCLIDE BONE LIVER T BODY 711YROID __ v'ifEY LUtG GI-ILI Y 93 4.30E-01 0.00E-01 1.18E-02 0.00E-01 0.00E-01 0.00E-01 1.31r 34 ZR 95 1.65E 03 5.21E 02 3.58E 02 0.00E-01 7.65E 02 0.LDE-01 1.20E 06 ZR 97 7.89E-01 1.56E-01 7.19E-02 0.00E-01 2.37E-01 0.00E-01 4.23E 04 NB 95 1.41E 05 7.81E 04 4.30E 04 0.00E-01 7.57E 04 0.00E-01 3.34E 08 MO 99 0.00E-01 4.47E 07 8.53E 06 0.00E-01 1.02E 08 0.00E-01 8.01E 07 1C 99M 5.77E 00 1.61E 01 2.08E 02 0.00E-01 2.40E 02 8.93E 00 1.06E 04 _ TC 101 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.009-01 0.00E-01 RU 103 1.81E 03 0.00E-01 7.74E 02 0.00E-01 6.38E 01 0.00E-01 1.51E 05 RU 105 1.57E-03 0.00E-01 6.08E-04 0.00E-01 1.98E-02 0.00E-01 1.27E 00 Rb 106 3.75E 04 0.00E-01 4.73E 03 0.00E-01 7.23E 04 0.00E-01 1.80E 06 AG 110M 9.63E 07 9.11E 07 5.54E 07 0.00E-01 1.74E 08 0.00E-01 2.56E 10 TE 125M 3.00E 07 1.08E 07 4.02E 06 8.39E 06 0.00E-01 0.00E-01 8.86E 07 TE 127M 8.44E 07 2.'9E 07 1.00E 07 2.01E 07 3.42E 08 0.00E-01 2.10E 08 TE 127 1.21E 03 4.29E 02 2.61E 02 8.36E 02 4.91E 03 0.00E-01 9.35E 04 TE 129M 1.10E 08 4.09E 07 1.74E 07 3.55E 07 4.61E 08 _0.00E-01 4.13E 08 5.23E-10 1.95E-10 1.27E-10 3.74E-10
- TE 129 2.20E-09 0.00E-01 2.86E-09 TE 13U4 6.57E 05 3.15E 05 2.63E 05 4.74E 05 3.29E 06 0.00E-01 2.53E 07 TE 131 6.70E-33 2.76E-33 2.09E-33 5.16E-33 2.93E-32 0.00E-01 5.5CE-34 TE 132 4.29E 06 2.72E 06 2.56E 06 2.87E 06 2.61E 07 0.00E-01 8.61E 07 _
I 130 7.39E 05 2.14E 06 8.54E 05 1.74E 08 3.26E 06 0.00E-01 1.64E 06 _ I 131 5.37E 08 7.52E 08 4.04E 08 2.20E 11 1.30E 09 G.00E-01 1.49E 08 1 132 2.92E-01 7.65E-01 2.74E-01 2.58E 01 1.20E 00 0.00E-01 3.33E-01 I 133 7.07E 06 1.20E 07 3.66E 06 1.67E 09 2.10E 07 0.00E-01 9.08E 06 I 134 3.61E-12 9.58E-12 3.44E-12 1.60E-10 1.51E-11 0.00E-01 1.26E-13 I 135 2.28E 04 5.88E 04 2.18E 04 3.78E 06 9.28E 04 0.00E-01 6.51E 04 c CS 134 9.82E 09 2.31E 10 1.07E 10 0.00E-01 7.34E 09 2.80E 09 2.87E 08 CS 136 4.44E 08 1.75E 09 1.17E 09 0.00E-01 9.52E 08 1.50E 08 1.41E 08 CS 137 1.34E 10 1.78E 10 6.20E 09 0.00E-01 6.06E 09 2.35E 09 2.53E 08 CS 138 1.66E-23 3.19E-23 1.60E-23 0.00E-01 2.36E-23 2.74E-24 1.45E-26 BA 139 8.44E-08 5.94E-11 2.46E-09 0.00E-01 5.60E-11 4.09E-11 7.53E-07 A-60 0
TNHJ A.5-7 (cmt.'d) GRASg-C01-MILK PFI1MAY FACIOR M~ MREM /YR PER LCI/SDC TEEN (RI FACIORS) NUCLTDE DOTE LIVER T BODY 'IHYROID KIDNEY LUtG GT-LLI BA 140 4.85E 07 5.95E 04 3.13E 06 0.00E-01 2.02E 04 4.00E 04 7.48E 07 BA 141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BA 142 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 LA 140 8.12E 00 3.99E 00 1.06E 00 0.00E-01 0.00E-01 0.00E-01 2.29E 05 LA 142 1.69E-11 7.52E-12 1.87E-12 0.00E-01 0.00E-01 0.00E-01 2.29E-07 CE 141 8.88E 03 5.93E 03 6.81E 02 0.00E-01 2.79E 03 0.00E-01 1.70E 07 - CE 143 7.64E 01 5.56E 04 6.21E 00 0.00E-01 2.49E 01 0.00E-01 1.67E 06 CE 144 6.58E 05 2.72E 05 3.54E 04 0.00E-01 1.63E 05 0.00E-01 1.66E 08 PR 143 2.90E 02 1.16E 02 1.44E 01 0.00E-01 6.73E 01 0.00E-01 9.55E 05 PR 144 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ND 147 1.82E 02 1.98E 02 1.19E 01 0.00E-01 1.16E 02 0.00E-01 7.15E 05 W 187 1.20E 04 9.78E 03 3.43E 03 0.00E-01 0.00E-01 0.00E-01 2.65E 06 NP 239 7.01E 00 6.61E-01 3.67E-01 0.00E-01 2.07E 00 0.00E-01 1.06E 05 O e
^~
O
'IALUE A.5-8 COW-MIIE PA'nMAY FACIOR GRASgMREM/Yo.PERUCI/SEC M
CHIID (RI F1CIORS) NUCLIDE DONE- LIVER T BODY 'nlYROID KIDNEY IDE GI-ILI H 3 0.00E-01 1.57E 03 3.57E 03 1.57E 03 1.57E 03 1.57E 03 1.57E 03 C 14 1.19E 09 2.39E 08 2.39E 06 2.39E 08 2.39E 08 2.39E 08 2.39E 08 NA -24 8.86E 06 8.86E 06 8.86E Of 8.86E 06 8.86E 06 8.86E 06 8.86E 06 P- 32- 7.77E 10 3.64E 09 3.00E 09 0.00E-01 0.00E-01 0.00E-01 2.15E 09 CR .51 0.00E-01 0.00E-01 1.02E 05 5.65E 04 1.54E 04 1.03E 05 -5.40E 06 MN 54 0.00E-01 2.10E 07- 5.59E 06 0.00E-01 -5.88E 06 0.00E-01 1.76E 07 MN 56 0.00E-01 1.29E-02 2.90E-03 0.00E-01 1.56E-02 0.00E-01 1.86E 00 FE 55 1.12E 08 5.93E 07 1.84E 07 0.00E-01 0.00E-01 3.35E 07 1.10E 07 FE 59 1.20E 08 1.94E 08 9.69E 07 0.00E-01 0.00E-01 S.64E 07 2.02E 08 00 58 10.iO0E-01 1.21E 07 3.71E 07 0.00E-01 0.00E-01 0.00E-01 7.07E 07 00 60' O.00E-01 4.32E 07 1.27E 08 0.00E-01 0.00E-01 0.00E 2.39E 08 NI 63 2.96E 10- 1.59E 09 1.01E 09 0.00E-01 0.00E-01 0.00E-01 1.07E 08 NI 65 2.07E 00- 1.95E-01 1.14E-01 0.00E-01 0.00E-01 0.00E-01 2.39E 01 64 0.00E-01 7.47E.04 4.51E 04 0.00E-01 1.81E 05 0.00E-01 3.51E 06-
) ZN CU 4.13E 09 1.10E 10 6.85E 09 0.00E-01 6,94E 09 0.00E-01 1.93E 09 ZN 69 2.36E-11 3.42E-11 3.16E-12 0.00E-01 2.07E-11 0.00E-01 2.15E-09 BR 83 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR- 84- 0.00E 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR. 85 0.00E 0.00E-01 C.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB 86 0.00E-01 8.77E 09 5.39E 09 0.00E-01 0.00E-01 0.00E-01 5.64E 08 RB 88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-91 0.00E-01 0.00E-01 RB -89 0.00E-01= C.00E-01= 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 4-89 6.62E 09 U.J0E-01 1.89E 08 0.00E-01 0.00E-01 0.00E-01 2.56E 08 SR- 90 1.12E 11 0.00E-01 2.83E 10 0.00E-01 0.00E-01 0.00E-01 1.50E 09 SR '91 '1.29E 05 0.00E-01 4.88E 03 0.00E-01 0.00E-01 '0.00E-01 2.85E 05 SR 92 2.19E 00 0.00E-01 8.78E-02 0.00E-01 0.00E-01 0.00E-01 4.15E 01 -Y 90 3.22E 02 0.00E-01 8.61E 00 0.00E-01 0.00E-01 0.00E-01 9.15E 05 Y ;91M- -2.70E 0.00E-01 9.82E-21 -0.00E-01 0.00E-01 0.00E-01 5.29E-16 Y 91: 3.90E 04 0.00E-01 1.04E 01 0.00E-01 0.00E-01 0.00E-01 5.20E 06 Y- 92 2.54E-04 0.00E-01 7.26E-06 0.00E-01 0.00E-01 0.00E-01 7.33E 00 A.-62 O
.. Q TNKE A.5-8 (&mit'd) q-OM-MIII PA7H&Y FAC7OR M MREM /YR PER UCI/SDC CHIID (RI FICK"S)
- NUCTJDE DOrJE IJVER T BODY THYROID _ KIDNEY lum GI-ILI Y 93 1.06E 00 0.00E-01 2.90E-02 0.00E-01 0.00E-01 t .00E-01 1.57E 04 ZR 95 3.83E 03 8.43E 02 7.50E 02 0.00E-01 1.21E 03 0.00E-01 8.79E 05 ZR 97 1.92E 00 2.77E-01 1.64E-01 0.00E-01 3.98E-01 0.00E-01 4.20E 04 NB 95 3.18E 05 1.24E 05 8.85E 04 0.00E-01 1.16E 05 0.00E-01 2.29E 08 MO 99 0.00E-01 8.14E 07 2.01E 07 e 90E-01 1.74E 08 0.00E-01 6.73E 07 TC 99M 1.32E 01 2.59E 01 4.30E 02 L.(CE-01 3.77E 02 1.32E 01 1.48E 04 TC 10/ 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RO 103 4.28E 03 0.00E-01 1.65E 03 0.00E-01 1.08E 04 0.00E-01 1.11E 05 IJtG GI-IL1 BA 140 2.38E 07 2.91E 04 1.53E 06 0.00E-01 9.88E 03 1.96E 04 3.67E 07 la 141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.001;-01 0.00E-01 0.00E-01 IW 142 0.00E-01 0.00P-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 1A 140 3.09E-02 1.52E-02 4.04E-03 0.00E-01 0.00E-01 0.00E-01 8 72E 02 1A 142 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01
.CE 141 1.19,E 04 7.88E 03 9.05E 02 0,00E-J1 3.71E 03 0.00E-01 2.25E 07 CE 143 1.69E-02 1.23E 01 1.38E-03 0.00E-01 5.53E-03 0.00E-01 3.70E 02 CE 144 1.23E 06 5.08E 05 6.60E 04 0.00E-01 3.04E 05 0.09E-01 3.09E 08 PR 113 1.77E 04 7.05E 03 8.78E 02 0.00E-01 4.10E 03 0.00E-01 5.81E 07 g 19 144 0.00E-01 0.00E-01 0.000-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 10 147 6.32E 03 6.87E 03 4.11E 02 0.00E-01 4.03E 03 0.00E-01 2.48E 07 W 187 1.81E-02 1.48E-02 5.18E-03 0.00E-01 0.00E-01 0.00E-01 4.00E 00 NP 239 2.26E-01 2.13E-02 1.19E-02 0.00E-01 6.70E-07 0.00E-01 3.43E 03 O
^~"
O
TNVE A.5-12 GRASg-COW-MEAT PA'11 FRAY F/Cim M MIEM/YR PCR LCI/SIE OIILD (RI F/C1m S) NLCLTDE IONE LIVER T ICDY '111YROID KIDNEY IUtG GI-ILI 11 3 0.00E-01 2.34E 02 2.34E 02 2.34E 02 2.34E 02 2.34E 02 2.34E 02 C 14 3.83E 08 7.67E 07 7.67E 07 7.67E 07 7.67E 07 7.67E 07 7.67E 07 14A 24 1.7)E-03 1.73E-03 1.73E-03 1.73E-03 1.73E-03 1.73E-03 1.73E-03 P 32 7.41E 09 3.47E 08 2.86E 08 0.00E-01 0.00E-01 0.00E-01 2.05E 08 CR 51 0.00E-01 0.00E-01 8.79E 03 4.88E 03 1.33E 03 8.91E 03 4.66E 05 MN 54 0.Q0E-01 8.01E 06 2.13E 06 0.00E-01 2.25E 06 0.00E-01 6.72E 06 _ FW 56 1.19E-10 0.00E-01 4.75E-12 0.00E-01 0.00E-01 0.00E-01 5.41E-10 FE 55 4.57E 08 2.42E 08 7.50E 07 0.00E-01 0.00E-01 1.37E 08 4.49E 07
)); 59 3.76E 08 6.09E 08 3.0lg 08 0.00E-01 0.00E-01 1.76E 08 6.34E 0Q 10 58 0.00E-01 1.64E 07 5.03E 07 0.00E-01 0.CDF-01 0.00E-01 9.58E 07 C0 60 0.00E-01 6.93E 07 2.04E 08 0.00E-01 0.003-01 0.00E-01 3.84E 08 NT 63 2.91E 10 1.56E 09 9.91E 08 0.00E-01 0.00E-01 0.00E-01 1.05E 08 NI 65 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 CU 64 0.00E-01 3.00E-07 1.81E-07 0.00E-01 7.24E-07 0.00E-01 1.41E-05 ZN 65 3.75E 08 1.00E 09 6.22E 08 0.00E-01 6.30E 08 0.00E-01 1.76E 08 7.N 69 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 83 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 84 0,00E-01 0.00E-01 0.00E-01 0200E-01 0.00E-01 0.00E-01 0.00E-01 BR 85 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB B6 0.00E-01 5.77E 08 3.55E 08 0.00E-01 0.00E-01 0.00E-01 3.71E 07 -
RB 88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB 89 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 SR 89 4.82E 08 0.00E-01 1.38E 07 0.00E-01 0.00E-01 0.00E-01 1.87E 07 SR 90 1.04E 10 0.00E-01 2.64E 09 0.00E-01 0.00E-01 0.00E-01 1.40E 08 SR 91 2.24E-10 0.00E-01 8.45E-12 0.00E-01 0.00E-01 0.00E-01 4.94E-10 SR 92 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Y 90 1.70E 02 0.00E-01 4.55E 00 0.00E-01 0.00E-01 0.00E-01 4.84E 05 Y 91M 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Y 91 1.80E 06 0.00E-01 4.82E 02 0.00E-01 0.00E-01 0.00E-01 2.40E 08 Y 92 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 A-74 0
TMVP. A.5-12 (Cant'd) GRASS-COW-MEAT PN111NAY FICIOR M MRIE/YR PER UCI/SIE CH11I) (RI FICIT S) 1RCLIDE trwE t.lVl@ T10W 711YROID EIDtHY 1,U!C GI-I.Lt Y 93 1.04E-11 0.00E-01 2.87E-13 0.00E-01 0.00E-01 0.00E-01 1.56E-07 7R 95 2.66E 06 5.86E 05 5.21E 05 0.00E-01 8.30E 05 0.00E-01 6.11E 08 ZR 97 3.22E-05 4.65E-06 2.74E-06 0. 0QJi-Q1 6.68E-06 0.001-11 7.05E-01 im 95 3.10E 06 1.21E 06 8.63E 05 0.00E-01 1.13E 06 0.00E-01 2.23E 09 MD 99 0.00E-01 1.15E 05 2.84E 04 0.00E-01 2.45E 05 0.00E-01 9.51E 04 7C 99M 6.27E-21 1.23E-20 2.04E-19 0.00E-01 1.79E-19 6.24E-21 7.00E-18 - 7C 101 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RU 103 1.55E 08 0.00E-01 5.95E 07 0.00E-01 3.90E 08 0.00E-01 4.000 09 RU 105 9.16E-28 0.00E-01 3.32E-28 0 ._00E-01 8.05E-27 0.00E-01 5.98E-25 RU 106 4.44E 09 0.00E-01 5.54E 08 0.00E-01 5.99E 09 0.00E-01 6.90E 10 IG 110M 8.34E 06 5.67E 06 4.53E 06 0.00E-01 1.06E 07 0.00E-01 6.74E 08 l'E 125M 5.69E 08 1.54E 08 7.59E 07 l 60E t 08 0.00E-01 0. 00E- 01 5.49E 08 7E 127M 1.77E 09 4.78E 08 2.11E 08 4.24E 08 5.06E 09 0.00E-01 1.44E 09 TE 127 3.41E-10 9.20E-11 7.32E-11 2.36E-10 9.71E-10 0.00E-01 1.33E-08 TE 129M 1.79E 09 5.00E 08 1.68E 08 5.77E 08 5.26E 09 0.00E-01 2.18E 09 TE 129 0.03E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 TE 131M 7.01E 02 2.43E 02 2.58E 02 4.99E 02 2.35E 03 0.00E-01 9.84E 03 TE 131 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-Q1, 7E 132 2.12E 06 9.39E 05 1.13E 06 1.37E 06 8.72E 06 0.00E-01 9.46E 06 I 130 3.05E-06 6.17E-06 3.18E-06 6.80E-04 9.22E-06 0.00E-01 2.89E-06 - I 131 1.66E 07 1.6711,07 9.47E 06 5.51E 09 2.74E 07 0.00E-01 1.4BE 06 I 132 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 1 133 5.70E-01 7.04E-01 2.66E-01 1.31E 02 1.17E 00 0.00E-01 2.84E-01 1 134 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0,00E-01 0.00E-01 0.00E-01 1 135 6.59E-17 1.19E-16 5.61E-17 1.05E-14 1.82E-16 0.00E-01 9.04E-17 CS 134 9.22E 08 1.51E 09 3.19E 08 0.00E-01 4.69E 08 1.68E 08 8.16E 06 g 136 1.59E 07 4.J6E 07 2.82E 07 0.00E-01 2.32E 07 3.46E 06 1.L3E 06 CS 137 1.33E 09 1.280 09 1.88E 08 0.00E-01 4.16E 08 1.50E 08 7.99E 06 CS 138 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 E 139 0.00E-01 _0.0QE-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 A-75 O
__.______..__.___.-_.._________._.____.-._m___._ l TAIUJ! A.5-12 (Omt'd) CRASg-GM-MEAT PA'I1MAY FICIOR M PJIIF./YR P!J1 (CI/SIE child (RI F/CIORS) MCLIDE TONE LIVER T 10DY 'HiYROID K}DNEY. IU!G G1-ILI IW 140 4.39E 07 3.84E 04 2.56E 06 0.00E-01 1.25E 04 2.29E 04 2.22E 07 BA 141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BA 142 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 IA 140 5.66E-02 1.98E-02 6.66E-03 0.00E-01 0.00E-01 0.00E-01 5.51E-02 LA 142 0.00E-01 0.00E-01 0.0CE-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 CE 141 2.22E 04 1.11E 04 1.64E 03 0.000-01 4.86E 03 0.00E 1.38E 07 CE 143 3.18E-02 1.72E 01 2.50E-03 0.00E-01 7.23E-03 0.00E-01 2.52E 02 CE 144 2.32E 06 7.26E 05 1.24E 05 0.00E-01 4.02E 05 0.00E-01 1.89E 08 PR 143 3.34E 04 1.00E 04 1.66E 03 0.00E-01 5.43E 03 0.00E-01 3.60E 07 PR 144 0.00E-01 0.00E401 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ND 147 1.19E 04 9.60E 03 7.43E 02 0.00E-01 5.27E 03 0.00E-01 1.52E 07 W 107 3.36E-02 1.99E-02 8.94E-03 0.00E-01 0.00E-01 0.00E-01 2.80E 00 NP 239 4.26E-01 3.06E-02 2.15E-02 0.00E-01 8.84E-02 0.00E-01 2.26E-03 O A-76
-_ _ .._ __ _ _ _ . _ __ ___m-______ . . - _ _ . _ _ _ . . _ _ _-
i i TMEJi A.5-13 VIgUrATICN PAUMAY FACIUt M MRIWYR PER LCI/SIE NXILT (RI FACIQtS) NtrIJDE D0tJE LIVIP T DODY MIYROID KITt1EY 11N3 GI-iQ + H 3 0.00E-01 2.26E 03 2.26E 03 2.26E 03 2.26E 03 2.26E 03 2.26E 03 C 14 2.38E 08 4.55E 07 4.55E 07 4.55E 07 4.55E 07 4.55E 07 4.55E 07 NA 24 2.69E 05 2.69E 05 2.69Pu05 2.69E 05 2.69E 05 2.69E 05 2.69E 05 P 32 1.40E 09 8.73E 07 5.42E 07 0.00E-01 0.00E-01 0.00E-01 1.58E 08 CR 51 0.00E-01 0.00E-01 4.64E 04 2.78E 04 1.02E 04 6.16E 04 1.17E 07 MN 54 0.00E 3.13E 00 5.97E 07 0.00E-01 9.31E 07 0.00E-01 9.58E 08 MN 56- 0.00E-01 1.59E 01 2.82E 00 0.00E-01 2.02E 01 0.00E-01 5.08E 02 FE 55 2.09E 08 1.45E 08 3.37E 07 0.00E-01 0.00E-01 8.06E 07 8.29E 07 FE 59 1.26E 08 2.96E 08 1.14E 08 0.00E-01 0.00E-01 0.288 07 9.83E 08 00 5fi 0.00E-01 3.07E 07 6.89E 07 0.00E-01 0.00E-01 0.00E-01 6.23E 08 00 60 0.00E-01 1,67E 08 3.69E 08 0.00E-01 0.00E-01 0.00E-01 3.14E 09 NI 63 1.04E 10 7.28E 08 3.49E 08 0.00E-01 0.00E-01 0.00E-01 1.50E 08 N1 65 6.93E 01- 9.01E 00 4.11E 00 0.00E-01 0.00E-01 0.00E-01 2.28E 02 CU 64 0.00E-01 9.21E 03 4.32E 03 0.00E-01 2.32E 04 0.00E-01 7.85E 05 ZN 65 3,17E 08 1.01E 09 4.56E 08 0.00E-01 6.75E 08 0.00E-01 6.36E 08 ZN 69 8.77E-06 1.68E-05 1.17E-06 0.00E-01 1.09E-05 0.00E-01 2.52E-06 Im 83 0.00E-01 0.00E-01 3.11E 00 0.00E-01 0.00E-01 0.00E-01 4.48E 00 BR 84 0.00E-01 0.00E-01 2.49E-11 0.00E-01 0.00E-01 0.00E-01 1.96E-16 BR 85 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01
-RB 86- 0.00E-01 2.19E 08- 1.02E 08 0.00E 0.00E-01 0.00E-01 4.33E 07 RB 88 0.00E-01 3.47E-22 1.84E-22 0.00E-01 0.00E-01 0.00E-0.1 0.00E-01 im 89 0.00E-01 1.41E-26 9.88E-27 0.00E-01 0.00E-01 0.00E-01 0.00E-01 '
SR 89 9.97E 09 0.00E-01 2.86E 08 0.00E-01 0.00E-01 0.00E-01 1.60E 09 SR 90_ 6.05E 11 0.00E-01 1.48E 11 0.00E-01 0.00E-01 0.00J -01 1.75E 10 SR- 91 3.03E 05 0.00E-01 1.22E 04 0.00E-01 0.00E-01 0.00E-01 1.44E 06 SR 92 4.27E 02 0.00E-01 1.85E 01 0.00E-01 0.00E-01 0.00E-01 8.46E 03 Y 90 1.33E 04 0.00E-01 3.56E 02 0.00E-01 0.00E-01 0.00E-01 1.41E 08 Y 91M 5.24E 0.00E-01 2.03E-10 -0.00E-01 0.00E-01 0.00E-01 1.54E-08 Y 91 5.11E 06 0.00E-01 1.37E 05 0.00E-01 0.00E-01 0.00E-01 2.81E 09
'Y- 92 9.16E-01 0.00E-01 2.68E-02 0.00E-01 0.00E-01 0.00E-01 1.60E 04 '
A-77 O
TMUE A.5-13 (Omt'd) gIII'ATICH PA'1 HAY FACIQ1 M MRIN/YR PER UCI/SEC ADULT (RI FIC1mS) Mr1TDE FOJE LIVER T DODY 'lHYROID KIDNEY IUfG GI-ILI Y 93 1.74E 02 0.00E-01 4.81E 00 0.00E-01 0.00E-01 0.00E-01 5.52E 06 ZR 95 1.18E 06 3.77E 05 2.55E 05 0.00E-01 5.92E 05 0.00E-01 1.20E 09 KR 97 3.37E 02 6.81E 01 3.11E 01 0.00E-01 1.03E 02 0.00E-01 2.11E 07 NB 95 1.43E 05 7.93E 04 4.26E 04 0.00E-01 7.84E 04 0.00E-01 4.81E 08 10 99 0.00E-01 6.15E 06 1.17E 06 0.00E-01 1.39E 07 0.00E-01 1.43E 07 3C 99M 3.10E 00 8.77E 00 1.12E 02 0.00E-01 1.33E 02 4.30E 00 5.19E 03 TC 101 8.34E-31 1.20E-30 1.18E-29 0.00E-01 2.16E-29 6.14E-31 0.00E-01 RU 103 4.76E 06 0.00E-01 2.05E 06 0.00E-01 1.82E 07 0.00E-01 5.56E 08 RU 105 5.39E 01 0.00E-01 2.13E 01 0.00E-01 6.97E 02 0.00E-01 3.30E 04 RU 106 1.93E 08 0.00E-01 2.44E 07 0.00E-01 3.72E 08 0.00E-01 1.25E 10 AG 110M 1.05E 07 9.75E 06 5.79E 06 0.00E-01 1.92E 07 0.00E-01 3.98E 09 JE 125M 9.66E 07 3.50E 07 1.29E 07 2.90E 07 3.93E 08 0.00E-01 3.86E 08 TE 127M 3.49E 08 1.25E 08 4.26E 07 8.93E 07 1.42E 09 0.00E-01 1.17E 09 127 5.66E 03 2.03E 03 1.23E 03 4.20E 03 2.31E 04 0.00E-01 4.47E 05 ()TE TE 129M 2.51E 08 9.38E 07 3.98E 07 8.63E 07 1.05E 09 0.Q0E-01 1.27E 09 7E 129 7.65E-04 2.87E-04 1.85E-04 5.87E-04 3.22E-03 0.00E-01 5.77E-04 TE 131M 9.12E 05 4.46E 05 3.72E 05 7.07E 05 4.52E 06 0.00E-01 4.43E 07 TE 131 1.51E-15 6.32E-16 4.78E-16 1.24E-15 6.63E-15 0.00E-01 2.14E-15 TE 132 4.30E 06 2.78E 06 2.61E 06 3.072 06 2.68E 07 0.00E-01 1.32E 08 I 130 3.95E 05 1.16E 06 4.57E 05 9.81E 07 1.81E 06 0.00E-01 9.97E 05 I 131 8.085 07 1.16E 08 6.62E 07 3.79E 10 1.98E 08 0.00E-01 3.05E 07 I 132 5.77E 01 1.54E 02 5.40E 01 5.40E 03 2.46E 02 0.00E-01 2.90E 01 I 133 2.09E 06 3.63E 06 1.11E 06 5.33E 08 6.33E 06 0.00E-01 3.26E 06 1 134 9.69E-05 2.63E-04 9.42E 4.56E-03 4.19E-04 0.00E-01 2.30E-07 I 135 3.90E 04 1.02E 05 3.77E 04 6.74E 06 1.64E 05 0.00E-01 1.15E 05 CS 134 4.67E 09 1.11E 10 9.08E 09 0.00E-01 3.59E 09 1.19E 09 1.94E 08 CS 136 4.20E 07 1.66E 08 1.19E 08 0.00E-01 9,22E 07 1.26E 07 1.88E 07 CS 137 6.36E 09 8.70E 09 5.70E 09 0.00E-01 2.95E 09 9.81E 08 1.68E 08 CS 138 -3.94E-11 7.78E-11 3.86E-11 0.00E-01 5.72E-11 5.65E-12 3.32E-16 BA 139 2.90E-02 2.q7E-05 8.50E-04 0.00E-01 1.93E-05 1.17E-05 5.15E-02 A-78 O
TMIE A.5-13 (Otut'd) VgUfATION PA31MAY FACIOR M MRfyJYR PER UCI/SDC ADULT (RI FN?IGS) NUCLIDE DONE LTVER T IODY 11NROID KIDNEY LUtG GI-ILI BA 140 1.29E 08 1.61E 05 8.42E 06 0.00E-01 5.49E 04 9.25E 04 2.65E 08 BA 141 1.28E-21 9.64E-25 4.31E-23 0.00E-01 8.96E-25 5.47E.25 6.01E-31 ljd 142 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 LA 140 1.98E 03 9.99E 02 2.64E 02 0.00E-01 0.00E-01 0.00E-01 7.33E 07 IA 142 1.42E-04 6.44E-05 1.61E-05 0.00E-01 0.00E-01 0.00E-01 4.70E-01 ~ CE 141 1.97E 05 1.33E 05 1.51E 04 0.00E-01 6.19E 04 0.00E-01 5.10E 08 CE 143 9.98E 02 7.38E 05 8.17E 01 0.00E-01 3.25E 02 0.00E-01 2.76E 07 CE 144 3.29E 07 1.38E 07 1.77E 06 0.00E-01 8.16E 06 0.00E-01 1.11E 10 PR 143 6.26E 04 2.518 04 3.11E 03 0.00E-01 1.45E 04 0.00E-01 2.74E 08 PR 144 3.13E-26 1.30E-26 1.59E-27 0.00E-01 7.32E-27 0.00E-01 0.00E-01 ND 147 3.36E 04 3.89E 04 2.32E 03 0.00E-01 2.27E 04 0.00E-01 1.87E 08 W 187 3.82E 04 3.20E 04 1.12E 04 0.00E-01 0.00E-01 0.00E-01 1.05E 07 NP 239 1.43E 03 1.40E 02 7.74E 01 0.00E-01 4.38E 02 0.00E-01 2.88E 07 O i A-79
- ~ . _ - - _ _ _ _ - - - - . - - _ _ - - - - - - - _ _ _ _ _ _ . - . .
TMEJ! A.5-14
\ PION PA'11MAY FAC'10R M MRD4/YR PER UCI/SFC TEDI (RI FACIORS)
NUCLIDE BONE LIVER T BODY '1HYROID KIDNEY IDG GI-ILI H 3 0.00E-01 2.59E 03 2.59E 03 2.59E 03 2.59E 03 2.59E 03 2.59E 03 C 14 3.69E 08 7.38E 07 7.38E 07 7.38E 07 7.38E 07 7.38E 07 7.38E 07 NA 24 2.39E 05 2.39E 05 2.39E 05 2.39E 05 2.39E 05 2.39E 05 2.39E 05 P 32 1.61E 09 9.96E 07 6.23E 07 0.00E-01 0.00E-01 0.00E-01 1.35E 08 CR 51 0.00E-01 0.00E-01 6.17E 04 3.43E 04 1.35E 04 8.81E 04 1.04E 07 MN 54 0.00E-01 4.54E 08 9.01E 07 0.00E-01 1.36E 08 0.00E-01 9.32E 08 FW 56 0.00E-01 1.44E 01 2.55E 00 0.00E-01 1.82E 01 0.00E-01 9.45E 02 FE 55 3.25E 08 2.31E 08 5.38E 07 0.00E-01 0.00E-01 1.46E 08 9.98E 07 FE 59 1.79E 08 4.18E 08 1.62E 08 0.00E-01 _0.00E-01 1.32E 08 9.90E 08
- CO 58 0.00E-01 4.36E 07 1.01E 08 0.00E-01 0.00E-01 0.00E-01 6.01E 08 00 60 0.00E-01 2.49E 08 5.608 08 0.00E-01 0.00E-01 0.00E-01 3.24E 09 NI 63 1.61E 10 1.13E 09 5.44E 08 0.00E-01 0.00E-01 0.00E-01 1.81E 08 NI 65 6.45E 01 8.24E 00 3.76E 00 0.00E-01 0.00E-01 0.00E-01 4.47E 02 CU 64 0.00E-01 8.34E 03 3.92E 03 0.00E-01 2.11E 04 0.00E-01 6.47E 05 KN 65 4.24E 08 1.47E 09 6.86E 08 0.00E-01 9.42E 08 0.00E-01 6.23E 08 EN 69 8.21E-06 1.56E 05 1.10E-06 0.00E-01 1.02E-05 0.00E-01 2.88E-05 BR 83 0.00E-01 0.00E-01 2.92E 00 0.00E-01 0.00E-01 0.00E-01 5.08E-17 DR 84 0.00E-01 0.00E-01 2.27E-11 0.09E-01 0.00E-01 0.00E-01 3.14E-28 BR 85 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB 86 0.00E-01 2.74E 08 1.29E 08 0.00E-01 0.00E-01 0.00E-01 4.05E 07
'RB 88 0.00E-01 3.21E-22 1.71E-22 0.00E-01 0.00E-01 0.00E-01 2.75E-29 RB 89 0.00E-01 1.26E-26 8.94E-27 0.00E-01 0.00E-01 0.00E-01 1.94E-35 SR 89 1.51E 10 0.00E-01 4.34E 08 0.00E-01 0.00E-01 0.00E-01 1.80E 09 SR - 90 7.51E 11 0.00E-01 1.85E 11 0.00E-01 0.00E-01 0.00E-01 2.11E 10 SR . 91 2.83E 05 0.00E-01 1.13E 04 0.00E-01 0.00E-01 0.00E-01 .1.28E 06 SR. 92 3.98E 02 0.00E-01 1.70E 01 0.00E-01 0.00E-01 0.00E-01 1.01E 04 Y 90 1.24E 04 0.00E-01 3.34E 02 0.00E-01 0.00E-01 0.00E-01 1.02E 08 Y 9D4 .4.88E-09 0.00E-01 1.87E-10 0.00E-01 0.00E-01 0.00E-01 2.30E-07 Y 91 .7.84E 06 0.00E-01 2.10E 05 0.00E-01 0.00E-01 0.00E-01 3.21E 09 Y- 92 8.61E-01 0.00E-01 2.49E-02 0.00E-01 0.00E-01 0.00E-01 2.36E 04 O
. - - - . = - _ _ - - .
. . _ ~ - - . . - . - . . . . - - - - . - . . . - . _- - ._...-.~_ _ - -
TNER A.5-14 (Omt'd) VgEI'ATION PADMAY FACIOR M MRD4/YR PER UCI/SEC TEEN (RI FNJIORS) NUCLIDE DONE LWER T KX7l MIYROID KIDNFY IUfG GI-LLI Y 93 1.63E 02 0.00E-01 4.47E 00 0.00E-01 0.00E-01 0.00E-01 4.99E 06 ZR 95 1.72E 06 5.44E 05 3.74E 05 0.00E-01 7.99E 05 0.00E-01 1.25E 09 ZR 97 3.12E 02 6.18E 01 2.8SE 01 0.00E-01 9.37E 01 0.00E-01 1.67E 07 NB 95 1.93E 05 1.07E 05 5.88E 04 0.00E-01 1.04E 05 0.00E-01 4.57E 08 MD 99 0.00E-01 5.65E 06 1.08E 06 0.00E-01 1.29E 07 0.00E-01 1.01E 07 7C 99M 2.74E 00 7.64E 00 9.90E 01 0.00E-01 1.14F 02 4.24E 00 5.02E 03 TC 101 7.76E-31 1.10E-30 1.08E-29 0.00E-01 2.00E-29 6.72E-31 0.00E-01 RU 103 6.81E 06 0.00E-01 2.91E 06 0.00E-01 2.40E 07 0.00E-01 5.69E 08 RU 105 5.01E 01 0.00E-01 1.94E 01 0.00E-01 6.32E 02 0.00E-01 4.04E 04 RU 106 3.09E 08 0.00E-01 3.90E 07 0.00E-0; 5.97E 08 0.00E-01 1.48E 10 AG 110M 1.52E 07 1.43E 07 8.72E 06 0.00E-01 2.74E 07 0.00E-01 4.03E 09 TE 125M 1.48E 08 5.34E 07__ 1.EBE 07 4.14E 07 0.00E-01 0.00E-01 4.39E 08 TE 127M 5.52E 08 1.96E 08 6.56E 07 1.31E 08 2.24E 09 0.00E-01 1.37E 09 TE 127 5.34E 03 1.89E 03 1.15E 03 3.68E 03 2.16E 04 0.00E-01 4.12E 05 129M 3.62E 08 1.34E 08 _. 5.73E 07 1.17E 08 1.51E 09 0.00E-01 1.36E 09 ( ) TB TE 129 7.16E-04 2.67E-04 1.74E-04 5.12E-04 3.01E-03 0.00E-01 3.92E-03 TE 13EH 8.44E 05 4.05E 05 3.38E 05 6.09E 05 4.22E 06 0.00E-01 3.25E 07 TE 131 1.41E-15 5.80E-16 4.40E-16 1.08E-15 6.15E-15 0.00E-01 1.15E-16 TE 132 3.91E 06 2.48E 06 2.33E 06 2.61E 06 2.37E 07 0.00E-01 7.84E 07 I 130 3.51E 05 1.02E 06 4.05E 05 8.28E 07 1.56E 06 0.00E-01 7.80E 05 I 131 7.69E 07 1.08E 08 5.78E 07 3.14E 10 1.85E 08 0.00E-01 2.13B 27 I 132 5.20E 01 1.36E 02 4.89E 01 4.59E 03 2.14E 02 0.00E-01 5.93E 01 I 133 1.94E 06 3.29E 06 1.00E 06 4.59E 08 5.77E 06 0.00E-01 2.49E 06 I 134 8.76E-05 2.32E-04 8.34E-05 3.87E-03 3.66E-04 0.00E-01 3.06E-06 I 135 3.52E 04 9.07E 04 3.36E 04 5.84E 06 1.43E 05 0.00E-01 1.01E 05 CS 134 7.10E 09 1.67E 10 7.75E 09 0.00E-01 5.31E 09 2.03E 09 2.08E 08 CS 136 4.28E 07 1.68E 08 1.13E 08 0.00E-01 9.16E 07 1.44E 07 1.35R 07 CS 137 1.01E 10 1.35E 10 4.69E 09 0.00E-01 4.59E 09 1.78E 09 1.92E 08 CS 138 3. :-11 6.98E-11 3.49E-11 0.00E-01 5.15E-11 6.00E-12 3.17E-14 BA 139 2. ', E-02 1.92E-05 7.96E-04 0.00E-01 1.81E-05 1.32E-05 2.44E-01 i l
___-___m. . _ _ _ _. _ _- . _ . . - - _ _ _ _. _ _ _ - _ _ _ _ _ - - . _ . - _ i TMER A.5-14 (Omt'd) VgETAT10t1 PR11MAY FEIUt M MREM /YR PER LCI/Str TEEli (RI F MIUlS) NtCLIDE _. B0 TIE LIVER T DODY 'JinT(OID KIDNEY 1 8 73 GI-141 BA 140 1.38E 08 1.69E 05 8.91E 06 0.00E-01 5.74E 04 1.14E 05 2.13E 08 BA 141 1.19E-21 8.90E-25 3.98E-23 0.00E-01 8.27E-25 6.10E-25 2.54E-27 in 142 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 LA 140 1.81E 03 8.89E 02 2.37E 02 0.00E-01 0.00E-01 0.00E-01 5.11E 07 IA 142 1.30E-04 5.78E-05 1.44E-05 0.00E-01 0.00E-01 0.00E-01 1.76E 00 CE 141 2.83E 05 1.89E 05 2.17E 04 0.00E-01 8.90E 04 0.00E-01 5.41E 08 CE 143 9.33E 02 6.79E 05 7.58E 01 0.00E-01 3.04E 02 0.00E-01 2.04E 07 CE 144 5.27E 07 2.18E 07 2.83E 06 0.00E-01 1.30E 07 0.00E-01 1.33E 10 PR 143 7.01E 04 2.80E 04 3.49E 03 0.00E-01 1.63E 04 0.00E-01 2.31E 08 PR 144 2.93E-26 1.20E-26 1.49E-27 0.00E-01 6.88E-27 0.00E-01 3.23E-29
' ND 147 3.66E 04 3.98E 04 2.38E 03 0.00E-01 2.34E 04 0.00E-01 1.44E 08 W 107 3.56E 04 2.90E 04 1.02E 04 0.00E-01 0.00E-01 0.00E-01 7.84E 06 NP '239 1.39E 02 1.31E 02 7.26E 01 0.00E-01 4.10E 02 0.00E-01 2.10E 07 O
1 l l . . -
I TNVE A.5-15 gETATIO1 PA'I15&Y F/C10R , M MREM /YR PER UCI/SDC OIIID (RI FICIOG) N!.CLIDE Dgt[E LTVER T DODY 'lifYROID KIDNFY IUtG GI-ILI H 3 0.00E-01 4.01E 03 4.01E 03 4.01E 03 4.01E 03 4.01E 03 4.01E 03 C 14 8.89E 08 1.78E 08 1.78E 08 1.78E 08 1.78E 08 1.78E 08 1.78E 08 NA 24 3.73E 05 3.73E 05 3.73E 05 3.73E 05 3.73E 05 3.73E 05 3.73E 05 P 32 3.73E 09 1.58E 08 1.30E 08 0.00E-01 0.00E-01 0.One-01 9.30E 07 CR 51 0.00E-01 0.00E-01 1.17E 05 6.50E 04 1.78E 04 1.138 05 6.21E 06 34 54 0.00E-01 6.65E 08 1.77E 08 0.00E-01 1.86E 08 0.00E-01 5.58E 08 MN 56 0.00E-01 1.88E 01 4.24E 00 -0.00E-01 2.27E 01 0.00E-01 2.72E 03 PE 55 8.00E 08 4.24E 08 1.31E 08 0.00E-01 0.00E-01 2.40E 08 7.86E 07 i FE 59 3.97E 08 6.43E 08 3.20E 08 0.00E-01 0.00E-01 1.06E 00 6.69E 08 00 56 0.00E-01 6.44E 07 1.97E 08 0.00E-01 0.00E-01 0.00E-01 3.76E 08 00 60 0.00E-01 1.78E 08 1.12E 09 0.00E-01 0.00E-01 0.00E-01 2.10E 09
- NI 63 3.95E 10 2,11E 09 1.34E 09 0.00E-01 0.00E-01 0.00E-01 1.42E 08 18 65 1.18E 02 1.11E 01 6.51E 00 0.00E-01 0.00E-01 0.00E-01 1.37E 03 CU 64 0.00E-01 1.10E 04 6.65E 03 0.00E-01 2.66E 04 0.00E-01 5.16E 05 ZN 65 8.12E 08 2.16E 09 1.35E 09 0.00E-01 1.36E 09 0.00E-01 3.80E 08 ZN 69 1.51E-05 2.19E-05 2.02E-06 0.00E-01 1.33E-05 0.00E-01 1.38E-03 BR 83 0.00E-01 0.00E-01 5.38E 00 0.00E-01 0.00E-01 0.00E-01 3.14E-17 BR 84 0.00E-01 0.00E-01 3.85E-11 0.00E-01 0.00E-01 0.00E-01 1.94E-28 BR 85 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB- 86 0.00E-01 4.52E 08 2.78E-08 0.00E 0.00E-01 0.00E-01 2.91E 07 RB 88 0.00E-01 4.43E-22 3.08E-22 0.00E-01 0.00E-01 0.00E-01 2.17E-23 RB 89 0.00E-01 1.67E-26 1.48E-26 0.00E-01 0.00E-01 0.00E-01 1.45E-28 SR 89 3.60E 10 0.00E-01 1.03E 09 0.00E-01 0.00E-01 0.00E-01 1.39E 09 l SR 90 1.24E 12 0.00E-01 3.15E 11 0.00E-01 0.00E-01 0.00E-01 1.67E 10 SR--91 5.21E 05 0.00E-01 1.97E 04 0.00E-01 0.00E-01 0.00E-01 1.15E 06 SR 92 7.29E 02 0.00E-01 2.92E 01 0.00E-01 0.00E-01 0.00E-01 1.38E 04 Y 90 2.30E 04 0.00E-01 6.17E 02 0.00E-01 0.00E-01 0.00E-01 6.56E 07 Y 91M 8.95E-09 0.00E-01 3.26E-10 0.00E-01 0.00E-01 0.00E-01 1.75E-05 Y .91 1.86E 07 0.00E 4.99E 03 0.00E-01 0.00E-01 0.00E 2.48E 09 Y 92 1.59E 00 0.00E-01 4.54E-02 0.00E-01 0.00E-01 0.00E-01 4.58P 04-A L
i TNVE A.5-15 (Cant.'d) ViglJrKfl0N PA'11MAY F/CIm M MRD4/YR PIR LC1/ Sir QIIID (RI FAC1mS)
!ECLIDE IWE LIVER T KOY Tl!YROID KIDNEY IUtB GI-ILI Y 93 3.01E 02 0.00E-01 8.26E 00 0.00E-01 0.00E-01 0.00E-01 4.48E 06 ZR 95 3.86E 06 8.49E 05 7.56E 05 0.00E-01 1.22E 06 0.00E-01 8.85E 08
_ZR 97 5.70E C2 8.248 01 4.86E 01 0.00E-01 1.18E 02 0.00E-01 1.2SE 07 NB 95. 4.11E 05 1.60E 05 1.14E 05 0.00E-01 1.50E 05 0.00E-01 2.96E 08 tt) 99 0.00E-01 7.71E 06 1.91E 06 0.00E-01 1.65E 07 0.00E-01 6.38E 06 TC 99M 4.71E 00 9.24E 00 4.86E_01 0.00E-01 1.34E 02 4.69E 00 5.26E OJ TC 101 1.43E-30 1.49E-30 1.89E-29 0.00E-01 2.55E-29 7.90E-31 4.75E-30 RU 103 1.53E 07 0.00E-01 5.86E 06 0.00E-01 3.85E 07 0.00E-01 3.96E 08 RU. 105 9.17E 01 0.00E-01 3.33E 01 0.00E-01 8.06E 02 0.00E-01 5.99E 04 RU 106 7.45E 08 0.00E-01 9.30E 07 0.00E-01 1.01E 09 0.00E-01 1.16E 10 AG 110H 3.21E 07 2.17E 07 1.73E 07 0.00E-01 4.04E 07 0.00E-01 2.58E 09 17 12SK 3.51E 08 9.50E 07 4.67E 07 9.84E 07 0.00E-01 0.00E-01 3.38E_08 _ TE 12ZM 1.32E 09 3.56E 08 1.57E 08 3.16E 08 3.77E 09 0.00E-01 1.07E 09 TE 127 9.85E 03 2.66E 03 2.11E 03 6.82E 03 2.80E 04 0.00E-01 3.85E 05 Tg_ 129M 8.41E 08 2.35E 08 7.88E 07 2.71E 08 2.47E 09 0.00E-01 1.03E 09 TE 129 1.33E-03 3.70E-04 3.15E-04 9.46E-04 3.88E-03 0.00E-01 8.25E-02 TE 131M 1.54E 06 5.33E 05 5.68E 05 1.10E 06 5.16E 06 0.00E-01 2.16E 07 TE 131 2.59E-15 7.90E-16 7.71E-16 1.98E-15 7.84E-15 0.00E-01 1.36E-14 TE 132 7.00E 06 3.10E 06 3.74E 06 4.51E 06 2.88E 07 0.00E-01 3.12E 07 I 130 6.16E 05 1.24E 06 6.41E 05 1.37E 08 1.86E 06 0.00E-01 5.82E 05 I 131 1.43E 08 1.44E 08 8.17E 07 4.76E 10 2.36E 08 0.00E-01 1.28E 07 I 132 9.23E 01 1.70E 02 7.80E 01 7.87E 03 2.60E 02 0.00E-01 2.00E 02 I 133 3.53E 06 4.37E 06 1.65E 06 0.12E OB 7.28E 06 0.00E-01 1.76E 06 I 134 1.56E-04 2.89E-04 1.33E-04 6.65E-03 4.42E-04 0.00E-01 1.92E-04 I 135 6.26E 04 1.13E 05 5.33E 04 9.98E 06 1.73E 05 0.00E-01 8.59E 04 C9 134 1.60E 10 2.63E 10 5.55E 09 0.00E-01 8.15E 09 2.93E 09 1.42E 08 CS 136 0.04E 07 2.21E 08 1.43E 08 0.00E-01 1.18E 08 1.76E 07 7.77E 06 c CS 137 2.39E 10 2.29E 10 3.38E 09 0.00E-01 7.46E 09 2.68E 09 1.43E 08 CS - 138 6.61E-11 9.20E-11 5.83E-11 0.00E-01 6.47E-11 6.96E-12 4.24E-11 BA 139 5.04E-02 2.698-05 1.46E-03 0.00E-01 2.35E 1,58E-05 2.91E 00 l' A-84 O l
TNur A.5-15 (Ctrit.'d) VIgUI'ATIW PK1HMY FNNOR M MRIM/YR PIR LCI/SIX* CHIID (RI FNNOIS) NtCLIDE KNE LIVIE T KOY 'IliYBOID lilfCEY IA!!C _ G1 -L1,1 In 140 2.77E 08 2.43E 05 1.62E 07 0.00E-01 7.90E 04 1.45E 05 1.40E 08 BA 141 2.20E-21 1.23E-24 7.16E-23 0.00E-01 1.07E-24 7.24E-24 1.25E-21 J L )42 0 QQE-01 0.00Feyl 0.00E-01 0.003-01 0.00E-01 0.00E-01 0.00E-01 LA 140 3.25E 03 1.14E 03 3.83E 02 0.00E-01 0.00E-01 0.00E-01 3.17E 07 LA 142 2.36E-04 7.51E-05 2.35E-05 0.00E-01 0.00E-01 0.00E-01 1.49E 01 CE 141 6.56E 05 3.27E 05 4.86E 04 0.00E-01 1.43E 05 0JQE-01 4.08E 08 CE 143 1.72E 03 9.31E 05 1.35E 02 0.00E-01 3.91E 02 0.00E-01 1.36E 07 CE 144 1.27E 08 3.98E 07 6.78E 06 0.00E-01 2.21E 07 0.00E-01 1.04E 10 J31 143 L,4 E 05 4.388 04 7.23E 03 0.00E-01 2.37E 04 0.00E-01 1.57E 08 PR 144 5.44E-26 1.68E-26 2.74E-27 0.00E-01 8.90E-27 0.00E-01 3.62E-23 ND 147 7.24E 04 5.86E 04 4.54E 03 0.00E-01 3.22E 04 0.00E-01 9.29E 07 W 187 6.47E 04 3.83E 04 1.72E 04 0.00E-01 _ 0.00E-01 0.00E-01 5.38E 07 NP 239 2.56E 03 1.84E 02 1.29E 02 0.00E-01 5.31E 02 0.00E-01 1.36E 07 O
^~*"
O
TRER A.5-16 GUf1D PIANE PNUMAY F/CIOR M MRD4/YR PIR UCI/Str (RI FACIOR). 11- 3 0.00E 00 Y-91M 1.00E 05 CS-134 6.86E 09 C-14 0.00E 00 Y-91 1.07E 07 CS-136 1.49E 08 NA-24 1.19E 07 Y-92 1.80E 05 CS-137 1.03E 10 P-32 0.00E 00 Y-93 1.85E 05 CS-138 3.59E 05 CR-51 4.66E 06 ZR-95 2.45E 08 Im-139 1.06E 05 MN-54 1.39E 09 ZR-97 2.96E 06 Im-140 2.05E 07
% 56 9.03E 05 Nn-95 1.37E 08 W 141 4.18E 04 FE-55 0.00E 00 MD-99 3.99E 06 1m-142 4.49E 04 FE-59 2473E 08 D 99M 1.84E 05 1A-140 1.92E 07 D 101 2.04E 04 Co-58 3.79E 08 RU-103 1.00E 08 IA-142 7.37E 05 00-60 2.15E 10 RU-105 6.36E 05 CE-141 1.37E 07 NI-63 0.00E 00 RU-106 4.21E 08 CE-143 2.31E 06 NI-65 '3.02E 05 G 110M 3.44E 09 CE-144 6.96E 07 CU-64 6.07E 05 TE-125M 1.55E 06 PR-143 0.00E 00 ZN-65 7.46E 08 TE-127M 9.17E 04 PR-144 1.83E 03 ZN-69 0.00E 00 TE-127 2.98E 03 ND-147 8.46E 06 DR-83 4.87E 03 TE-129M 1.98E 07 W-187 2.36E 06 BR-84 2.03E 05 TE-129 2.62E 04 NP-239 1.71E 06 h 85 0.00E 00 TE-131M 8.038 06 O & 86 RB-88 8.99E 06 3.31E 04 TE-131 TE-132 2.92E 04 4.23E 06 W 89 1.21E 05 I-130 5.51E 06 SR-89 2.16E 04 I-131 1.720 07 SR-90 0.00E 00 1-132 1.25E 06 SR-91 2.14E 06 I-133 2.45E 06 SR-92 7.77E 05 I-134 4.47E 05 Y-90 4.49E 03 I-135 2.53E 06 A-86 O
L
i TNVJi A.5-17 GRASS -MILK PATIMAY F/CIOR PRD4/YR PER LCI/SEC ADULT l
!ACLIDE 11CtJE LIVER T IODY 'I1!YROID KIDNEY LUTC GI-ILI H 3 0.002-01 1.56E 03 1.56E 03 1.56E 03 1.56E 03 1.56E 03 1.56E 03 C 14 2.63E 08 5.27E 07 5.27E 07 5.27E 07 5.27E 07 5.27E 07 5.27E 07 NA 24 2.93E 05 2.93E 05 2.93E 05 2.93E 05 2.93E 05 2.93E 05 2.93E 05 P 32 2.05E 10 1.27E 09 7.93E 08 0.00E-01 0.00E-01 0.00E-01 2.31E 09 ,
CR 51 0.00E-01 0.00E-01 3.43E 03 2.05E 03 7.55E 02 4.55E 03 8.62E 05 FN 54 0.00E 1.01E 06 1.93E 05 0.00E-01 3.00E 05 0.00E-01 3.09E 06 MN 56 0.00E-01 4.99E-04 8.85E-05 0.00E-01 6.34E-04 0.00E-01 1.ME-02 . FE 55 3.26E 05 2.25E 05 5.26E 04 0.00E-01 0.00E-01 1.26E 05 1.29E 05 FE 59 3.8EE 05 9.07E 05 3.48E 05 _ Q.00E-01 0.00E-01 2.54E 05. 3.02E 06 00 58 0.00E-01 5.66E 05 1.27E 06 0.00E-01 0.00E-01 0.00E-01 1.15E 07 CO 60 0.00E-01 1.97E 06 4.34E 06 0.00E-01 0.00E-01 0.00E-01 3.70E 07 NI 63 8.07E 08 5.65E 07 2.71E 07 0.00E-01 0.00E-01 0.00E-01 1.17E 07 NI 65 5.56E-02 7.22E-03 3.30E-03 0.00E-01 0.00E-01 0.00E-01 1.83E-01 CU 64 0.00E-01 2.66E 03 1.25E 03 0.00E-01 6.70E 03 0.00E-01 2.27E 05 ZN 65 1.65E 08 5.24E 08 2.37E 08 0.00E-01 3.50E 08 0.00E-01 3.30E 08 ZN 69 6.27E-13 1.20E-12 8.34E-14 0.00E-01 7.79E-13 0.00E-01 1.80E-13 at 83 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 IVt 84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 31 85 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RD 86 0.00E-01 3.11E 08 1.45E 08 0.00E-01 0.00E-01 0.00E-01 6.14E 07 RB 88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB 89 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E 01 0.'00E-01 SR 89 3.05E 09 0.00E-01 8.75E 07 0.00E-01 0.00E-01 0.00E-01 4.o9E 08 SR 90 9,83E 10 0.00E-01 2.41E 10 0.00E-01 0.00E-01 0.00E-01 2.84E 09 SR 91 6.02E 04 0.00E-01 2.43E 03 0.00E-01 0.00E-01 0.0rE-01 2.87E 05 SR 92 1.03E 00 0.00E-01 4.45E-02 0.00E-01 0.00E-01 0.00E-01' 2.04E 01 Y 90 8.49E 00 0.00E-01 2.28E-01 0.00E-01 0.00E-01 0.00E-01 9.00E 04 Y 91f4 7;24E-21 0.00E-01 2.80E-22 0.00E-01 0.00E-01 0.00E-01 2.13E-20 i Y 91 1.03E.03- 0.00E-01 2.76E 01 0.00E-01 0.00E-01 0.00E-01 5.67E 05 Y 92 6.71E-06 0.00E-01 1.96E-07 0.00u-01 0.00E-01 0.00E-01 1.18E-01 A-87 l l L .- - - ;. -.
gu 2g 0 h w:;' TAlur. A.5-17 (Ont.'d) GRASSpT-MIIJ; PRI1MAY F/CIUt M MRIF/YR PER LCI/SDC ADULT MICLIDE IONE LIVER T KOY '11IYROID ElDWY IUtG G1-1LI Y 93 2.80E-02 0.00E-01 7.73E-04 0.00E-01 0.00E-01 0.00E-01 0.87E 02 ZR 95 1.13E 02 3.63E 01 2.46E 01 0.00E-01 5.70E 01 0.00E-01 1.15E 05 ZR 97 5.20E-02 1.05E-02 4.80E-03 0.00E-01 1.58E-02 0.00E-01 - 3.25E 03 NB 95 9.91E 03 S.51E 03 2.96E 03 0.00E-01 5.45E 03 0.00E-01 3.35E 07 FD 99 0.00E-01 2.97E 06 5.65E 05 0.00E-01 6.73E 06 0.00E-01 6.89E 06
'IC 99M J.99E-01 1.13E 00 1.44E 01 0.00E-01 1.71E 01 5.53E-01 6.67E ()2 - 'IC 101 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RU 103 1.22E 02 0.00E-01 5.26E 01 0.00E-01 4.66E 02 0.00E-01 1.43E 04 HU 105 1,03E-04 0.00E-01 4.07E-05 0.00E-01 1,33E-03 0.00E-01 6.30E-02 RU 106 2.45E 03 0.00E-01 3.10E 02 0.00E-01 4.73E 03 0.00E-01 1.58E 05 7G 110M 6.99E 06 6.46E 06 3.84E 06 0.00E-01 1.27E 07 0.00E-01 2.64E 09 TE 125M 1.95E 06 7.08E 05 2.62E 05 5.88E 05 7.95E 06 0.00E-01 7.81E 06 TE 127M 5.49E 06 1.96E 06 6.70E 05 1.40E 06 2.23E 07 0.00E-01 1.84E 07 TE 127 7.84E 01 2.82E 01 1.70E 01 5.81E 01 3.19E 02 0.00E-01 6.19E 03 3'E 129M 7.22E 06 2.69E 06 1.14E 06 2.48E 06 3.02E 07 0.00E-01 3.64E 07 7E 129 3.41E-11 1.28E-11 8.31E-12 2.62E-11 1.43E-10 0.00E-01 2.57E-11 TE 13)M 4.33E 04 2.12E 04 1.77E 04 3.36E 04 2.15E 05 0.00E-01 2.10E 06 TE 131 4.40E-34 1.04E-34 1.39E-34 __3 62E-34 1.93E-33 0,00E-01 6.23E-35 'IE 132 2.88E 05 1.86E 05 1.75E 05 2.06E 05 1.80E 06 0.00E-01 8.82E 06 -
1 130 5.04E 05 1.49E 06 5.87E 05 1.26E 08 2.32E 06 0.00E-01 1.28E 06 - I 131 3.55E 08 5.08E 08 2.91E 08 1.67E 11 8.71E 08 0,00E-01 1.34E 0Q I 132 1.98E-01 5.29E-01 1.85E-01 1.85E 01 8.43E-01 0.00E-01 9.94E-02 I 133 4.65E 06 8.00E 06 2.46E 06 1.19E 09 1.41E 07 0.00E-01 7.26E 06 I 134 2.44E-12 6.63E-12 2.37E-12 1.15E-10 1.05E-11 0.00E-01 5.78E-15 I 135 1.54E 04 4.04E 04 1.49E 04 2.66E 06 6.46E 04 0.00E-01 4.56E 04 CS 134 1.70E 10 4.04E 10 3.30E 10 0.00E-01 1.31E 10 4.34E G2 7.06E 08 [3 136 7.83E 08 3.09E 09 2.23E_09 0.00E-01 1.72E 09 2.36E 08 3.51E 08 CS 137 2.21E 10 3.03E 10 1.98E 10 0.00E-01 1.03E 10 3.42E 09 5.86E 08 CS 138 2.75E-23 5.43E-23 2.69E-23 0.00E-01 3.99E-23 3.94E-24 2.32E-28 BA 139 5.48E-09 3.90E-12 1.60E-10 0.00E-01 3.65E-12 2.21E-1? 9.71E-09 A-88 O
- _ . _ _ _ _ . _ . - _ - - - _ . _ _ . _ _ _ _ .__m. - _ . . _ _ _ . _ . _ _ . _ _ _ . , . _ . - ._.m._.__
TAluz A.5-17 (Ctut'd) MILK PAllMAY F/CIOR GRASSY M MREP JYR PTR UCI/SDC ADULT , l
!U.*LIDE IGE LIVIE TIYVY 'IRYROID KICUPY IARU GI-ILI BA 140 3.23E 06 4.05E 03 2.11E 05 0.00E-01 1.38E 03 2.32E 03 6.64E 06 BA 141 0.00E-01 0 00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 PA 142 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 IA 140 5.43E-01 2.73E-01 7.23E-02 0.00E-01 0.00E-01 0.00E-01 2.01E 04 IA 142 1.13E-12 5.12E-13 1.28E-13 0.00E-01 0.00E-01 0.00E-01 3.74E-09 l
,CE 141 5.81E 02 3.93E 02 4.46E 01 0.00E-01 1.83B 02 0.00E-01 1.50E 06 j
-CE 143 4.99E 00 3.69E 03 4.08E-01 0.00E-01 1.62c 00 0.00E-01 1.38E 05 CE 144 4.292 04 1.79E 04 2.30E 03 0.00E-01 1.06E 04 0.00E-01 1.45E 07 '
J'E 143 1.90E 01 7.60E 00 9.39E-01 0.00E-01 4.39E 00 0.00E-01 8.30E 04 PR 144 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ND 147 1.14E 01 1.31E 01 7.85E-01 0.00E-01 7.67E 00 0.00E-01 6.30E 04 _W 187 7.87E 02 6.58E 02 2.30E 02 0.00E-01 0.00E-01 0.00E-01 2.16E 05 NP 239 4.41E-01 4.33E-02 2.39E-02 0.00E-01 1.35E-01 0.00E-01 8.89E 03 O A-89
TNUJ A.5-18 MILK PN111NAY FICIM GRASSY M MRI2 4/YR PIR UCI/SIE TT121 FRCidDE IONE I.IVER T DODY '111YROID KIrtfEY 1,Um GI-ILI 11 3 0.00E-01 2.03E 03 2.03E 03 2.03E 03 2.03E 03 2.03E 03 2.03E 03 C 14 4.86E 08 9.72E 07 9.72E 07 9.72E 07 9.72E 07 9.72E 07 9.72E 07 NA 24 5.11E 05 5.11E 05 5.11E 05 5.11E 05 5.11E 05 5.11E 05 5.11E 05 P 32 3.78E 10 2.34E 09 1.47E 09 0.00E-01 0.00E-01 0.00E-01 3.18E 09 CR 51 0.00E-01 0.00E-01 5.99E 03 3.33E 03 1.31E 03 8.55E 03 1.01E 06 MN 54 0.00E-01 1.68E 00 3.34C 05 0.00E-01 5.02E 05 0.00E-01 3.45E 06 - PJJ 56 0.00E-01 8.85E-04 1.57E-04 0.00E-01 1.12E-03 0.00E-01 5.82E-02 FE 55 5.79E 05 4.10E 05 9.57E 04 0.00E-01 0.00E-01 2.60E 05 1.78E 05 FE 59 6.74E 05 1.57E 06 6.07E 05 0.00_E-01 0.00E-01 4.96E 05 3.72E 06 00 58 0.00E-01 9.52E 05 2.19E 06 0.00E-01 0.00E-01 0.00E-01 1.31E 07 00 60 0.00E-01 3.34E 06 7.52E 06 0.00E-01 0.00E-01 0.00E-01 4.35E 07 NI 63 1.42E 09 1.00C 08 4.81E 07 0.00E-01 0.00E-01 0.00E-01 1.59E 07 NI 65 1.02E-01 1.30E-02 5.92E-03 0.00E-01 0.00E-01 0.00E-01 7.05E-01 CU 64 0.00E-01 4.74E 03 2.23E 03 0.00E-01 1.20E 04 0.00E-01 3.67E 05 ZN 65 2.531 08 8.78E 08 4.09E 08 0.00E-01 5.62E 08 0.00E-01 3.72E 08 ZN 69 1.15E-12 2.20E-12 1.54E-13 0.00E-01 1.44E-12 0.00E-01 4.05E-12 BR 83 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 85 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB 86 0.00E-01 5.67E 08 2.67E 08 0.00E-01 0.00E-01 0.00E-01 8.40E 07 BB 88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB 89 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 SR 89 5.62E 09 0.00E-01 1.61E 08 0.00E-01 0.00E-01 0.00E-01 6.69E 08 SR 90 1.39E 11 0.00E-01 3.43E 10 0,00E-01 0.00E-01 0.00E-01 3.90E 09 SR 91 1.11E 05 0.00E-01 4.40E 03 0.00E-01 0.00E-01 0.00E-01 5.02E 05 SR 92 1.88E 00 0.00E-01 8.02E-02 0.00E-01 0.00E-01 0.00E-01 4.80E 01 Y 90 1.56E 01 0.00E-01 4.20E-01 0.00E-01 0.00E-01 0.00E-01 1.29E 05 Y 91M 1.33E-20 0.00E-01 5.07E-22 0.00E-01 0.00E-01 0.00E-01 6.26E-19 Y 91 1.90E 03 0.00E-01 5.08E 01 0.00E-01 0.00E-01 0.00E-01 7.77E 05 Y 92 1.24E-05 0.00E-01 3.59E-07 0.00E-01 0.00E-01 0.00E-01 3.40E-01 A-90 0
l l TAlHE A.5-18 (Omt 'd) CRASSfAT-MIIX PNI1!NAY FACIU1 M MRIM/YR PER (CI/SDC TEEN IM't,TDE TO7E I.IVER T 110DY 'lilYROID KIDNEY IAftG GI-IL1 Y 93 5.16E-02 0.00E-01 1.41E-03 0.00E-01 0.00E-01 0.00E-01 1.58E 03 ZR 95 1.98E 02 6.25E 01 4.30E 01 0.00E-01 9.18E 01 0.00E-01 1.44E 05
,ZR 97 9.478-02 1.87E-02 8.63E-03 0.00E-01 2.84E-02 0.00E-01 5.07E 03 10 95 1.69E 04 9.37E 03 5.16E 03 0. 00E -01 9.09E 03 0.00E-01 4.01E 07 MD 99 0.00E-01 5.37E 06 1.02E 06 0.00E-01 1.23E 07 0.00E-01 9.61E 06
'IC 99M 6.92E-01 1.93E 00 2.50E 01 0.00E-01 2.88E 01 1.07E 00 1.27E 0_3 7C 101 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RU 103 2.17E 02 0.00E-01 9.28E 01 0.00E-01 7.66E 02 0.00E-01 1.81E 04 RU 105 1.88E-04 0.00E-01 7.30E-05 0.00E-01 2.37E-03 0.00E-01 1.52E-01 RU 106 4.50E 03 0.00E-01 5.67E 02 0.00E-01 8.68E 03 0.00E-01 2.16E 05 AG 110M 1.16E 07 1.09E 07 6.65E 06 0.00E-01 2.08E 07 0.00E-01 3.07E 09
'IE 125M 3.60E 06 1.30E 06 4.82E 05 1.01E 06 0.00E-01 0.00E-01 1,06E 07 TE 127M 1.01E 07 3.59E 06 1.20E 06 2.41E 06 4.10E 07 0.00E-01 2.52E 07 TE 127 1.45E 02 5.15E 01 3.13E 01 1.00E 02 5.89E 02 0.00E-01 1.12E 04 TE 129M 1.32E 07 4.90E 06 2.09E 06 4.26E 06 5.53E 07 0.00E-01 4.96E 07 TE 129 6.28E-11 2.34E-11 1.53E-11 4.48E-11 2.63E-10 0.00E-01 3.43E-10 TE 131M 7.89E 04 3.78E 04 3.16E 04 5.69E 04 3.94E 05 0.00E-01 3.04E 06 TE 131 0,04E-34 3.31E-34 2.51E-34 6.19E-34 3.51E-33 0.00E-01 6.60E-35 it 132 5.15E 05 3.26E 05 3.07E 05 3.44E 05 3.13E 06 0.00E-01 1.03E 07 I 130 8.87E 05 2.57E 06 1.02E 06 2.09E 08 3.95E 06 0.00E-01 1.97E 06 -
1 131 6.45E 09 9u03E 08 4.85E 08 2.63E 11 1.55E 09 0.00E-01 1.79E 08 I 132 3.51E-01 9.18E-01 3.29E-01 3.09E 01 1.45- 00 0.00E-01 4.00E-01 1 133 8.49E 06 1.44E 07 4.39E 06 2.01E 09 2.52E 07 0.00E-01 1.09E 07 i 134 4.34E-12 1.15E-11 4.13E-12 IJ2E-10 1.81E-11 0.00E-01 1.51E-13 I 135 2.74E 04 7.05E 04 2.61E 04 4.54E 06- 1.11E 05 0.00E-01 7.82E 04 CS 134 2.94E 10 6.93E 10 3.22E 10 0.00E-01 2.20E 10 0.41E 09 8.62E 08 CS 136 1.33E 09 5.25E 09 3.32E 09 0.00E-01 2.86E 09 4.50S 08 4.22E 08 CS 137 4.02E 10 5.34E 10 1.86E 10 0.00E-01 1.82E 10 7.06E 09 7.60E 08 CS .138 4.99E-23 9.58E-23 4.79E-23 0.00E-01 7.07E-23 8.23E-24 4.34E-26 _TW 139 1.01E-08 7.13E-12 2.95E-10 0.00E-01 6.72E-12 4.91E-12 9.04E-08 A-91 0
_ . , _ _ _ _ _ _ _ . _ . _ . . _ _ _ _ _ _ . _ _ _ _ _ _ ~ _ _ _ . _ _ . _ _ . _ _ _ . _ _ _ _ . _ _ _ _ _ _ TMME A.5-18 (Ctnt'd) G MSS T-MILK PA'IlMAY FICKR
. MREM /YR PER LCI/SDC TEEN L(T'LTDE TGE LIVER T FY)DY 'I1NROID KIENEY Ill!G GI-Ill 1% 140 5.82E 06 7.14E 03 3.75E 05 0.00E-01 2.42E 03 4.08E 03 8.98E 06 BA 141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 C.00E-01 In 142 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 LA 140 9.75E-01 4.79E-01 1.27E-01 0.00E-01 0.00E-01 0.00E-01 2.75E 04 IA 142 2.03E-12 9.03E 13 2.25E-13 0.00E-01 0.00E-01 0.00E-01 2.75E-08 fE 141 1.07E 03 7.12E 02 8.18E 01 0.00E-01 3.35E 02 0.00E-01 2.04E 06 CE 143 9.17E 00 6.67E 03 7.45E-01 0.00E-01 2.99E 00 0.00E 2.01E 05 CE 144 7.90E 04 3.27E 04 4.24E 03 0.00E-01 1.95E 04 0.00E-01 1.99E 07 PR 143 3.48E 01 1.39E 00 1.73E 00 0.00E-01 8.08E 00 0.00E-01 1.15E 05 PR 144 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E ND 147 2.19E 01 2.38E 01 1.42E 00 0.00E-01 1.40E 01 0.00E-01 8.57E 04 W 187 1.44E 03 1.17E 03 4.11E 0? 0.00E-01 0.00E-01 0.00E-01 3.18E 05- i NP 239 8.41E-01 7.93E-02 4.41E-02 0.00E-01 2.49E-01 0.00E-01 1.28E 04 O
A-92 O l l 1 I I l
_._ - - .-.~ .. . . _ . - - . . _ _ _ _ - - - . . - . l TAlfP. A.5-19 GRASSpT-MILK PM1!WAY F/C1m ! M~ MREN/YR PER UCI/SEC CHIID 1RCLIDE IGE LIVER T IrffY 'li!YROID KIDtTEY TAl!G GI-ILI 11 3 0.00E-01 3.20E 03 3.20E 03 3.20E 03 3.20E 03 3.20E 03 3.20E 03 C 14 1.19E 09 2.39E 08 2.39E 08 2.39E 08 2.39E 08 2.39E 08 2.39E 08 NA. 24 1.06E 06 1.06E 06 1.06E 06 1.06E 06 1.06E 06 1.06E 06 1.06E OC
? 32 9.33E 10 4.37E 09 3.60E 09 0.00E-01 0.00E-01 0.00E-01 2.58E 09 CR 51 0.00E-01 0.00E-01 1.22E 04 6.78E 03 1.85E 03 1.24E 04 6.488 05 '
W 54 0.00E-01 2.52E 06 6.70E 05 0.00E-01 7.06E 05 0.00E-01 2.11E 06 MN 56 0.00E-01 1.54E-03 3.40E-04 0.00E-01 1.87E-03 0.00E-01 2.24E-01 FE 55 1.45E 06 7.70E 05 2.39E 05 0.00E-01 0.00E-01 4.36E 05 1.43E 05 FE 59- 1.56E 06 2.53E 06 1.26E 06 0.00E-01 0.00E-01 7.33E 05 2.63E 06 00 58 0.00E-01 1.46E 06 4.45E 06 0.00E-01 0.00E-01 0.00E-01 8.49E 06 00 60 0.00E-01 5.18E 06 1.53E 07 0.00E-01 0.00E-01 0.00E-01 2.87E 07 JiT 63 3.56E 09 1.90E 08 1.21E 08 0.00E-01 0.00E-01 0.001-01 1.28E 07 NI 65 2.49E-01 2.34E-02 1.37E-02 0.00E-01 0.00E-01 0.00E-01 2.87E 00 CU 64 0.00E-01 8.23E 03 -5.03E 03 0.00E-01 2.01E 04 0.00E-01 3.91E 05 ZN 65 4.96E 08 1.32E 09- 8.22E 08 0.00E-01 0.33E 08 0.00E-01 2 J2E OD-ZN 69 2.84E-12 4.10E-12 3.79E-13 0.00E-01 2.49E-12 0.00E-01 2.58E-10
- BR 83' O.00E-01 0.00E-01 0.00E-01 -0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 DR 85 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB 86 0.00E-01 1.05E 09 6.47E 08 0.00E-01 0.00E-01 0.00E-01 6.77E 07
- RH 88 ode-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB 89 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 SR- 89 1.39E 10 0.00E 3.97E 08 0.00E-01 0.00E-01 0.00E-01 5.38E 08 +
SR 90 2.35E 11 0.00E-01 5.95E 10 0.00E-01 0.00E-01 0.00E-01 3.16E 09 SR 91 2.71E 05 0.00E-01 1.02E 04 0.00E-01 0.00E-01 0.00E-01 5.99E 05 SR 4.60E 00 0.00E-01 1.84E-01 0.00E-01 0.00E-01 0.00E-01 8.71E 01 Y 90 3.86E 01 0.00E-01 J.03E-00 0.00E-01 0.00E-01 0.00E-01 1.10E 05
--Y 9LM 3.24E-20 0.0CE-01 1.18E-21 0.00E-01 0.00E-01 0.00E-01 6.34E-17 Y 91 4.68E 03 0.00E-01 1.25E 00 0.00E-01 0.00E-01 0.00E-01 6.24E 05 Y- 92- 3.04E-05 0.00E-01 8.71E-07 0.00E-01 0.00E-01 0.00E-01 8.79E-01 A-93
. Im. . . . _ . _ , . , . - . _ . . - _ . - , , , , . . . , , , . . _ - , _ , _ . _ . , , _ . . , . . , - - . _ . . . _ . , _ . , , _ , . , - . . , - . - . . . . -
, . . _ _ _ __m._ ___ _ . _ _. _ _ _ . . . . _ _ _ _ _ _.- _ _ _ ___ TMVR A.5-19 (Cbut'd) G1 ASS p -MILK Pldilh%Y F/CIOR M MREM /YR PER UCI/SBC OIIID NUCLTDE DCUE LIVIR T DODY 'linTOID KIDNirl LlRG GI-LLl Y 93 1.27E-01 0.00E-01 3.48E-03 0.00E-01 0.00E-01 0.00E-01 1.89E 03 ZR 95 4.60E 02 1.01E 02 9.00E 01 0.00E-01 1.45E 02 0.00E-01 1.05E 05 ZR 97 2.30E-01 3.33E-02 1.96E-02 0.00E-01 4.7BE-02 OdQR-01 5.04E 03 NB 95 3.82E 04 1.49E 04 1.06E 04 0.00E-01 1.40E 04 0.00E-01 2.75E 07 MD 99. 0.00E-01 9.76E 06 2.42E 06 0.00E-01 2.08E 07 0.00E-01 8.07E 06
'IC 99M 1.59E 00 3.11E 00 5.16B 01 0.00E-01 4.52E 01 1 58E 00 1.77E 03
'It 101 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RU 103 5.14E 02 0.00E-01 1.97B 02 0.00E-01 1.29E 03 0.00E-01 1.33E 04 E11 105 4.59E-04 0.00E-01 1.67E-04 0.00E-01 4.04E-03 0.00E-01 3.00E-01 RU 106 1.11E 04 0.00E-01 1.30E 03 0.00E-01 1.50E 04 0.00E-01 1.72E 05 NJ 110M 2.51E 07 1.69E 07 1.35E 07 0.00E-01 3.15E 07 0.00E-01 2.01E 09 TE 125M 8.85E 06 - 2.40E 06 1.18F 06 2.48E 06 0.00E-01 0.00E-01 8.54E 06 TE 127M 2.50E 07 6.72E 06 2.96E 06 5.97E 06 7.12E 07 0.00E-01 2.02E 07 TE 127 3.57E 02 9.64E 01 7.67E 01 2.47E 02 1.02E 03 0.00E-01 1.40E 04 TE 129M 3.26E 07 9.096.06 3.05E 06 1.05E 07 9.56E 07 0.00E-01 3.97E 07 TE 129 55E 4.32E-11 3.68E-11 1.11E-10 4.53E-10 0.00E-01 9.64E-09 TE 131M *..92E 05 6.64E 04 7.07E 04 1.37E 05 6.43E 05 0.00E-01 2.69E 06 TB 131 1.97E-33 6.01E-34 5.87E-34_. 1.51E-33 5.97E-33 0.00E-01 1.04E-32 TE 132 1.23E 06. 5.44E 05 6.58E 05 7.93E 05 5.05E 06 0.00E-01 5.48E 06 I 130 2.07E 06 4.19E 06 2.16E 06 4.52E 08 6.27E 06 0.00E-01 1.96E 06-1 131 1.56E 09 1.57E 09 8.94E 09 5.20E 11 2.58E 09 0.00E-01 1.40E 08 I- _132 8.30E-01' 1.52E 00 7.01E-01 7.07E 01 2.33E 00 0.00E-01 1.79E 00 I 133 2.06E 07 2.55E 07 9.65E 06 4.74E 09 4.25E 07 0.00E-01 1.03E 07 I 134 1.03E-11 1.91E-11 8.77E-12 4.39E-10 2.92E-11 0.00E-01 1.26E-11 I 135 6.49E 04 1.17E 05 5.52E 04 1.03E 07 1.79E 05 0.01E-01 8.90E 04 CS 134 6.79E 10 1.11E 11 2.35E 10 0.00E-01 3.45E 10 1.24E 10 6.01E 08 CS 136 3.01E 09 8.27E 09 5.35E 09 0,00E-01 4.40E 09 6.57E 08 2._91E 08 CS 137 9.67E 10 9.26E 10 1.37E 10 0.00E-01 3.02E 10 1.09E 10 3.80E 08 '
CS 138 1.21E-22 1.68E-22 1.07E-22 0.00E-01 1.18E-22 1.27E-23 7.74E-23 PA 139 2.49E-08 1.33E-11 7.21E-10 0.00E-01 1_.J 6E-11 7.82E-12 1'.44E-06 A-94 O
TABLE A.5-19 (Ccot'd) GRASSp%T-MILK PNnMAY FICIOR M MREM /YR PER UCI/SDC OII1D tRICLIDE FO4E LIVER T IY3DY 'IHYROID KIDNEY IUto GI-ILI BA 140 1.41E 07 1.23E 04 8.21E 05 0.00E-01 4.01E 03 7.34E 03 7.12E 06 BA 141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 J}A 142 0.00E-01 0.00P- \___.0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 1A 140 2.33E 00 8.16E , 2.75E-01 0.00E-01 0.00E-01 0.00F-01 2.27E 04 LA 142 4.91E-12 1.56E-12 4.90E-13 0.00E-01 0.00E-01 0.00E-01 3.10E-07 CE 141 2.63R 03 1.31E 03 1.94E 02 0.00E-01 5.74E 02 0.00E-01 1.63E 06 v CE 143 2.25E 01 1.22E 04 1.77E 00 0.00E-01 5.12E 00 0.00E-01 1.79E 05 CE 144 1.95E 05 6.11E 04 1.04E 04 0.00E-01 3.38E 04 0.00E-01 1.59E 07 PR 143 8.62E 01 2.59E 01 4.28E 00 0.00E-01 1.40E 01 0.00E-01 9.30E 04 PR 144 0.00E-01 0 90E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ND 147 5.36E 01 4.34E 01 3.36E 00 0.00E-01 2.38E 01 0.00E-01 6.8EL 94 W 187 3.49E 03 2.07E 03 9.28E 02 0.00E-01 0.00E-01 0.00E-01 2.19e 05 NP 239 2.07E 00 1.49E-01 1.04E-01 0.00E-01 4.30E-01 0.00E-01 1.10E 04 0 m A-95
, -. - . - - . - - . - - . -- - ~ - _ _ _ _ - . - . - _ - . .
I p TNVE A.5-20 GRASSp-MILK PA'IEAY EAC'IOR M MREM /YR PER LCI/SEC INFNH'
'NUCLIDE BONE LIVER T BODY THYROID KIDNEY IUTC GT-ILT 11 3 0.00E-01 4.86E 03 4.86E 03 4.86E 03 4.86E 03 4.86E 03 4.86E 03 C- 14 2.34E 09 5.00E 08 5.00E 08 5.00E 08 5.00E 08 5.00E 08 5.00E 08 NA 24 1.85E 06 1.85E 06 1.85E 06 1.85E 06 1.85E 06 1.85E 06 1.85E Og P 32 1.92E 11 1.13E 10 7.45E 09 0.00E-01 0.00E-01 0.00E-01 2.60E 09 CR 51 0.00E-01 0.00E-01 1.94E 04 1.26E 04 2.76E 03 2.46E 04 5.64E 05
. MN 54 0.00E-01 4,68E 06 1.06E 06 0.00E-01 1.04E 06 0.00E-01 1.72E 06 MN 56 0.00E-01 3.78E-03 6.51E-04 0.00E-01 3.25E-03 0.00E-01 3.43E-01 FE 55 1.76E 06 1.13E 06 3.03E 06 0.00E-01 0.00E-01 5.54E 05 1.44E 05
' FE 59 2.92E 06 5.09E 06 2.01E 06 0.00E-01 0.00E-01 1.51E 06 2.43E 06 00 58 0.00E-01 .2.91E 06 7.26E 06 0.00E-01 0.00E-01 0.00E-01 7.2SE 06 00 60 0.00E-01 1.06E 07 2.50E 07 0.00E-01 0.00E-01 0.00E-01 2.52E 07 NT 63 4.19E 09 2.59E 08 1.45E 08 0.00E-01 0.00E-01 0,00E-01 1.29E 07
- NI 65 5.27E-01 5.96E-02 2.71E-02 0.00E-01 0.00E-01 0.00E-01 4.54E 00
- CU 64 0.00E-01 2.07E 04 9.58E 03 0.00E-01 3.50E 04 0.00E-01 4.2SE 05 ZN 65 6.66E 08 2.28E 09 1.05E 09 0.00E-01 1.11E 09 0.00E-01 1.93E 09
.ZN 69 6.04E-12 1.09E-11 8.10E-13 0.00F 01 4.52E-12 0.00E-01 8.87E-10 INF 83 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01
- BR 84 0.00E-01 0.00E-01 -0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 85 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB 86 0.00E-01 2.67E 09 1.32E 09 0.00E-01 0.00E-01 0.00E-01 6.83E 07 RB 88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB 89 0.00E-01 0.00E-01 0.0C -01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 SR 89 2.64E 10 0.00E-01 7.58E 08 0.0F -01 0.00E-01 0.00E-01 5.43E 08 SR -90 2.55E 11 0.00E-01 6.50E 10 0.00E-01 0.00E-01 0.00E-01 3.19E 09 SR- 91- 5.65E 05 -0.00E-01 2.05E 03 0.00E-01 0.00E-01 0.00E-01 6.69E 05 SR 92 9.78E 00 0.00E-01 3.63E-01 0.00E-01 0.00E-01 0.00E-01 1.05E 02 Y -90 8.'16E Ol' O.00E-01 2.19E 00 0.00E-01 0.00E-01 0.00E-01 1.13E 05 Y- 91M 6.87E-20 0.00E-01 2.34E-21 0.00E-01 0.00E-01 0.00E-01 =2.29E-16 Y. 91 8.79E 03 0.00E-01 2.34E 02 0.00E-01 0.00E-01 0.00E-01 6.30E 05 Y 92- 6.47E 05 0.00E-01 1.82E-06 0.00E-01 0.00E-01 0.00E-01 1.23E 00 1
L A-96 () l
- -. . . . = . - - . . . _ - . . . -
TRRR A.5-20 (Lint'd) MILK PA11MAY FACTOR GRASS M hRE y M/YR PER IEI SEC INFANT NUCLIDE BONR LIVER T BODY SEYROID KIDNEY IUtG GI-U21 - Y 93 2.70E-01 0.00E-01 7.36E-03 0.00E-01 0.00E-01 0.00E 2.13E 03 ZR 95 8.17E 02 1.99E 02 1.41E 02 0.00E-01 2.14E 02 0.00E-01 9.91E 04 ZR 97 4.88E-01 8.37E-02 3.82E-02 0.00E-01 8.44E-02 0.00E-01 5.34E 03 1E3 95 7.12E 34 2.93E 04 1.70E 04 0.00E-01 2.10E 04 0.00E-01 2.48E 07 ND- 9'. 01 2.50E 07 4.87E 06 0.00E-01 3.73E 07 0.00E-01 8.22E 06 TC t32._ . 4 6.81E 00 8.77E 01 0.00E-01 7.33E 01 3.56E 00 1.98E 03 TC 11 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RU > 0.00E-01 3.48E 02 0.00E-01 2.16E 03 0.00E-01 1.26E 04 RU . 0.00E-01 3.26E-04 0.00E-01 7.12E-03 0.00E-01 3.85E-01 RU L- >i 0.00E-01 2.85E 03 0.00E-01 2.70E 04 0.00E-01 1.73E 05 AG -11c; az 07 3.38E 07 2.24E 07 0.00E-01 4.83E 07 0.00E-01 1.75E 09 UT 125M 1.81E 07 6.05E 06 2.45E 06 6.09E 06 0.00E-01 0.00E-01 8.62E 06 TE 127M 5.05E 07 1.68E 07 6.12E 06 1.46E 07 1.24E 08 0.00E-01 2.04E 07 103 127 7.59E 02 2.54E 02 1.63E 02 6.18E 02 1.85E 03 0.00E-01 1.59E 04 129M 6.69E 07 2.29E 07 1.03E 07 2.57E 07 1.67E 08 0.00E-01 3.99E 07 ( } TE TE -129 3.28E-10 1.13E-10 7.66E-11 2.75E-10 8.17E-10 0.00E-01 2.62E-08 TE 131M 4.05E 05 1.63E 05 1.35E 05 3.31E 05 1.12E 06 0.00E-01 2.75E 06
-TE- 131 4.18E-33 1.54E-33 1.17E33 3.73E-33 1.07E-32 0.00E-01 1.69E-31 TE 132 2.53E 06 1.25E 06 1.17E 06 1.85E 06 7.84E 06 0.00E-01 4.64E 06 I 130 4.26E 06 9.38E 06 3.76E 06 1.05E 09 1.03E 07 0.00E-01 2.01E 06 I- 131 3.26E 09 3.85E 09 1.69E 09 1.26E 12 4.49E 09 0.00E-01 1.37E 08 I- 132 1.72E 00 3.49E 00 1.24E 00 1.64E 02 3.90E 00 0.00E-01 2.83E 00 I 133 4.35E 07 6.34E 07 1.86E 07 1.15E 10 7.45E 07 0.00E-01 1.07E 07 I 134 2.13E-11' 4,36E-11 1.55E-11 1.02E-09 4.80E-11 0.00E-01 4.51E-11 I 135 1.35E 05 2.68E 05 9.79E 04 2.41E 07 2.99E 05 0.00E-01 9.71E 04 CS 134 1.09E 11 2.04E 11 2.06E 10 0.00E-01 5.25E 10 1.86E 10 5.54E 08 CS 136 5.88E-09 1.73E 10 6.45E 09 0.00E-01 6.89E 09 1.41E 09 2.63E 08 - CS 137 1.54E 11 1.81E 11 1.28E 10 0.00E-01 4.85E 10 1.96E 10 5.65E 08 CS 138 2.55E-22 4.15E-22 2.01E-22 0.00E-01 2.07E-22 3.23E-23 6.63E-22 ' RA 139 5.30E-08 3.51E-11 1.53E-09 0.00E-01 2.11E-11 2.1?E-11 3.35E-06 A-97
TNIE A.5-20 (Otz:t'd) GRASSpT-MILK PATIMAY F1CIOR M MRDVYR PER UCI/SEC INFNfI' NUCLIDE DONE LIVER T BODY 'lHYROID KIDNEY LIR G GI-LLI BA 140 2.89E 07 2.89E 04 1.49E 06 0.00E-01 6.87E 03 1.78E 04 7.11E 06 BA 141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 PA 142 0.00E-01 0.00E-01 0.00E-01 0.002-01 0.00E-01 0.00E-01 0.00E-01 IA 140 4.88E 00 1.92E 00 4.94E-01 0.00E-01 0.00E-01 0.00E-01 2.26E 04 LA 142. 1.03E-11 3.78E-12 9.06E-13 0.00E-01 0.00E-01 0.00E-01 6.43E CE 141 5.20E 03 3.17E 03 3.74E 02 0.00E-01 9.79E 02 0.00E-01 1.64E 06 CE 143 4.76E 01 3.16E 04 3.61E 00 0.00E-01 9.21E 00 0.00E-01 1.84E 05 CE 144 2.79E 05 1.14E 05 1.56E 04 0.00E-01 4.62E 04 0.00E-01 1.60E 07 PR 143 1.78E 02 6.67E 01 0.84E 00 0.00E-01 2.48E 01 0.00E-01 9.41E 04 PR 144 0.00E-01 0.00E-01 0.00E-01 0.00E-01 C.00E-01 0.00E-0] 0.00E-01 ND 147 1.06E 02 1.09E 02 6.69E 00 0.00E-01 4.21E 01 0.00E-01 6.92E 04 W 187 7.35E 03 5.11E 03 1.77E 03 0.00E-01 0.00E-01 0.00E-01 3.00E 05 NP -239 4.38E 00 3.91E-01 2.21E-01 0.00E-01 7.80E-01 0.00E-01 1.13E 04 r_ mia A-98 ( l
i O APIM OIX B 1+3toorological Model O M
~
O
l l APPF2OIX B g) ( b PROPRIETARY D30FATION SUPPLIED BY SAI
'Ihe X/Q's and D/Q's are calculated using the guidance of Reg. Guide 1.111.
'Ihe constant man wind di.rection tedel, as defined in equation 3 of Reg. Guide 1.111, is used to calculated X/O values.
2 2 (X/Q)D
= n 2.032{3g)exp[-he /2 0 zj (x)]
NxU fg)(x) Where h e
= Effective release height (m). (All releases frun Nolf Creek Generating Station are considered as ground relmses therefore he = 0.)
= Hours of valid data for weathar corditions in given n)g direction, windspeed class 1, and atnospheric stability class j.
N = 'Ibtal hours of valid data IJ 1
= Midpoint of windspeed class (m/s) x =
Distance dowTraind (m)
= Vertical plum sped without volumetric correction at f)(x) distance x and stability class j. See Figte B.1 (x) = Vertical plume spread with columtric correction for release within buildings wake cavity, at distance x and stability class j.
For ground level releases (x) is the lesser of (c g) (x) + 0.5D / 7?- ) or
\f cjg) (x) l Where D
= FM im m adjacent bui] ding height either up-or down-wind fran the release point l
l OCCM B-2 k
O
-2.032 = (2/ .)
a 22.5 sector I divided by width, in radians, of y (X/Q)D
= Average effluent concentration, X, nornalized to source strength, Q, at distance x in Sector D.
For WCGS the above Meteoregical Mcriel will simplify to the following equation for X/Q: 2.032 i n (X/Q)D . NUx p (x)
- % calculation of the relative disposition per unit area, D/Q, is perfonned using the deposition rate graphs found in Reg. Guide 1.111. For a 22.5 sector, since the effluent concentration is assumed uniform across the sector, the relative deposition par unit area is assuned uniform across the sector.
'1he calculation of D/0 is determined frcxn relative deposition by the following relationship D/Q =- D f3 (x)
- DEPL f (x)
- (2 ,r/16) x V Whem:
D = Relative deposition rate for windspeed class i and f3(x) stability class j at downwud distance x (1/m). See Figure B.3. (2g16)x = Length of arc across sector at downwind distance x (m). D/O -= Relative deposition per unit area (m). DEPLg (x).= -Reduction factor due to plume depletion at distance x for windspeed i and stability class j.
1 Figure B.1 1000 i f r p- __ I f
/
Y
/
/ / /
l / / - r
} }
_/ - y
/ /
/ /
/ / /
A # 100 [ ' , f 7
/ '
/
/ / / f ^
)$2
/ ?l ? /^ ,~
s/ / )V _/ /t /~,/ s y / / 7 / / /
/
Qc i // / o ff ,
/ y
~
{ l
,/ , , ,
,/
U
/ l / / / /
s / / F/ / 10 ,- / / _m h i
/ - p '.- _ , _
1
/
'.,j / '
, j l ll
/ / / i ii
-! / / / l I
! ii ij
/ V f_ l )llk
/ / l llj
/, /
/
1
- 0.1 1.0 1a ~ }g 3 PLUME TRAVEL DISTANCE (KILor.1ETERS)
Vertical Standard Deviation of Materialin a Plume tLetters denote Pasqudi Stahdity Cl.ml NOTE: THESE ARE STANDARD RELA TION 0lttPS AND MAY H AVE TO RE, MOOlFIED FOR CER TAIN TYPCS Of TERnAIN AND/OR CLLMAItr CONOt t ONS E G., VAtt.E Y OESE R T. OVE R WATER). ODCM g _ ,g _ _ - _ _ _ _ _ _ _ . ..____________m- - . - _ _ _ - _ - _ _ _ _ _ _ _ _ _ _ _ _ _
>w,w - ~ u c- > .,..ss +r.si, -- ix.. ...--n.. saue - -ses.~. .-+s, +-4_
.a na. a. .s .s , sir as-, ~L_. Lu.,-s ~1 ->...sn+,>.amn..w.., n1sn.Jsru-r...a.,,.
2
-N I 8
m 4 o
/
~
ci
'M
/ o n
f
/
j
/
/
CC w b y w e
/ o -;
/ dO g-.2 eg . /-f-
/ I c
- co -
2 e ,/ ,< u. a.
,- g x
- tn
/ a J
W m Q C F-- w 2 O
-J E
C J m'
/
I
/
/
/
J l C
" O ci ci g- y ,r o
q o n 6 n I
- U ll'I Ill OfJifjpf gg gy 7 o l
.- . , .. . . . _ - . . . . . . . . . . ~ - - . . . . _ ~ ~ ~ . - . . . ~ . _ . . - ,-.. , - . . - . . . . . . . . ~ . - - ~ . . -
Figuro-B.3
. ',Q 10 r I
104 -s '
~ -s ,,
a-w 's, s s. _
" \
x N~ E
- \ ~
-p w N - l g i-2 O 10-5 N\ '
p ^x% i 1-4 ! , 2 m } '
- 4 6 1 4
s o
- a. .
N i i e i, i i w iN i i : I o ;j
-- s7 j N { l
..( $ 1
{ l I l l L E.
.a w
M-s1I i C _10-6 l
! a i . i +
i --% 1 10-7 0.1 1.0 10.0 100.0, 200.0 PLUME TRAVEL OtSTANCE (KILOMETERS) r-(. .ODCM B-6 L( . I l .,}}